None(e1,e2)	15	17	however , co-administration of duloxetine with aluminum- and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	40	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	4	7	single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .
None(e1,e2)	10	22	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate mofetil , and muromonab-cd3 .
None(e1,e2)	22	41	although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide , these disturbances have been reported with oral carbonic_anhydrase_inhibitors and have , in some instances , resulted in drug interactions ( e.g. , toxicity associated with high-dose salicylate therapy ) .
None(e1,e2)	18	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	43	quinidine : coadministration of a 10-mg single dose of aripiprazole with quinidine ( 166 mg/day for 13 days ) , a potent inhibitor of cyp2d6 , increased the auc of aripiprazole by 112 % but decreased the auc of its active metabolite , dehydroaripiprazole , by 35 % .
None(e1,e2)	0	23	aprepitant is unlikely to interact with drugs that are substrates for the p-glycoprotein transporter , as demonstrated by the lack of interaction of aprepitant with digoxin in a clinical drug interaction study .
None(e1,e2)	48	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	3	11	potassium supplements and potassium-sparing_diuretics lotensin can attenuate potassium loss caused by thiazide_diuretics .
None(e1,e2)	19	21	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	0	9	analgesic /anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	9	11	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	48	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	4	8	the concomitant administration of quinolones including norfloxacin with glyburide ( a sulfonylurea agent ) has , on rare occasions , resulted in severe hypoglycemia .
None(e1,e2)	9	11	additive depressant effect when used with general anesthetics , sedatives , antianxiety_drugs , hypnotics , alcohol , and other opiate analgesics .
effect(e1,e2)	4	8	the concurrent use of robinul injection with other anticholinergics or medications with anticholinergic activity , such as phenothiazines , antiparkinson drugs , or tricyclic antidepressants , may intensify the antimuscarinic effects and may result in an increase in anticholinergic side effects .
None(e1,e2)	8	10	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa reductase inhibitor .
None(e1,e2)	3	16	patients receiving other narcotic_analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	19	22	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic_agents such as quinidine and procainamide , cardiac glycosides and tricyclic anti-depressants .
None(e1,e2)	33	39	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic_antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	0	13	irinotecan concentrations were similar in patients receiving bolus-ifl alone and in combination with avastin .
None(e1,e2)	10	22	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	11	21	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	33	49	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	4	6	hmg-coa reductase inhibitors : lovastatin , simvastatin warning potential for serious reactions such as risk of myopathy including rhabdomyolysis .
None(e1,e2)	2	4	if replacing clonidine by beta-blocker therapy , the introduction of beta blockers should be delayed for several days after clonidine administration has stopped .
None(e1,e2)	59	83	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	15	other drug interactions cimetidine , erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of mhd .
None(e1,e2)	0	4	rifampin : co-administration of vioxx with rifampin 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50 % decrease in rofecoxib plasma concentrations .
None(e1,e2)	0	8	aminoglycosides : the mixing of piperacillin with an aminoglycoside in vitro can result in substantial inactivation of the aminoglycoside .
effect(e1,e2)	10	18	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
None(e1,e2)	10	26	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton_pump_inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	4	22	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	4	13	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	26	32	limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50 % for the first sixty ( 60 ) minutes following alfenta induction the concomitant use of erythromycin with alfenta can significantly inhibit alfenta clearance and may increase the risk of prolonged or delayed respiratory depression .
None(e1,e2)	22	49	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
effect(e1,e2)	2	8	meperidine : amphetamines potentiate the analgesic effect of meperidine .
None(e1,e2)	7	22	inhibitors of this isoenzyme ( e.g. , macrolide_antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	0	12	methotrexate : caution should be used if diflunisal is administered concomitantly with methotrexate .
None(e1,e2)	21	70	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide_antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	4	18	antacids : administration of flurbiprofen to volunteers under fasting conditions , or with antacid suspension yielded similar serum flurbiprofen time profiles in young subjects ( n=12 ) .
effect(e1,e2)	1	9	oral neomycin_sulfate may enhance the effect of coumarin in anticoagulants by decreasing vitamin k availability .
None(e1,e2)	14	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	10	15	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
mechanism(e1,e2)	18	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	49	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	9	29	however , co-administration of duloxetine with aluminum- and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	6	69	cancidas reduced the blood auc0-12 of tacrolimus by approximately 20 % , peak blood concentration ( cmax ) by 16 % , and 12-hour blood concentration ( c12hr ) by 26 % in healthy subjects when tacrolimus ( 2 doses of 0.1 mg/kg 12 hours apart ) was administered on the 10th day of cancidas 70 mg daily , as compared to results from a control period in which tacrolimus was administered alone .
None(e1,e2)	4	8	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	40	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	7	12	inducers and inhibitors of hepatic metabolism : rifampin reduced plasma concentrations of carvedilol by about 70 % .
None(e1,e2)	33	36	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	18	53	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	36	40	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	31	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	28	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone/ ethinyl_estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	24	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	42	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
advise(e1,e2)	6	28	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin_b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	2	7	warfarin : meclofenamate_sodium enhances the effect of warfarin .
None(e1,e2)	36	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	21	41	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
effect(e1,e2)	1	3	since indomethacin and potassium-sparing_diuretics , including midamor , may each be associated with increased serum potassium levels , the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently .
None(e1,e2)	12	24	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
mechanism(e1,e2)	5	26	in vitro data suggest that itraconazole , when compared to ketoconazole , has a less pronounced effect on the biotransformation system responsible for the metabolism of astemizole .
None(e1,e2)	2	5	isoflurane , enflurane , and halothane decrease the ed50 of nuromax by 30 % to 45 % .
None(e1,e2)	27	40	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
advise(e1,e2)	24	27	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
None(e1,e2)	0	29	probenecid : probenecid , a renal tubular secretion blocking agent , administered at a dose of 500 mg four times a day , did not change the pharmacokinetics of levetiracetam 1000 mg twice daily .
None(e1,e2)	14	22	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease_inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	19	21	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	16	19	although not studied systematically in clinical trials , no drug interactions were observed when vecuronium , pancuronium , or atracurium were administered following varying degrees of recovery from single doses or infusions of nimbex .
None(e1,e2)	32	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	12	amiodarone or verapamil : the risk of myopathy/rhabdomyolysis is increased when either amiodarone or verapamil is used concomitantly with a closely related member of the hmg-coa reductase inhibitor class ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	7	12	aspirin : concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations , peak plasma levels , and auc values .
None(e1,e2)	5	21	therefore , intake of supplemental folic_acid should not exceed 1000 micrograms ( g , sometimes mcg ) per day to prevent folic_acid from masking symptoms of vitamin b12 deficiency .
None(e1,e2)	7	15	other drug interactions cimetidine , erythromycin and dextropropoxyphene had no effect on the pharmacokinetics of mhd .
None(e1,e2)	16	22	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin_sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	20	39	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine_oxidase_inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	45	55	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	35	37	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	36	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	21	23	the clinical significance of this reduction is not known , hence zalcitabine is not recommended to be ingested simultaneously with magnesium/ aluminum -containing antacids .
None(e1,e2)	12	18	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	4	27	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	5	10	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
None(e1,e2)	9	18	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	5	12	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	30	35	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	14	50	in another study , toradoliv/im was given with two doses of 5000 u of heparin to 11 healthy volunteers , resulting in a mean template bleeding time of 6.4 minutes ( 3.2 to 11.4 min ) compared to a mean of 6.0 minutes ( 3.4 to 7.5 min ) for heparin alone and 5.1 minutes ( 3.5 to 8.5 min ) for placebo .
None(e1,e2)	46	60	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	13	20	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac_tromethamine protein binding .
None(e1,e2)	14	16	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	31	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	16	when concomitant treatment with agents with b-blocking properties and clonidine is to be terminated , the b-blocking_agent should be discontinued first .
None(e1,e2)	19	86	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	37	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	30	lithium - coadministration of racemic citalopram ( 40 mg/day for 10 days ) and lithium ( 30 mmol/day for 5 days ) had no significant effect on the pharmacokinetics of citalopram or lithium .
None(e1,e2)	42	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	23	27	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao_inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
mechanism(e1,e2)	33	42	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic_acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	14	17	hemodynamic and electrophysiologic interactions have also been observed after concomitant administration with propranolol , diltiazem , and verapamil .
None(e1,e2)	15	29	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	20	24	it is recommended that buspirone hydrochloride not be used concomitantly with mao inhibitors because the effects of concomitant administration of buspirone_hcl with most other psychotropic_drugs have not been studied , the concomitant use of buspirone hcl with other cns-active drugs should be approached with caution .
mechanism(e1,e2)	16	32	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	40	42	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking_agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	4	12	antacids ( aluminum- or magnesium -containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
None(e1,e2)	7	20	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac_tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	26	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	13	23	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
mechanism(e1,e2)	5	15	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination_hormonal_contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	73	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	9	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	0	11	ketamine is clinically compatible with the commonly used general and local anesthetic_agents when an adequate respiratory exchange is maintained .
None(e1,e2)	28	33	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	30	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	87	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	16	lotensin has been used concomitantly with beta-adrenergic-blocking_agents , calcium-channel-blocking agents , diuretics , digoxin , and hydralazine , without evidence of clinically important adverse interactions .
None(e1,e2)	2	4	antiarrhythmics : bepridil , lidocaine ( systemic ) and quinidine
None(e1,e2)	15	42	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	22	27	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	12	15	amiodarone may suppress certain cyp450 enzymes , including cyp1a2 , cyp2c9 , cyp2d6 , and cyp3a4 .
advise(e1,e2)	7	19	monoamine oxidase inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine_oxidase_inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	8	32	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	7	9	drug-drug interactions have not been observed between argatroban and digoxin or erythromycin .
None(e1,e2)	6	19	magnesium/aluminum-containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/aluminum-containing antacid_products .
None(e1,e2)	13	19	there have been no reported cases from spontaneous reports of drug interaction between ssris and d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp .
None(e1,e2)	21	86	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	3	14	symptoms resolved when clonidine was withdrawn and recurred when the patient was rechallenged with clonidine .
None(e1,e2)	42	44	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	46	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	35	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
int(e1,e2)	60	62	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin_b12 and folic_acid .
None(e1,e2)	0	2	pegasys contains benzyl_alcohol .
None(e1,e2)	29	34	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	75	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	34	41	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	2	13	interactions for vitamin_d_analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	0	5	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
None(e1,e2)	8	10	these medications have included heparin , warfarin , beta-adrenergic_receptor_blockers , calcium_channel_antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	107	160	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	12	14	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	59	63	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	11	16	there are reports of enhanced as well as diminished effects of anticoagulants when given concurrently with corticosteroids .
mechanism(e1,e2)	25	32	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
advise(e1,e2)	3	5	thus , when nsaids and lithium are administered concurrently , subjects should be observed carefully for signs of lithium toxicity .
advise(e1,e2)	13	18	although the clinical significance is not known , it is not recommended that cefditoren_pivoxil be taken concomitantly with antacids .
None(e1,e2)	5	45	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	17	70	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide_antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
effect(e1,e2)	17	27	although there are no study data to evaluate the possibility , nitric oxide donor compounds , including sodium_nitroprusside and nitroglycerin , may have an additive effect with inomax on the risk of developing methemoglobinemia .
None(e1,e2)	11	13	in study 1 , patients with colorectal cancer were given irinotecan/ 5-fu / leucovorin ( bolus-ifl ) with or without avastin .
None(e1,e2)	8	14	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .
mechanism(e1,e2)	9	14	the concomitant use of other cyp3a4 inhibitors such as diltiazem and erythromycin with transdermal fentanyl may also result in an increase in fentanyl plasma concentrations , which could increase or prolong adverse drug effects and may cause serious respiratory depression .
None(e1,e2)	23	113	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	13	19	other cyp3a4 inducers include , but are not limited to , rifabutin , rifapentine , phenytoin , carbamazepine , phenobarbital and st. johns wort .
None(e1,e2)	45	55	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	11	13	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	25	26	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal_contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	67	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	6	potassium-sparing_diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	22	34	at 24 hours postdose , a similar proportion of patients treated with methotrexate alone ( 94 % ) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib ( 88 % ) had methotrexate plasma concentrations below the measurable limit ( 5 ng/ml ) .
None(e1,e2)	0	2	antacid ( magnesium-aluminum_hydroxide ) : cerivastatin plasma concentrations were not affected by co-administration of antacid .
effect(e1,e2)	4	17	in patients receiving nonselective monoamine_oxidase_inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic_agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	0	39	theophylline vioxx 12.5 , 25 , and 50 mg administered once daily for 7 days increased plasma theophylline concentrations ( auc ( 0- ) ) by 38 to 60 % in healthy subjects administered a single 300-mg dose of theophylline .
None(e1,e2)	26	40	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	11	16	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	15	29	in a single subject given one dose of ciprofloxacin 2 hours after a dose of didanosine -placebo tablets , a greater than 50 % reduction in the auc of ciprofloxacin was observed .
None(e1,e2)	0	41	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	13	15	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
None(e1,e2)	12	37	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	5	7	it may increase excretion of barbiturates , lithium , and asa and may also increase the toxicity of salicylates .
mechanism(e1,e2)	6	15	methotrexate : ketoprofen , like other nsaids , may cause changes in the elimination of methotrexate leading to elevated serum levels of the drug and increased toxicity .
None(e1,e2)	4	15	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
None(e1,e2)	40	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	40	60	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	5	7	amphotericin b or corticosteroids or corticotropin ( acth )
None(e1,e2)	0	9	ampicillin : in a study of healthy volunteers , chloroquine significantly reduced the bioavailability of ampicillin .
None(e1,e2)	11	42	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	31	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	12	21	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	0	6	rifampin : coadministration of rifampin and mepron suspension results in a significant decrease in average steady- state plasma atovaquone concentrations .
None(e1,e2)	13	27	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium_channel_blocking_drugs , and isoniazid .
mechanism(e1,e2)	5	12	products containing calcium and other multivalent_cations likely will interfere with absorption of alendronate .
None(e1,e2)	44	49	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	46	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	120	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	7	amphotericin_b injection and potassium-depleting agents : when corticosteroids are administered concomitantly with potassium-depleting agents ( e.g. , amphotericin b , diuretics ) , patients should be observed closely for development of hypokalemia .
None(e1,e2)	46	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	23	the extent to which ssri -tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
None(e1,e2)	3	26	in patients receiving nalfon and a steroid concomitantly , any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal .
None(e1,e2)	18	20	another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl_estradiol and levonorgestrel ( cyp3a4 substrates ) .
None(e1,e2)	3	7	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	13	18	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	7	11	example inducers include aminoglutethimide , carbamazepine , nafcillin , nevirapine , phenobarbital , phenytoin , and rifamycins .
None(e1,e2)	14	18	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide_diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	19	60	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
mechanism(e1,e2)	2	11	cimetidine , caffeine , and erythromycin may increase plasma levels of clozapine , potentially resulting in adverse effects .
None(e1,e2)	7	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	15	17	however , it adversely affected response duration suggesting that pyridoxine should not be administered with hexalen and/or cisplatin .1
None(e1,e2)	8	12	oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic_agents , eg , tolbutamide and chlorpropamide , by inhibiting their metabolism in the liver .
None(e1,e2)	23	28	since amiodarone is a substrate for cyp3a4 , there is the potential that the use of st. john s wort in patients receiving amiodarone could result in reduced amiodarone levels .
None(e1,e2)	0	27	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
None(e1,e2)	69	91	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	8	15	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum_hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
effect(e1,e2)	11	18	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
mechanism(e1,e2)	18	45	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	2	atorvastatin : atorvastatin increases the auc for norethindrone and ethinyl estradiol .
None(e1,e2)	34	40	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
mechanism(e1,e2)	12	27	because anafranil is highly bound to serum protein , the administration of anafranil to patients taking other drugs that are highly bound to protein ( e.g. , warfarin , digoxin ) may cause an increase in plasma concentrations of these drugs , potentially resulting in adverse effects .
None(e1,e2)	76	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	30	toxicology studies of heroin-related deaths reveal frequent involvement of other central_nervous_system_depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	8	14	the concurrent use of intravenously or orally administered methylxanthines ( e.g. , aminophylline , theophylline ) by patients receiving brovana has not been completely evaluated .
None(e1,e2)	7	17	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist_analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	2	18	carbamazepine : felbatol causes a decrease in the steady-state carbamazepine plasma concentrations and an increase in the steady-state carbamazepine_epoxide plasma concentration .
None(e1,e2)	11	22	erythromycin ( 500 mg t.i.d ) produced a 4-fold increase in vardenafil auc and a 3-fold increase in cmax when co-administered with vardenafil 5 mg in healthy volunteers .
None(e1,e2)	52	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	11	13	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	14	18	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
effect(e1,e2)	2	30	isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	0	2	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
None(e1,e2)	3	27	when bezalip or bezalip_retard is used at the same time as other medicines or substances the following interactions must be taken into account : - bezalip and bezalip_retard may enhance the action of anticoagulants of the coumarin type .
effect(e1,e2)	6	21	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	47	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	22	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	4	47	in vivo studies : nitrates : the blood pressure lowering effects of sublingual nitrates ( 0.4 mg ) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1 , 4 and 8 hours were potentiated by a 20 mg dose of vardenafil in healthy middle-aged subjects .
None(e1,e2)	1	21	when cholestyramine resin is given for long periods of time , concomitant supplementation with water-miscible ( or parenteral ) forms of fat-soluble_vitamins should be considered .
effect(e1,e2)	4	21	renal clearance measurements of pah can not be made with any significant accuracy in patients receiving sulfonamides , procaine , or thiazolesulfone .
None(e1,e2)	2	18	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
None(e1,e2)	9	11	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic_antidepressants or sympathomimetic_agents ;
None(e1,e2)	28	79	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	37	53	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	23	25	exposure from the proposed topical dose is about 1 % of that from the 100 mg oral dose , even when co-administered with tmp / smx .
None(e1,e2)	0	13	aspirin /acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
mechanism(e1,e2)	16	36	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	110	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	25	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
mechanism(e1,e2)	6	19	phenytoin : altered serum levels of phenytoin ( increased and decreased ) have been reported in patients receiving concomitant ciprofloxacin .
None(e1,e2)	18	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	57	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	15	18	insulin or oral hypoglycemics : agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
None(e1,e2)	10	14	there was no effect on the 3 major metabolites ( 5-dfur , 5-fu and fbal ) .
None(e1,e2)	44	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	15	may interact with cefamandole naftate , cephalothin sodium , magnesium sulfate , prednisolone_sodium_succinate , and prochlorperazine_edisylate .
None(e1,e2)	15	19	the following drugs have been coadministered with kerlone and have not altered its pharmacokinetics : cimetidine , nifedipine , chlorthalidone , and hydrochlorothiazide .
None(e1,e2)	23	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	4	10	nonsteroidal anti-inflammatory agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal antiinflammatory agents ) and corticosteroids increases the risk of gastrointestinal side effects .
None(e1,e2)	39	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	40	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	17	31	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	4	11	while all the selective serotonin_reuptake_inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
effect(e1,e2)	6	15	literature reports indicate that coadministration of indomethacin may reduce the natriuretic and antihypertensive effects of furosemide in some patients by inhibiting prostaglandin synthesis .
None(e1,e2)	25	29	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	6	8	dextromethorphan is a substrate for both cyp2d6 and cyp3a4 .
None(e1,e2)	102	145	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	19	levothyroxine_sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum_hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	9	27	in one survey , 2.3 % of patients taking labetalol_hcl in combination with tricyclic antidepressants experienced tremor , as compared to 0.7 % reported to occur with labetalol_hcl alone .
None(e1,e2)	94	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	50	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	35	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	17	45	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	7	theophylline : the pharmacokinetics of theophylline ( aminophylline 5.8 mg/kg infused over 20 minutes ) were unchanged following a single oral dose of albendazole ( 400 mg ) in 6 healthy subjects .
None(e1,e2)	2	14	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	12	21	antihypertensives : amiodarone should be used with caution in patients receiving - receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	94	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	66	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	5	26	because of the potential for arava levels to continue to increase with multiple dosing , caution should be used if patients are to be receiving both arava and rifampin .
None(e1,e2)	12	14	oral contraceptives : the effect of oral contraceptives on the pharmacokinetics of d.h.e_._45 ( dihydroergotamine_mesylate ) injection , usp has not been studied .
None(e1,e2)	3	14	hypotension patients on diuretic therapy : patients on diuretics and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril .
None(e1,e2)	57	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	4	16	the hypotensive effect of sodium_nitroprusside is augmented by that of most other hypotensive drugs , including ganglionic_blocking_agents , negative inotropic agents , and inhaled anesthetics .
None(e1,e2)	5	28	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable/dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
None(e1,e2)	0	5	cyclosporin : reports indicate that cyclosporine levels may be increased during concomitant treatment with allopurinol sodium for injection .
None(e1,e2)	6	8	- vitamin k ( e.g. , aquamephyton , synkayvite ) use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood
None(e1,e2)	33	41	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	15	47	in a phase i trial using escalating doses of taxol ( 110-200 mg/m2 ) and cisplatin ( 50 or 75 mg/m2 ) given as sequential infusions , myelosuppression was more profound when taxol was given after cisplatin than with the alternate sequence ( ie , taxol before cisplatin ) .
None(e1,e2)	21	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	57	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	anticonvulsants ( phenytoin ) : steady state plasma exposure ( auc ) of valdecoxib ( 40 mg bid for 12 days ) was decreased by 27 % when co-administered with multiple doses ( 300 mg qd for 12 days ) of phenytoin ( a cyp 3a4 inducer ) .
None(e1,e2)	55	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	26	34	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	2	28	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	4	11	co-administration of warfarin and cerivastatin did not alter the pharmacokinetics of cerivastatin_sodium .
None(e1,e2)	15	16	non-steroidal anti-inflammatory agents : seizures have been reported in patients taking enoxacin concomitantly with the nonsteroidal_anti-inflammatory_drug fenbufen .
None(e1,e2)	68	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
advise(e1,e2)	2	17	a 5-mg vardenafil dose should not be exceeded when used in combination with 200 mg once daily ketoconazole .
advise(e1,e2)	34	48	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot_alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	0	2	pyrazolone_derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
None(e1,e2)	6	21	there is limited experience with concomitant antihypertensive_agents such as alpha-blockers , calcium channel-blockers , ace inhibitors , and diuretics ( both thiazide -like and loop ) .
None(e1,e2)	23	27	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
mechanism(e1,e2)	11	17	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
None(e1,e2)	31	37	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic_agents , such as disopyramide , are used concurrently .
effect(e1,e2)	13	36	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium_channel_blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	0	8	diltiazem plasma levels were not significantly affected by lovastatin or pravastatin .
None(e1,e2)	39	46	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	10	the pharmacokinetics of benzodiazepines are unaltered in the presence of flumazenil and vice versa .
None(e1,e2)	39	41	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	16	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	8	22	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	6	33	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	4	sumatriptan and d.h.e_._45 ( dihydroergotamine_mesylate ) injection , usp should not be taken within 24 hours of each other..
None(e1,e2)	16	18	close supervision and careful adjustment of dosage are required when this drug is given concomitantly with anticholinergic or sympathomimetic_drugs .
None(e1,e2)	6	8	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron-containing preparations .
None(e1,e2)	6	12	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	45	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	27	terfenadine : no clinically significant changes occurred in heart rate or corrected qt intervals , or in terfenadine metabolite or lomefloxacin pharmacokinetics , during concurrent administration of lomefloxacin and terfenadine at steady-state in 28 healthy males .
mechanism(e1,e2)	7	11	a case report of one patient taking amiodarone 200 mg and indinavir 800 mg three times a day resulted in increases in amiodarone concentrations from 0.9 mg/l to 1.3 mg/l .
None(e1,e2)	5	23	use in conjunction with other antiepileptic_drugs : the addition of felbatol to antiepileptic drugs ( aeds ) affects the steady-state plasma concentrations of aeds .
None(e1,e2)	27	32	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	20	25	clinical studies in healthy volunteers show that the pharmacokinetics of cancidas are not altered by itraconazole , amphotericin b , mycophenolate , nelfinavir , or tacrolimus .
None(e1,e2)	30	39	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic_acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	0	18	protease_inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination_hormonal_contraceptives ;
None(e1,e2)	0	2	ampicillin / amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
None(e1,e2)	28	36	several tricyclic antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic_antidepressants .
None(e1,e2)	16	21	coumarin anticoagulants altered coagulation parameters and/or bleeding have been reported in patients taking capecitabine concomitantly with coumarin-derivative_anticoagulants such as warfarin and phenprocoumon .
None(e1,e2)	4	14	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	41	45	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	0	9	antihypertensive_medications , other , especially diazoxide , or pre anesthetic and anesthetic agents used in surgery or skeletal-muscle relaxants , nondepolarizing , used in surgery
None(e1,e2)	3	32	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
None(e1,e2)	11	23	acetaminophen : in normal volunteers , concomitant administration of diflunisal and acetaminophen resulted in an approximate 50 % increase in plasma levels of acetaminophen .
None(e1,e2)	26	76	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	28	138	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	70	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	12	18	such individuals are referred to as poor metabolizers of drugs such as debrisoquin , dextromethorphan , and the tricyclic_antidepressants .
effect(e1,e2)	7	15	tissue culture and animal studies indicate that elspar can diminish or abolish the effect of methotrexate on malignant cells.14 this effect on methotrexate activity persists as long as plasma asparagine levels are suppressed .
None(e1,e2)	0	10	antidepressants , tricyclic : amphetamines may enhance the activity of tricyclic or sympathomimetic agents ;
None(e1,e2)	21	27	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	4	24	these data indicate that levetiracetam does not influence the plasma concentration of other aeds and that these aeds do not influence the pharmacokinetics of levetiracetam .
None(e1,e2)	5	38	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin_b .
None(e1,e2)	27	33	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	8	12	in patients taking an anticonvulsant ( eg , valproic_acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	9	11	in patients receiving a potent cyp3a4 inducer such as rifampicin or phenytoin , a dose increase to 500 mg daily should be considered in the absence of severe adverse drug reaction , and clinical response and adverse events should be carefully monitored ( see clinical pharmacology-pharmacokinetics-drug-drug interactions and dosage and administration-dosage adjustment sections ) .
None(e1,e2)	3	12	in patients receiving nalfon and a steroid concomitantly , any reduction in steroid dosage should be gradual in order to avoid the possible complications of sudden steroid withdrawal .
None(e1,e2)	0	4	estrogens , including oral contraceptives : estrogens may decrease the hepatic metabolism of certain corticosteroids , thereby increasing their effect .
None(e1,e2)	11	15	it is recommended that the combination of intravenous dantrolene sodium and calcium_channel_blockers , such as verapamil , not be used together during the management of malignant hyperthermia crisis until the relevance of these findings to humans is established .
None(e1,e2)	2	14	coadministration of digoxin did not have effects on either the safety or efficacy of ibutilide in the clinical trials .
None(e1,e2)	3	31	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	2	25	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
None(e1,e2)	9	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	9	19	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	3	23	example inhibitors include azole_antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	39	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	4	21	animal experience indicates that clorazepate_dipotassium prolongs the sleeping time after hexobarbital or after ethyl alcohol , increases the inhibitory effects of chlorpromazine , but does not exhibit monoamine oxidase inhibition .
None(e1,e2)	0	13	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
effect(e1,e2)	0	18	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	11	19	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
None(e1,e2)	24	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	13	58	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic_acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	69	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	22	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns_depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	19	22	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns_depressants ( including alcohol ) has additive depressant effects .
mechanism(e1,e2)	25	42	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	4	24	the resulting increase in nitrofurantoin serum levels may increase toxicity , and the decreased urinary levels could lessen its efficacy as a urinary tract antibacterial .
None(e1,e2)	0	15	digoxin : concomitant administration of erythromycin and digoxin has been reported to result in elevated digoxin serum levels .
None(e1,e2)	40	44	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	32	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
mechanism(e1,e2)	0	2	histamine_h2_antagonists : cimetidine inhibits cyp3a4 and can increase serum amiodarone levels .
None(e1,e2)	2	11	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	11	13	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	15	26	in general , these are drugs that have one or more pharmacologic activities similar to bepridil_hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac_glycosides and tricyclic anti-depressants .
None(e1,e2)	1	9	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	11	30	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	16	18	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin_sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	0	12	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	12	45	however , in another study in healthy volunteers , the pharmacokinetics of butorphanol were significantly altered ( 29 % decrease in auc and 38 % decrease in cmax ) when a 1-mg dose of stadol ns was administered 1 minute after a 20-mg dose of sumatriptan nasal spray .
None(e1,e2)	7	32	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	2	43	pimozide and celexa - in a controlled study , a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in qtc values of approximately 10 msec compared to pimozide given alone .
None(e1,e2)	33	79	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
None(e1,e2)	21	46	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	28	46	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	10	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	18	in addition , certain drugs that are metabolized by this isoenzyme , including many antidepressants ( tricyclic_antidepressants , selective_serotonin_reuptake_inhibitors , and others ) , may inhibit the activity of this isoenzyme , and thus may make normal metab-olizers resemble poor metabolizers with regard to concomitant therapy with other drugs metabolized by this enzyme system , leading to drug interactions .
None(e1,e2)	8	25	experience with co-administration of hmg-coa reductase inhibitors and fentanyl in patients is limited , therefore , consideration should be given to temporarily suspending use of hmg-coa_reductase_inhibitors in patients receiving fentanyl .
mechanism(e1,e2)	2	4	co-administration of tikosyn with verapamil resulted in increases in dofetilide peak plasma levels of 42 % , although overall exposure to dofetilide was not significantly increased .
None(e1,e2)	3	15	antipyrine : because atorvastatin does not affect the pharmacokinetics of antipyrine , interactions with other drugs metabolized via the same cytochrome isozymes are not expected .
None(e1,e2)	8	10	however , co-administration of duloxetine with aluminum- and magnesium -containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	17	32	rifampin : following concomitant administration of a single dose of arava to subjects receiving multiple doses of rifampin , m1 peak levels were increased ( ~40 % ) over those seen when arava was given alone .
None(e1,e2)	15	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	2	loop_diuretics : furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients .
None(e1,e2)	0	20	cyclosporine : elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone_class .
None(e1,e2)	46	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	46	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	45	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	59	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	12	there is one report suggesting that the concomitant use of trazodone_hydrochloride ( desyrel ) and buspirone hcl may have caused 3- to 6-fold elevations on sgpt ( alt ) in a few patients .
None(e1,e2)	0	41	ritonavir - combined administration of a single dose of ritonavir ( 600 mg ) , both a cyp3a4 substrate and a potent inhibitor of cyp3a4 , and escitalopram ( 20 mg ) did not affect the pharmacokinetics of either ritonavir or escitalopram .
None(e1,e2)	0	2	aspirin : vardenafil ( 10 mg and 20 mg ) did not potentiate the increase in bleeding time caused by aspirin ( two 81 mg tablets ) .
effect(e1,e2)	6	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	74	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	2	16	lithium : nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .
None(e1,e2)	45	51	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	1	10	anesthetics/ sedatives /hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	31	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	53	55	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	13	34	in a parallel group drug interaction study comparing the intravenous prodrug form of valdecoxib at 40 mg bid ( n=10 ) vs placebo ( n=9 ) , valdecoxib had no effect on in vitro aspirin -mediated inhibition of arachidonate- or collagen-stimulated platelet aggregation .
None(e1,e2)	51	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	19	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	28	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	19	20	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type_1c_antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	66	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	5	7	potassium-sparing diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	2	26	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	40	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	7	33	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	2	11	effects of lapatinib on drug metabolizing enzymes and drug transport systems lapatinib inhibits cyp3a4 and cyp2c8 in vitro at clinically relevant concentrations .
None(e1,e2)	49	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	43	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	9	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
effect(e1,e2)	14	34	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	8	18	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	30	39	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	11	19	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
advise(e1,e2)	1	23	these antibiotics should be used in the myasthenic patient only where definitely indicated , and then careful adjustment should be made of adjunctive anticholinesterase dosage .
None(e1,e2)	9	17	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	107	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	23	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace_inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	0	4	aspirin , warfarin , heparin , nsaids
None(e1,e2)	13	41	neuromuscular blockers : in one study of 10 healthy volunteers , administration of precedex for 45 minutes at a plasma concentration of 1 ( one ) ng/ml resulted in no clinically meaningful increases in the magnitude or neuromuscular blockade associated with rocuronium administration .
None(e1,e2)	27	37	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	0	21	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
mechanism(e1,e2)	2	4	coadministration of itraconazole and cyclosporine , tacrolimus or digoxin has led to increased plasma concentrations of the latter three drugs .
None(e1,e2)	28	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	18	31	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	13	17	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
None(e1,e2)	0	23	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists_.
None(e1,e2)	54	63	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	38	90	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	9	tambocor has been administered to patients receiving digitalis_preparations or beta-adrenergic_blocking_agents without adverse effects .
effect(e1,e2)	0	18	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	1	25	phenytoin/ phenobarbital : the coadministration of phenytoin or phenobarbital will not affect plasma concentrations of vitamin d , but may reduce endogenous plasma levels of calcitriol /ergocalcitriol by accelerating metabolism .
effect(e1,e2)	6	11	the potential for increased sedation when guanfacine is given with other cns-depressant_drug should be appreciated .
None(e1,e2)	35	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	30	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
advise(e1,e2)	6	25	therefore , it is recommended that fluvoxamine tablets not be used in combination with maois , or within 14 days of discontinuing treatment with a maoi .
None(e1,e2)	18	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	79	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	1	10	intravenous ranitidine was shown to double the bioavailability of oral alendronate .
None(e1,e2)	0	5	antacids : concomitant administration of magnesium_hydroxide and aluminum hydroxide does not interfere with the rate or extent of the absorption of ketoprofen administered as orudis .
None(e1,e2)	26	39	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	36	60	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
advise(e1,e2)	1	22	since apraclonidine may reduce pulse and blood pressure , caution in using drugs such as beta-blockers ( ophthalmic and systemic ) , antihypertensives , and cardiac glycosides is advised .
None(e1,e2)	96	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	7	20	in addition , the beneficial effects of levodopa in parkinsons disease have been reported to be reversed by phenytoin and papaverine .
effect(e1,e2)	6	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	2	oral contraceptives rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and norethindrone .
None(e1,e2)	8	10	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	4	13	therefore , administration of quinolones with antacids containing calcium , magnesium , or aluminum ;
None(e1,e2)	24	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	69	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	85	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	19	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	2	25	tolbutamide : aprepitant , when given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , decreased the auc of tolbutamide ( a cyp2c9 substrate ) by 23 % on day 4 , 28 % on day 8 , and 15 % on day 15 , when a single dose of tolbutamide 500 mg was admini , stered orally prior to the administration of the 3-day regimen of aprepitant and on days 4,8 , and 15 .
None(e1,e2)	25	27	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
None(e1,e2)	49	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	8	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	0	20	intestinal_adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	71	75	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone_anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	0	8	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	12	20	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	27	33	however , in a well-controlled study of patients with lymphoma on combination therapy , allopurinol did not increase the marrow toxicity of patients treated with cyclophosphamide , doxorubicin , bleomycin , procarbazine and/or mechlorethamine .
None(e1,e2)	40	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	22	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	0	8	tolbutamide : in diabetic patients receiving diflunisal and tolbutamide , no significant effects were seen on tolbutamide plasma levels or fasting blood glucose .
effect(e1,e2)	10	22	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	18	35	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	19	22	the following drugs have been coadministered with kerlone and have not altered its pharmacokinetics : cimetidine , nifedipine , chlorthalidone , and hydrochlorothiazide .
None(e1,e2)	0	14	non-steroidal_anti-inflammatory_agents : in some patients with compromised renal function who are being treated with non-steroidal_anti-inflammatory_drugs , the co-administration of lisinopril may result in a further deterioration of renal function .
None(e1,e2)	22	43	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate_hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic_antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	40	50	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot_derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	1	5	- furazolidone ( e.g. , furoxone ) or
None(e1,e2)	10	12	calcium channel blockers , dihydropyridine : e.g. , felodipine , nifedipine , nicardipine
None(e1,e2)	14	16	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	4	10	if replacing clonidine by beta-blocker therapy , the introduction of beta_blockers should be delayed for several days after clonidine administration has stopped .
None(e1,e2)	75	81	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	2	cyclosporin , tacrolimus , sirolimus
None(e1,e2)	69	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	2	8	cimetidine : cimetidine can inhibit the metabolism of chloroquine , increasing its plasma level .
None(e1,e2)	26	45	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	10	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	5	12	concomitant single dose administration of valdecoxib 20 mg with multiple doses of ketoconazole and fluconazole produced a significant increase in exposure of valdecoxib .
effect(e1,e2)	28	50	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	2	13	- a monoamine_oxidase_inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
advise(e1,e2)	4	30	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	47	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	17	22	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and naratriptan within 24 hours is contraindicated .
None(e1,e2)	35	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	22	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	21	a possible interaction has been suggested with hormonal_contraceptives and the herbal supplement st. johns wort based on some reports of oral contraceptive users experiencing breakthrough bleeding shortly after starting st. johns wort .
None(e1,e2)	16	24	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	19	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
mechanism(e1,e2)	2	14	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	9	19	intestinal adsorbents ( e. g. , charcoal ) and digestive_enzyme_preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	18	24	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	47	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	13	45	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum_hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	14	21	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta_blockers .
None(e1,e2)	55	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	14	30	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	45	85	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	23	nicardipine_hcl usually does not alter the plasma levels of digoxin , however , serum digoxin levels should be evaluated after concomitant therapy with nicardipine_hcl is initiated .
None(e1,e2)	62	126	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	15	28	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	10	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	48	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	36	38	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	7	17	the elimination half life of midazolam and triazolam also increased ( 1.5-2.5 fold ) during coadministration with diltiazem .
advise(e1,e2)	14	22	due to a theoretical risk of a pharmacodynamic interaction , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and frova within 24 hours of each other should be avoided ( see a href= frova_od.htm # ci contraindications ) .
None(e1,e2)	32	59	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	0	19	ketoconazole did not affect the conversion of losartan to the active metabolite after intravenous administration of losartan , and erythromycin had no clinically significant effect after oral administration .
None(e1,e2)	32	36	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	4	33	delayed adverse reactions to iodinated_contrast_media : a review of the literature revealed that 12.6 % ( range 11-28 % ) of 501 patients treated with various interleukin-2 containing regimens who were subsequently administered radiographic_iodinated_contrast_media experienced acute , atypical adverse reactions .
None(e1,e2)	6	17	interactions for vitamin d analogues ( vitamin_d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	114	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	18	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	55	85	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	19	39	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
advise(e1,e2)	11	17	because of the small effect on half-life , the coadministration with probenecid to extend the half-life of ertapenem is not recommended .
None(e1,e2)	0	12	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
None(e1,e2)	27	34	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	14	17	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	80	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	43	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	7	9	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
None(e1,e2)	24	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
advise(e1,e2)	9	15	however , it adversely affected response duration suggesting that pyridoxine should not be administered with hexalen and/or cisplatin.1
None(e1,e2)	0	7	mao_inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	45	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	17	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	22	24	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	38	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	32	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	11	14	concurrent administration of etanercept ( another tnf -blocking agent ) and anakinra ( an interleukin-1_antagonist ) has been associated with an increased risk of serious infections , and increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
None(e1,e2)	95	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	0	24	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	13	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	23	25	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	16	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	12	the administration of local anesthetic_solutions containing epinephrine or norepinephrine to patients receiving monoamine_oxidase_inhibitors , tricyclic antidepressants or phenothiazines may produce severe , prolonged hypotension or hypertension .
None(e1,e2)	0	12	acarbose did not interfere with the absorption or disposition of the sulfonylurea glyburide in diabetic patients .
None(e1,e2)	1	20	high-dose cyclosporin_a resulting in concentrations above 2000 ng/ml administered with oral etoposide has led to an 80 % increase in etoposide exposure with a 38 % decrease in total body clearance of etoposide compared to etoposide alone .
mechanism(e1,e2)	0	36	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	22	24	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	6	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	23	46	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	14	25	however , other published reports describe modest elevations ( less than two-fold ) of clozapine and metabolite concentrations when clozapine was taken with paroxetine , fluoxetine , and sertraline .
None(e1,e2)	0	6	amiodarone taken concomitantly with quinidine increases quinidine serum concentration by 33 % after two days .
None(e1,e2)	40	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	9	additionally , paroxetine did not alter the pharmacokinetics of sonata , reflecting the absence of a role of cyp2d6 in zaleplon s metabolism .
None(e1,e2)	43	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	15	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	46	55	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	11	27	- methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate
None(e1,e2)	15	17	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	48	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	12	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	0	14	furosemide : clinical studies , as well as post-marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	19	29	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone /ethinyl estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
effect(e1,e2)	0	11	diphenhydramine_hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	1	4	and videx , ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution may substantially interfere with the absorption of quinolones , resulting in systemic levels considerably lower than desired .
None(e1,e2)	13	42	thus , if a patient has been titrated to a stable dosage of equetrotm , and then begins a course of treatment with one of these cyp3a4 or epoxide hydrolase inhibitors , it is reasonable to expect that a dose reduction for equetrotm may be necessary .
None(e1,e2)	10	23	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium_carbonate , and terbutaline .
None(e1,e2)	6	8	the administration of lower doses of vardenafil with alpha-blockers has not been completely evaluated to determine if they can be safely administered together .
None(e1,e2)	31	33	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	14	23	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	13	17	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	26	40	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	1	32	because nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon , the concomitant use of nalfon and salicylates is not recommended .
None(e1,e2)	10	16	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
None(e1,e2)	4	11	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	12	15	antimycobacterial agents : rifampin contraindicated since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir .
None(e1,e2)	0	9	alcohol ( increases bioavailability by 50 % ) , cimetidine , and valproates .
None(e1,e2)	0	2	lithium : diclofenac decreases lithium renal clearance and increases lithium plasma levels .
None(e1,e2)	0	21	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
effect(e1,e2)	0	13	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
None(e1,e2)	12	14	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	12	19	in patients with chronic hepatitis c treated with pegasys in combination with copegus , pegasys treatment did not affect ribavirin distribution or clearance .
None(e1,e2)	39	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	21	cephalosporins -cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
mechanism(e1,e2)	2	13	rifampin : rifampin increases the metabolism of ethinyl estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
None(e1,e2)	10	18	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum -containing antacid preparations .
None(e1,e2)	0	18	carbamazepine : steady-state trough plasma carbamazepine and carbamazepine 10 , 11 epoxide concentrations were not affected by concomitant gabapentin ( 400 mg tid ;
effect(e1,e2)	13	19	phenobarbital toxicity has been reported to have occurred in a patient on chronic phenobarbital treatment following the initiation of diclofenac therapy .
mechanism(e1,e2)	10	42	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	15	17	concomitant administration with racemic citalopram citalopram - since escitalopram is the active isomer of racemic citalopram ( celexa ) , the two agents should not be coadministered .
None(e1,e2)	4	6	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
effect(e1,e2)	2	10	use of cerubidine in a patient who has previously received doxorubicin increases the risk of cardiotoxicity .
None(e1,e2)	15	27	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	7	25	insulin : a clinical study in 6 insulin -dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulin s ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	6	12	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	15	25	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	42	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	43	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
mechanism(e1,e2)	0	7	acetaminophen : may increase plasma concentration of synthetic_estrogens , possibly by inhibiting conjugation .
None(e1,e2)	42	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
effect(e1,e2)	0	15	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
effect(e1,e2)	15	5	in an emergency situation when opioid analgesia must be administered to a patient receiving revia , the amount of opioid required may be greater than usual , and the resulting respiratory depression may be deeper and more prolonged .
int(e1,e2)	6	8	the effect of concomitant administration of fluconazole and glipizide has been demonstrated in a placebo-controlled crossover study in normal volunteers .
None(e1,e2)	10	19	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	22	24	the potentiating action of hydroxyzine must be considered when the drug is used in conjunction with central nervous system depressants such as narcotics , non-narcotic_analgesics and barbiturates .
None(e1,e2)	10	31	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine_hcl was not altered .
advise(e1,e2)	2	12	patients receiving antihistamines should be advised against the concurrent use of other cns_depressant_drugs .
None(e1,e2)	4	32	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	10	12	in study 1 , patients with colorectal cancer were given irinotecan /5-fu/ leucovorin ( bolus-ifl ) with or without avastin .
effect(e1,e2)	8	23	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ;
None(e1,e2)	4	6	therefore , administration of quinolones with antacids containing calcium , magnesium , or aluminum ;
None(e1,e2)	3	10	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	45	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	34	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	21	33	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	49	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	13	18	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	1	17	ampicillin/ amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
None(e1,e2)	9	21	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	102	128	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	14	the net effect of these interactions is summarized in the following table : aed aed felbatol
None(e1,e2)	0	18	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium_hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	13	21	in studies in normal volunteers , there was no pharmacodynamic interaction between intravenous iloprost and either nifedipine , diltiazem , or captopril .
effect(e1,e2)	15	27	h2 blockers/proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton_pump_inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	42	51	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
effect(e1,e2)	2	13	taking a rauwolfia_alkaloid while you are taking or within 2 weeks of taking mao_inhibitors may increase the risk of central nervous system depression or may cause a severe high blood pressure reaction .
advise(e1,e2)	6	14	refer to the package insert for lithium preparations before use of such preparations with hydrochlorothiazide .
None(e1,e2)	36	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	87	106	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	71	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	9	17	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	29	39	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
None(e1,e2)	0	2	diltiazem , nifedipine , verapamil
None(e1,e2)	63	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	6	protease_inhibitors : amprenavir , lopinavir , nelfinavir , and ritonavir have been shown to decrease plasma levels of combination hormonal contraceptives ;
None(e1,e2)	14	22	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	6	14	no interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor .
mechanism(e1,e2)	0	9	magnesium - and aluminum-containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	1	4	and calcium_channel_antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
None(e1,e2)	0	12	phenytoin : accutane has not been shown to alter the pharmacokinetics of phenytoin in a study in seven healthy volunteers .
None(e1,e2)	9	11	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
None(e1,e2)	13	29	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	28	30	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	16	21	in studies in normal volunteers , there was no pharmacodynamic interaction between intravenous iloprost and either nifedipine , diltiazem , or captopril .
effect(e1,e2)	0	16	clindamycin has been shown to have neuromuscular blocking properties that may enhance the action of other neuromuscular_blocking_agents .
None(e1,e2)	22	24	propranolol : in normal volunteers , there was no clinically significant pharmacokinetic or pharmacodynamic interaction with concomitant administration of single doses of lovastatin and propranolol .
None(e1,e2)	24	38	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	26	31	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including protease inhibitors , macrolide antibiotics , and azole_antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	6	41	ketoconazole - combined administration of racemic citalopram ( 40 mg ) and ketoconazole ( 200 mg ) decreased the cmax and auc of ketoconazole by 21 % and 10 % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
None(e1,e2)	14	31	dose reduction of rifabutin to half the standard dose and a dose increase of crixivan to 1000 mg ( three 333-mg capsules ) every 8 hours are recommended when rifabutin and crixivan are coadministered .
None(e1,e2)	20	22	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	65	95	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	4	24	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	37	44	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	23	36	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
effect(e1,e2)	0	7	fenfluramine may increase slightly the effect of antihypertensive_drugs , e.g. , guanethidine , methyldopa , reserpine .
None(e1,e2)	20	35	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	61	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	37	40	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	0	47	platelet_inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin_sodium .
mechanism(e1,e2)	4	10	elevated plasma levels of theophylline have been reported with concomitant quinolone use .
None(e1,e2)	2	22	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic_acid , and tolbutamide in vitro .
None(e1,e2)	11	36	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
None(e1,e2)	0	20	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	22	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	40	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	22	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	24	37	because busulfan is eliminated from the body via conjugation with glutathione , use of acetaminophen prior to ( 72 hours ) or concurrent with busulfex may result in reduced busulfan clearance based upon the known property of acetaminophen to decrease glutathione levels in the blood and tissues .
None(e1,e2)	3	16	may interact with cefamandole_naftate , cephalothin sodium , magnesium sulfate , prednisolone sodium succinate , and prochlorperazine_edisylate .
None(e1,e2)	55	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	12	oral contraceptives : the effect of oral contraceptives on the pharmacokinetics of d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp has not been studied .
None(e1,e2)	8	28	in rats , simultaneous ingestion of disulfiram and nitrite in the diet for 78 weeks has been reported to cause tumors , and it has been suggested that disulfiram may react with nitrites in the rat stomach to form a nitrosamine , which is tumorigenic .
None(e1,e2)	39	57	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	18	29	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	0	15	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
None(e1,e2)	20	32	however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from 0.07 l/kg/h without aspirin to 0.11 l/kg/h with aspirin .
None(e1,e2)	5	7	subsequent adjustment of doses of mercaptopurine or azathioprine should be made on the basis of therapeutic response and the appearance of toxic effects .
None(e1,e2)	16	36	insulin : a clinical study in 6 insulin-dependent diabetic patients demonstrated no effect of extraneal on insulin absorption from the peritoneal cavity or on insulins ability to control blood glucose when insulin was administered intraperitoneally with extraneal .
None(e1,e2)	17	45	in patients with mild to moderate hypertension , administration of 25 mg daily of vioxx with the ace_inhibitor benazepril , 10 to 40 mg for 4 weeks , was associated with an average increase in mean arterial pressure of about 3 mm hg compared to ace_inhibitor alone .
None(e1,e2)	12	22	antimycobacterial agents : rifampin contraindicated since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir .
None(e1,e2)	33	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	20	29	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type_anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	38	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	33	45	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	12	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	22	47	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	18	29	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid_analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	2	6	aspirin , warfarin , heparin , nsaids
None(e1,e2)	53	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	36	hiv protease inhibitors : indinavir ( 800 mg t.i.d . ) co-administered with vardenafil 10 mg resulted in a 16-fold increase in vardenafil auc , a 7-fold increase in vardenafil cmax and a 2-fold increase in vardenafil half-life .
None(e1,e2)	79	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	58	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	4	29	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	28	93	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	10	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	5	23	the extent to which ssri- tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
None(e1,e2)	46	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	4	13	skeletal muscle relaxants : amphotericin_b -induced hypokalemia may enhance the curariform effect of skeletal_muscle_relaxants ( e.g. , tubocurarine ) .
None(e1,e2)	23	52	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	15	32	because nalfon has not been shown to produce any additional effect beyond that obtained with aspirin alone and because aspirin increases the rate of excretion of nalfon , the concomitant use of nalfon and salicylates is not recommended .
None(e1,e2)	7	16	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal anti-inflammatory agents , folic acid , corticosteroids and/or narcotics .
None(e1,e2)	42	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	1	12	when paroxetine , a potent inhibitor of cyp2d6 , was co-administered with brovana at steady-state , exposure to either drug was not altered .
None(e1,e2)	0	14	cephalosporins -cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	0	9	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	14	16	close supervision and careful adjustment of dosage are required when anafranil is administered with anticholinergic or sympathomimetic_drugs .
None(e1,e2)	51	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	27	33	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin_d .
None(e1,e2)	28	32	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	9	11	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	89	99	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	34	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants .when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	7	15	increased toxicity ( cns depression ) : cns_depressants , mao inhibitors , tricyclic antidepressants , phenothiazines .
effect(e1,e2)	1	7	( thiazides may decrease arterial responsiveness to norepinephrine .
None(e1,e2)	129	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	6	concomitant administration of an aluminum -containing antacid had no significant effect in the bioavailability of 6mna .
None(e1,e2)	0	15	antacid ( magnesium-aluminum hydroxide ) : cerivastatin plasma concentrations were not affected by co-administration of antacid .
None(e1,e2)	0	1	adrenergic_blockers adrenergic_blockers are inhibited by amphetamines .
None(e1,e2)	0	2	alcohol , barbiturates , or narcotics : potentiation of orthostatic hypotension may occur .
None(e1,e2)	40	42	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei / arb ) .
None(e1,e2)	18	23	pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole , resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong qt intervals .
mechanism(e1,e2)	7	17	during administration of multiple oral doses of tambocor to healthy subjects stabilized on a maintenance dose of digoxin , a 13 % -19 % increase in plasma digoxin levels occurred at six hours postdose .
None(e1,e2)	13	22	an increase in serum lithium concentration has been reported during concomitant administration of lithium with atacand , so careful monitoring of serum lithium levels is recommended during concomitant use .
mechanism(e1,e2)	3	11	concomitant administration of fenofibrate ( equivalent to 145mg tricor ) with pravastatin ( 40 mg ) once daily for 10 days has been shown to increase the mean cmax and auc values for pravastatin by 36 % ( range from 69 % decrease to 321 % increase ) and 28 % ( range from 54 % decrease to 128 % increase ) , respectively , and for 3 -hydroxy-iso-pravastatin by 55 % ( range from 32 % decrease to 314 % increase ) and 39 % ( range from 24 % decrease to 261 % increase ) , respectively in 23 healthy adults .
None(e1,e2)	18	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	33	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	0	16	valproate : a recent case study has shown a possible increase in the plasma level of valproate when co administered with isoniazid .
None(e1,e2)	0	17	antacids or h 2 -receptor antagonists : the effect of increased gastric ph on the bioavailability of ceftibuten was evaluated in 18 healthy adult volunteers .
None(e1,e2)	4	24	the risk of using bromocriptine_mesylate in combination with other drugs has not been systematically evaluated , but alcohol may potentiate the side effects of bromocriptine_mesylate .
None(e1,e2)	28	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	22	nonsteroidal_anti-inflammatory_drugs : the administration of diflunisal to normal volunteers receiving indomethacin decreased the renal clearance and significantly increased the plasma levels of indomethacin .
None(e1,e2)	67	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	41	70	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	32	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	20	23	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic_acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	77	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	41	anticonvulsants ( phenytoin ) : steady state plasma exposure ( auc ) of valdecoxib ( 40 mg bid for 12 days ) was decreased by 27 % when co-administered with multiple doses ( 300 mg qd for 12 days ) of phenytoin ( a cyp 3a4 inducer ) .
None(e1,e2)	69	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	15	25	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	0	13	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
None(e1,e2)	0	20	beta_blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	1	3	- alcohol , barbiturates , or narcotics : potentiation of otthostatic hypotension may occur
None(e1,e2)	0	13	antiepileptic_drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic drugs ( phenytoin , carbamazepine ) .
None(e1,e2)	50	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	13	25	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
effect(e1,e2)	17	48	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin_sodium .
None(e1,e2)	44	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	32	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	2	9	- a steroid_medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
mechanism(e1,e2)	19	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	21	25	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	43	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	15	nephrotoxicity has been reported following concomitant administration of other cephalosporins with potent diuretics such as furosemide .
None(e1,e2)	4	46	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	0	9	albuterol , antihistamines , antidiabetic drugs , diuretics , digitalis .
mechanism(e1,e2)	18	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	13	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
effect(e1,e2)	6	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	38	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	43	48	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	0	2	selegiline : combination_hormonal_contraceptives may increase the serum concentration of selegiline .
None(e1,e2)	10	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	31	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	15	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	19	23	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric_acid_derivatives , niacin ( nicotinic_acid ) , erythromycin , azole antifungals .
None(e1,e2)	21	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	15	17	it is believed that the toxicity may have resulted from a previously unrecognized interaction between isoniazid and acetaminophen and a molecular basis for this interaction has been proposed .
None(e1,e2)	7	23	dexbrompheniramine can interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
effect(e1,e2)	0	12	flexeril may enhance the effects of alcohol , barbiturates , and other cns_depressants .
mechanism(e1,e2)	10	13	in another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome p450 3a4 , increased the exposure ( auc ) of des-ciclesonide by approximately 3.6-fold at steady state , while levels of ciclesonide remained unchanged .
None(e1,e2)	10	12	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	27	29	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	9	21	therefore , interactions could occur following concomitant administration of psychotropic_drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	26	38	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
effect(e1,e2)	1	8	because lithium may enhance the serotonergic effects of escitalopram , caution should be exercised when lexapro and lithium are coadministered .
None(e1,e2)	6	20	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety_agents .
None(e1,e2)	10	20	in vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol .
mechanism(e1,e2)	18	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	42	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	16	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	18	interactions with other cns agents : concurrent use of levo-dromoran with all central_nervous_system_depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	0	15	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	12	18	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	13	29	a clinical study in healthy male volunteers ( n=24 ) demonstrated that mixing novolog with nph human insulin immediately before injection produced some attenuation in the peak concentration of novolog , but that the time to peak and the total bioavailability of novolog were not significantly affected .
None(e1,e2)	14	20	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive_drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	11	48	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
advise(e1,e2)	3	7	therefore , if theophylline is co-administered with fluvoxamine_maleate , its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored .
None(e1,e2)	10	13	the patient was also chronically receiving phenytoin , phenobarbital , digoxin , and levothyroxine_sodium .
None(e1,e2)	55	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	39	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	0	4	antiarrhythmic_agents_,_class_i ( such as flecainide , lidocaine , or quinidine ) : concurrent use with arbutamine may have a proarrhythmic effect .
effect(e1,e2)	14	17	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	7	28	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	23	28	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	13	35	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	75	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	22	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
effect(e1,e2)	6	31	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	35	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	71	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	6	tacrolimus : co-administration of tacrolimus and bosentan has not been studied in man .
effect(e1,e2)	9	12	nephrotoxicity has been reported following concomitant administration of other cephalosporins with potent diuretics such as furosemide .
None(e1,e2)	10	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	22	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	3	9	clinical studies of pegasys alone or in combination with copegus did not include sufficient numbers of subjects aged 65 or over to determine whether they respond differently from younger subjects .
None(e1,e2)	15	17	after 14 days of co-administration , mean trough concentrations of clozapine and its metabolites , n-desmethylclozapine and clozapine_n-oxide , were elevated with fluvoxamine by about three-fold compared to baseline concentrations .
None(e1,e2)	10	26	while it is not known whether this interaction occurs with fibrates other than gemfibrozil , myopathy and rhabdomyolysis have occasionally been associated with the use of fibrates alone , including clofibrate .
None(e1,e2)	13	27	however , because higher doses ( up to 360 mg qd ) of omeprazole are tolerated in zollinger-ellison ( ze ) patients , no dose adjustment for omeprazole is recommended at current doses .
None(e1,e2)	35	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	21	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	0	5	colestipol : plasma concentrations of atorvastatin decreased approximately 25 % when colestipol and atorvastatin were coadministered .
None(e1,e2)	3	6	as with other agents_with_b-blocking_properties , if coreg is to be administered orally with calcium channel blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
None(e1,e2)	26	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	21	in 5 other schizophrenic patients treated with oral haloperidol and rifampin , discontinuation of rifampin produced a mean 3.3-fold increase in haloperidol concentrations .
None(e1,e2)	11	20	if phenytoin or other hepatic enzyme inducers are taken concurrently with norpace or norpace cr , lower plasma levels of disopyramide may occur .
None(e1,e2)	25	42	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	12	27	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	88	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	15	23	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists_.
None(e1,e2)	13	20	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot_derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
effect(e1,e2)	17	21	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	16	23	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin_converting_enzyme_inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	8	19	magnesium- and aluminum-containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	11	13	a causal relationship between these events and the concomitant administration of lithium and haldol has not been established ;
None(e1,e2)	15	25	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	43	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	102	106	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	87	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	21	drugs metabolized by cytochrome p450 enzymes the drug interaction study evaluating the effect of grepafloxacin on theophylline indicates that grepafloxacin inhibits theophylline metabolism , which is mediated by cyp1a2 .
None(e1,e2)	14	16	therefore , the potential for such drug interaction should be considered in patients receiving azopt ( brinzolamide ophthalmic suspension ) 1 % .
None(e1,e2)	59	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	0	2	zalcitabine inhibited lamivudine phosphorylation at high concentration ratios ( 10 and 100 ) ;
mechanism(e1,e2)	49	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	2	tolbutamide : aprepitant , when given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , decreased the auc of tolbutamide ( a cyp2c9 substrate ) by 23 % on day 4 , 28 % on day 8 , and 15 % on day 15 , when a single dose of tolbutamide 500 mg was admini , stered orally prior to the administration of the 3-day regimen of aprepitant and on days 4,8 , and 15 .
None(e1,e2)	7	12	in neither case were the pharmacokinetics of sumatriptan affected by coadministration with stadol_ns .
None(e1,e2)	13	33	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	133	162	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	10	48	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	8	28	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	4	13	in vivo studies : nitrates : the blood pressure lowering effects of sublingual nitrates ( 0.4 mg ) taken 1 and 4 hours after vardenafil and increases in heart rate when taken at 1 , 4 and 8 hours were potentiated by a 20 mg dose of vardenafil in healthy middle-aged subjects .
None(e1,e2)	31	78	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	11	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
None(e1,e2)	18	36	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic_products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	6	18	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	21	23	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
mechanism(e1,e2)	2	12	even so dextromethorphan plasma concentrations in the presence of high doses of valdecoxib were almost 5-fold lower than those seen in cyp 2d6 poor metabolizers suggesting that dose adjustment is not necessary .
None(e1,e2)	22	32	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	19	the following drugs have been coadministered with kerlone and have not altered its pharmacokinetics : cimetidine , nifedipine , chlorthalidone , and hydrochlorothiazide .
effect(e1,e2)	23	39	it is , however , possible that concomitant use of other known photosensitizing agents such as griseofulvin , thiazide diuretics , sulfonylureas , phenothiazines , sulfonamides and tetracyclines might increase the photosensitivity reaction of actinic keratoses treated with the levulan_kerastick for topical solution .
None(e1,e2)	21	56	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	4	22	these six volunteers received terfenadine alone ( 60 mg twice daily ) for 8 days , followed by terfenadine in combination with dirithromycin ( 500 mg once daily ) for 10 days .
None(e1,e2)	2	29	effects of antacids on felbatol the rate and extent of absorption of a 2400 mg dose of felbatol as monotherapy given as tablets was not affected when coadministered with antacids .
None(e1,e2)	13	19	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	47	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	28	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl_estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	31	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	57	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	5	probenecid : as with other b-lactams , the renal excretion of cephalexin is inhibited by probenecid .
None(e1,e2)	133	145	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	13	drugs which inhibit cyp 3a4 ( e.g. , ketoconazole , macrolide_antibiotics such as erythromycin ) have the potential to result in increased plasma concentrations of corticosteroids .
None(e1,e2)	19	29	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic_agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	0	12	warfarin : no significant differences were observed in the steady-state pharmacokinetics of r-warfarin or s-warfarin with the addition of tiagabine given as a single dose .
None(e1,e2)	12	38	antihypertensives : amiodarone should be used with caution in patients receiving - receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	15	23	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	3	29	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	2	4	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
None(e1,e2)	22	30	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate mofetil , and muromonab-cd3 .
None(e1,e2)	11	26	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	22	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
effect(e1,e2)	0	7	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	20	24	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	69	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	17	23	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	20	41	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
int(e1,e2)	0	8	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	30	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	0	2	glyburide : glyburide is a cyp 2c9 substrate .
None(e1,e2)	18	22	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate_hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	8	35	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	30	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	62	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	6	8	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	33	85	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	3	11	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e. g. , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	16	28	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	34	39	this observed increase in the bioavailability of fexofenadine may be due to transport-related effects , such as p-glycoprotein . in vivo animal studies also suggest that in addition to enhancing absorption , ketoconazole decreases fexofenadine gastrointestinal secretion , while erythromycin may also decrease biliary excretion .
None(e1,e2)	0	19	mao_inhibitors : serious side effects and even death have been reported following the concomitant use of certain drugs with mao_inhibitors .
None(e1,e2)	6	8	certain concomitant medications ( such as rifampin , anticonvulsants , st .
None(e1,e2)	31	40	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	3	45	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
advise(e1,e2)	19	29	in patients receiving concurrent therapy with clonidine , if therapy is to be discontinued , it is suggested that zebeta be discontinued for several days before the withdrawal of clonidine .
None(e1,e2)	35	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	13	analgesic/anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	2	20	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	8	10	in vitro mixing of an aminoglycoside with beta-lactamtype antibiotics ( penicillins or cephalosporins ) may result in a significant mutual inactivation .
None(e1,e2)	3	15	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	12	17	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	0	4	macrolide_antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	18	38	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	26	40	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	96	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	23	this did not result in any statistically or clinically relevant changes in the pharmacokinetic parameters of either caffeine or its major metabolite , paraxanthine .
effect(e1,e2)	23	48	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	1	34	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
None(e1,e2)	3	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	0	6	mineral_oil interferes with the absorption of fat-soluble_vitamins , including vitamin d preparations .
None(e1,e2)	68	79	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
None(e1,e2)	0	2	fluconazole and ketoconazole : ketoconazole and fluconazole are predominantly cyp 3a4 and 2c9 inhibitors , respectively .
None(e1,e2)	8	26	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	14	23	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic_acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	13	18	although trough citalopram plasma levels were unaffected , given the enzyme-inducing properties of carbamazepine , the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered .
None(e1,e2)	57	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	76	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	6	33	particular caution is necessary when using romazicon in cases of mixed drug overdosage since the toxic effects ( such as convulsions and cardiac dysrhythmias ) of other drugs taken in overdose ( especially cyclic_antidepressants ) may emerge with the reversal of the benzodiazepine effect by flumazenil .
None(e1,e2)	71	75	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	28	45	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	34	42	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	26	32	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	12	26	interactions with other cns agents : concurrent use of levo-dromoran with all central_nervous_system_depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	9	13	caution should be exercised when taking this medicine certain antibiotics , such as erythromycin , clarithromycin , or azithromycin .
mechanism(e1,e2)	8	10	promethazine : coadministration of a single dose of zaleplon and promethazine ( 10 and 25 mg , respectively ) resulted in a 15 % decrease in maximal plasma concentrations of zaleplon , but no change in the area under the plasma concentration-time curve .
None(e1,e2)	39	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	31	39	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
mechanism(e1,e2)	15	21	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	17	31	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	13	28	other chemotherapy agents in a separate study , concomitant administration of lapatinib with capecitabine did not meaningfully alter the pharmacokinetics of either agent ( or the metabolites of capecitabine ) .
None(e1,e2)	4	22	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	24	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	6	13	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	5	8	the in vitro interaction between nevirapine and the antithrombotic_agent warfarin is complex .
None(e1,e2)	0	17	theophylline : enoxacin is a potent inhibitor of the cytochrome p-450 isozymes responsible for the metabolism of methylxanthines .
None(e1,e2)	3	12	standard monitoring of methotrexate -related toxicity should be continued if vioxx and methotrexate are administered concomitantly .
None(e1,e2)	10	19	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid_preparations .
None(e1,e2)	22	48	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	3	20	oral hypoglycemics : diclofenac does not alter glucose metabolism in normal subjects nor does it alter the effects of oral hypoglycemic_agents .
None(e1,e2)	9	46	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	13	26	while it is not known whether this interaction occurs with fibrates other than gemfibrozil , myopathy and rhabdomyolysis have occasionally been associated with the use of fibrates alone , including clofibrate .
None(e1,e2)	19	33	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	27	41	ritonavir - combined administration of a single dose of ritonavir ( 600 mg ) , both a cyp3a4 substrate and a potent inhibitor of cyp3a4 , and escitalopram ( 20 mg ) did not affect the pharmacokinetics of either ritonavir or escitalopram .
None(e1,e2)	21	29	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis_preparations , furosemide , spironolactone , lidocaine , glyceryl_trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
effect(e1,e2)	5	15	when other antiplatelet agents or anticoagulants are used concomitantly , there is the potential for flolan to increase the risk of bleeding .
None(e1,e2)	32	60	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin_b12 and folic acid .
None(e1,e2)	13	33	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
effect(e1,e2)	5	41	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic_antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	8	13	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	19	70	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	5	14	- probenecid : pretreatment with probenecid reduces both the natriuresis and hyperreninemia produced by bumetanide .
None(e1,e2)	2	5	antacids ( aluminum - or magnesium -containing ) : concomitant administration of 300-mg cefdinir capsules with 30 ml maalox tc suspension reduces the rate ( cmax ) and extent ( auc ) of absorption by approximately 40 % .
None(e1,e2)	59	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	19	21	psychoactive drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	19	37	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	129	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	29	33	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	0	2	furosemide : toradol iv/im reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20 % ( mean sodium and urinary output decreased 17 % ) .
None(e1,e2)	0	10	warfarin : increased inr ( international normalized ratio ) when arava and warfarin were co-administered has been rarely reported .
None(e1,e2)	13	15	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
None(e1,e2)	3	14	while all the selective_serotonin_reuptake_inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , paroxetine , and fluvoxamine , inhibit p450 2d6 , they may vary in the extent of inhibition .
effect(e1,e2)	4	12	antidepressants , tricyclic : amphetamines may enhance the activity of tricyclic or sympathomimetic_agents ;
None(e1,e2)	8	20	no interaction was noted with the mao-b inhibitor selegiline in two multiple-dose interaction studies when entacapone was coadministered with a levodopa /dopa decarboxylase inhibitor ( n=29 ) .
None(e1,e2)	83	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	6	19	caution should be exercised when administering etopophos with drugs that are known to inhibit phosphatase activities ( e.g. , levamisole_hydrochloride ) .
None(e1,e2)	21	38	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	69	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	7	19	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	66	75	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	35	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	3	12	quinolones , including nalidixic_acid , may enhance the effects of the oral anticoagulant warfarin or its derivatives .
None(e1,e2)	42	47	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	10	18	pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , ketoconazole , erythromycin and azithromycin .
None(e1,e2)	30	32	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel_blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	11	13	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	10	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	43	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	18	23	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	19	65	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	41	119	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	7	9	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	23	47	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	3	27	benzodiazepines : combination hormonal_contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	3	5	the interaction between lomefloxacin and cimetidine has not been studied .
effect(e1,e2)	7	9	in patients , the concomitant administration of digoxin with dofetilide was associated with a higher occurrence of torsade de pointes .
None(e1,e2)	44	94	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	8	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	51	53	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	9	16	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium_channel_blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	20	22	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic_acid , phenylbutazone , and diazepam .
None(e1,e2)	0	2	digoxin : rofecoxib 75 mg once daily for 11 days does not alter the plasma concentration profile or renal elimination of digoxin after a single 0.5 mg oral dose .
None(e1,e2)	26	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	10	in the same study it was shown that didanosine and stavudine had no significant effect on the intracellular phosphorylation of zalcitabine in peripheral blood mononuclear cells .
None(e1,e2)	41	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	45	alprazolam : when fluvoxamine maleate ( 100 mg qd ) and alprazolam ( 1 mg q.d . were co-administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1/2 , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
None(e1,e2)	12	16	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	33	39	the extent of plasma protein binding of atovaquone in human plasma is not affected by the presence of therapeutic concentrations of phenytoin ( 15 mcg/ ml ) , nor is the binding of phenytoin affected by the presence of atovaquone .
mechanism(e1,e2)	2	12	antibiotics : macrolide_antibiotics have been reported to cause a significant decrease in corticosteroid clearance .
None(e1,e2)	36	42	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	29	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	38	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	9	11	drug-drug interactions have not been observed between argatroban and digoxin or erythromycin .
mechanism(e1,e2)	14	26	drugs which inhibit cyp 3a4 ( e.g. , ketoconazole , macrolide antibiotics such as erythromycin ) have the potential to result in increased plasma concentrations of corticosteroids .
mechanism(e1,e2)	0	7	ketoconazole tablets may alter the metabolism of cyclosporine , tacrolimus , and methylprednisolone , resulting in elevated plasma concentrations of the latter drugs .
None(e1,e2)	16	20	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	15	18	there is limited experience with concomitant antihypertensive agents such as alpha-blockers , calcium channel-blockers , ace_inhibitors , and diuretics ( both thiazide-like and loop ) .
None(e1,e2)	0	4	diazepam : diazepam ( valium ) is a cyp 3a4 and cyp 2c19 substrate .
None(e1,e2)	28	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	38	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin_b .
None(e1,e2)	40	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	85	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	38	47	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	0	31	aspirin /acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	11	13	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
None(e1,e2)	4	22	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	93	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	43	there have been postmarketing reports of drug interactions when erythromycin is coadministered with cisapride , resulting in qt prolongation , cardiac arrythmias , ventricular tachycardia , ventricular fibrulation , and torsades de pointes , most like due to inhibition of hepatic metabolism of cisapride by erythromycin .
effect(e1,e2)	9	12	interactions with other cns agents : concurrent use of levo-dromoran with all central_nervous_system_depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	43	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	9	18	accordingly , careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin .
None(e1,e2)	18	47	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	19	140	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	23	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	28	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
int(e1,e2)	5	7	a two-way interaction between the hydantoin_antiepileptic , phenytoin , and the coumarin anticoagulants has been suggested .
None(e1,e2)	32	52	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
None(e1,e2)	76	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	29	because anafranil is highly bound to serum protein , the administration of anafranil to patients taking other drugs that are highly bound to protein ( e.g. , warfarin , digoxin ) may cause an increase in plasma concentrations of these drugs , potentially resulting in adverse effects .
None(e1,e2)	0	13	allegra should not be taken closely in time with aluminum and magnesium containing antacids .
None(e1,e2)	25	52	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	16	20	no significant drug-drug pharmacokinetic interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , cimetidine and phenobarbital .
None(e1,e2)	42	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	38	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	77	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	116	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	17	no interaction with the tricyclic_antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/ dopa-decarboxylase_inhibitor .
None(e1,e2)	35	44	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	12	tetracyclines : concomitant treatment with accutane and tetracyclines should be avoided because accutane use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of tetracyclines
mechanism(e1,e2)	19	86	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	3	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	9	11	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	36	42	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	16	31	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	88	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	43	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	5	diuretics : diclofenac and other nsaids can inhibit the activity of diuretics .
mechanism(e1,e2)	2	9	inh ( isoniazid ) is also reported to affect ketoconazole concentrations adversely .
None(e1,e2)	0	6	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	7	16	in a study with concomitant administration of aspirin and fosinopril sodium , the bioavailability of unbound fosinoprilat was not altered .
None(e1,e2)	97	119	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	18	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	15	folic acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
None(e1,e2)	15	30	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	14	16	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
None(e1,e2)	15	45	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	12	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	34	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	46	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	22	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	10	30	in a drug interaction study , co-administration of orally inhaled ciclesonide and oral erythromycin , an inhibitor of cytochrome p450 3a4 , had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin .
advise(e1,e2)	3	10	routine administration of vaccines or toxoids should be deferred until corticosteroid therapy is discontinued if possible .
None(e1,e2)	26	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	7	9	discontinuation of cimetidine in well-controlled patients receiving tricyclic_antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants .
None(e1,e2)	13	29	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	6	26	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	8	33	concomitant administration of fenofibrate ( equivalent to 145mg tricor ) with pravastatin ( 40 mg ) once daily for 10 days has been shown to increase the mean cmax and auc values for pravastatin by 36 % ( range from 69 % decrease to 321 % increase ) and 28 % ( range from 54 % decrease to 128 % increase ) , respectively , and for 3 -hydroxy-iso-pravastatin by 55 % ( range from 32 % decrease to 314 % increase ) and 39 % ( range from 24 % decrease to 261 % increase ) , respectively in 23 healthy adults .
effect(e1,e2)	20	28	due to their similar mechanism of action , it is expected that the neuromuscular blockade produced by any of the non-depolarizing_muscle_relaxants could be prolonged in the presence of piperacillin .
None(e1,e2)	17	30	although there was no effect of aprepitant on the plasma auc of r ( + ) or s_(_-_)_warfarin determined on day 3 , there was a 34 % decrease in s_(_-_)_warfarin ( a cyp2c9 substrate ) trough concentration accompanied by a 14 % decrease in the prothrombin time ( reported as international normalized ratio or inr ) 5 days after completion of dosing with aprepitant .
None(e1,e2)	118	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	11	31	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	2	23	another oral azole_antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
None(e1,e2)	33	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
effect(e1,e2)	0	6	sodium_cephalothin may enhance the nephrotoxicity of coly-mycin_m parenteral .
effect(e1,e2)	3	34	toxicology studies of heroin -related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	9	30	in patients taking furosemide , nifedipine , diltiazem , ace_inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	21	32	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	0	2	aspirin : ketoprofen does not alter aspirin absorption ;
None(e1,e2)	21	27	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	7	31	co-administration of cyp3a4 inhibitors ( eg , ketoconazole , itraconazole , erythromycin , grapefruit juice , cimetidine ) with felodipine may lead to several- fold increases in the plasma levels of felodipine , either due to an increase in bioavailability or due to a decrease in metabolism .
mechanism(e1,e2)	6	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	40	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	102	106	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	7	22	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial_agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	71	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	13	drug interactions : a . drugs enhancing heparin effect : oral anticoagulants : heparin_sodium may prolong the one-stage prothrombin time .
None(e1,e2)	8	13	ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity .
None(e1,e2)	3	6	no inhibition of deferasirox metabolism by hydroxyurea is expected based on the results of an in vitro study .
None(e1,e2)	14	16	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
effect(e1,e2)	12	26	the ecg changes and/or hypokalemia that may result from the administration of non-potassium_sparing_diuretics ( such as loop or thiazide diuretics ) can be acutely worsened by beta-agonists , especially when the recommended dose of the beta-agonist is exceeded .
None(e1,e2)	32	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	4	39	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	12	18	there is limited experience with concomitant antihypertensive agents such as alpha-blockers , calcium_channel-blockers , ace inhibitors , and diuretics ( both thiazide-like and loop ) .
None(e1,e2)	0	8	acidifying_agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	8	25	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	10	15	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	23	25	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic_medications , or other drugs that produce cns depression .
None(e1,e2)	1	25	plasma tca concentrations may need to be monitored and the dose of the tca may need to be reduced if a tca is co-administered with duloxetine .
None(e1,e2)	2	10	coadministration of entecavir with lamivudine , adefovir dipivoxil , or tenofovir_disoproxil_fumarate did not result in significant drug interactions .
None(e1,e2)	20	53	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	83	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
effect(e1,e2)	8	10	in these patients whose hypertension was controlled with nifedipine , vardenafil 20 mg produced mean additional supine systolic/diastolic blood pressure reductions of 6/5 mm hg compared to placebo .
None(e1,e2)	1	5	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
mechanism(e1,e2)	2	20	coadministration of aprepitant with these drugs or other drugs that are known to be metabolized by cyp2c9 , such as phenytoin , may result in lower plasma concentrations of these drugs .
None(e1,e2)	16	32	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	112	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	25	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	4	13	since blood level of calcitriol /ergocalcitriol will be reduced , higher doses of rocaltrol may be necessary if these drugs are administered simultaneously .
None(e1,e2)	0	21	furosemide : in normal volunteers , the concomitant administration of diflunisal and furosemide had no effect on the diuretic activity of furosemide .
None(e1,e2)	10	20	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	28	60	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	15	33	when initiating a multi-day course of grepafloxacin in a patient maintained on theophylline , the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments .
None(e1,e2)	2	25	- a steroid_medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	51	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	13	other cyp3a4 inducers include , but are not limited to , rifabutin , rifapentine , phenytoin , carbamazepine , phenobarbital and st. johns wort .
None(e1,e2)	20	24	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	16	36	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	0	17	nicotine : nicotine may provoke vasoconstriction in some patients , predisposing to a greater ischemic response to ergot therapy .
None(e1,e2)	46	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	0	14	catecholamine-depleting_drugs , such as reserpine , may have an additive effect when given with beta-blocking_agents .
None(e1,e2)	5	14	lithium - coadministration of racemic citalopram ( 40 mg/day for 10 days ) and lithium ( 30 mmol/day for 5 days ) had no significant effect on the pharmacokinetics of citalopram or lithium .
None(e1,e2)	0	8	digoxin : the concomitant administration of dynacirc ( isradipine ) and digoxin in a single-dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of digoxin .
None(e1,e2)	10	13	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	0	19	erythromycin use in patients who are receiving high doses of theophylline may be associated with an increase in serum theophylline levels and potential theophylline toxicity .
None(e1,e2)	5	10	concomitant medications were grouped as ace_inhibitors , oral anticoagulants , calcium_channel_blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	7	12	increased toxicity ( cns depression ) : cns_depressants , mao inhibitors , tricyclic_antidepressants , phenothiazines .
None(e1,e2)	39	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	15	29	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns_depressants , causing increased cns depression .
None(e1,e2)	10	32	in a drug interaction study , co-administration of orally inhaled ciclesonide and oral erythromycin , an inhibitor of cytochrome p450 3a4 , had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin .
None(e1,e2)	40	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	26	drug-drug interactions between keppra and other antiepileptic drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	62	128	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	29	42	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
effect(e1,e2)	12	20	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin_sodium .
None(e1,e2)	0	7	omeprazole should be taken as directed and proquin_xr should be taken with a main meal of the day , preferably the evening meal..
None(e1,e2)	75	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	3	9	the use of nsaids in patients who are receiving ace_inhibitors may potentiate renal disease states .
None(e1,e2)	30	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	13	15	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
None(e1,e2)	13	18	in studies in normal volunteers , there was no pharmacodynamic interaction between intravenous iloprost and either nifedipine , diltiazem , or captopril .
None(e1,e2)	0	15	protease_inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	4	29	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	23	45	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	33	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	26	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	4	14	- when bezalip or bezalip_retard is used concurrently with anion-exchange resins ( e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of bezalip or bezalip retard is impaired
None(e1,e2)	13	43	although acid-base and electrolyte disturbances were not reported in the clinical trials with dorzolamide , these disturbances have been reported with oral carbonic anhydrase inhibitors and have , in some instances , resulted in drug interactions ( e.g. , toxicity associated with high-dose salicylate therapy ) .
None(e1,e2)	23	36	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	39	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	24	as with other drugs that block angiotensin ii or its effects , concomitant use of potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , or salt substitutes containing potassium may lead to increases in serum potassium .
None(e1,e2)	15	28	co-administration of myobloc and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare-like_compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
None(e1,e2)	7	13	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal anti-inflammatory agents , folic_acid , corticosteroids and/or narcotics .
None(e1,e2)	10	15	tablet if a patient receiving clonidine hydrochloride is also taking tricyclic_antidepressants , the effect of clonidine may be reduced , thus necessitating an increase in dosage .
effect(e1,e2)	0	11	quinolones , including norfloxacin , may enhance the effects of oral anticoagulants , including warfarin or its derivatives or similar agents .
None(e1,e2)	15	17	potential pharmacokinetic interactions were assessed in clinical pharmacokinetic studies ( phenytoin , valproate , oral contraceptive , digoxin , warfarin , probenecid ) and through pharmacokinetic screening in the placebo-controlled clinical studies in epilepsy patients .
None(e1,e2)	57	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	18	26	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	0	40	ace_inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei/ arb ) .
None(e1,e2)	7	11	anticholinesterases ( neostgmine , physostigmine ) , lignocaine , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .
None(e1,e2)	1	3	ketoconazole/ itraconazole , macrolides , including erythromycin
None(e1,e2)	9	29	in eight hiv-infected patients , the steady-state auc of ciprofloxacin was decreased an average of 26 % ( 95 % ci = 14 % , 37 % ) when ciprofloxacin was administered 2 hours prior to a marketed chewable/dispersible tablet formulation of videx .
None(e1,e2)	26	30	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	6	8	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
effect(e1,e2)	5	14	similarly , the effects of phenytoin on phenobarbital , valproic acid and sodium plasma valproate concentrations are unpredictable
effect(e1,e2)	4	20	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	29	33	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	3	33	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic_acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	7	22	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
None(e1,e2)	24	26	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide_mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	1	13	- antidiabetic_drugs : ( oral agents and insulin ) dosage adjustment of the antidiabetic_drug may be required
None(e1,e2)	18	31	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	4	7	fluconazole , and the 5-ht3_antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
advise(e1,e2)	4	20	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g . certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin b ) .
effect(e1,e2)	3	20	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic_agonists .
None(e1,e2)	22	35	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	26	67	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	26	41	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	6	22	paclitaxel - in one report , l-glutamine at a dose of 10 grams three times daily , given 24 hours after receiving paclitaxel , appeared to prevent the development of myalgia and arthralgia , adverse reactions of paclitaxel .
None(e1,e2)	8	27	antiretroviral agents : no drug interactions with other antiretroviral_medications have been identified that would warrant alteration of either the enfuvirtide dose or the dose of the other antiretroviral_medication .
None(e1,e2)	49	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	21	in order to maintain phenytoin levels , limit adverse experiences , and achieve the felbamate dose of 3600 mg/day , a phenytoin dose reduction of approximately 40 % was necessary for eight of these 10 subjects .
None(e1,e2)	18	20	because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine , duloxetine and thioridazine should not be co-administered .
None(e1,e2)	2	4	cyclosporine , tacrolimus and digoxin concentrations should be monitored at the initiation of itraconazole therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
None(e1,e2)	30	40	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	21	32	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	4	6	benzthiazide may interact with alcohol , blood_thinner s , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	26	65	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	14	analgesic /anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	10	26	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic_acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	18	20	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	46	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	13	propranolol : in a single dose study in normal volunteers , coadministration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability .
None(e1,e2)	1	6	because heparin , aspirin , or activase may cause bleeding complications , careful monitoring for bleeding is advised , especially at arterial puncture sites .
None(e1,e2)	33	37	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	111	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	74	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	46	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	4	5	other drug interactions oral contraceptives keppra ( 500 mg twice daily ) did not influence the pharmacokinetics of an oral contraceptive containing 0.03 mg ethinyl estradiol and 0.15 mg levonorgestrel , or of the luteinizing hormone and progesterone levels , indicating that impairment of contraceptive efficacy is unlikely .
None(e1,e2)	6	13	anabolic steroids ( particularly c-17 alkylated androgens such as oxymetholone , methandrostenolone , norethandrolone , and similar compounds ) enhanced tendency toward edema .
None(e1,e2)	55	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	16	31	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	6	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	26	36	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
advise(e1,e2)	7	15	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	30	37	total body clearance of simulect was reduced by an average 22 % and 51 % when azathioprine and mycophenolate mofetil , respectively , were added to a regimen consisting of cyclosporine , usp ( modified ) and corticosteroids .
None(e1,e2)	28	45	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	7	erythromycin and clarithromycin ( and possibly other macrolide_antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
effect(e1,e2)	3	18	the use of dextromethorphan_hydrobromide may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
None(e1,e2)	10	47	although increased plasma concentrations ( auc 0-24 hrs ) of loratadine and/or descarboethoxyloratadine were observed following coadministration of loratadine with each of these drugs in normal volunteers ( n = 24 in each study ) , there were no clinically relevant changes in the safety profile of loratadine , as assessed by electrocardiographic parameters , clinical laboratory tests , vital signs , and adverse events .
None(e1,e2)	43	45	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	24	46	carbamazepine : carbamazepine causes an approximate 50 % increase in the clearance of felbatol at steady state and , therefore , the addition of carbamazepine results in an approximate 40 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	66	117	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	22	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	17	19	because of its primary cns effect , caution should be used when equetrotm is taken with other centrally_acting_drugs and alcohol .
None(e1,e2)	44	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	49	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	2	22	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	21	38	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	5	18	pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole , resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong qt intervals .
None(e1,e2)	2	11	co-administration of warfarin and cerivastatin did not alter the pharmacokinetics of cerivastatin_sodium .
None(e1,e2)	10	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	11	alprazolam : when fluvoxamine maleate ( 100 mg qd ) and alprazolam ( 1 mg q.d . were co-administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1/2 , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
effect(e1,e2)	4	12	cns-active drugs ethanol : sonata 10 mg potentiated the cns-impairing effects of ethanol 0.75 g/kg on balance testing and reaction time for 1 hour after ethanol administration and on the digit symbol substitution test ( dsst ) , symbol copying test , and the variability component of the divided attention test for 2.5 hours after ethanol administration .
None(e1,e2)	53	55	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	17	other : there appears to be no pharmacokinetic interaction between acitretin and cimetidine , digoxin , or glyburide .
None(e1,e2)	9	34	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	6	27	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	30	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	34	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle_relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	15	31	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
effect(e1,e2)	2	23	cyclopropane or halogenated_hydrocarbon_anesthetics increase cardiac autonomic irritability and may sensitize the myocardium to the action of certain intravenously administered catecholamines , such as dopamine .
effect(e1,e2)	2	12	administration of thiazide_diuretics to hypoparathyroid patients who are concurrently being treated with ergocalciferol may cause hypercalcemia .
None(e1,e2)	28	160	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	5	16	this could lead to decreased salicylate serum levels or increase the risk of salicylate toxicity when corticosteroid is withdrawn .
None(e1,e2)	8	21	notably , systemic exposure ( auc0-12 ) of dapsone_hydroxylamine ( dha ) was more than doubled in the presence of tmp/ smx .
None(e1,e2)	3	29	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	16	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	8	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	5	8	it may also interact with amantadine or other anticholinergic_drugs or maois , which may intensify the anticholinergic action .
None(e1,e2)	9	38	fifteen to 30 minutes of exposure to 1.25 mac isoflurane or enflurane had minimal effects on the duration of action of initial doses of nimbex and therefore , no adjustment to the initial dose should be necessary when nimbex is administered shortly after initiation of volatile agents .
None(e1,e2)	0	6	ketoconazole : in healthy subjects receiving ketoconazole , a cyp3a4 inhibitor , at 200 mg twice daily for 7 days , systemic exposure ( auc ) to lapatinib was increased to approximately 3.6-fold of control and half-life increased to 1.7-fold of control .
effect(e1,e2)	10	19	nonsteroidal anti-inflammatory agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal antiinflammatory agents ) and corticosteroids increases the risk of gastrointestinal side effects .
None(e1,e2)	32	53	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	29	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	32	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	7	9	since bacteriostatic drugs , such as the tetracycline_class of antibiotics , may interfere with the bactericidal action of penicillins , it is not advisable to administer these drugs concomitantly .
None(e1,e2)	20	34	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	16	39	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	4	8	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	27	32	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g . ketoconazole , ampicillin esters , iron salts , digoxin ) .
None(e1,e2)	74	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	20	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	16	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	12	14	no clinically important pharmacokinetic interactions occurred when prinivil was used concomitantly with propranolol or hydrochlorothiazide .
None(e1,e2)	15	20	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	19	46	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	2	4	sucralfate and antacids : quinolones form chelates with metal cations .
None(e1,e2)	11	19	other cyp3a4 inducers include , but are not limited to , rifabutin , rifapentine , phenytoin , carbamazepine , phenobarbital and st. johns wort .
None(e1,e2)	33	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	23	29	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic acid ) , erythromycin , azole antifungals .
None(e1,e2)	28	47	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic_acid , and acetaminophen .
None(e1,e2)	3	16	potential interactions between taxol , a substrate of cyp3a4 , and protease inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	15	40	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	4	28	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	24	30	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	8	21	this drug may interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	1	5	in opioid -dependent patients , mixed_agonist/antagonist_analgesics may precipitate withdrawal symptoms .
None(e1,e2)	44	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	18	central_nervous_system_depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	8	28	in clinical studies where patients were on chronic theophylline therapy , lomefloxacin had no measurable effect on the mean distribution of theophylline concentrations or the mean estimates of theophylline clearance .
None(e1,e2)	0	18	quinolone_antibiotic s : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	0	11	antipyrine : antipyrine pharmacokinetics were not significantly different before and after tiagabine multiple-dose regimens .
int(e1,e2)	61	70	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide_antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	21	24	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
mechanism(e1,e2)	10	12	trough plasma enoxacin levels were also 20 % higher when caffeine and enoxacin were administered concomitantly .
None(e1,e2)	75	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	18	potential interactions between taxol , a substrate of cyp3a4 , and protease inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	15	21	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	10	28	- lithium : lithium should generally not be given with diuretics ( such as bumetanide ) because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	10	17	pyrantel ( e.g. , antiminth ) - taking piperazine and pyrantel together may decrease the effects of piperazine .
None(e1,e2)	46	73	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	85	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	35	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	73	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	2	11	use of prinivil with potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
mechanism(e1,e2)	16	21	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	3	12	persons taking most antibiotics , methotrexate and pyrimethamine invalidate folic acid and vitamin_b12 diagnostic blood assays .
None(e1,e2)	0	37	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
effect(e1,e2)	1	18	some quinolones , including ciprofloxacin , have been associated with transient elevations in serum creatinine in patients receiving cyclosporine concomitantly .
None(e1,e2)	19	22	anticoagulants : coagulation parameters should be tested more frequently and monitored regularly during simultaneous administration of high doses of heparin , oral anticoagulants , or other drugs that may affect the blood coagulation system or the thrombocyte function .
advise(e1,e2)	4	31	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	0	24	anticholinergic_agents : although ipratropium bromide is minimally absorbed into the systemic circulation , there is some potential for an additive interaction with concomitantly used anticholinergic_medications .
None(e1,e2)	0	2	probenecid : probenecid , a renal tubular secretion blocking agent , administered at a dose of 500 mg four times a day , did not change the pharmacokinetics of levetiracetam 1000 mg twice daily .
None(e1,e2)	10	19	beta-blocking agents a pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine .
None(e1,e2)	0	9	diuretics : studies in normal volunteers have shown that flurbiprofen like other nonsteroidal anti-inflammatory drugs , can interfere with the effects of furosemide .
None(e1,e2)	17	28	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin_reuptake_inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
effect(e1,e2)	9	23	spontaneous reports of serotonin syndrome associated with co-administration of zyvox and serotonergic agents , including antidepressants such as selective serotonin reuptake inhibitors ( ssris ) , have been reported .
None(e1,e2)	44	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	4	10	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	27	38	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao_inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	8	13	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	46	49	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	0	14	estrogens , including oral contraceptives : estrogens may decrease the hepatic metabolism of certain corticosteroids , thereby increasing their effect .
effect(e1,e2)	0	12	clonidine_hydrochloride may enhance the cns-depressive effects of alcohol , barbiturates or other sedatives .
advise(e1,e2)	0	17	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
None(e1,e2)	31	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	29	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	86	94	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	85	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	14	immunosuppressive drugs , fibric acid derivatives , niacin ( nicotinic acid , erythromycin , azole_antifungals : skeletal muscle .
effect(e1,e2)	0	9	antihistamines may have additive effects with alcohol and other cns_depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	6	8	other reported interactions with amiodarone : fentanyl ( cyp3a4 substrate ) in combination with amiodarone may cause hypotension , bradycardia , and decreased cardiac output .
mechanism(e1,e2)	3	13	the administration of guanfacine concomitantly with known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half-life and plasma concentration .
None(e1,e2)	18	20	magnesium/aluminum-containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium / aluminum -containing antacid products .
None(e1,e2)	93	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	62	75	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	20	31	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl_alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants .when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	26	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	39	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	65	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	23	29	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	81	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	24	38	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	1	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	4	26	the prior administration of succinylcholine does not enhance the duration , but quickens the onset and may increase the depth , of neuromuscular block induced by tracrium .
None(e1,e2)	35	37	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin_ii_receptor_antagonists ( acei /arb ) .
None(e1,e2)	23	30	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns_depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	0	25	levothyroxine_sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol_hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	0	18	macrolide_antibiotics ( e. g. erythromycin and troleandomycin ) : agents of the ergot alkaloid class , of which d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp is a member , have been shown to interact with antibiotics of the macrolide class , resulting in increased plasma levels of unchanged alkaloids and peripheral vasoconstriction .
None(e1,e2)	14	23	although a dose adjustment of azithromycin is not recommended when administered in combination with nelfinavir , close monitoring for known side effects of azithromycin , such as liver enzyme abnormalities and hearing impairment , is warranted .
None(e1,e2)	10	40	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	18	33	drugs demonstrated to be cyp 3a inhibitors of possible clinical significance on the basis of clinical studies involving alprazolam ( caution is recommended during coadministration with alprazolam ) : coadministration of fluoxetine with alprazolam increased the maximum plasma concentration of alprazolam by 46 % , decreased clearance by 21 % , increased half-life by 17 % , and decreased measured psychomotor performance .
None(e1,e2)	22	26	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
effect(e1,e2)	3	5	concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
None(e1,e2)	59	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	5	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv_protease_inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	6	21	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium_citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	22	28	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	0	14	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal_anti-inflammatory_drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
None(e1,e2)	8	11	no information is available about the use of butorphanol concurrently with mao_inhibitors .
effect(e1,e2)	14	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	24	41	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	8	16	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	0	2	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
None(e1,e2)	75	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	71	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	17	heparin : since heparin is contraindicated in patients with heparin-induced thrombocytopenia , the co-administration of argatroban and heparin is unlikely for this indication .
mechanism(e1,e2)	7	9	inhibitors of cyp1a2 : concomitant use of duloxetine with fluvoxamine , an inhibitor of cyp1a2 , results in approximately a 6-fold increase in auc and about a 2.5-fold increase in cmax of duloxetine .
None(e1,e2)	0	9	corticosteroids : a relationship of functional antagonism exists between vitamin_d analogues , which promote calcium absorption , and corticosteroids , which inhibit calcium absorption .
mechanism(e1,e2)	0	10	antacids or sucralfate substantially interfere with the absorption of some quinolones , resulting in low urine levels .
None(e1,e2)	0	32	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	12	17	plasma concentrations of quinolone antibiotics are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	105	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	52	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	69	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	12	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	0	8	phenobarbital : estimates of steady-state pharmacokinetic parameters for phenobarbital or gabapentin ( 300 mg tid ;
effect(e1,e2)	14	23	furosemide : clinical studies , as well as post-marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	5	13	digoxin : concomitant administration of tiagabine did not affect the steady-state pharmacokinetics of digoxin or the mean daily trough serum level of digoxin .
effect(e1,e2)	6	41	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin_m parenteral .
effect(e1,e2)	1	35	several tricyclic_antidepressants have been reported to block the pharmacologic effects of guanethidine , clonidine , or similar agents , and such an effect may be anticipated with cmi because of its structural similarity to other tricyclic_antidepressants .
None(e1,e2)	41	90	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	79	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	33	39	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
advise(e1,e2)	5	7	thus , concomitant administration of enoxacin and bismuth_subsalicylate should be avoided .
None(e1,e2)	78	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	41	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	11	- lofexidine may enhance the cns depressive effects of alcohol , barbiturates and other sedatives
None(e1,e2)	17	29	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	8	29	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
effect(e1,e2)	0	8	antihistamines may partially counteract the anticoagulation effects of heparin or warfarin .
None(e1,e2)	5	14	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
None(e1,e2)	0	8	antibiotics : no human drug interaction studies with antibiotics were conducted .
None(e1,e2)	42	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	11	13	the administration of guanfacine concomitantly with known microsomal enzyme inducer ( phenobarbital or phenytoin ) to two patients with renal impairment reportedly resulted in significant reductions in elimination half-life and plasma concentration .
None(e1,e2)	9	21	rifabutin , another rifamycin , is structurally similar to rifampin and may possibly have some of the same drug interactions as rifampin .
None(e1,e2)	23	29	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
advise(e1,e2)	10	30	although specific drug interaction studies have not been conducted with alphagan_p , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	0	2	cyclosporine , tacrolimus and digoxin concentrations should be monitored at the initiation of itraconazole therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
None(e1,e2)	23	35	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	16	22	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	20	22	in vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome cyp 2c9 substrates/inhibitors sulphenazole , tolbutamide and nifedipine .
advise(e1,e2)	1	15	- perhexiline_hydrogen_maleate or mao-inhibitors ( with hepatotoxic potential ) must not be administered together with bezalip or bezalip retard .
None(e1,e2)	23	27	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac_glycosides and tricyclic anti-depressants .
None(e1,e2)	5	39	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	26	69	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	22	37	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	16	24	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	14	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	21	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	10	17	garlic capsules garlic capsules should not be used while taking saquinavir ( fortovase ) as the sole protease_inhibitor due to the risk of decreased saquinavir plasma concentrations .
None(e1,e2)	28	37	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	17	31	the risk of myopathy during treatment with drugs of this class is increased with concurrent administration of cyclosporine , fibric acid derivatives , niacin ( nicotinic acid ) , erythromycin , azole_antifungals .
None(e1,e2)	13	16	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	0	21	rifampin : when a single 375-mg dose of aprepitant was administered on day9 of a 14-day regimen of 600 mg/day of rifampin , a strong cyp3a4 inducer , the auc of aprepitant decreased approximately 11-fold and the mean terminal half-life decreased approximately 3-fold .
None(e1,e2)	6	16	the pharmacokinetics and protein binding of fosphenytoin , phenytoin , and diazepam were not altered when diazepam and cerebyx were concurrently administered in single submaximal doses .
effect(e1,e2)	14	17	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	10	18	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	16	25	the auc and cmax of both the ( r ) and ( s ) isomers of warfarin were unaffected by concurrent dosing of 0.3 mg cerivastatin_sodium .
None(e1,e2)	0	3	prednisone /prednisolone : rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone .
None(e1,e2)	17	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
advise(e1,e2)	3	5	patients treated with acebutolol plus catecholamine_depletors should , therefore , be observed closely for evidence of marked bradycardia or hypotension which may present as vertigo , syncope/presyncope , or orthostatic changes in blood pressure without compensatory tachycardia .
None(e1,e2)	87	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	3	18	warfarin : when fluvoxamine_maleate ( 50 mg tid ) was administered concomitantly with warfarin for two weeks , warfarin plasma concentrations increased by 98 % and prothrombin times were prolonged .
None(e1,e2)	42	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	6	21	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
mechanism(e1,e2)	0	10	valdecoxib caused a statistically significant increase in plasma exposures of r-warfarin and s-warfarin ( 12 % and 15 % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as inr ) of warfarin .
None(e1,e2)	18	24	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	0	9	digoxin : studies of concomitant administration of flurbiprofen and digoxin to healthy men ( n= 14 ) did not show a change in the steady state serum levels of either drug .
None(e1,e2)	22	29	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	4	7	the concomitant use of alcohol or other central_nervous_system_depressants may have an additive effect .
None(e1,e2)	45	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	6	8	naproxen : the concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .
None(e1,e2)	56	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	57	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	16	should it be decided to discontinue therapy in patients receiving beta-blockers and clonidine concurrently , the beta-blocker should be discontinued slowly over several days before the gradual withdrawal of clonidine .
None(e1,e2)	6	8	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	5	digitalis_glycosides : therapeutic effects of digitalis_glycosides may be reduced .
None(e1,e2)	6	8	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	80	108	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	3	warfarin : when fluvoxamine_maleate ( 50 mg tid ) was administered concomitantly with warfarin for two weeks , warfarin plasma concentrations increased by 98 % and prothrombin times were prolonged .
None(e1,e2)	13	18	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
effect(e1,e2)	4	6	the concurrent use of tetracycline and penthrane ( methoxyflurane ) has been reported to result in fatal renal toxicity .
None(e1,e2)	14	26	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	1	4	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	28	132	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	23	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	33	35	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	5	7	probenecid : as with other b-lactam_antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
effect(e1,e2)	6	8	anticoagulants , oral : co-administration of corticosteroids and warfarin usually results in inhibition of response to warfarin , although there have been some conflicting reports .
None(e1,e2)	20	25	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum_hydoxide , cholestyramine resin , colestipol_hydrochloride , ferrous sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	10	13	concomitant crohn s disease medications were antibiotics , antivirals , corticosteroids , 6-mp/ aza and aminosalicylates .
advise(e1,e2)	5	23	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
effect(e1,e2)	14	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
advise(e1,e2)	3	20	plasma concentrations of cyclosporine should therefore be closely monitored , and its dosage reduced accordingly , in patients treated with nicardipine .
None(e1,e2)	20	41	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	0	8	dopamine_d2_receptor_antagonists ( e.g. , phenothiazines , butyrophenones , risperidone ) and isoniazid may reduce the therapeutic effects of levodopa .
None(e1,e2)	42	60	clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in inr or warfarin dose ( baseline vs. end of the clinical studies ) , and the need to change the warfarin dose during the trials due to changes in inr or due to adverse events was similar among bosentan - and placebo-treated patients .
None(e1,e2)	2	5	naproxen , naproxen_sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
None(e1,e2)	6	18	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	12	17	eprosartan has been shown to have no effect on the pharmacokinetics of digoxin and the pharmacodynamics of warfarin and glyburide .
None(e1,e2)	95	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	10	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	20	45	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic_agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	43	48	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	0	5	platelet_inhibitors : drugs such as acetylsalicylic_acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	6	29	may interact with the following : beta-adrenergic_blocking_agents ( these medicines may make your condition worse and prevent the adrenergic bronchodilators from working properly ) and disopyramide , quinidine , phenothiazines , and procainamide ( these medicines may increase the risk of heart problems ) .
None(e1,e2)	17	34	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot_alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	13	17	on the basis of the metabolism of bexarotene by cytochrome p450 3a4 , ketoconazole , itraconazole , erythromycin , gemfibrozil , grapefruit juice , and other inhibitors of cytochrome p450 3a4 would be expected to lead to an increase in plasma bexarotene concentrations .
None(e1,e2)	59	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	10	there is a significant increase in exposure to imatinib when gleevec is coadministered with ketoconazole ( cyp3a4 inhibitor ) .
None(e1,e2)	24	31	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
mechanism(e1,e2)	22	28	the following drug interactions have been identified involving nizoral tablets and other drugs metabolized by the cytochrome p450 3a4 enzyme system : ketoconazole tablets inhibit the metabolism of terfenadine , resulting in an increased plasma concentration of terfenadine and a delay in the elimination of its acid metabolite .
None(e1,e2)	22	39	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal_anti-inflammatory_agents ] is contraindicated .
None(e1,e2)	26	42	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
effect(e1,e2)	5	8	propoxyphene : in cases of propoxyphene overdosage , amphetamine cns stimulation is potentiated and fatal convulsions can occur .
None(e1,e2)	38	52	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
mechanism(e1,e2)	8	38	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	4	24	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	15	65	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood_thinner s ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	16	18	doxazosin mesylate has been administered without any evidence of an adverse drug interaction to patients receiving thiazide_diuretics , beta-blocking_agent s , and nonsteroidal anti-inflammatory drugs .
None(e1,e2)	28	44	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
effect(e1,e2)	0	8	trecator may potentiate the adverse effects of other antituberculous_drugs administered concomitantly .
effect(e1,e2)	3	13	naproxen and other nsaids can reduce the antihypertensive effect of propranolol and other beta-blockers .
None(e1,e2)	10	12	amiodarone may suppress certain cyp450 enzymes , including cyp1a2 , cyp2c9 , cyp2d6 , and cyp3a4 .
None(e1,e2)	12	22	h2 blockers/proton pump inhibitors : long-term suppression of gastric acid secretion by h2_blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	0	28	digoxin : the concomitant administration of dynacirc ( isradipine ) and digoxin in a single-dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of digoxin .
None(e1,e2)	11	37	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic_antidepressants : flupenthixol increases the effect of tricyclic antidepressants
effect(e1,e2)	0	19	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns_depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	39	49	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	20	31	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	38	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	4	32	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	0	42	phenytoin : no significant differences were observed in mean phenytoin auc , c max , c min or t max ( although c max increased by 11 % ) when extended phenytoin sodium capsules ( 100 mg tid ) were coadministered with lomefloxacin ( 400 mg qd ) for five days in 15 healthy males .
None(e1,e2)	11	13	effects of gabitril on other antiepilepsy drugs ( aeds ) : phenytoin : tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy .
None(e1,e2)	24	49	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
None(e1,e2)	26	39	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	6	20	it is not known whether other progestational_contraceptives , such as implants and injectables , are adequate methods of contraception during acitretin therapy .
None(e1,e2)	10	18	patients should be advised against the simultaneous use of other cns_depressant_drugs , and cautioned that the effect of alcohol may be increased .
effect(e1,e2)	3	6	phenothiazines - taking piperazine and a phenothiazine together may increase the risk of convulsions ( seizures ) .
advise(e1,e2)	10	22	concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations and peak plasma levels .
None(e1,e2)	12	14	pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , ketoconazole , erythromycin and azithromycin .
None(e1,e2)	8	16	in a study of schizophrenic patients who received clozapine under steady state conditions , fluvoxamine or paroxetine was added in 16 and 14 patients , respectively .
None(e1,e2)	6	9	known drug interactions include barbiturates , tranquilizers , and alcohol .
None(e1,e2)	114	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	15	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	0	15	theophylline serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and pegasys .
None(e1,e2)	13	20	other concomitant therapy in healthy subjects there were no clinically significant interactions when felodipine was given concomitantly with indomethacin or spironolactone .
effect(e1,e2)	16	21	ampicillin/amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
None(e1,e2)	107	126	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	13	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	10	18	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	0	24	vardenafil ( 20 mg ) did not potentiate the hypotensive effects of alcohol during the 4-hour observation period in healthy volunteers when administered with alcohol ( 0.5 g/kg body weight ) .
None(e1,e2)	19	25	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	12	14	in patients with chronic hepatitis c treated with pegasys in combination with copegus , pegasys treatment did not affect ribavirin distribution or clearance .
None(e1,e2)	36	47	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	35	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	42	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
None(e1,e2)	10	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	41	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	26	41	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	14	17	amiodarone taken concomitantly with procainamide for less than seven days increases plasma concentrations of procainamide and n-acetyl procainamide by 55 % and 33 % , respectively .
None(e1,e2)	0	4	amiodarone is metabolized to desethylamiodarone by the cytochrome p450 ( cyp450 ) enzyme group , specifically cytochromes p450 3a4 ( cyp3a4 ) and cyp2c8 .
None(e1,e2)	41	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
mechanism(e1,e2)	5	8	however , co administration of fexofenadine_hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine .
None(e1,e2)	2	19	- a monoamine_oxidase_inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	71	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	17	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	3	6	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	10	12	the combination of therapeutic doses of intravenous dantrolene sodium and verapamil in halothane a-chloralose anesthetized swine has resulted in ventricular fibrillation and cardiovascular collapse in association with marked hyperkalemia .
None(e1,e2)	18	22	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	0	8	central_nervous_system_depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	48	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	34	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	9	24	phase ii clinical trial data , where iressa and vinorelbine have been used concomitantly , indicate that iressa may exacerbate the neutropenic effect of vinorelbine .
None(e1,e2)	6	12	data from a randomized trial of hexalen and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity ;
None(e1,e2)	6	12	potassium-sparing diuretics such as spironolactone , triamterene , or amiloride , or potassium supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
None(e1,e2)	8	30	promethazine : coadministration of a single dose of zaleplon and promethazine ( 10 and 25 mg , respectively ) resulted in a 15 % decrease in maximal plasma concentrations of zaleplon , but no change in the area under the plasma concentration-time curve .
None(e1,e2)	7	39	the extent of plasma protein binding of atovaquone in human plasma is not affected by the presence of therapeutic concentrations of phenytoin ( 15 mcg/ ml ) , nor is the binding of phenytoin affected by the presence of atovaquone .
None(e1,e2)	30	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	16	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	44	46	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	13	drugs that cause significant sustained elevation in gastric ph ( histamine_h2-receptor_antagonists such as ranitidine or cimetidine ) may reduce plasma concentrations of iressa and therefore potentially may reduce efficacy .
None(e1,e2)	53	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	5	42	in a multiple-dose study , enoxacin caused a dose-related increase in the mean elimination half-life of caffeine , thereby decreasing the clearance of caffeine by up to 80 % and leading to a five-fold increase in the auc and the half-life of caffeine .
None(e1,e2)	9	11	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	12	22	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	13	29	ganciclovir : administration of videx 2 hours prior to or concurrent with oral ganciclovir was associated with a 111 ( 114 ) % increase in the steady-state auc of didanosine ( n = 12 ) .
None(e1,e2)	41	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	13	serum lithium levels should be monitored frequently if inspra is administered concomitantly with lithium .
None(e1,e2)	10	19	it is recommended to avoid concurrent administration of ethambutol with aluminum_hydroxide containing antacids for at least 4 hours following ethambutol administration .
effect(e1,e2)	8	24	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine_class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety_agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	14	18	the use of codeine may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
None(e1,e2)	24	48	in addition , steady state levels of racemic citalopram were not significantly different in poor metabolizers and extensive cyp2d6 metabolizers after multiple-dose administration of citalopram , suggesting that coadministration , with escitalopram , of a drug that inhibits cyp2d6 , is unlikely to have clinically significant effects on escitalopram metabolism .
None(e1,e2)	105	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	37	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	22	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac_tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	35	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	16	35	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	3	48	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	49	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	22	28	there are case reports of patients who developed increased bun , serum creatinine and serum potassium levels , and weight gain when furosemide was used in conjunction with nsaids .
effect(e1,e2)	4	11	the anticoagulant effect of heparin is enhanced by concurrent treatment with antithrombin_iii ( human ) in patients with hereditary antithrombin iii deficiency .
None(e1,e2)	32	36	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	9	11	allegra should not be taken closely in time with aluminum and magnesium containing antacids .
None(e1,e2)	22	28	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	9	11	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
advise(e1,e2)	4	6	during concomitant therapy of ponstel with furosemide , the patient should be observed closely for signs of renal failure , as well as to assure diuretic efficacy .
None(e1,e2)	1	45	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	10	16	nephrotoxicity has been reported following concomitant administration of cephalosporins with aminoglycoside_antibiotics or potent diuretics such as furosemide .
None(e1,e2)	18	50	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium_hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	5	7	oral anticoagulants interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants .
None(e1,e2)	24	26	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	51	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	14	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
effect(e1,e2)	0	10	chlorthalidone may add to or potentiate the action of other antihypertensive_drugs .
None(e1,e2)	30	35	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	26	34	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	53	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	54	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	56	70	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	0	5	cyclosporin : after introduction of chloroquine ( oral form ) , a sudden increase in serum cyclosporin level has been reported .
None(e1,e2)	11	48	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	0	24	beta_blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	25	35	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	37	43	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	83	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	54	65	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	0	20	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	30	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	31	43	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	58	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	19	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	38	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	30	44	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	10	20	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
effect(e1,e2)	2	10	administration of doxapram to patients who are receiving sympathomimetic or monoamine_oxidase_inhibiting_drugs may result in an additive pressor effect .
None(e1,e2)	7	11	therapeutic concentrations of digoxin , warfarin , ibuprofen , naproxen , piroxicam , acetaminophen , phenytoin andtolbutamide did not alter ketorolac tromethamine protein binding .
advise(e1,e2)	4	7	if concomitant treatment with frovatriptan and an ssri is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	16	33	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	135	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	6	8	blunting of the antihypertensive effect of beta-adrenoceptor_blocking_agents by nonsteroidal_anti-inflammatory_drugs has been reported .
None(e1,e2)	50	62	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	23	29	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	2	18	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	1	9	if novolog is mixed with nph human insulin , novolog should be drawn into the syringe first .
None(e1,e2)	28	30	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	0	37	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	129	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	34	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium_hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	0	2	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
advise(e1,e2)	0	6	anafranil should not be used with mao_inhibitors .
None(e1,e2)	105	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	3	24	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl_estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	14	19	drugs metabolized by cytochrome p450 enzymes the drug interaction study evaluating the effect of grepafloxacin on theophylline indicates that grepafloxacin inhibits theophylline metabolism , which is mediated by cyp1a2 .
None(e1,e2)	20	28	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	67	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	20	interactions for vitamin d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	26	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	10	18	the use of antacids should be considered in place of h2_blockers or proton pump inhibitors in patients receiving sprycel therapy .
None(e1,e2)	8	29	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	55	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	10	16	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic_agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	18	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	50	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	18	20	caution should be exercised when the following drugs are administered concomitantly with lodosyn ( carbidopa ) given with levodopa or carbidopa -levodopa combination products .
None(e1,e2)	2	4	vasoconstrictors : d.h.e_._45 ( dihydroergotamine_mesylate ) injection , usp should not be used with peripheral vasoconstrictors because the combination may cause synergistic elevation of blood pressure .
None(e1,e2)	9	16	accordingly , careful patient monitoring and dose adjustment of metformin is recommended in patients concomitantly taking cephalexin and metformin .
None(e1,e2)	5	15	concomitant administration with racemic citalopram citalopram - since escitalopram is the active isomer of racemic citalopram ( celexa ) , the two agents should not be coadministered .
None(e1,e2)	10	22	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial_agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	26	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	13	acidifying agents : gastrointestinal acidifying agents ( guanethidine , reserpine , glutamic_acid_hcl , ascorbic_acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	40	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	2	23	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	24	32	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
advise(e1,e2)	4	33	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	10	12	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
None(e1,e2)	52	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	15	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	0	29	central_nervous_system_depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle_relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	2	13	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
effect(e1,e2)	2	13	ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity .
None(e1,e2)	85	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	33	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	23	toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	37	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	34	36	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	22	24	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	12	16	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	1	8	magnesium/ aluminum -containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/aluminum-containing antacid products .
None(e1,e2)	32	38	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	71	80	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	25	30	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	10	23	after 14 days of co-administration , mean trough concentrations of clozapine and its metabolites , n-desmethylclozapine and clozapine n-oxide , were elevated with fluvoxamine by about three-fold compared to baseline concentrations .
None(e1,e2)	32	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	15	33	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
mechanism(e1,e2)	21	28	intestinal adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
None(e1,e2)	24	85	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
effect(e1,e2)	4	12	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
None(e1,e2)	76	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	9	corticosteroids : a relationship of functional antagonism exists between vitamin_d_analogues , which promote calcium absorption , and corticosteroids , which inhibit calcium absorption .
None(e1,e2)	44	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	0	22	alcohol : alcohol ( 0.5 g/kg body weight : approximately 40 ml of absolute alcohol in a 70 kg person ) and vardenafil plasma levels were not altered when dosed simultaneously .
None(e1,e2)	0	2	diphenhydramine : diphenhydramine is reported to be a weak inhibitor of aldehyde oxidase in rat liver , but its inhibitory effects in human liver are not known .
None(e1,e2)	0	15	antipyrine : because atorvastatin does not affect the pharmacokinetics of antipyrine , interactions with other drugs metabolized via the same cytochrome isozymes are not expected .
None(e1,e2)	38	43	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	24	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
effect(e1,e2)	11	23	as with other antipsychotic agents , it should be noted that haldol may be capable of potentiating cns depressants such as anesthetics , opiates , and alcohol .
None(e1,e2)	22	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	26	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	13	no interaction with the tricyclic_antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/dopa-decarboxylase inhibitor .
None(e1,e2)	26	30	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic_agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	8	18	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
None(e1,e2)	4	9	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace inhibitor therapy .
None(e1,e2)	11	18	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .
None(e1,e2)	0	29	tolazamide : a case of severe hypoglycemia has been reported in a type ii diabetic patient maintained on tolazamide ( 1 gm/day ) 11 days after the addition of doxepin ( 75 mg/day ) .
None(e1,e2)	0	8	aspirin : concurrent administration of aspirin may lower meclofenamate_sodium plasma levels , possibly by competing for protein-binding sites .
None(e1,e2)	8	16	the effect of foods highly fortified with elemental iron ( primarily iron-fortified breakfast cereals ) on cefdinir absorption has not been studied .
None(e1,e2)	18	20	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	40	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	13	22	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium_hydroxide s ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
effect(e1,e2)	4	34	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	22	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	31	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	3	5	cholestyramine-concomitant intake of cholestyramine and vitamin_k may reduce the absorption of vitamin k .
None(e1,e2)	40	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	42	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	2	11	digoxin : digoxin concentrations are increased by about 15 % when digoxin and carvedilol are administered concomitantly .
None(e1,e2)	9	16	these agents include medications such as : anticoagulants , platelet_inhibitors including acetylsalicylic acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	62	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	8	12	data from a randomized trial of hexalen and cisplatin plus or minus pyridoxine in ovarian cancer indicated that pyridoxine significantly reduced neurotoxicity ;
None(e1,e2)	16	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	44	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	22	36	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	3	7	noncardioselective beta-blockers ( nadolol , porpranolol , timolol ) may exacerbate rebound hypertension when guanfacine is withdrawn .
None(e1,e2)	9	31	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	0	8	cancidas did not increase the plasma levels of cyclosporine .
None(e1,e2)	6	20	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	30	34	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
mechanism(e1,e2)	0	8	d-amphetamine with desipramine or protriptyline and possibly other tricyclics cause striking and sustained increases in the concentration of d-amphetamine in the brain ;
None(e1,e2)	7	21	in a study involving healthy subjects receiving tambocor and propranolol concurrently , plasma flecainide levels were increased about 20 % and propranolol levels were increased about 30 % compared to control values .
None(e1,e2)	7	10	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
mechanism(e1,e2)	2	4	administration of diltiazem_hydrochloride with digoxin in 24 healthy male subjects increased plasma digoxin concentrations approximately 20 % .
None(e1,e2)	17	24	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	91	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	9	32	inhibitors of cyp1a2 : concomitant use of duloxetine with fluvoxamine , an inhibitor of cyp1a2 , results in approximately a 6-fold increase in auc and about a 2.5-fold increase in cmax of duloxetine .
None(e1,e2)	0	9	anticoagulants : ten patients who were stabilized on oral anticoagulants were given guanfacine , 1-2 mg/day , for 4 weeks .
None(e1,e2)	59	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	6	14	monoamine oxidase inhibitors : coadministration of moclobemide resulted in a 27 % decrease in almotriptan clearance and an increase in cmax of approximately 6 % .
None(e1,e2)	2	19	effect of aeds in pediatric patients there was about a 22 % increase of apparent total body clearance of levetiracetam when it was co-administered with enzyme-inducing aeds .
None(e1,e2)	12	14	products containing calcium and other multivalent cations ( such as aluminum , magnesium , iron ) are likely to interfere with absorption of ibandronate .
None(e1,e2)	29	33	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin_d .
None(e1,e2)	40	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	10	14	use with allopurinol : the principal pathway for detoxification of azathioprine is inhibited by allopurinol .
None(e1,e2)	0	10	rifampin : following concomitant administration of a single dose of arava to subjects receiving multiple doses of rifampin , m1 peak levels were increased ( ~40 % ) over those seen when arava was given alone .
None(e1,e2)	12	14	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	23	126	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	17	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	14	35	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	16	18	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	2	42	effects of felbatol on low-dose combination oral contraceptives a group of 24 nonsmoking , healthy white female volunteers established on an oral contraceptive regimen containing 30 mg ethinyl estradiol and 75 mg gestodene for at least 3 months received 2400 mg/day of felbamate from midcycle ( day 15 ) to midcycle ( day 14 ) of two consecutive oral contraceptive cycles .
None(e1,e2)	2	18	although other hormonal_contraceptives are highly effective , there have been reports of pregnancy from women who have used combined_oral_contraceptives , as well as topical/injectable/implantable/insertable hormonal birth control products .
None(e1,e2)	88	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	26	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic_acid ( 20 % decrease in binding ) , tolbutamide , prednisolone ( 10 % decrease in binding ) , or warfarin .
None(e1,e2)	32	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	5	15	a single dose of liquid antacid did not affect the c max or auc of ceftibuten ;
None(e1,e2)	8	30	however , co-administration of duloxetine with aluminum- and magnesium -containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	69	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	34	64	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	1	5	- rifampin ( rifadin , rifamate ) ;
None(e1,e2)	1	3	- anticoagulants ( blood_thinner s ) or
mechanism(e1,e2)	0	8	welchol decreased the cmax and auc of sustained-release verapamil ( calan sr ) by approximately 31 % and 11 % , respectively .
None(e1,e2)	31	39	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	27	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	0	33	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
None(e1,e2)	3	26	therefore , when hydroflumethiazide and nonsteroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained . )
None(e1,e2)	0	7	calcium supplements : uncontrolled intake of additional calcium -containing preparations should be avoided .
None(e1,e2)	20	36	triazolam - combined administration of racemic citalopram ( titrated to 40 mg/day for 28 days ) and the cyp3a4 substrate triazolam ( single dose of 0.25 mg ) did not significantly affect the pharmacokinetics of either citalopram or triazolam .
advise(e1,e2)	0	8	netilmicin should not be administered concomitantly with potent loop_diuretics such as furosemide and ethacrynic acid as the potential for ototoxicity is enhanced by the combination .
mechanism(e1,e2)	5	20	ascorbic acid : doses of ascorbic_acid ( vitamin c ) 1 g/day have been reported to increase plasma concentration of synthetic_estrogens by ~47 % , possibly by inhibiting conjugation ;
None(e1,e2)	30	43	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	24	25	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis_drug rifampin .
None(e1,e2)	9	19	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns_depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	4	21	co-administration of tikosyn with verapamil resulted in increases in dofetilide peak plasma levels of 42 % , although overall exposure to dofetilide was not significantly increased .
mechanism(e1,e2)	2	11	theophylline : grepafloxacin is a competitive inhibitor of the metabolism of theophylline .
None(e1,e2)	78	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	0	7	aminosalicylic_acid may also decrease the absorption of vitamin_b12 , which can lead to a deficiency .
None(e1,e2)	30	54	diltiazem : in patients with mild to moderate hypertension , administration of aprepitant once daily , as a tablet formulation comparable to 230 mg of the capsule formulation , with diltiazem 120 mg 3 times daily for 5 days , resulted in a 2-fold increase of aprepitant auc and a simultaneous 1.7-fold increase of diltiazem auc .
None(e1,e2)	26	33	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	6	17	no interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa /dopa-decarboxylase inhibitor .
None(e1,e2)	0	13	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	27	36	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
effect(e1,e2)	8	20	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl_alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
advise(e1,e2)	5	29	therefore , nitroglycerin or other nitrates ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting captopril .
None(e1,e2)	52	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	42	49	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e . 45 ( dihydroergotamine mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	5	10	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	0	21	steroids enhance the renal toxicity of edetate calcium disodium in animals . 7 edetate calcium disodium interferes with the action of zinc_insulin preparations by chelating the zinc . 7
None(e1,e2)	23	31	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
advise(e1,e2)	5	7	therefore , the combination of ketoprofen and probenecid is not recommended .
None(e1,e2)	29	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	15	24	because there is a theoretical basis that these effects may be additive , use of ergotamine -containing or ergot-type medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	16	24	because the tetracyclines have been shown to depress plasma prothrombin activity , patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage .
None(e1,e2)	52	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	28	digoxin : the concomitant administration of dynacirc ( isradipine ) and digoxin in a single-dose pharmacokinetic study did not affect renal , nonrenal and total body clearance of digoxin .
None(e1,e2)	0	8	digoxin : when multiple doses of atorvastatin and digoxin were coadministered , steady-state plasma digoxin concentrations increased by approximately 20 % .
None(e1,e2)	80	142	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	63	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	5	11	caution should be exercised when anticoagulants are given in conjunction with atromid-s .
None(e1,e2)	0	5	theophylline : the pharmacokinetics of theophylline ( aminophylline 5.8 mg/kg infused over 20 minutes ) were unchanged following a single oral dose of albendazole ( 400 mg ) in 6 healthy subjects .
advise(e1,e2)	5	31	caution should be taken when enablex is used concomitantly with medications that are predominantly metabolized by cyp2d6 and which have a narrow therapeutic window , such as flecainide , thioridazine and tricyclic_antidepressants ( see clinical pharmacology ) .
None(e1,e2)	1	44	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	24	36	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	6	19	beta-adrenergic blocking agents : coadministration of beta-adrenergic_blocking_agents did not have any effect on either the safety or efficacy of ibutilide in the clinical trials .
None(e1,e2)	105	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	11	interactions with other antiretroviral_drugs : significant decreases in the auc of delavirdine ( 20 % ) and indinavir ( 84 % ) occurred following simultaneous administration of these agents with videx .
None(e1,e2)	10	14	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	1	15	anesthetics/ sedatives /hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	6	54	cancidas reduced the blood auc0-12 of tacrolimus by approximately 20 % , peak blood concentration ( cmax ) by 16 % , and 12-hour blood concentration ( c12hr ) by 26 % in healthy subjects when tacrolimus ( 2 doses of 0.1 mg/kg 12 hours apart ) was administered on the 10th day of cancidas 70 mg daily , as compared to results from a control period in which tacrolimus was administered alone .
None(e1,e2)	24	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	16	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	36	53	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
mechanism(e1,e2)	6	28	plasma levels of several closely related tricyclic_antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	0	8	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	6	20	of the 229 patients who had potassium_depleting_diuretics added to their concomitant medications in the diamond trials , the patients on tikosyn had a non-significantly reduced relative risk for death of 0.68 ( 95 % ci 0.376 , 1.230 ) .
None(e1,e2)	27	46	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	33	35	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	83	110	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	23	33	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
int(e1,e2)	10	12	when administered concurrently , the following drugs may interact with beta-adrenergic_receptor_blocking_agents : anesthetics , general : exaggeration of the hypotension induced by general anesthetics .
None(e1,e2)	4	25	a possible interaction between glyburide and ciprofloxacin , a fluoroquinolone antibiotic , has been reported , resulting in a potentiation of the hypoglycemic action of glyburide .
None(e1,e2)	56	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	11	diphenhydramine hydrochloride has additive effects with alcohol and other cns_depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	0	13	dicumarol : it has been reported that allopurinol prolongs the half-life of the anticoagulant , dicumarol .
None(e1,e2)	0	17	lithium serum concentrations should be monitored closely when initiating or changing therapy with bextra in patients receiving lithium .
None(e1,e2)	3	5	pyrazolone derivatives ( phenylbutazone , oxyphenbutazone , and possibly dipyrone ) : concomitant administration with aspirin may increase the risk of gastrointestinal ulceration .
None(e1,e2)	6	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	13	19	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	2	26	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	6	22	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	5	12	codeine in combination with other narcotic_analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	41	50	this interaction , which has not been investigated using higher doses of fluvoxamine , may be more pronounced if a 300 mg daily dose is co-administered , particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg . if alprazolam is co-administered with fluvoxamine tablets , the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended .
None(e1,e2)	68	70	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide_antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	0	7	warfarin - administration of 40 mg/day racemic citalopram for 21 days did not affect the pharmacokinetics of warfarin , a cyp3a4 substrate .
None(e1,e2)	85	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	71	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	33	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin_d .
advise(e1,e2)	2	4	co-administration of myobloc and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare-like compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
None(e1,e2)	1	21	when amiodarone is added to flecainide therapy , plasma flecainide levels may increase two-fold or more in some patients , if flecainide dosage is not reduced .
None(e1,e2)	1	27	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
None(e1,e2)	58	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	7	48	inhibitors of this isoenzyme ( e.g. , macrolide_antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	20	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	13	however , patients receiving infusions of flolan in clinical trials were maintained on anticoagulants without evidence of increased bleeding .
None(e1,e2)	7	16	oral contraceptives : the effect of oral contraceptives on the pharmacokinetics of d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp has not been studied .
None(e1,e2)	0	41	ketoconazole : when a single 125-mg dose of aprepitant was administered on day5 of a 10-day regimen of 400 mg/day of ketoconazole , a strong cyp3a4 inhibitor , the auc of aprepitant increased approximately 5-fold and the mean terminal half-life of aprepitant increased approximately 3-fold .
None(e1,e2)	30	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	124	130	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	30	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
mechanism(e1,e2)	2	8	co-administration of bosentan decreased the plasma concentrations of glyburide by approximately 40 % .
effect(e1,e2)	13	20	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic_agonists .
None(e1,e2)	97	121	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	43	59	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	19	28	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	13	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	24	antithyroid_agents may decrease thyroidal uptake of sodium iodide i131 , a rebound in uptake may occur up to 5 days after sudden withdrawal of carbimazole .
None(e1,e2)	6	10	extended release tablets : administration of nifedipine with digoxin increased digoxin levels in 9 of 12 normal volunteers .
None(e1,e2)	15	17	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	8	13	clonidine hydrochloride may enhance the cns-depressive effects of alcohol , barbiturates or other sedatives .
None(e1,e2)	17	29	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	9	21	when amiodarone is added to flecainide therapy , plasma flecainide levels may increase two-fold or more in some patients , if flecainide dosage is not reduced .
None(e1,e2)	9	17	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace_inhibitors during therapy with lithium .
advise(e1,e2)	2	10	microdosed minipill progestin preparations are not recommended for use with soriatane .
None(e1,e2)	37	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	18	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	18	19	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone /ethinyl estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	26	28	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
mechanism(e1,e2)	16	23	a 21 ( 17 ) % decrease in the steady-state auc of ganciclovir was observed when videx was administered 2 hours prior to ganciclovir , but not when the two drugs were administered simultaneously ( n = 12 ) .
None(e1,e2)	7	14	beta-blockers : in controlled clinical studies , adrenergic_beta-receptor_blockers have been frequently administered concomitantly with nicardipine_hcl .
None(e1,e2)	0	11	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	8	13	a clinical interaction study was also conducted with alosetron and the cyp3a4 substrate cisapride .
None(e1,e2)	25	33	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal_contraceptive ortho-novum produced average decreases of norethindrone and ethinyl_estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	4	37	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	40	50	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
None(e1,e2)	32	40	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	33	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	8	11	dosage adjustment may be required if cyclosporine , tacrolimus , or methylprednisolone are given concomitantly with nizoral tablets .
None(e1,e2)	7	9	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	9	19	hydrochlorothiazide : in normal volunteers , concomitant administration of diflunisal and hydrochlorothiazide resulted in significantly increased plasma levels of hydrochlorothiazide .
None(e1,e2)	17	20	pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly , including thiazide diuretics , digoxin , and cimetidine .
effect(e1,e2)	2	12	however , iloprost has the potential to increase the hypotensive effect of vasodilators and antihypertensive agents .
None(e1,e2)	21	41	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	2	4	antacids and kaolin : antacids and kaolin can reduce absorption of chloroquine ;
None(e1,e2)	13	17	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	60	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	20	22	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
effect(e1,e2)	15	26	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic_antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	17	19	no interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa / dopa-decarboxylase_inhibitor .
mechanism(e1,e2)	3	17	the increase of phenobarbital level , however , is small ( 15 % ) when given with trileptal .
mechanism(e1,e2)	8	23	studies in humans show that the absorption of chlorothiazide as reflected in urinary excretion is markedly decreased even when administered one hour before colestipol_hydrochloride .
None(e1,e2)	65	79	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	23	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine receptors , thus inhibiting the central stimulant effects of amphetamines and can be used to treat amphetamine poisoning .
None(e1,e2)	21	26	the pharmacokinetics of terfenadine and its acid metabolite and the electrocardiographic qt c interval were measured during both periods : with terfenadine alone , and with terfenadine plus dirithromycin .
None(e1,e2)	78	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	15	increased toxicity ( cns depression ) : cns depressants , mao_inhibitors , tricyclic antidepressants , phenothiazines .
None(e1,e2)	28	37	the ecg changes and/or hypokalemia that may result from the administration of non-potassium sparing diuretics ( such as loop or thiazide diuretics ) can be acutely worsened by beta-agonists , especially when the recommended dose of the beta-agonist is exceeded .
None(e1,e2)	19	150	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	2	10	with oral dapsone treatment , folic acid antagonists such as pyrimethamine have been noted to possibly increase the likelihood of hematologic reactions
None(e1,e2)	31	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	18	20	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	35	50	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	8	15	because lithium may enhance the serotonergic effects of escitalopram , caution should be exercised when lexapro and lithium are coadministered .
None(e1,e2)	22	26	the following medications have been administered in clinical trials with simulect with no increase in adverse reactions : atg/alg , azathioprine , corticosteroids , cyclosporine , mycophenolate_mofetil , and muromonab-cd3 .
None(e1,e2)	3	11	drug-drug interactions between keppra and other antiepileptic drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	12	19	additive cns depression may occur when antihistamines are administered concomitantly with other cns_depressants including barbiturates , tranquilizers , and alcohol .
None(e1,e2)	28	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	1	40	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	22	28	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
None(e1,e2)	32	34	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	33	53	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	23	human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in an eight-fold increase in the mean auc of cisapride .
None(e1,e2)	39	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	45	48	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	49	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	33	37	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	21	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	11	20	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
None(e1,e2)	38	44	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	30	32	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	10	21	co-administration of anastrozole and tamoxifen resulted in a reduction of anastrozole plasma levels by 27 % compared with those achieved with anastrozole alone .
None(e1,e2)	44	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	7	patients receiving hydantoins , sulfonamides , or sulfonylureas should be observed for increased activity of these drugs and , therefore , signs of toxicity from these drugs .
None(e1,e2)	4	8	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	4	15	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
int(e1,e2)	2	12	experience with nonsteroidal_anti-inflammatory_drugs ( nsaids ) suggests the potential for interactions with furosemide and ace inhibitors .
mechanism(e1,e2)	19	42	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	22	33	although specific drug interaction studies have not been conducted with alphagan p , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , or anesthetics ) should be considered .
None(e1,e2)	2	22	alcohol : alcohol ( 0.5 g/kg body weight : approximately 40 ml of absolute alcohol in a 70 kg person ) and vardenafil plasma levels were not altered when dosed simultaneously .
None(e1,e2)	15	27	inhibitors of cyp2d6 : because cyp2d6 is involved in duloxetine metabolism , concomitant use of duloxetine with potent inhibitors of cyp2d6 may result in higher concentrations of duloxetine .
None(e1,e2)	13	30	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	19	24	another oral azole antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
effect(e1,e2)	42	47	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic_antidepressants
None(e1,e2)	53	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	46	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	19	23	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/ sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	62	82	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	14	34	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	2	73	tolbutamide : aprepitant , when given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , decreased the auc of tolbutamide ( a cyp2c9 substrate ) by 23 % on day 4 , 28 % on day 8 , and 15 % on day 15 , when a single dose of tolbutamide 500 mg was admini , stered orally prior to the administration of the 3-day regimen of aprepitant and on days 4,8 , and 15 .
None(e1,e2)	34	55	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	9	12	talk to your doctor if you are taking certain antibiotics such as erythromycin , clarithromycin or azithromycin .
None(e1,e2)	38	44	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	0	14	theophylline : following co-administration of two 250-mg dirithromycin tablets administered once daily with 200-mg theophylline tablets administered twice daily for 10 days to 14 healthy subjects , the steady-state plasma concentration of theophylline was not significantly altered .
None(e1,e2)	13	17	these data indicate that levetiracetam does not influence the plasma concentration of other aeds and that these aeds do not influence the pharmacokinetics of levetiracetam .
None(e1,e2)	33	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	40	47	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	6	16	however , co-administration of duloxetine with aluminum - and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	0	9	ergotamine : concurrent use of erythromycin and ergotamine or dihydroergotamine has been associated in some patients with acute ergot toxicity characterized by severe peripheral vasospasm and dysesthesia .
None(e1,e2)	85	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	16	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	6	8	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
mechanism(e1,e2)	10	19	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
None(e1,e2)	20	29	terfenadine : no clinically significant changes occurred in heart rate or corrected qt intervals , or in terfenadine metabolite or lomefloxacin pharmacokinetics , during concurrent administration of lomefloxacin and terfenadine at steady-state in 28 healthy males .
None(e1,e2)	22	32	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
mechanism(e1,e2)	4	9	these studies indicate that ketoconazole or erythromycin co-administration enhances fexofenadine gastrointestinal absorption .
None(e1,e2)	11	16	alcohol : there was no significant difference between aripiprazole coadministered with ethanol and placebo coadministered with ethanol on performance of gross motor skills or stimulus response in healthy subjects .
mechanism(e1,e2)	19	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	10	20	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
mechanism(e1,e2)	2	8	antacids containing magnesium_trisilicate , when administered concomitantly with nitrofurantoin , reduce both the rate and extent of absorption .
None(e1,e2)	2	6	studies with ace_inhibitors in combination with diuretics indicate that the dose of the ace inhibitor can be reduced when it is given with a diuretic .
None(e1,e2)	27	32	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	0	5	sedatives /hypnotics : triazolam , midazolam contraindicated due to potential for serious and/or life-threatening reactions such as prolonged or increased sedation or respiratory depression .
None(e1,e2)	42	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	30	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	4	8	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	1	18	because dexfenfluramine is a serotonin releaser and reuptake inhibitor , dexfenfluramine should not be used concomitantly with a mao_inhibitor .
None(e1,e2)	6	16	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	41	55	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	24	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	13	43	pimozide and celexa - in a controlled study , a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in qtc values of approximately 10 msec compared to pimozide given alone .
None(e1,e2)	4	6	coadministration of entecavir with lamivudine , adefovir_dipivoxil , or tenofovir disoproxil fumarate did not result in significant drug interactions .
None(e1,e2)	66	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	70	80	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	2	4	nafazodone , fluvoxamine , cimetidine ( consider xanax dose reduction ) .
None(e1,e2)	11	23	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	15	36	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	22	32	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
effect(e1,e2)	15	27	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating_drugs .
None(e1,e2)	9	11	in vitro studies demonstrated no evidence of incompatibility of heparin with extraneal .
None(e1,e2)	110	127	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	26	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
effect(e1,e2)	4	11	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	5	10	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	19	30	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
int(e1,e2)	0	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	2	50	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
None(e1,e2)	24	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	10	12	dolasetron mesylate did not inhibit the antitumor activity of four chemotherapeutic_agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	23	35	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	20	29	cimetidine - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of 400 mg/day cimetidine for 8 days resulted in an increase in citalopram auc and cmax of 43 % and 39 % , respectively .
None(e1,e2)	8	12	flexeril may enhance the effects of alcohol , barbiturates , and other cns_depressants .
None(e1,e2)	5	10	drug/laboratory test interactions as with cephalothin , high concentrations of cefoxitin ( 100 micrograms/ml ) may interfere with measurement of serum and urine creatinine levels by the jaff reaction , and produce false increases of modest degree in the levels of creatinine reported .
None(e1,e2)	33	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	36	in order to avoid the occurrence of severe hypersensitivity reactions , all patients treated with taxol should be premedicated with corticosteroids ( such as dexamethasone ) , diphen-hydramine and h2 antagonists ( such as cimetidine or ranitidine ) .
None(e1,e2)	20	24	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl_alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	69	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	20	magnesium - and aluminum-containing antacids , administered concomitantly with lomefloxacin , significantly decreased the bioavailability ( 48 % ) of lomefloxacin .
None(e1,e2)	0	36	cancidas reduced the blood auc0-12 of tacrolimus by approximately 20 % , peak blood concentration ( cmax ) by 16 % , and 12-hour blood concentration ( c12hr ) by 26 % in healthy subjects when tacrolimus ( 2 doses of 0.1 mg/kg 12 hours apart ) was administered on the 10th day of cancidas 70 mg daily , as compared to results from a control period in which tacrolimus was administered alone .
None(e1,e2)	2	5	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
effect(e1,e2)	14	23	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	8	12	mercaptopurine/azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric_acid .
None(e1,e2)	14	17	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	10	34	in the first study , concomitant administration of 0.2 mg cerivastatin_sodium and 12 g cholestyramine resulted in decreases of more than 22 % for auc and 40 % for cmax when compared to dosing cerivastatin_sodium alone .
None(e1,e2)	8	40	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	26	30	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	11	18	because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole ( an imidazole ) and oral hypoglycemic_agents , such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets ( an imidazole ) can not be ruled out .
None(e1,e2)	10	21	vitamin a : because of the relationship of accutane to vitamin_a , patients should be advised against taking vitamin supplements containing vitamin_a to avoid additive toxic effects
None(e1,e2)	6	9	when concomitant administration of ketoconazole with aripiprazole occurs , aripiprazole dose should be reduced to one-half of its normal dose .
None(e1,e2)	0	4	cyclosporine , tacrolimus and digoxin concentrations should be monitored at the initiation of itraconazole therapy and frequently thereafter , and the dose of these three drug products adjusted appropriately .
None(e1,e2)	26	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	18	magnesium/aluminum-containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium /aluminum-containing antacid products .
None(e1,e2)	77	79	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin_sodium under-dosage .
None(e1,e2)	85	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	26	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron_supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	0	18	aspirin : in normal volunteers , a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly .
None(e1,e2)	0	10	promethazine : coadministration of a single dose of zaleplon and promethazine ( 10 and 25 mg , respectively ) resulted in a 15 % decrease in maximal plasma concentrations of zaleplon , but no change in the area under the plasma concentration-time curve .
None(e1,e2)	51	53	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	16	21	as with other agents with b-blocking properties , if coreg is to be administered orally with calcium_channel_blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
None(e1,e2)	10	21	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	23	32	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous sulfate , sodium_polystyrene_sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	0	8	sucralfate or divalent or trivalent cations such as iron ;
None(e1,e2)	4	53	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	3	23	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	87	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	27	other substances : grapefruit juice given to healthy volunteers increased amiodarone auc by 50 % and cmax by 84 % , resulting in increased plasma levels of amiodarone .
None(e1,e2)	1	10	- anabolic_steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
advise(e1,e2)	4	17	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
effect(e1,e2)	8	52	hypotension patients on diuretic therapy : patients on diuretics and especially those in whom diuretic therapy was recently instituted , as well as those on severe dietary salt restriction or dialysis , may occasionally experience a precipitous reduction of blood pressure usually within the first hour after receiving the initial dose of captopril .
None(e1,e2)	0	7	astemizole , bepridil , sparfloxacin , and terodiline .
effect(e1,e2)	0	18	cyclophosphamide treatment , which causes a marked and persistent inhibition of cholinesterase activity , potentiates the effect of succinylcholine_chloride .
None(e1,e2)	33	36	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	1	5	certain antibiotics , especially the aminoglycosides and polymyxins ;
None(e1,e2)	21	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	28	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	41	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	56	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	12	18	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	0	2	pegasys and copegus are excreted by the kidney , and the risk of toxic reactions to this therapy may be greater in patients with impaired renal function .
None(e1,e2)	13	27	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
int(e1,e2)	8	16	caution should be exercised when administering nabumetone with warfarin since interactions have been seen with other nsaids .
None(e1,e2)	31	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	11	colestipol : plasma concentrations of atorvastatin decreased approximately 25 % when colestipol and atorvastatin were coadministered .
None(e1,e2)	0	10	amphotericin_b or potassium-depleting diuretics ( benzothiadiazines and related drugs , ethacrynic_acid and furosemide ) enhanced hypokalemia .
None(e1,e2)	38	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	4	12	calcium channel blockers , dihydropyridine : e.g. , felodipine , nifedipine , nicardipine
effect(e1,e2)	0	6	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
None(e1,e2)	18	21	caution should be exercised when the following drugs are administered concomitantly with lodosyn ( carbidopa ) given with levodopa or carbidopa- levodopa combination products .
None(e1,e2)	8	12	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	21	70	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	0	25	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
None(e1,e2)	15	32	carbamazepine - combined administration of racemic citalopram ( 40 mg/day for 14 days ) and carbamazepine ( titrated to 400 mg/day for 35 days ) did not significantly affect the pharmacokinetics of carbamazepine , a cyp3a4 substrate .
effect(e1,e2)	7	22	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	2	4	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	32	51	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	7	13	mineral oil-concomitant intake of mineral oil and vitamin_k may reduce the absorption of vitamin_k .
None(e1,e2)	11	35	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	114	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	85	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	20	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	25	34	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis_kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	5	14	probenecid : concomitant administration of toradol oral and probenecid resulted in decreased clearance of ketorolac and significant increases in ketorolac plasma levels ( total auc increased approximately threefold from 5.4 to 17.8 m g/h/ml ) and terminal half-life increased approximately twofold from 6.6 to 15.1 hours .
None(e1,e2)	14	60	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin_b12 and folic acid .
mechanism(e1,e2)	3	9	digoxin : some calcium_blockers may increase the concentration of digitalis_preparations in the blood .
None(e1,e2)	14	26	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic_agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	7	18	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta blockers .
None(e1,e2)	46	79	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
None(e1,e2)	0	6	dexamethasone : steady-state trough concentrations of albendazole_sulfoxide were about 56 % higher when 8 mg dexamethasone was coadministered with each dose of albendazole ( 15 mg/kg/day ) in eight neurocysticercosis patients .
mechanism(e1,e2)	8	27	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	49	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	93	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	50	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	93	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	31	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	10	48	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	80	88	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	4	9	on administration of oral amiodarone , the need for digitalis therapy should be reviewed and the dose reduced by approximately 50 % or discontinued .
None(e1,e2)	24	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	0	8	gabitril is considered to be a non-enzyme inducing aed .
None(e1,e2)	19	21	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium_citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
None(e1,e2)	15	20	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	30	42	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	6	16	probenecid : the oral combination of probenecid before intramuscular injection of pipracil produces an increase in piperacillin peak serum level of about 30 % .
None(e1,e2)	4	6	antacids and kaolin : antacids and kaolin can reduce absorption of chloroquine ;
None(e1,e2)	3	26	therefore , when hydrochlorothiazide and non-steroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
None(e1,e2)	3	22	concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations and peak plasma levels .
None(e1,e2)	0	21	monoamine_oxidase_inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic_antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	100	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	18	34	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	28	40	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	0	4	hmg-coa_reductase_inhibitors : lovastatin , simvastatin warning potential for serious reactions such as risk of myopathy including rhabdomyolysis .
None(e1,e2)	27	42	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	6	8	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
mechanism(e1,e2)	11	52	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	4	6	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	10	24	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	6	7	potential for other drugs to affect abilify aripiprazole is not a substrate of cyp1a1 , cyp1a2 , cyp2a6 , cyp2b6 , cyp2c8 , cyp2c9 , cyp2c19 , or cyp2e1 enzymes .
effect(e1,e2)	8	16	in diabetic patients , the metabolic effects of androgens may decrease blood glucose and therefore , insulin requirements .
None(e1,e2)	13	18	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	65	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	4	fluconazole , and the 5-ht3_antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	0	3	non-selective_monoamine_oxidase_(_mao_)_inhibitors - including phenelzine_sulfate , tranylcypromine sulfate and pargyline hc1 .
None(e1,e2)	32	34	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	127	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	45	49	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	22	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic_acid , and tolbutamide in vitro .
None(e1,e2)	1	5	- sulfoxone ( e.g. , diasone ) or
None(e1,e2)	18	24	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	14	24	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide_mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	18	32	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	0	12	platelet_inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	26	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	34	40	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	6	10	antihypertensive medications , other , especially diazoxide , or pre anesthetic and anesthetic agents used in surgery or skeletal-muscle relaxants , nondepolarizing , used in surgery
None(e1,e2)	7	9	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
None(e1,e2)	16	26	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim/sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	6	10	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa reductase inhibitor .
None(e1,e2)	3	28	example inhibitors include azole_antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	0	8	probenecid : as with other b-lactam antibiotics , probenecid inhibits the renal excretion of cefdinir , resulting in an approximate doubling in a.c. a 54 % increase in peak cefdinir plasma levels , and a 50 % prolongation in the apparent elimination half-life .
None(e1,e2)	71	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	36	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	9	14	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
None(e1,e2)	0	21	boric_acid may interact with the idoxuridine preparation causing a gritty substance to form or may interact with the preservative in the idoxuridine preparation causing a toxic effect in the eye .
None(e1,e2)	20	31	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	51	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	47	54	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
effect(e1,e2)	1	7	warfarin- vitamin_k can antagonize the effect of warfarin
effect(e1,e2)	1	14	if desipramine_hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative /hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	36	43	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
None(e1,e2)	31	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	12	23	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists_.
None(e1,e2)	16	26	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	1	15	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl_estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
None(e1,e2)	2	18	methotrexate : valdecoxib_10_mg bid did not show a significant effect on the plasma exposure or renal clearance of methotrexate .
None(e1,e2)	21	50	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	42	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	0	17	skeletal_muscle_relaxants : amphotericin b-induced hypokalemia may enhance the curariform effect of skeletal muscle relaxants ( e.g. , tubocurarine ) .
None(e1,e2)	24	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	47	49	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	62	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	8	16	in 10 otherwise healthy subjects with epilepsy ingesting phenytoin , the steadystate trough ( cmin ) phenytoin plasma concentration was 17 5 micrograms/ml .
None(e1,e2)	6	20	anticoagulants : potentiation of warfarin-type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	58	60	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	4	24	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	9	16	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
mechanism(e1,e2)	16	19	phenytoin : in post-marketing experience , there have been reports of both increases and decreases in phenytoin levels with dexamethasone co-administration , leading to alterations in seizure control .
None(e1,e2)	0	46	cholestyramine resin may interfere with the pharmacokinetics of drugs that undergo enterohepatic circulation , the discontinuance of cholestyramine resin could pose a hazard to health if a potentially toxic drug such as digitalis has been filtrated to a maintenance level while the patient was taking cholestyramine resin .
None(e1,e2)	14	25	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central_nervous_system_depressant effects .
None(e1,e2)	27	29	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
mechanism(e1,e2)	14	27	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
effect(e1,e2)	3	16	concurrent administration of vasopressor_drugs ( for the treatment of hypotension related to obstetric blocks ) and ergot-type_oxytocic_drugs may cause severe , persistent hypertension or cerebrovascular accidents .
None(e1,e2)	6	21	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	24	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
advise(e1,e2)	11	13	combinations of these drugs have not been studied and coadministration of crixivan and atazanavir is not recommended .
None(e1,e2)	13	18	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	9	12	drug-drug interactions between keppra and other antiepileptic drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	59	108	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	8	18	interactions for vitamin b3 ( niacin ) : antihypertensive therapy : nicotinic acid may potentiate the effects of ganglionic_blocking_agents and vasoactive drugs resulting in postural hypotension .
None(e1,e2)	78	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	17	21	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
mechanism(e1,e2)	5	10	however , co administration of fexofenadine_hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine .
None(e1,e2)	77	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	9	21	alcohol : it should be borne in mind that alcohol ingestion may increase the danger inherent in any intentional or unintentional sinequan overdosage .
None(e1,e2)	49	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	28	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable/dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
None(e1,e2)	18	29	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	61	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	6	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	59	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	100	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	2	15	co-administration of myobloc and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare-like_compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
None(e1,e2)	3	9	ergot derivatives : dihydroergotamine , ergonovine , ergotamine , methylergonovine contraindicated due to potential for serious and life-threatening reactions such as acute ergot toxicity characterized by peripheral vasospasm and ischemia of the extremities and other tissues .
None(e1,e2)	55	81	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	30	32	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	39	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	7	13	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	34	53	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	30	42	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
advise(e1,e2)	1	17	- perhexiline_hydrogen_maleate or mao-inhibitors ( with hepatotoxic potential ) must not be administered together with bezalip or bezalip_retard .
None(e1,e2)	54	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	6	when taken orally , imidazole_compounds like ketoconazole may enhance the anticoagulant effect of coumarin-like drugs .
None(e1,e2)	20	29	naproxen : the concomitant administration of diflunisal and naproxen in normal volunteers had no effect on the plasma levels of naproxen , but significantly decreased the urinary excretion of naproxen and its glucuronide metabolite .
None(e1,e2)	15	19	other cyp3a4 inducers include , but are not limited to , rifabutin , rifapentine , phenytoin , carbamazepine , phenobarbital and st. johns wort .
None(e1,e2)	6	22	when vardenafil dosing was separated from terazosin 10 mg by 6 hours , 7 of 28 subjects who received 20 mg of vardenafil experienced a decrease in standing systolic blood pressure below 85 mm hg .
None(e1,e2)	6	22	administration of diltiazem hydrochloride concomitantly with propranolol in five normal volunteers resulted in increased propranolol levels in all subjects and bioavailability of propranolol was increased approximately 50 % .
None(e1,e2)	15	20	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	0	6	amphotericin_b or corticosteroids or corticotropin ( acth )
None(e1,e2)	5	13	in controlled clinical trials of augmentin_xr , 22 patients received concomitant allopurinol and augmentin_xr .
None(e1,e2)	0	9	lithium : nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .
None(e1,e2)	15	20	digoxin : in a study in 12 patients with congestive heart failure where ketoprofen and digoxin were concomitantly administered , ketoprofen did not alter the serum levels of digoxin .
None(e1,e2)	11	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	3	20	patients receiving both indomethacin and furosemide should be observed closely to determine if the desired diuretic and/or antihypertensive effect of furosemide is achieved .
None(e1,e2)	12	17	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	13	31	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	9	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	5	10	it is desirable to monitor tca plasma levels whenever a tca is going to be co-administered with another drug known to be an inhibitor of p450 2d6 .
None(e1,e2)	21	32	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle_relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	7	13	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
None(e1,e2)	18	43	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	27	47	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic_acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel_blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	18	20	digoxin - in subjects who had received 21 days of 40 mg/day racemic citalopram , combined administration of citalopram and digoxin ( single dose of 1 mg ) did not significantly affect the pharmacokinetics of either citalopram or digoxin .
None(e1,e2)	0	6	tolbutamide : in diabetic patients receiving diflunisal and tolbutamide , no significant effects were seen on tolbutamide plasma levels or fasting blood glucose .
mechanism(e1,e2)	2	10	isoflurane , enflurane , and halothane decrease the ed50 of nuromax by 30 % to 45 % .
None(e1,e2)	12	22	antidepressants : in vitro data indicate that nefazodone inhibits the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	9	11	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	65	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	41	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	2	ketoconazole : ketoconazole may inhibit both synthetic and catabolic enzymes of vitamin d .
None(e1,e2)	1	14	analgesic/ anti-inflammatory ( e.g. , acetaminophen , aspirin , codeine and codeine combinations , ibuprofen , indomethacin ) .
None(e1,e2)	144	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	19	interactions for vitamin d analogues ( vitamin_d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	37	41	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic_agents , such as disopyramide , are used concurrently .
None(e1,e2)	0	20	aspirin : in normal volunteers , a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly .
None(e1,e2)	38	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	22	24	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine_oxidase_(_mao_)_inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	34	40	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	114	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
effect(e1,e2)	15	20	pharmacologic studies indicate that there may be additive effects in prolonging av conduction when using beta-blockers or digitalis concomitantly with tiazac .
None(e1,e2)	28	38	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	39	44	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	39	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	14	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	15	18	because there is a theoretical basis that these effects may be additive , use of ergotamine -containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	51	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	13	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	83	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	17	the bioavailability of the capsule formulation of cefprozil was not affected when administered 5 minutes following an antacid .
None(e1,e2)	18	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	18	21	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
effect(e1,e2)	3	6	concurrent use of tetracyclines with oral contraceptives may render oral contraceptives less effective .
None(e1,e2)	47	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	139	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	57	62	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	9	14	chlorpropamide : chlorpropamides plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
None(e1,e2)	28	31	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	1	3	organic nitrates - l-arginine supplements theoretically may potentiate the effects of organic nitrates if taken concomitantly .
None(e1,e2)	23	54	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	3	5	the conversion of 6-deoxy_penciclovir to penciclovir is catalyzed by aldehyde oxidase .
None(e1,e2)	9	35	if desipramine hydrochloride is to be combined with other psychotropic_agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	26	36	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	69	71	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	50	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	100	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	18	33	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	35	43	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	26	78	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary_vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
None(e1,e2)	10	12	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	6	28	concomitant administration of targretin capsules and gemfibrozil resulted in substantial increases in plasma concentrations of bexarotene , probably at least partially related to cytochrome p450 3a4 inhibition by gemfibrozil .
None(e1,e2)	17	42	hypotension was more likely to occur if the calcium antagonist were a dihydropyridine derivative , e.g. , nifedipine , while left ventricular failure and av conduction disturbances , including complete heart block , were more likely to occur with either verapamil or diltiazem .
None(e1,e2)	70	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	22	49	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate_hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant_drugs .
None(e1,e2)	1	18	magnesium/aluminum-containing antacid_products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/ aluminum -containing antacid products .
None(e1,e2)	0	6	verapamil : coadministration of almotriptan and verapamil resulted in a 24 % increase in plasma concentrations of almotriptan .
None(e1,e2)	29	37	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	95	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	7	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
None(e1,e2)	11	17	other cyp3a4 inducers include , but are not limited to , rifabutin , rifapentine , phenytoin , carbamazepine , phenobarbital and st. johns wort .
None(e1,e2)	0	20	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving concomitant lithium and ace_inhibitor therapy .
None(e1,e2)	9	11	patients taking these drugs with lodosyn and levodopa or carbidopa - levodopa combination products should be carefully observed for loss of therapeutic response .
None(e1,e2)	13	17	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	2	36	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
advise(e1,e2)	5	9	wait 5 weeks after stopping escitalopram before starting a non-selective_mao_inhibitor .
None(e1,e2)	29	52	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	68	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	58	87	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	54	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	0	12	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	48	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	15	17	in vitro studies demonstrated that the plasma protein binding of des-ciclesonide was not affected by warfarin or salicylic_acid , indicating no potential for protein binding-based drug interactions .
None(e1,e2)	11	19	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	24	34	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	8	warfarin : meclofenamate sodium enhances the effect of warfarin .
None(e1,e2)	28	89	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	71	82	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	9	other agents : prinivil has been used concomitantly with nitrates and/or digoxin without evidence of clinically significant adverse interactions .
None(e1,e2)	9	11	fexofenadine had no effect on the pharmacokinetics of either erythromycin or ketoconazole .
None(e1,e2)	13	21	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
mechanism(e1,e2)	54	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	51	66	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	49	54	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	10	17	no significant drug interactions have been reported in studies of candesartan_cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	4	6	hmg-coa reductase inhibitors : simvastatin ( cyp3a4 substrate ) in combination with amiodarone has been associated with reports of myopathy/rhabdomyolysis .
mechanism(e1,e2)	10	34	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	0	11	hormonal_contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	18	58	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid_products .
None(e1,e2)	4	6	single doses of either cholestyramine or colestipol resins bind the hydrochlorothiazide and reduce its absorption from the gastrointestinal tract by up to 85 and 43 percent , respectively .
None(e1,e2)	7	9	digoxin : studies of concomitant administration of flurbiprofen and digoxin to healthy men ( n= 14 ) did not show a change in the steady state serum levels of either drug .
None(e1,e2)	10	18	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
None(e1,e2)	14	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
mechanism(e1,e2)	30	37	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
advise(e1,e2)	17	49	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	0	6	antacids , kaolin-pectin , sulfasalazine , neomycin , cholestyramine , certain anticancer drugs , and metoclopramide may interfere with intestinal digoxin absorption , resulting in unexpectedly low serum concentrations .
None(e1,e2)	6	15	dexamethasone : steady-state trough concentrations of albendazole_sulfoxide were about 56 % higher when 8 mg dexamethasone was coadministered with each dose of albendazole ( 15 mg/kg/day ) in eight neurocysticercosis patients .
None(e1,e2)	44	62	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	14	19	dose adjustment is not recommended.levetiracetam had no effect on plasma concentrations of carbamazepine , valproate , topiramate , or lamotrigine .
None(e1,e2)	131	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	9	- mephenytoin ( e.g. , mesantoin ) use of sulfapyridine with these medicines may increase the chance of side effects of these medicines
None(e1,e2)	76	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	32	the monoamine oxidase inhibitory effects of isocarboxazid may persist for a substantial period after discontinuation of the drug , and this should be borne in mind when another drug is prescribed following isocarboxazid .
None(e1,e2)	15	41	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	2	14	coadministration of crixivan and other drugs that inhibit cyp3a4 may decrease the clearance of indinavir and may result in increased plasma concentrations of indinavir .
None(e1,e2)	0	25	warfarin : when healthy subjects were administered starlix 120 mg three times daily before meals for four days in combination with a single dose of warfarin 30 mg on day 2 , there were no alterations in the pharmacokinetics of either agent .
None(e1,e2)	29	48	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	55	97	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	11	23	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	2	17	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	18	37	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline_salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	19	28	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
mechanism(e1,e2)	10	21	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective_serotonin_reuptake_inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
None(e1,e2)	7	11	cardiac effects of dopamine are antagonized by beta-adrenergic_blocking_agents , such as propranolol and metoprolol .
effect(e1,e2)	3	5	therefore , when edecrin and non-_steroidal_anti-_inflammatory_agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
effect(e1,e2)	6	18	adrenergic agents : some individuals receiving zyvox may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic_agents , vasopressor or dopaminergic agents .
None(e1,e2)	33	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	45	51	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	6	8	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	15	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	35	49	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	17	20	there have been greater than 2-fold increases in previously stable plasma levels of other antidepressants , including nortriptyline , when fluoxetine_hydrochloride has been administered in combination with these agents .
None(e1,e2)	0	2	methotrexate : humira has been studied in rheumatoid arthritis patients taking concomitant mtx .
None(e1,e2)	14	29	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	2	17	ketoconazole : ketoconazole 400 mg daily did not have any clinically important effect on the pharmacokinetics of rofecoxib .
None(e1,e2)	0	18	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
advise(e1,e2)	6	16	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	31	85	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	40	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	25	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
None(e1,e2)	30	33	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	22	27	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating_drugs .
None(e1,e2)	19	49	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton pump inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
None(e1,e2)	14	34	although it has not been established that there is an interaction between clozapine and benzodiazepines or other psychotropics , caution is advised when clozapine is initiated in patients taking a benzodiazepine or any other psychotropic_drug .
None(e1,e2)	26	42	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	26	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	12	23	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic_analgesic s , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	17	25	risk of anaphylactic reaction : although it is known that patients on beta-blockers may be refractory to epinephrine in the treatment of anaphylactic shock , beta-blockers can , in addition , interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks .
None(e1,e2)	2	4	cyclosporin , tacrolimus , sirolimus
None(e1,e2)	34	50	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	0	14	potassium supplements and potassium-sparing diuretics : fosinopril sodium can attenuate potassium loss caused by thiazide_diuretics .
None(e1,e2)	8	11	mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	29	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	13	ethoxzolamide may increase the action of tricyclics , amphetamines , procainamide , and quinidine .
None(e1,e2)	74	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	33	59	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	16	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	76	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	9	28	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	0	9	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable/dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
None(e1,e2)	55	83	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	2	41	anticonvulsants ( phenytoin ) : steady state plasma exposure ( auc ) of valdecoxib ( 40 mg bid for 12 days ) was decreased by 27 % when co-administered with multiple doses ( 300 mg qd for 12 days ) of phenytoin ( a cyp 3a4 inducer ) .
None(e1,e2)	66	74	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	10	20	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	0	10	cytotoxic_agents : enhanced bone marrow suppression by cyclophosphamide and other cytotoxic_agents has been reported among patients with neoplastic disease , except leukemia , in the presence of allopurinol .
None(e1,e2)	94	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	29	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	46	63	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic_acid .
None(e1,e2)	21	41	in addition , results from regression analyses of patient pharmacokinetic data suggest that co-administration of other inducers of drug clearance ( efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine ) with cancidas may result in clinically meaningful reductions in caspofungin concentrations .
None(e1,e2)	63	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	36	in a multiple dose study of theophylline ( 400 mg once daily for 3 days ) and cetirizine ( 20 mg once daily for 3 days ) , a 16 % decrease in the clearance of cetirizine was observed .
None(e1,e2)	13	17	other cyp3a4 inducers include , but are not limited to , rifabutin , rifapentine , phenytoin , carbamazepine , phenobarbital and st. johns wort .
None(e1,e2)	29	31	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	24	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	46	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	47	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	37	43	carbamazepine : coadministration of carbamazepine ( 200 mg bid ) , a potent cyp3a4 inducer , with aripiprazole ( 30 mg qd ) resulted in an approximate 70 % decrease in cmax and auc values of both aripiprazole and its active metabolite , dehydro-aripiprazole .
None(e1,e2)	26	45	aprepitant , when given as a regimen of 125 mg on day 1 and 80 mg/day on days 2 and 3 , increased the auc of methylprednisolone , a cyp3a4 substrate , by 1.34-fold on day 1 and by 2.5-fold on day 3 , when methylprednisolone was coadministered intravenously as 125 mg on day 1 and orally as 40 mg on days 2 and 3 .
advise(e1,e2)	21	30	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic_antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	35	37	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	24	26	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic_acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
effect(e1,e2)	14	26	the possibility of hypotensive effects with prinivil can be minimized by either discontinuing the diuretic or increasing the salt intake prior to initiation of treatment with prinivil .
None(e1,e2)	2	12	carbamazepine : tiagabine had no effect on the steady-state plasma concentrations of carbamazepine or its epoxide metabolite in patients with epilepsy .
None(e1,e2)	25	33	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	28	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	26	iron_supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	10	34	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	5	15	valproate : the addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8 % , which resulted in an increase of approximately 40 % in the free tiagabine concentration .
None(e1,e2)	21	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	43	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	56	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	15	24	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
effect(e1,e2)	4	30	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	2	17	interactions with mixed_agonist/antagonist_opioid_analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	12	42	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	19	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	129	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	97	105	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	0	8	aminosalicylic_acid may decrease the amount of digoxin ( lanoxin , lanoxicaps ) that gets absorbed into your body .
None(e1,e2)	30	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	35	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	17	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	24	30	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	9	25	ritonavir ( 600 mg b.i.d . ) co-administered with vardenafil 5 mg resulted in a 49-fold increase in vardenafil auc and a 13-fold increase in vardenafil cmax .
None(e1,e2)	33	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	15	histamine_h2-receptor_antagonists : histamine h2-receptor antagonists appear to have no significant effect on the bioavailability of ciprofloxacin .
None(e1,e2)	6	18	non-steroidal anti-inflammatory drugs ( but not aspirin ) : these drugs in combination with very high doses of quinolones have been shown to provoke convulsions in pre-clinical studies .
effect(e1,e2)	20	34	the concurrent use of two or more drugs with anticholinergic activity -- such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian drug ( eg , trihexyphenidyl ) , and/or a tricyclic_antidepressant ( eg , amitriptyline ) -- commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
None(e1,e2)	21	23	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	0	4	buprenorphine is metabolized to norbuprenorphine by cytochrome cyp 3a4 .
None(e1,e2)	98	108	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	11	in patients taking furosemide , nifedipine , diltiazem , ace_inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	40	50	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid_hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	3	cyclosporine : combination hormonal_contraceptives may inhibit the metabolism of cyclosporine , leading to increased plasma concentrations ;
mechanism(e1,e2)	6	20	cimetidine : in the presence of cimetidine at 300 mg qid ( n=12 ) the mean apparent oral clearance of gabapentin fell by 14 % and creatinine clearance fell by 10 % .
None(e1,e2)	30	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	9	28	antacids : concomitant administration of antacids containing magnesium or aluminum with videx chewable/dispersible buffered tablets or pediatric powder for oral solution may potentiate adverse events associated with the antacid components .
None(e1,e2)	59	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	19	magnesium/aluminum-containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/ aluminum -containing antacid products .
None(e1,e2)	0	13	colestipol -concomitant intake of colestipol and vitamin k may reduce the absorption of vitamin_k .
None(e1,e2)	8	16	alcohol : there was no significant difference between aripiprazole coadministered with ethanol and placebo coadministered with ethanol on performance of gross motor skills or stimulus response in healthy subjects .
advise(e1,e2)	4	6	the concomitant use of sodium_cephalothin and coly-mycin_m parenteral should be avoided .
None(e1,e2)	2	8	effects of erythromycin on felbatol the coadministration of erythromycin ( 1000 mg/day ) for 10 days did not alter the pharmacokinetic parameters of cmax , cmin , auc , ci/kg or tmax at felbamate daily doses of 3000 or 3600 mg/day in 10 otherwise healthy subjects with epilepsy .
None(e1,e2)	3	6	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
advise(e1,e2)	12	21	because of its primary cns effect , caution should be used when equetrotm is taken with other centrally acting drugs and alcohol .
None(e1,e2)	44	46	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	32	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	25	32	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	3	18	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	0	6	potassium-sparing_diuretics ( spironolactone , amiloride , triamterene , and others ) or potassium supplements can increase the risk of hyperkalemia .
None(e1,e2)	22	31	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	20	22	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	14	16	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	3	5	antidiabetic agents ( insulin , sulfonylureas ) : requirements for insulin or oral antidiabetic agents may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
None(e1,e2)	2	4	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
None(e1,e2)	16	31	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	1	11	- methyldopa ( e.g. , aldomet ) use of methyldopa with sulfapyridine may increase the chance of side effects affecting the liver and/or the blood
None(e1,e2)	20	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	5	15	probenecid : as with other b-lactams , the renal excretion of cephalexin is inhibited by probenecid .
None(e1,e2)	7	29	warfarin : co- administration of warfarin and cerivastatin to healthy volunteers did not result in any changes in prothrombin time or clotting factor vii when compared to co-administration of warfarin and placebo .
None(e1,e2)	7	37	although glucocorticoids have been shown to reduce proleukin -induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	13	25	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	6	21	coadministration of esomeprazole 30 mg and diazepam , a cyp2c19 substrate , resulted in a 45 % decrease in clearance of diazepam .
None(e1,e2)	5	10	in several well-controlled studies , guanfacine was administered together with diuretics with no drug interactions reported .
None(e1,e2)	34	42	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	62	75	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	6	20	administration of rifampin concomitantly with oral amiodarone has been shown to result in decreases in serum concentrations of amiodarone and desethylamiodarone .
mechanism(e1,e2)	5	21	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	12	16	pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , ketoconazole , erythromycin and azithromycin .
None(e1,e2)	2	26	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid -associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	80	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	110	114	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	1	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	19	95	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	72	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	4	25	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic_medications , or other drugs that produce cns depression .
None(e1,e2)	20	29	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	50	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	33	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	10	13	- drugs that may decrease plasma phenytoin concentrations include : carbamazepine , chronic alcohol abuse , reserpine
effect(e1,e2)	6	40	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	42	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
effect(e1,e2)	6	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	23	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	24	42	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	9	15	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	15	37	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	0	9	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace inhibitors during therapy with lithium .
None(e1,e2)	48	50	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	7	9	the absorption of tetracycline , furosemide , penicillin_g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
None(e1,e2)	39	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	40	73	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	47	62	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic_acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
effect(e1,e2)	14	18	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	5	32	concomitant administration of diflunisal and acetaminophen in dogs , but not in rats , at approximately 2 times the recommended maximum human therapeutic dose of each ( 40 to 52 mg/kg/day of diflunisal /acetaminophen ) resulted in greater gastrointestinal toxicity than when either drug was administered alone .
None(e1,e2)	29	31	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
None(e1,e2)	8	39	hypotension was more likely to occur if the calcium_antagonist were a dihydropyridine derivative , e.g. , nifedipine , while left ventricular failure and av conduction disturbances , including complete heart block , were more likely to occur with either verapamil or diltiazem .
None(e1,e2)	46	60	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin_b12 and folic acid .
None(e1,e2)	31	33	drugs that inhibit cyp3a4 cyp3a4 is a minor metabolic pathway for the elimination of zaleplon because the sum of desethylzaleplon ( formed via cyp3a4 in vitro ) and its metabolites , 5-oxo-desethylzaleplon and 5-oxo-desethylzaleplon_glucuronide , account for only 9 % of the urinary recovery of a zaleplon dose .
None(e1,e2)	23	25	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	0	10	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	18	31	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	30	59	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	53	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	25	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
None(e1,e2)	2	21	co-administration of naltrexone with acamprosate produced a 25 % increase in auc and a 33 % increase in the cmax of acamprosate .
None(e1,e2)	2	4	fluoxetine , ocs , sertraline , diltiazem , macrolide antibiotics ( exercise caution ) .
None(e1,e2)	11	19	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	17	29	effects of antacids on felbatol the rate and extent of absorption of a 2400 mg dose of felbatol as monotherapy given as tablets was not affected when coadministered with antacids .
None(e1,e2)	16	26	after the coadministration of 200 mg oral ketoconazole twice daily and one 20 mg dose of loratadine to 11 subjects , the auc and cmax of loratadine averaged 302 % ( 142 s.d . ) and 251 % ( 68 s.d . ) , respectively , of those obtained after co-treatment with placebo .
None(e1,e2)	1	27	because eprosartan is not metabolized by the cytochrome p450 system , inhibitors of cyp450 enzyme would not be expected to affect its metabolism , and ketoconazole and fluconazole , potent inhibitors of cyp3a and 2c9 , respectively , have been shown to have no effect on eprosartan pharmacokinetics .
None(e1,e2)	76	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	6	certain other antibiotics ( aminoglycosides and polymyxin ) have also been reported to interfere with the nerve transmission at the neuromuscular junction .
None(e1,e2)	51	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	1	9	- lofexidine may enhance the cns depressive effects of alcohol , barbiturates and other sedatives
None(e1,e2)	85	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	26	58	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	20	32	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	0	8	phenytoin : isoniazid may increase serum levels of phenytoin .
advise(e1,e2)	21	25	plasma tca concentrations may need to be monitored and the dose of the tca may need to be reduced if a tca is co-administered with duloxetine .
None(e1,e2)	95	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	20	48	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	8	12	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	25	27	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	6	21	iron supplements and foods fortified with iron concomitant administration of cefdinir with a therapeutic iron supplement containing 60 mg of elemental iron ( as feso4 ) or vitamins supplemented with 10 mg of elemental iron reduced extent of absorption by 80 % and 31 % , respectively .
None(e1,e2)	21	43	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	16	20	another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive_agents ethinyl estradiol and levonorgestrel ( cyp3a4 substrates ) .
advise(e1,e2)	0	29	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
None(e1,e2)	15	34	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
advise(e1,e2)	3	5	patients on oral antidiabetic_agents receiving velcade treatment may require close monitoring of their blood glucose levels and adjustment of the dose of their antidiabetic medication .
advise(e1,e2)	8	15	concomitant administration with racemic citalopram citalopram - since escitalopram is the active isomer of racemic citalopram ( celexa ) , the two agents should not be coadministered .
None(e1,e2)	18	31	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	35	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	36	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	12	15	bile acid binding resins may also interfere with the absorption of oral phosphate supplements and hydrocortisone .
None(e1,e2)	7	20	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	10	17	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic_antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
advise(e1,e2)	6	14	consequently , it is recommended that fluvoxamine not be used in combination with either terbinafine , astemizole , or cisapride .
None(e1,e2)	24	28	the concurrent use of two or more drugs with anticholinergic activity -- such as an antipsychotic drug ( eg , chlorpromazine ) , an antiparkinsonian_drug ( eg , trihexyphenidyl ) , and/or a tricyclic antidepressant ( eg , amitriptyline ) -- commonly results in excessive anticholinergic effects , including dry mouth and associated dental complications , blurred vision , and , in patients exposed to high temperature and humidity , hyperpyrexia .
None(e1,e2)	21	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	4	6	the concurrent use of toradol with muscle_relaxants has not been formally studied .
None(e1,e2)	8	17	since animal studies suggest that the action of barbiturates may be prolonged by therapy with chlorpropamide , barbiturates should be employed with caution .
None(e1,e2)	107	115	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	20	anticholinergics or other medications with anticholinergic activity - anticholinergic effects may be potentiated when these medications are used concurrently with diphenidol ;
None(e1,e2)	33	37	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	17	43	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal_muscle_relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	25	28	data from in vitro studies of benzodiazepines other than alprazolam suggest a possible drug interaction for the following : ergotamine , cyclosporine , amiodarone , nicardipine , and nifedipine .
None(e1,e2)	115	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	20	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	110	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	13	15	h-2 antagonists : in studies with human volunteers , co-administration of cimetidine or ranitidine with ibuprofen had no substantive effect on ibuprofen serum concentrations .
None(e1,e2)	6	28	in a pharmacokinetic interaction study with warfarin , bioavailability parameters , the degree of protein binding , and the anticoagulant effect ( measured by prothrombin time ) of warfarin were not significantly changed .
None(e1,e2)	6	13	until data on possible interactions between verapamil and disopyramide phosphate are obtained , disopyramide should not be administered within 48 hours before or 24 hours after verapamil administration .
None(e1,e2)	46	80	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	65	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	5	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	55	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	20	cyclosporine : elevated serum levels of cyclosporine have been reported with concomitant use of cyclosporine with other members of the quinolone_class .
None(e1,e2)	10	13	anesthetics/sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	19	29	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	47	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	23	in renal and cardiac transplant recipients , a reduction of cyclosporine dose ranging from 15 % to 48 % was necessary to maintain cyclosporine trough concentrations similar to those seen prior to the addition of diltiazem .
None(e1,e2)	36	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	19	27	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
mechanism(e1,e2)	3	15	- indomethacin : indomethacin blunts the increases in urine volume and sodium excretion seen during bumetanide treatment and inhibits the bumetanide-induced increase in plasma renin activity .
mechanism(e1,e2)	16	41	other potentially important drug interactions : benzodiazepines : benzodiazepines metabolized by hepatic oxidation ( e.g. , alprazolam , midazolam , triazolam elc . ) should be used with caution because the clearance of these drugs is likely to be reduced by fluvoxamine .
None(e1,e2)	16	18	the potential effects of increased plasma concentrations of midazolam or other benzodiazepines metabolized via cyp3a4 ( alprazolam , triazolam ) should be considered when coadministering these agents with aprepitant .
None(e1,e2)	28	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	12	19	dose adjustment is not recommended.levetiracetam had no effect on plasma concentrations of carbamazepine , valproate , topiramate , or lamotrigine .
None(e1,e2)	24	27	therefore , esomeprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( eg , ketoconazole , iron salts and digoxin ) .
None(e1,e2)	124	132	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	35	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	68	79	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	2	7	coadministration of ethoxzolamide with other diuretics , amphotericin_b , and corticosteroids may cause hypokalemia .
None(e1,e2)	15	25	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
mechanism(e1,e2)	16	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	17	27	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
None(e1,e2)	29	40	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	11	22	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	17	19	other drugs : in small groups of patients ( 7-10/interaction study ) , the concomitant administration of azathioprine , gold , chloroquine , d-penicillamine , prednisolone , doxycycline , or digitoxin did not significantly affect the peak levels and auc values of diclofenac .
None(e1,e2)	4	7	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	78	90	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	43	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	4	12	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	0	4	warfarin : co-administration of bosentan 500 mg b.i.d . for 6 days decreased the plasma concentrations of both s-warfarin ( a cyp2c9 substrate ) and r-warfarin ( a cyp3a4 substrate ) by 29 and 38 % , respectively .
None(e1,e2)	16	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	25	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	12	nonsteroidal_anti-inflammatory_drugs ( nsaids ) -a drug interaction study of eplerenone with an nsaid has not been conducted .
None(e1,e2)	3	26	therefore , when midamor and non-steroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained .
None(e1,e2)	2	18	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	31	37	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
effect(e1,e2)	19	24	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	6	18	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	33	35	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide_dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	87	143	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	11	other interactions : vardenafil had no effect on the pharmacodynamics of glyburide ( glucose and insulin concentrations ) and warfarin ( prothrombin time or other pharmacodynamic parameters ) .
None(e1,e2)	7	9	immunosuppressive drugs , fibric acid derivatives , niacin ( nicotinic_acid , erythromycin , azole antifungals : skeletal muscle .
effect(e1,e2)	0	48	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	5	8	when carbamazepine is added to aripiprazole therapy , aripiprazole dose should be doubled .
None(e1,e2)	13	30	in another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome p450 3a4 , increased the exposure ( auc ) of des-ciclesonide by approximately 3.6-fold at steady state , while levels of ciclesonide remained unchanged .
None(e1,e2)	12	23	a 21 ( 17 ) % decrease in the steady-state auc of ganciclovir was observed when videx was administered 2 hours prior to ganciclovir , but not when the two drugs were administered simultaneously ( n = 12 ) .
None(e1,e2)	8	18	aminoglycosides : the mixing of piperacillin with an aminoglycoside in vitro can result in substantial inactivation of the aminoglycoside .
None(e1,e2)	18	47	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide_diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	63	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	30	aspirin/acetaminophen : pharmacokinetic or pharmacodynamic drug-drug interactions have not been demonstrated between argatroban and concomitantly administered aspirin ( 162.5 mg orally given 26 and 2 hours prior to initiation of argatroban 1 g/kg/min . over 4 hours ) or acetaminophen ( 1000 mg orally given 12 , 6 and 0 hours prior to , and 6 and 12 hours subsequent to , initiation of argatroban 1.5 g/kg/min . over 18 hours ) .
None(e1,e2)	40	42	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	8	21	specific interaction studies have demonstrated the following : cyclosporine_a : during the first day of concomitant administration , trough concentrations of bosentan were increased by about 30-fold .
None(e1,e2)	31	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	4	14	the concomitant intake of alcohol and acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate .
None(e1,e2)	8	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	9	34	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	21	23	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	22	methotrexate renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin , potentially leading to increased plasma levels of methotrexate .
None(e1,e2)	0	5	antidiabetic_drugs ( oral agents and insulin ) : hypoglycemia or hyperglycemia ;
None(e1,e2)	11	35	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	12	14	co-medications that induce cyp 3a4 ( e.g. , rifampicin , phenytoin , carbamazepine , phenobarbital , or st. john s wort ) may significantly decrease exposure to exemestane .
None(e1,e2)	0	7	thioridazine : coadministration of single doses of sonata 20 mg and thioridazine 50 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration .
None(e1,e2)	26	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	11	anticoagulants : there have been reports of increased anticoagulant effects when erythromycin and oral anticoagulants were used concomitantly .
None(e1,e2)	23	34	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	2	4	fluconazole and ketoconazole : ketoconazole and fluconazole are predominantly cyp 3a4 and 2c9 inhibitors , respectively .
None(e1,e2)	10	14	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease_inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	13	19	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns_depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	1	13	rarely salicylate toxicity may occur in patients who discontinue steroids after concurrent high-dose aspirin therapy .
None(e1,e2)	27	32	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao_inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	1	5	- naltrexone ( e.g. , trexan ) ( with long-term , high-dose use ) or
None(e1,e2)	36	40	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	2	14	h2 blockers/ proton_pump_inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton_pump_inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	71	105	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral_hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	23	29	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	17	21	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	14	20	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
mechanism(e1,e2)	2	24	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	48	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	6	10	glyburide : the concomitant administration of ciprofloxacin with the sulfonylurea glyburide has , on rare occasions , resulted in severe hypoglycemia .
None(e1,e2)	14	16	the concomitant intake of alcohol and acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate .
None(e1,e2)	102	118	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	36	40	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	0	24	chlorpromazine : chlorpromazine blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines , and can be used to treat amphetamine poisoning .
None(e1,e2)	6	11	dosage adjustment may be required if cyclosporine , tacrolimus , or methylprednisolone are given concomitantly with nizoral tablets .
None(e1,e2)	19	36	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
advise(e1,e2)	14	16	since acetaminophen in high doses has been associated with hepatotoxicity , concomitant administration of diflunisal and acetaminophen should be used cautiously , with careful monitoring of patients .
None(e1,e2)	40	43	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
advise(e1,e2)	1	15	because tetracyclines have been shown to depress plasma prothrombin activity , patients who are on anticoagulant therapy may require downward adjustment of their anticoagulant dosage .
None(e1,e2)	30	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	33	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	6	21	particular caution is recommended when administering gleevec with cyp3a4 substrates that have a narrow therapeutic window ( e.g. , cyclosporine or pimozide ) .
None(e1,e2)	6	8	fluoxetine , ocs , sertraline , diltiazem , macrolide_antibiotics ( exercise caution ) .
None(e1,e2)	18	27	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	0	4	catecholamine-depleting_drugs , such as reserpine , may have an additive effect when given with beta-blocking agents .
None(e1,e2)	81	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
mechanism(e1,e2)	21	33	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
None(e1,e2)	5	33	concomitant administration of diflunisal and acetaminophen in dogs , but not in rats , at approximately 2 times the recommended maximum human therapeutic dose of each ( 40 to 52 mg/kg/day of diflunisal/ acetaminophen ) resulted in greater gastrointestinal toxicity than when either drug was administered alone .
None(e1,e2)	41	101	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	4	36	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	2	12	antihypertensives : amiodarone should be used with caution in patients receiving - receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	21	23	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic_analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	18	40	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac_glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop_diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	12	33	high-dose cyclosporin a resulting in concentrations above 2000 ng/ml administered with oral etoposide has led to an 80 % increase in etoposide exposure with a 38 % decrease in total body clearance of etoposide compared to etoposide alone .
None(e1,e2)	5	20	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	24	30	the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	6	12	when initiating a multi-day course of grepafloxacin in a patient maintained on theophylline , the theophylline maintenance dose should be halved for the period of concurrent use of grepafloxacin and monitoring of serum theophylline concentrations should be initiated as a guide to further dosage adjustments .
None(e1,e2)	0	9	erythromycin : in healthy individuals , plasma concentrations of atorvastatin increased approximately 40 % with coadministration of atorvastatin and erythromycin , a known inhibitor of cytochrome p450 3a4 .
None(e1,e2)	6	22	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	6	18	inhibitors of cyp3a4 ( eg , ketoconazole ) or cyp2d6 ( eg , quinidine , fluoxetine , or paroxetine ) can inhibit aripiprazole elimination and cause increased blood levels .
None(e1,e2)	27	29	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	59	62	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
int(e1,e2)	0	10	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	7	13	oral neomycin inhibits the gastrointestinal absorption of penicillin_v , oral vitamin b-12 , methotrexate and 5-fluorouracil .
None(e1,e2)	28	49	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	12	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	23	35	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	3	14	plasma levels of flecainide have been reported to increase in the presence of oral amiodarone ;
None(e1,e2)	1	3	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	1	5	oral contraceptives multiple doses of cefditoren_pivoxil had no effect on the pharmacokinetics of ethinyl estradiol , the estrogenic component in most oral contraceptives .
None(e1,e2)	43	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	94	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	62	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic_acid .
effect(e1,e2)	2	6	administration of phenytoin to patients receiving dopamine_hcl has been reported to lead to hypotension and bradycardia .
effect(e1,e2)	9	11	in a small ( n=30 ) combination study of arava with methotrexate , a 2- to 3-fold elevation in liver enzymes was seen in 5 of 30 patients .
None(e1,e2)	0	4	antacids and kaolin : antacids and kaolin can reduce absorption of chloroquine ;
None(e1,e2)	2	14	interactions for vitamin_d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	32	37	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	2	26	effect of aeds in pediatric patients there was about a 22 % increase of apparent total body clearance of levetiracetam when it was co-administered with enzyme-inducing aeds .
None(e1,e2)	19	38	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	6	10	anticholinergics : concurrent administration of certain anticholinergic_compounds , such as belladonna_alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	15	18	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
None(e1,e2)	52	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	32	34	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	11	17	trimethoprim alone or in combination with sulfamethoxazole : concomitant use of trimethoprim alone or in combination with sulfamethoxazole is contraindicated .
None(e1,e2)	8	23	effects of gabitril on other antiepilepsy drugs ( aeds ) : phenytoin : tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy .
effect(e1,e2)	0	6	dimenhydrinate may decrease emetic response to apomorphine .
None(e1,e2)	51	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	6	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	45	53	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	14	antacid ( magnesium-aluminum_hydroxide ) : cerivastatin plasma concentrations were not affected by co-administration of antacid .
None(e1,e2)	9	14	in separate studies of patients receiving maintenance doses of warfarin , hydrochlorothiazide , or digoxin , irbesartan administration for 7 days had no effect on the pharmacodynamics of warfarin ( prothrombin time ) or pharmacokinetics of digoxin .
None(e1,e2)	20	36	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	8	10	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective_serotonin_reuptake_inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
None(e1,e2)	23	56	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	6	caffeine theobromine grepafloxacin , like other quinolones , may inhibit the metabolism of caffeine and theobromine .
None(e1,e2)	30	32	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
advise(e1,e2)	4	19	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
effect(e1,e2)	4	20	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	4	24	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	11	28	coumarin-type anticoagulants : several short-term controlled studies failed to wshow that ibuprofen significantly affected prothrombin times or a variety of other clotting factors when administered to individuals on coumarin-type_anticoagulants .
None(e1,e2)	22	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	19	34	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	30	36	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium_channel_blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	4	6	monoamine oxidase inhibitors and tricyclic_antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	26	28	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	17	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	1	7	- antidiabetic_drugs : ( oral agents and insulin ) dosage adjustment of the antidiabetic drug may be required
None(e1,e2)	7	9	the pressor effects of catecholamines such as dopamine or norepinephrine are enhanced by bretylium tosylate .
None(e1,e2)	21	25	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
None(e1,e2)	43	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	5	- divalproex ( e.g. , depakote ) or
None(e1,e2)	36	38	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
advise(e1,e2)	3	20	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
effect(e1,e2)	7	11	thioridazine : coadministration of single doses of sonata 20 mg and thioridazine 50 mg produced additive effects on decreased alertness and impaired psychomotor performance for 2 to 4 hours after administration .
None(e1,e2)	78	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	13	19	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	32	42	the iv methylprednisolone dose should be reduced by approximately 25 % , and the oral methylprednisolone dose should be reduced by approximately 50 % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
None(e1,e2)	0	11	lithium toxicity was usually reversible upon discontinuation of lithium and the ace_inhibitor .
None(e1,e2)	12	30	results from human in vitro metabolism studies and nonclinical studies show that revlimid ( lenalidomide ) is neither metabolized by nor inhibits or induces the cytochrome p450 pathway suggesting that lenalidomide is not likely to cause or be subject to p450-based metabolic drug interactions in man .
None(e1,e2)	4	18	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	16	28	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	58	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	26	55	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	7	32	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
None(e1,e2)	7	31	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	24	60	clinical experience with concomitant administration of bosentan and warfarin in patients with pulmonary arterial hypertension did not show clinically relevant changes in inr or warfarin dose ( baseline vs. end of the clinical studies ) , and the need to change the warfarin dose during the trials due to changes in inr or due to adverse events was similar among bosentan - and placebo-treated patients .
None(e1,e2)	26	30	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	2	6	antacids and kaolin : antacids and kaolin can reduce absorption of chloroquine ;
None(e1,e2)	14	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	17	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	29	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	9	digoxin : in controlled studies in healthy volunteers , bepridil_hydrochloride either had no effect ( one study ) or was associated with modest increases , about 30 % ( two studies ) in steady-state serum digoxin concentrations .
None(e1,e2)	6	19	drug/laboratory test interaction after treatment with ampicillin , a false-positive reaction for glucose in the urine may occur with copper_sulfate tests ( benedicts solution , fehlings solution , or clinitest tablets ) but not with enzyme based tests such as clinistix and glucose enzymatic test strip usp .
None(e1,e2)	5	24	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace inhibitors , and with some angiotensin_ii_receptor_antagonists .
None(e1,e2)	48	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	0	14	edecrin may increase the ototoxic potential of other drugs such as aminoglycoside and some cephalosporin_antibiotics .
None(e1,e2)	87	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	46	76	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	11	30	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	13	15	the effects of medicinal products with similar properties such as inotropes milrinone , enoximone , amrinone , olprinone and cilostazol may be exacerbated by anagrelide .
None(e1,e2)	10	15	after 14 days of co-administration , mean trough concentrations of clozapine and its metabolites , n-desmethylclozapine and clozapine n-oxide , were elevated with fluvoxamine by about three-fold compared to baseline concentrations .
None(e1,e2)	12	25	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa_reductase_inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	22	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	25	27	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	22	37	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium_colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	17	24	garlic capsules garlic capsules should not be used while taking saquinavir ( fortovase ) as the sole protease_inhibitor due to the risk of decreased saquinavir plasma concentrations .
None(e1,e2)	34	58	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting_enzyme_(_ace_)_inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	116	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	76	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	23	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	1	5	- carbamazepine ( e.g. , tegretol ) or
mechanism(e1,e2)	6	19	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
advise(e1,e2)	2	15	co-administration of botox and aminoglycosides or other agents interfering with neuromuscular transmission ( e.g. , curare-like_compounds ) should only be performed with caution as the effect of the toxin may be potentiated .
None(e1,e2)	10	38	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	102	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	11	tetracycline , a bacteriostatic_antibiotic , may antagonize the bactercidal effect of penicillin and concurrent use of these drugs should be avoided .
mechanism(e1,e2)	1	7	orlistat- orlistat may decrease the absorption of vitamin_k .
None(e1,e2)	6	11	drugs with a narrow therapeutic index digoxin a single dose of eszopiclone 3 mg did not affect the pharmacokinetics of digoxin measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days .
None(e1,e2)	39	102	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	24	32	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	16	61	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	13	27	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	29	40	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
effect(e1,e2)	7	22	other cns depressant drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
None(e1,e2)	11	20	drugs with a narrow therapeutic index digoxin a single dose of eszopiclone 3 mg did not affect the pharmacokinetics of digoxin measured at steady state following dosing of 0.5 mg twice daily for one day and 0.25 mg daily for the next 6 days .
advise(e1,e2)	7	31	anticoagulants : while studies have not shown diclofenac to interact with anticoagulants of the warfarin type , caution should be exercised , nonetheless , since interactions have been seen with other nsaids .
None(e1,e2)	15	17	drugs whose absorption is sensitive to ph may be negatively impacted by concomitant administration of omeprazole and valdecoxib .
None(e1,e2)	8	12	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
effect(e1,e2)	6	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	21	31	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
mechanism(e1,e2)	13	16	substances that are potent inhibitors of cyp3a4 activity ( eg , ketoconazole and itraconazole ) decrease gefitinib metabolism and increase gefitinib plasma concentrations .
None(e1,e2)	10	12	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
int(e1,e2)	0	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	32	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace_inhibitors or angiotensin ii receptor antagonists ( acei/arb ) .
None(e1,e2)	13	33	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	8	70	this drug may interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	7	14	furosemide : when aliskiren was co-administered with furosemide , the auc and cmax of furosemide were reduced by about 30 % and 50 % , respectively .
None(e1,e2)	2	11	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	79	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	14	antimycobacterial_agents : rifampin contraindicated since the coadministration of this product with saquinavir in an antiretroviral regimen reduces the plasma concentrations of saquinavir .
effect(e1,e2)	2	7	response to sympathomimetic_agents may be enhanced by colchicine .
None(e1,e2)	28	45	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle_relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	10	14	in vitro binding studies with human serum proteins indicate that glipizide binds differently than tolbutamide and does not interact with salicylate or dicumarol .
mechanism(e1,e2)	15	31	although no clinical studies have been conducted , it is likely that the metabolism of levobupivacaine may be affected by the known cyp3a4 inducers ( such as phenytoin , phenobarbital , rifampin ) , cyp3a4 inhibitors ( azole antimycotics e.g. , ketoconazole ;
None(e1,e2)	1	10	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid preparations .
advise(e1,e2)	0	29	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	10	12	there was no effect on the 3 major metabolites ( 5-dfur , 5-fu and fbal ) .
None(e1,e2)	21	49	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	33	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	16	18	antiepileptic drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic_drugs ( phenytoin , carbamazepine ) .
None(e1,e2)	10	16	absorption of tetracyclines is impaired by antacids containing aluminum , calcium , or magnesium , and iron -containing preparations .
None(e1,e2)	73	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	24	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
None(e1,e2)	24	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	35	38	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	41	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	19	22	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , citalopram , escitalopram , fluoxetine , sertraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	0	5	apomorphine - prior ingestion of diphenidol may decrease the emetic response to apomorphine in the treatment of poisoning .
None(e1,e2)	1	47	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	22	38	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	0	18	lithium reversible increases in serum lithium concentrations and toxicity have been reported during concomitant administration of lithium with ace_inhibitors , and with some angiotensin ii receptor antagonists .
None(e1,e2)	24	45	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	0	8	5-ht3_antagonists : in clinical drug interaction studies , aprepitant did not have clinically important effects on the pharmacokinetics of ondansetron or granisetron .
None(e1,e2)	10	12	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	0	30	ace_inhibitors and angiotensin ii receptor antagonists ( hypertension ) - in clinical studies of patients with hypertension , the addition of inspra 50 to 100 mg to ace inhibitors and angiotensin_ii_receptor_antagonists increased mean serum potassium slightly ( about 0.09-0.13 meq/l ) .
None(e1,e2)	122	128	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	7	10	coadministration of ethoxzolamide with other diuretics , amphotericin_b , and corticosteroids may cause hypokalemia .
None(e1,e2)	10	25	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	13	21	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	2	11	effects of gabitril on other antiepilepsy drugs ( aeds ) : phenytoin : tiagabine had no effect on the steady-state plasma concentrations of phenytoin in patients with epilepsy .
None(e1,e2)	7	14	studies with ace inhibitors in combination with diuretics indicate that the dose of the ace_inhibitor can be reduced when it is given with a diuretic .
None(e1,e2)	102	116	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	13	cimetidine : cimetidine does not affect the pharmacokinetics of fosfomycin when coadministered with monurol .
None(e1,e2)	113	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	36	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	65	116	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	49	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	2	28	interactions for vitamin_d analogues ( vitamin d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat_soluble_vitamins ;
None(e1,e2)	1	4	since colestipol_hydrochloride is an anion_exchange_resin , it may have a strong affinity for anions other than the bile acids .
None(e1,e2)	2	4	furthermore , rifampin , phenytoin , phenobarbital , and other inducers of cytochrome p450 3a4 may cause a reduction in plasma bexarotene concentrations .
None(e1,e2)	19	32	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	8	47	interactions may also occur with the following : anti-depressants /anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	46	57	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	31	33	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
effect(e1,e2)	28	35	delayed adverse reactions to iodinated contrast media : a review of the literature revealed that 12.6 % ( range 11-28 % ) of 501 patients treated with various interleukin-2 containing regimens who were subsequently administered radiographic_iodinated_contrast_media experienced acute , atypical adverse reactions .
advise(e1,e2)	18	40	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	33	36	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	5	7	bromocriptine mesylate may interact with dopamine_antagonists , butyrophenones , and certain other agents .
None(e1,e2)	89	94	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	19	21	in one man , the c max of terfenadine was 8.1 ng/ml with terfenadine alone and 7.2 ng/ml with terfenadine plus dirithromycin .
None(e1,e2)	4	22	amitriptyline in combination with clonidine enhances the manifestation of corneal lesions in rats epidural injection clonidine may potentiate the cns-depressive effect of alcohol , barbiturates or other sedating drugs .
None(e1,e2)	8	21	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	15	21	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic_agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	0	2	barbiturates , carbamazepine , and phenytoin decrease the half-life of doxycycline .
None(e1,e2)	6	8	urinary acidifying agents these agents ( ammonium_chloride , sodium_acid_phosphate , etc . ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
advise(e1,e2)	12	15	as with most psychoactive medications , patients should be advised to avoid alcohol while taking abilify
None(e1,e2)	21	34	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	13	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	8	26	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
mechanism(e1,e2)	3	8	studies showed that diltiazem increased the auc of midazolam and triazolam by 3-4 fold and the cmax by 2-fold , compared to placebo .
None(e1,e2)	14	24	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	10	13	in clinical studies , coadministration of welchol with atorvastatin , lovastatin , or simvastatin did not interfere with the lipid-lowering activity of the hmg-coa reductase inhibitor .
None(e1,e2)	44	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	10	15	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	29	38	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	13	19	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	29	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	22	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	9	17	patients who begin taking diclofenac or who increase their diclofenac dose or any other nsaid while taking digoxin , methotrexate , or cyclosporine may develop toxicity characteristics for these drugs .
None(e1,e2)	22	26	serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of crohn s disease including corticosteroids , antibiotics ( metronidazole or ciprofloxacin ) and aminosalicylates .
None(e1,e2)	13	23	antacids or h 2 receptor antagonists : when dirithromycin is administered immediately following antacids or h 2 -receptor antagonists , the absorption of dirithromycin is slightly enhanced .
None(e1,e2)	16	19	hydrochlorothiazide : a study in normal healthy volunteers has shown that concomitant administration of dynacirc ( isradipine ) and hydrochlorothiazide does not result in altered pharmacoktnetics of either drug .
None(e1,e2)	91	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	65	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	53	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	32	36	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	24	32	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
mechanism(e1,e2)	0	10	isoflurane , enflurane , and halothane decrease the ed50 of nuromax by 30 % to 45 % .
effect(e1,e2)	4	19	skeletal muscle relaxants : amphotericin_b -induced hypokalemia may enhance the curariform effect of skeletal muscle relaxants ( e.g. , tubocurarine ) .
mechanism(e1,e2)	5	18	additionally , higher than expected tricyclic_antidepressant levels have been observed when they are begun in patients already taking cimetidine .
None(e1,e2)	26	35	cimetidine : in a study in healthy volunteers , a one-week course of cimetidine at 400 mg b.i.d . with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations ( 36 % ) and significant increase in area under the curve ( 50 % ) .
None(e1,e2)	60	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	7	22	a case report of one patient taking amiodarone 200 mg and indinavir 800 mg three times a day resulted in increases in amiodarone concentrations from 0.9 mg/l to 1.3 mg/l .
None(e1,e2)	0	11	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	26	38	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	16	19	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	41	56	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	29	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	30	46	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	15	20	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
effect(e1,e2)	4	20	although not studied with alosetron , inhibition of n-acetyltransferase may have clinically relevant consequences for drugs such as isoniazid , procainamide , and hydralazine .
None(e1,e2)	12	20	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
advise(e1,e2)	1	10	if nifedipine therapy is initiated in a patient currently receiving cimetidine , cautious titration is advised .
effect(e1,e2)	12	15	increases in prothrombin time have been noted in patients receiving long- term warfarin therapy after flutamide was initiated .
None(e1,e2)	58	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	75	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	24	ace_inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei/arb ) .
None(e1,e2)	48	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	indinavir concentration rifabutin concentration
None(e1,e2)	11	13	potential interactions between taxol , a substrate of cyp3a4 , and protease_inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	9	34	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	11	33	these in vitro studies suggest that concomitant administration of zalcitabine and lamivudine in humans may result in sub-therapeutic concentrations of active phosphorylated zalcitabine , which may lead to a decreased antiretroviral effect of zalcitabine .
None(e1,e2)	11	25	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	45	75	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	50	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	34	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	22	26	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	39	42	a rare , but serious , constellation of symptoms , termed serotonin syndrome , has been reported with the concomitant use of selective serotonin reuptake inhibitors ( ssris ) and agents for migraine therapy , such as imitrex ( sumatriptan_succinate ) and dihydroergotamine .
None(e1,e2)	0	8	vitamin_d : the coadministration of any of the vitamin_d_analogues should be avoided as this could create possible additive effects and hypercalcemia .
None(e1,e2)	11	25	the possibility of increased interaction should be kept in mind when orudis doses greater than 50 mg as a single dose or 200 mg of ketoprofen per day are used concomitantly with highly bound drugs .
None(e1,e2)	14	17	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
None(e1,e2)	35	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	54	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	44	131	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	24	36	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	48	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	34	37	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine_oxidase_inhibitors , and beta_adrenergic_blocking_agents .
None(e1,e2)	22	30	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
mechanism(e1,e2)	10	16	protease inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	15	17	other cyp3a4 inducers include , but are not limited to , rifabutin , rifapentine , phenytoin , carbamazepine , phenobarbital and st. johns wort .
None(e1,e2)	19	28	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	23	28	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	14	20	the oral dexamethasone doses should be reduced by approximately 50 % when coadministered with aprepitant , to achieve exposures of dexamethasone similar to those obtained when it is given without aprepitant .
None(e1,e2)	0	20	lamivudine : in vitro studies in peripheral blood mononuclear cells , u937 and molt-4 cells revealed that lamivudine significantly inhibited zalcitabine phosphorylation in a dose dependent manner .
None(e1,e2)	24	43	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal_anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	13	21	in a study involving healthy subjects receiving tambocor and propranolol concurrently , plasma flecainide levels were increased about 20 % and propranolol levels were increased about 30 % compared to control values .
None(e1,e2)	14	16	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	9	26	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	27	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	23	101	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	20	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic_acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	4	10	however , coadministration of escitalopram ( 20 mg ) and ritonavir ( 600 mg ) , a potent inhibitor of cyp3a4 , did not significantly affect the pharmacokinetics of escitalopram .
None(e1,e2)	6	24	benzthiazide may interact with alcohol , blood_thinner s , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	75	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	9	atorvastatin : atorvastatin increases the auc for norethindrone and ethinyl_estradiol .
None(e1,e2)	3	7	for example , diuretics ( e.g. , thiazides ) may activate the renin-angiotensin-aldosterone system .
None(e1,e2)	35	42	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	78	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	14	the use of nuromax before succinylcholine to attenuate some of the side effects of succinylcholine has not been studied .
None(e1,e2)	20	22	therefore , interactions could occur following concomitant administration of psychotropic drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	5	29	in em individuals treated with paroxetine or fluoxetine , the auc of atomoxetine is approximately 6- to 8-fold and css , max is about 3- to 4-fold greater than atomoxetine alone .
None(e1,e2)	29	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	36	other quinolones have demonstrated moderate to marked interference with the metabolism of caffeine , resulting in a reduced clearance , a prolongation of plasma half-life , and an increase in symptoms that accompany high levels of caffeine .
None(e1,e2)	5	9	inomax has been administered with tolazoline , dopamine , dobutamine , steroids , surfactant , and high-frequency ventilation .
None(e1,e2)	21	29	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	9	25	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	10	24	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	1	36	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	3	8	specific effects of felbatol on other antiepileptic drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
None(e1,e2)	38	43	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	12	24	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	15	58	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood_thinner s ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic_acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
advise(e1,e2)	1	12	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	24	32	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	0	15	leucovorin : the concentration of 5-fluorouracil is increased and its toxicity may be enhanced by leucovorin .
None(e1,e2)	26	54	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	21	33	the extent of plasma protein binding of atovaquone in human plasma is not affected by the presence of therapeutic concentrations of phenytoin ( 15 mcg/ ml ) , nor is the binding of phenytoin affected by the presence of atovaquone .
None(e1,e2)	8	9	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv protease inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	0	24	protease_inhibitors : in vitro data indicate that indinavir and ritonavir markedly inhibit the metabolism of cisapride which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	0	5	hiv_protease_inhibitors : the effect of amprenavir on total drug concentrations of other hiv protease inhibitors in subjects receiving both agents was evaluated using comparisons to historical data .
None(e1,e2)	0	2	mercaptopurine / azathioprine : allopurinol inhibits the enzymatic oxidation of mercaptopurine and azathioprine to 6-thiouric acid .
None(e1,e2)	8	16	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	27	33	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	0	11	ritonavir and indinavir : upon concomitant administration of 5 mg of vardenafil with 600 mg bid ritonavir , the cmax and auc of ritonavir were reduced by approximately 20 % .
effect(e1,e2)	12	17	risk of anaphylactic reaction : although it is known that patients on beta-blockers may be refractory to epinephrine in the treatment of anaphylactic shock , beta-blockers can , in addition , interfere with the modulation of allergic reaction and lead to an increased severity and/or frequency of attacks .
None(e1,e2)	15	24	because there is a theoretical basis that these effects may be additive , use of ergotamine -containing or ergot-type medications ( like dihydroergotamine or methysergide ) and naratriptan within 24 hours is contraindicated .
None(e1,e2)	24	42	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	9	16	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	49	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	25	drug-drug interactions albuterol - strattera should be administered with caution to patients being treated with systemically-administered ( oral or intravenous ) albuterol ( or other beta2_agonists ) because the action of albuterol on the cardiovascular system can be potentiated resulting in increases in heart rate and blood pressure .
None(e1,e2)	33	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	17	oral contraceptives rofecoxib did not have any clinically important effect on the pharmacokinetics of ethinyl estradiol and norethindrone .
None(e1,e2)	55	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	0	9	iodine or iodine excess may decrease the effect of carbimazole , and an iodine deficiency can increase the effect of carbimazole .
None(e1,e2)	18	22	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	5	24	- a phenothiazine such as chlorpromazine ( thorazine ) , fluphenazine ( prolixin , permitil ) , prochlorperazine ( compazine ) , promethazine ( phenergan ) , and others ;
None(e1,e2)	5	22	methotrexate renal tubular transport of methotrexate may be inhibited by concomitant administration of ciprofloxacin , potentially leading to increased plasma levels of methotrexate .
None(e1,e2)	3	12	colestipol-concomitant intake of colestipol and vitamin k may reduce the absorption of vitamin_k .
None(e1,e2)	0	5	methotrexate : concomitant administration of methotrexate and some nsaids has been reported to reduce the clearance of methotrexate , enhancing the toxicity of methotrexate .
None(e1,e2)	28	35	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	3	44	alprazolam : when fluvoxamine_maleate ( 100 mg qd ) and alprazolam ( 1 mg q.d . were co-administered to steady state , plasma concentration and other pharmacokinetics parameters ( auc , cmax , t1/2 , ) of alprazolam were approximately twice those observed when alprazolam was administered alone ;
None(e1,e2)	7	27	concurrent administration of a tnf antagonist with orencia has been associated with an increased risk of serious infections and no significant additional efficacy over use of the tnf_antagonists alone .
int(e1,e2)	7	19	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
int(e1,e2)	0	4	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	4	7	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	98	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	18	in addition , drugs that are actively secreted via this route ( e.g. , triamterene , metformin and amiloride ) should be co-administered with care as they might increase dofetilide levels .
None(e1,e2)	59	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	20	magnesium /aluminum-containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/aluminum-containing antacid_products .
None(e1,e2)	21	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	45	82	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	4	13	if a patient requires tikosyn and anti-ulcer therapy , it is suggested that omeprazole , ranitidine , or antacids ( aluminum and magnesium hydroxides ) be used as alternatives to cimetidine , as these agents have no effect on the pharmacokinetic profile of tikosyn .
None(e1,e2)	26	32	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
mechanism(e1,e2)	1	7	when itraconazole was coadministered with phenytoin , rifampin , or h2antagonists , reduced plasma concentrations of itraconazole were reported .
None(e1,e2)	0	4	tricyclic_antidepressants ( such as amitriptyline ) ;
effect(e1,e2)	5	49	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	26	34	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	49	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	8	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	47	50	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic_acid , and acetaminophen .
None(e1,e2)	21	27	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	0	14	lithium : inhibition of renal lithium clearance , leading to an increase in plasma lithium concentration , has been reported with some prostaglandin synthesis-inhibiting drugs .
None(e1,e2)	0	9	antihypertensives : amphetamines may antagonize the hypotensive effects of antihypertensives .
advise(e1,e2)	5	10	care should be taken if labetalol is used concomitantly with calcium_antagonist s of the verapamil type .
None(e1,e2)	6	18	data from in vitro studies of alprazolam suggest a possible drug interaction with alprazolam for the following : sertraline and paroxetine .
None(e1,e2)	17	20	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and naratriptan within 24 hours is contraindicated .
None(e1,e2)	21	44	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	10	20	other drug interactions : no pharmacokinetic interactions were observed between vardenafil and the following drugs : glyburide , warfarin , digoxin , maalox , and ranitidine .
advise(e1,e2)	23	26	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type medications ( like dihydroergotamine or methysergide ) and axert within 24 hours of each other should be avoided .
None(e1,e2)	17	19	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
mechanism(e1,e2)	5	15	leucovorin : the concentration of 5-fluorouracil is increased and its toxicity may be enhanced by leucovorin .
None(e1,e2)	30	32	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	20	24	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	12	this effect of aspirin ( which also lowers serum concentrations of other nonsteroidal_anti-inflammatory_drugs given with it ) has been demonstrated in patients with rheumatoid arthritis ( n= 15 ) as well as normal volunteers ( n= 16 ) .
None(e1,e2)	12	30	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux sodium .
None(e1,e2)	30	34	use lowest possible dose of atorvastatin with careful monitoring , or consider hmg-coa reductase inhibitors that are not primarily metabolized by cyp3a4 , such as pravastatin , fluvastatin , or rosuvastatin in combination with crixivan .
None(e1,e2)	69	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	36	40	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
None(e1,e2)	11	28	may interact anticoagulants ( altered hypo-prothrombinemic effect ) , barbiturates , rifampin and other inducers of hepatic microsomal enzyme oxidation system ( decreased effect of diethylstilbestrol ) , corticosteroids ( increased effect of corticosteroids ) .
None(e1,e2)	85	91	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	2	3	cholestyramine and colestipol resins : absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins .
int(e1,e2)	3	11	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	9	18	heparin : since heparin is contraindicated in patients with heparin -induced thrombocytopenia , the co-administration of argatroban and heparin is unlikely for this indication .
None(e1,e2)	26	28	reciprocal interactions may occur with concomitant use of antizol and drugs that increase or inhibit the cytochrome p450 system ( e.g. , phenytoin , carbamazepine , cimetidine , ketoconazole ) , though this has not been studied
None(e1,e2)	19	26	in a single-dose crossover study examining lansoprazole 30 mg and omeprazole 20 mg each administered alone and concomitantly with sucralfate 1 gram , absorption of the proton_pump_inhibitors was delayed and their bioavailability was reduced by 17 % and 16 % , respectively , when administered concomitantly with sucralfate .
mechanism(e1,e2)	18	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	7	doxorubicin : doxorubicin caused a decrease in zalcitabine phosphorylation ( 50 % inhibition of total phosphate formation ) in u937/molt 4 cells .
None(e1,e2)	19	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	4	29	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
effect(e1,e2)	9	11	some reports have shown that the concomitant administration of thiazides with vitamin_d causes hypercalcemia .
None(e1,e2)	85	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	50	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant_drugs .
None(e1,e2)	23	84	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	29	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	0	38	valproate : available data suggest that there is no significant effect of valproate on the clearance of felbatol at steady state , therefore , the addition of valproate is not expected to cause a clinically important effect on felbatol ( felbamate ) plasma concentrations .
None(e1,e2)	0	6	glyburide : the concomitant administration of ciprofloxacin with the sulfonylurea glyburide has , on rare occasions , resulted in severe hypoglycemia .
mechanism(e1,e2)	4	14	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	0	7	sodium_iodide ( 123i and 131i ) , sodium_pertechnetate_tc99m : uptake of radiolabeled ions may be decreased .
None(e1,e2)	22	31	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	0	32	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	78	99	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	16	18	renal clearance measurements of pah can not be made with any significant accuracy in patients receiving sulfonamides , procaine , or thiazolesulfone .
None(e1,e2)	3	15	use of antithrombotics aspirin and heparin have been administered concomitantly with and following infusions of activase in the management of acute myocardial infarction or pulmonary embolism .
None(e1,e2)	24	45	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
effect(e1,e2)	26	28	serious anticholinergic symptoms ( i.e. , severe dry mouth , urinary retention and blurred vision ) have been associated with elevations in the serum levels of tricyclic_antidepressant when cimetidine therapy is initiated .
None(e1,e2)	7	9	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	30	44	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	0	17	cimetidine : cimetidine has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various tricyclic_antidepressants .
effect(e1,e2)	6	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	16	20	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	4	13	warfarin , digoxin , salicylate , and heparin the in vitro binding of warfarin to plasma proteins is only slightly reduced by ketorolac tromethamine ( 99.5 % control vs 99.3 % ) when ketorolac plasma concentrations reach 5 to10 m g/ml .
advise(e1,e2)	20	28	because both of these drugs have negative inotropic properties and the effects of coadministration with tambocor are unknown , neither disopyramide nor verapamil should be administered concurrently with tambocor unless , in the judgment of the physician , the benefits of this combination outweigh the risks .
None(e1,e2)	36	49	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	44	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	38	limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50 % for the first sixty ( 60 ) minutes following alfenta induction the concomitant use of erythromycin with alfenta can significantly inhibit alfenta clearance and may increase the risk of prolonged or delayed respiratory depression .
None(e1,e2)	17	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	16	37	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
mechanism(e1,e2)	16	22	antifungals : in vitro and/or in vivo data indicate that fluconazole , itraconazole , and oral ketoconazole markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	0	13	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	16	18	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety agents .
None(e1,e2)	11	13	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	80	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza_virus_vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	92	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	12	metoclopramide : bioavailability is mildly reduced ( approximately 10 % ) when zalcitabine and metoclopramide are coadministered .
None(e1,e2)	55	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	44	104	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	36	53	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	23	32	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
effect(e1,e2)	4	8	when other potent parental antihypertensive_drugs , such as diazoxide , are used in combination with hydralazine , patients should be continuously observed for several hours for any excessive fall in blood pressure .
None(e1,e2)	76	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	8	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	21	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
mechanism(e1,e2)	11	35	binding to serum proteins : the following agents may either inhibit levothyroxine_sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	33	73	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	3	31	blood levels of hydrodolasetron increased 24 % when dolasetron was coadministered with cimetidine ( nonselective inhibitor of cytochrome p-450 ) for 7 days , and decreased 28 % with coadministration of rifampin ( potent inducer of cytochrome p-450 ) for 7 days .
None(e1,e2)	13	16	the hypotensive effect of sodium nitroprusside is augmented by that of most other hypotensive_drugs , including ganglionic_blocking_agents , negative inotropic agents , and inhaled anesthetics .
None(e1,e2)	0	21	h2_receptor_antagonists : cimetidine coadministration leads to an increased peak plasma concentration and auc of cisapride , there is no effect on cisapride absorption when it is coadministered with ranitidine .
None(e1,e2)	44	49	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic_antidepressants , and by other anticonvulsant_drugs .
None(e1,e2)	0	6	theophylline : the effect of steady-state fluvoxamine l50 mg bid on the pharmacokinetics of a single dose of theophylline ( 375 mg ) as 442 mg aminophylline was evaluated in 12 healthy non-smoking , male volunteers .
None(e1,e2)	26	48	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	14	16	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	41	53	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	28	combination of amiodarone with other antiarrhythmic therapy should be reserved for patients with life-threatening ventricular arrhythmias who are incompletely responsive to a single agent or incompletely responsive to amiodarone .
effect(e1,e2)	0	7	phospholine_iodide potentiates other cholinesterase inhibitors such as succinylcholine or organophosphate and carbamate insecticides .
None(e1,e2)	2	12	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	12	24	ketoconazole : ketoconazole has been reported to decrease the metabolism of certain corticosteroids by up to 60 % , leading to increased risk of corticosteroid side effects .
None(e1,e2)	62	77	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	9	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	5	7	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
None(e1,e2)	15	17	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	8	14	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	17	38	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal_anti-inflammatory_agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	21	32	hormonal contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
advise(e1,e2)	2	11	subutex and suboxone should be prescribed with caution to patients on benzodiazepines or other drugs that act on the central nervous system , regardless of whether these drugs are taken on the advice of a physician or are taken as drugs of abuse .
None(e1,e2)	1	10	because dexfenfluramine is a serotonin releaser and reuptake inhibitor , dexfenfluramine should not be used concomitantly with a mao inhibitor .
None(e1,e2)	59	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	21	concomitant use of tricyclic_antidepressants with other drugs metabolized by cytochrome p450iid6 may require lower doses than usually prescribed for either the tricyclic_antidepressant or the other drug .
None(e1,e2)	6	18	dosage adjustment may be warranted when levobupivacaine is concurrently administered with cyp3a4 inhibitors and cyp1a2 inhibitors as systemic levobupivacaine levels may rise resulting in toxicity .
None(e1,e2)	17	22	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	42	59	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	6	11	clidinium may decrease the effect of phenothiazines , levodopa , and ketoconazole .
mechanism(e1,e2)	18	20	aspirin : in normal volunteers , a small decrease in diflunisal levels was observed when multiple doses of diflunisal and aspirin were administered concomitantly .
None(e1,e2)	36	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	32	41	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel_blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	4	6	in patients receiving nonselective monoamine_oxidase_inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	3	8	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	2	6	fluoxetine , ocs , sertraline , diltiazem , macrolide antibiotics ( exercise caution ) .
advise(e1,e2)	8	11	blood glucose concentrations should be carefully monitored when itraconazole and oral hypoglycemic_agents are coadministered .
effect(e1,e2)	13	30	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	31	35	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	14	38	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer_acetate .
None(e1,e2)	0	9	fentanyl anesthesia : severe hypotension has been reported during fentanyl anesthesia with concomitant use of a beta blocker and a calcium channel blocker .
None(e1,e2)	15	21	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
effect(e1,e2)	11	24	anticholinergics : concurrent administration of certain anticholinergic compounds , such as belladonna_alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	32	49	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	10	47	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole_antifungal_agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
effect(e1,e2)	0	13	codeine in combination with other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , or other cns depressants ( including alcohol ) has additive depressant effects .
None(e1,e2)	38	60	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	9	37	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
effect(e1,e2)	8	12	anakinra : concurrent administration of anakinra ( an interleukin-1_antagonist ) and another tnf-blocking_agent has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
None(e1,e2)	33	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	1	35	when atropine and pralidoxime are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine .
None(e1,e2)	23	58	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical_steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
effect(e1,e2)	3	11	concomitant administration of mefloquine and other related compounds ( eg , quinine , quinidine and chloroquine ) may produce electrocardiographic abnormalities and increase the risk of convulsions .
None(e1,e2)	100	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	0	3	monoamine_oxidase_(_mao_)_inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	6	15	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	22	25	- anabolic steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
None(e1,e2)	7	14	in controlled clinical trials , however , beta_blockers including metoprolol were concurrently administered with felodipine and were well tolerated .
None(e1,e2)	41	49	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	15	26	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis drug rifampin .
advise(e1,e2)	20	41	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	3	5	acidifying agents : gastrointestinal_acidifying_agents ( guanethidine , reserpine , glutamic acid hcl , ascorbic acid , fruit juices , etc . ) lower absorption of amphetamines .
None(e1,e2)	19	36	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
mechanism(e1,e2)	13	26	cimetidine : in a study in healthy volunteers , a one-week course of cimetidine at 400 mg b.i.d . with a single 5 mg dose of isradipine on the sixth day showed an increase in isradipine mean peak plasma concentrations ( 36 % ) and significant increase in area under the curve ( 50 % ) .
None(e1,e2)	33	41	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns_depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
effect(e1,e2)	0	30	isoflurane or enflurane administered with nitrous oxide/oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	33	35	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	0	15	selective_serotonin_reuptake_inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	14	30	results from human in vitro metabolism studies and nonclinical studies show that revlimid ( lenalidomide ) is neither metabolized by nor inhibits or induces the cytochrome p450 pathway suggesting that lenalidomide is not likely to cause or be subject to p450-based metabolic drug interactions in man .
None(e1,e2)	34	45	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
int(e1,e2)	3	10	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic_drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
None(e1,e2)	29	31	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	9	17	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
None(e1,e2)	4	17	effects of antacids on felbatol the rate and extent of absorption of a 2400 mg dose of felbatol as monotherapy given as tablets was not affected when coadministered with antacids .
None(e1,e2)	7	23	in a ten-subject study , coadministration of diltiazem ( 120 mg bid ) with lovastatin resulted in a 3-4 times increase in mean lovastatin auc and cmax vs. lovastatin alone ;
None(e1,e2)	41	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	49	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	78	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	14	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
advise(e1,e2)	10	12	if leprosy-associated inflammatory reactions develop in patients being treated with dapsone and clofazimine , it is still advisable to continue treatment with both drugs .
None(e1,e2)	18	45	the following specific interactions have been reported : itraconazole co-administration of another extended release formulation of felodipine with itraconazole resulted in approximately 8-fold increase in the auc , more than 6- fold increase in the cmax , and 2-fold prolongation in the half- life of felodipine .
None(e1,e2)	5	22	this drug may interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
mechanism(e1,e2)	2	8	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	6	19	beta-blocking agents a pharmacokinetic study of felodipine in conjunction with metoprolol demonstrated no significant effects on the pharmacokinetics of felodipine .
None(e1,e2)	20	59	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine_hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	59	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	7	9	however , ldl-c reduction was greater when atorvastatin and colestipol were coadministered than when either drug was given alone .
None(e1,e2)	10	29	should it be decided to discontinue therapy in patients receiving beta-blockers and clonidine concurrently , the beta-blocker should be discontinued slowly over several days before the gradual withdrawal of clonidine .
None(e1,e2)	7	9	additionally , anti-malarial drugs , such as chloroquine and mefloquine , may antagonize the activity of carbamazepine .
None(e1,e2)	2	5	antacid ( magnesium-aluminum_hydroxide ) : cerivastatin plasma concentrations were not affected by co-administration of antacid .
None(e1,e2)	2	24	although trough citalopram plasma levels were unaffected , given the enzyme-inducing properties of carbamazepine , the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered .
int(e1,e2)	4	6	the extent to which ssri - tca interactions may pose clinical problems will depend on the degree of inhibition and the pharmacokinetics of the ssri involved .
None(e1,e2)	75	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	12	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	16	20	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic_acid , and warfarin .
None(e1,e2)	17	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	3	7	pharmacokinetic interactions between nisoldipine and beta-blockers ( atenolol , propranolol ) were variable and not significant .
None(e1,e2)	8	14	other reported interactions with amiodarone : fentanyl ( cyp3a4 substrate ) in combination with amiodarone may cause hypotension , bradycardia , and decreased cardiac output .
None(e1,e2)	14	24	an adequate period of observation must be provided for any patient in whom either long-acting_benzodiazepines ( such as diazepam ) or large doses of short-acting_benzodiazepines ( such as 10 mg of midazolam ) have been used .
None(e1,e2)	27	29	caution should be taken when enablex is used concomitantly with medications that are predominantly metabolized by cyp2d6 and which have a narrow therapeutic window , such as flecainide , thioridazine and tricyclic antidepressants ( see clinical pharmacology ) .
None(e1,e2)	25	27	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	5	10	patients taking these drugs with lodosyn and levodopa or carbidopa- levodopa combination products should be carefully observed for loss of therapeutic response .
None(e1,e2)	2	35	nifedipine : vardenafil 20 mg , when co-administered with slow-release nifedipine 30 mg or 60 mg once daily , did not affect the relative bioavailability ( auc ) or maximum concentration ( cmax ) of nifedipine , a drug that is metabolized via cyp3a4 .
advise(e1,e2)	7	27	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	27	30	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	13	20	the principal drugs given ( number of patients in parentheses ) were : cardiac_glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	0	2	nonsteroidal_anti-inflammatory_drugs ( nsaids ) -a drug interaction study of eplerenone with an nsaid has not been conducted .
None(e1,e2)	112	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	14	in a study of 12 schizophrenic patients coadministered oral haloperidol and rifampin , plasma haloperidol levels were decreased by a mean of 70 % and mean scores on the brief psychiatric rating scale were increased from baseline .
None(e1,e2)	38	47	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic_acid , and acetaminophen .
None(e1,e2)	66	113	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	10	19	as with other antihypertensive agents , the antihypertensive effect of losartan may be blunted by the non-steroidal anti-inflammatory drug indomethacin
None(e1,e2)	8	15	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , paroxetine , and fluvoxamine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	105	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	40	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	93	107	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	29	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	10	26	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid -associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	29	32	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin_b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	14	26	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	37	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	9	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	15	19	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	37	59	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	0	10	mao_inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	22	26	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
None(e1,e2)	0	17	glyburide : an increased risk of elevated liver aminotransferases was observed in patients receiving concomitant therapy with glyburide .
None(e1,e2)	43	50	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	32	34	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	0	6	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
effect(e1,e2)	5	10	pharmacokinetic data indicate that oral ketoconazole inhibits the metabolism of astemizole , resulting in elevated plasma levels of astemizole and its active metabolite desmethylastemizole which may prolong qt intervals .
None(e1,e2)	10	12	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	108	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	8	23	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	0	22	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
None(e1,e2)	8	10	compounds that have been tested in man include antipyrine , digoxin , propranolol , theophylline , and warfarin and no clinically meaningful interactions were found .
None(e1,e2)	3	10	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	7	15	fenfluramine may increase slightly the effect of antihypertensive_drugs , e.g. , guanethidine , methyldopa , reserpine .
None(e1,e2)	29	48	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic_analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	19	33	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central_nervous_system_(_cns_)_depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	112	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	3	18	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	30	36	drugs that may alter imatinib plasma concentrations drugs that may increase imatinib plasma concentrations : caution is recommended when administering gleevec with inhibitors of the cyp3a4 family ( e.g. , ketoconazole , itraconazole , erythromycin , clarithromycin ) .
None(e1,e2)	4	22	monoamine oxidase inhibitors and tricyclic_antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic_antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	10	30	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
effect(e1,e2)	3	5	concurrent use of butorphanol with central_nervous_system_depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	13	23	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	34	49	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	7	9	standard therapy includes antibiotics , such as penicillin and gentamicin ;
None(e1,e2)	7	17	no clinically significant effect of famotidine , valproate , or lithium was seen on the pharmacokinetics of aripiprazole ( see clinical pharmacology : drug- drug interactions ) .
mechanism(e1,e2)	6	16	milk , milk products , and calcium -rich foods or drugs may impair the absorption of emcyt .
None(e1,e2)	3	11	other agents : prinivil has been used concomitantly with nitrates and/or digoxin without evidence of clinically significant adverse interactions .
None(e1,e2)	0	8	vitamin_a and oral retinoids : concomitant administration of vitamin_a and/or other oral retinoids with acitretin must be avoided because of the risk of hypervitaminosis a .
None(e1,e2)	28	44	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium_chloride , folic acid , and acetaminophen .
effect(e1,e2)	9	20	therefore , a slower onset can be anticipated if stadol_ns is administered concomitantly with , or immediately following , a nasal_vasoconstrictor .
None(e1,e2)	17	27	in addition , neuromuscular blocking action is enhanced by general anesthetics , local anesthetics like lidocaine , procaine , beta-blockers , metaclopramide , lithium carbonate , and terbutaline .
effect(e1,e2)	14	18	there have been isolated reports of patients experiencing increases in their prothrombin times when etidronate was added to warfarin therapy .
None(e1,e2)	46	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	27	lithium : in a study conducted in healthy subjects , mean steady-state lithium plasma levels increased approximately 17 % in subjects receiving lithium 450 mg bid with celebrex 200 mg bid as compared to subjects receiving lithium alone .
None(e1,e2)	0	4	amphotericin_b or corticosteroids or corticotropin ( acth )
None(e1,e2)	41	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	11	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
mechanism(e1,e2)	17	24	drugs that cause significant sustained elevation in gastric ph ( histamine h2-receptor antagonists such as ranitidine or cimetidine ) may reduce plasma concentrations of iressa and therefore potentially may reduce efficacy .
None(e1,e2)	23	154	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	21	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	9	33	drugs that have been associated with peripheral neuropathy include antiretroviral_nucleoside_analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	24	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	1	10	cephalosporins- cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
mechanism(e1,e2)	1	15	oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic agents , eg , tolbutamide and chlorpropamide , by inhibiting their metabolism in the liver .
None(e1,e2)	46	63	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	2	18	antidepressants ( tricyclic ) , atropine or other anticholinergic agents , or digitalis glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	39	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	4	cytokines ( interferon , interleukin ) : cytokines have been reported to induce both hyperthyroidism and hypothyroidism .
None(e1,e2)	5	25	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	8	14	digoxin : when multiple doses of atorvastatin and digoxin were coadministered , steady-state plasma digoxin concentrations increased by approximately 20 % .
None(e1,e2)	21	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	30	43	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	14	17	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	17	29	terfenadine : no clinically significant changes occurred in heart rate or corrected qt intervals , or in terfenadine metabolite or lomefloxacin pharmacokinetics , during concurrent administration of lomefloxacin and terfenadine at steady-state in 28 healthy males .
None(e1,e2)	17	38	protein binding in vitro , diclofenac interferes minimally or not at all with the protein binding of salicylic_acid ( 20 % decrease in binding ) , tolbutamide , prednisolone ( 10 % decrease in binding ) , or warfarin .
None(e1,e2)	10	21	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	69	85	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	44	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	20	other antiarrhythmic drugs ( eg , quinidine , procainamide , lidocaine , propranolol ) have occasionally been used concurrently with norpace .
None(e1,e2)	92	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	10	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	16	41	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
effect(e1,e2)	2	15	vasoconstrictors : d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp should not be used with peripheral_vasoconstrictors because the combination may cause synergistic elevation of blood pressure .
None(e1,e2)	26	78	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole_antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
advise(e1,e2)	16	18	however , prudent medical practice dictates careful monitoring of prothrombin time in all patients treated with azithromycin and warfarin concomitantly .
int(e1,e2)	11	25	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
advise(e1,e2)	20	22	because of the risk of serious ventricular arrhythmias and sudden death potentially associated with elevated plasma levels of thioridazine , duloxetine and thioridazine should not be co-administered .
None(e1,e2)	13	19	sinus bradycardia has been reported with oral amiodarone in combination with lidocaine ( cyp3a4 substrate ) given for local anesthesia .
effect(e1,e2)	5	11	agents increasing serum potassium : prinivil attenuates potassium loss caused by thiazide-type_diuretics .
None(e1,e2)	35	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	10	23	it is not clear whether this represents an interaction with tikosyn or the presence of more severe structural heart disease in patients on digoxin ;
None(e1,e2)	38	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	39	57	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	12	35	interactions with other cns agents : concurrent use of levo-dromoran with all central_nervous_system_depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	11	32	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	5	12	antidepressants ( tricyclic ) , atropine or other anticholinergic agents , or digitalis_glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	1	40	when atropine and pralidoxime are used together , the signs of atropinization ( flushing , mydriasis , tachycardia , dryness of the mouth and nose ) may occur earlier than might be expected than when atropine is used alone because pralidoxime may potentiate the effect of atropine .
None(e1,e2)	1	11	racemic citalopram did not alter the mean auc or cmax of pimozide .
None(e1,e2)	1	12	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid preparations .
None(e1,e2)	0	9	antihistamines : amphetamines may counteract the sedative effect of antihistamines .
None(e1,e2)	29	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	16	metformin : when starlix 120 mg three times daily before meals was administered in combination with metformin 500 mg three times daily to patients with type 2 diabetes , there were no clinically relevant changes in the pharmacokinetics of either agent .
None(e1,e2)	8	10	no data are available for the coadministration of invirase / ritonavir or fortovase/ritonavir and garlic capsules .
None(e1,e2)	29	44	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
mechanism(e1,e2)	15	17	in an in vitro study in human liver microsomes , inhibition of cyp2a6 hydroxylation of coumarin by fondaparinux ( 200 m m m i.e. , 350 mg/l ) was 17-28 % .
None(e1,e2)	10	18	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
None(e1,e2)	26	42	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	16	21	in a study in 36 patients with mild to moderate hypertension where the antihypertensive effects of prinivil alone were compared to prinivil given concomitantly with indomethacin , the use of indomethacin was associated with a reduced antihypertensive effect , although the difference between the two regimens was not significant .
None(e1,e2)	54	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	15	23	reports in the literature suggest that plasma levels of doxorubicin ( and its active metabolite doxorubicinol ) may be increased when paclitaxel and doxorubicin are used in combination .
None(e1,e2)	8	16	specific effects of felbatol on other antiepileptic drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
None(e1,e2)	0	5	carbamazepine : steady-state trough plasma carbamazepine and carbamazepine 10 , 11 epoxide concentrations were not affected by concomitant gabapentin ( 400 mg tid ;
None(e1,e2)	8	26	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	20	24	the effectiveness of progestin-only pills is reduced by hepatic enzyme-inducing drugs such as the anticonvulsants phenytoin , carbamazepine , and barbiturates , and the antituberculosis_drug rifampin .
None(e1,e2)	4	14	drugs that induce cyp3a4 rifampin : cyp3a4 is ordinarily a minor metabolizing enzyme of zaleplon .
None(e1,e2)	0	27	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	14	17	gleevec will increase plasmaconcentration of other cyp3a4 metabolized drugs ( e.g. , triazolo-benzodiazepines , dihydropyridine_calcium_channel_blockers , certain hmg-coa_reductase_inhibitors , etc . ) .
None(e1,e2)	4	15	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
mechanism(e1,e2)	10	16	specific effects of felbatol on other antiepileptic drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
None(e1,e2)	3	11	the co-administration of natrecor with iv vasodilators such as nitroglycerin , nitroprusside , milrinone , or iv ace inhibitors has not been evaluated ( these drugs were not co-administered with natrecor in clinical trials ) .
None(e1,e2)	0	48	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	2	28	h2 blockers/ proton_pump_inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	3	23	oral hypoglycemics : bepridil has been safely used in diabetic patients without significantly lowering their blood glucose levels or altering their need for insulin or oral hypoglycemic agents .
None(e1,e2)	14	32	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	1	27	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	34	39	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
mechanism(e1,e2)	6	11	upon administration of 10 mg of vardenafil with 800 mg tid indinavir , the cmax and auc of indinavir were reduced by 40 % and 30 % , respectively .
None(e1,e2)	1	31	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	8	36	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	30	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	31	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	42	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	14	25	corticosteroids : dexamethasone : aprepitant , when given as a regimen of 125mg with dexamethasone coadministered orally as 20 mg on day 1 , and aprepitant when given as 80 mg/day with dexamethasone coadministered orally as 8 mg on days 2 through 5 , increased the auc of dexamethasone , a cyp3a4 substrate by 2.2-fold , on days 1 and 5 .
None(e1,e2)	0	15	allopurinol : in a study of healthy male volunteers no significant pharmacokinetic interaction occurred when captopril and allopurinol were administered concomitantly for 6 days .
effect(e1,e2)	5	8	therefore the , combination of anakinra with other tnf-blocking_agents , including humira , may also result i n similar toxicities .
None(e1,e2)	22	34	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	4	6	the concomitant intake of alcohol and acamprosate does not affect the pharmacokinetics of either alcohol or acamprosate .
None(e1,e2)	24	29	dopamine antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
mechanism(e1,e2)	10	17	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl_estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	10	13	ingestion of diclofenac may increase serum concentrations of digoxin and methotrexate and increase cyclosporine s nephrotoxicity .
None(e1,e2)	5	20	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	22	48	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	0	45	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	98	149	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	10	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	110	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	9	chlorpropamide : chlorpropamides plasma half-life may be prolonged by allopurinol , since allopurinol and chlorpropamide may compete for excretion in the renal tubule .
None(e1,e2)	35	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	0	7	methotrexate - there is one report that methotrexate may decrease the possible effectiveness of supplemental l-glutamine for chemotherapy-induced mucositis .
mechanism(e1,e2)	0	2	hydrocodone increases gabapentin auc values by 14 % .
None(e1,e2)	8	12	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	6	noncardioselective_beta-blockers ( nadolol , porpranolol , timolol ) may exacerbate rebound hypertension when guanfacine is withdrawn .
None(e1,e2)	14	18	no interaction with the tricyclic antidepressant imipramine was shown in a single-dose study with entacapone without coadministered levodopa/ dopa-decarboxylase_inhibitor .
None(e1,e2)	14	20	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety_agents .
None(e1,e2)	0	2	omeprazole : omeprazole is a cyp 3a4 substrate and cyp 2c19 substrate and inhibitor .
None(e1,e2)	12	14	when such drugs are withdrawn from patients receiving acarbose in combination with sulfonylureas or insulin , patients should be observed closely for any evidence of hypoglycemia .
None(e1,e2)	21	29	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	24	26	co-administration of aliskiren did not significantly affect the pharmacokinetics of lovastatin , digoxin , valsartan , amlodipine , metformin , celecoxib , atenolol , atorvastatin , ramipril or hydrochlorothiazide .
None(e1,e2)	110	112	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	5	12	persons taking most antibiotics , methotrexate and pyrimethamine invalidate folic acid and vitamin_b12 diagnostic blood assays .
None(e1,e2)	8	14	oral anticoagulants may potentiate the hypoglycemic action of hypoglycemic_agents , eg , tolbutamide and chlorpropamide , by inhibiting their metabolism in the liver .
None(e1,e2)	17	35	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	31	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	52	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	136	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	12	heparin sodium injection should not be mixed with doxorubicin , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with heparin and a precipitate may form .
None(e1,e2)	41	53	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	23	patients receiving other narcotic analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
effect(e1,e2)	0	13	noncardioselective_beta-blockers ( nadolol , porpranolol , timolol ) may exacerbate rebound hypertension when guanfacine is withdrawn .
None(e1,e2)	38	80	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	42	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	54	61	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	4	9	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace inhibitors during therapy with lithium .
None(e1,e2)	9	19	antihistamines may have additive effects with alcohol and other cns_depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety_agents .
None(e1,e2)	0	4	albuterol , antihistamines , antidiabetic_drugs , diuretics , digitalis .
None(e1,e2)	23	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
advise(e1,e2)	2	46	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	35	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	29	35	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	12	40	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
mechanism(e1,e2)	5	14	cyclosporin : reports indicate that cyclosporine levels may be increased during concomitant treatment with allopurinol_sodium for injection .
None(e1,e2)	18	22	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
mechanism(e1,e2)	29	36	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	3	10	concomitant administration of naproxen and aspirin is not recommended because naproxen is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations and peak plasma levels .
None(e1,e2)	105	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	38	43	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	52	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	70	77	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin_c ; warfarin sodium under-dosage .
None(e1,e2)	20	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	72	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	4	10	antidepressants , tricyclic : amphetamines may enhance the activity of tricyclic or sympathomimetic agents ;
None(e1,e2)	12	19	additional reductions in blood pressure may occur when flolan is administered with diuretics , antihypertensive agents , or other vasodilators .
None(e1,e2)	9	11	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine_derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	10	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	33	41	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic_antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	22	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	20	diuretic : hydrochlorothiazide , given concomitantly with ketoprofen , produces a reduction in urinary potassium and chloride excretion compared to hydrochlorothiazide alone .
None(e1,e2)	20	24	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide_mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	102	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	3	14	the use of nimbex before succinylcholine to attenuate some of the side effects of succinylcholine has not been studied .
None(e1,e2)	11	12	drug-drug interactions between keppra and other antiepileptic drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	1	24	- anabolic_steroids ( nandrolone [ e.g. , anabolin ] , oxandrolone [ e.g. , anavar ] , oxymetholone [ e.g. , anadrol ] , stanozolol [ e.g. , winstrol ] ) or
effect(e1,e2)	14	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	10	21	no significant drug interactions have been reported in studies of candesartan_cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	3	13	nevertheless , plasma lithium levels should be monitored with appropriate adjustment to the lithium dose in accordance with standard clinical practice .
None(e1,e2)	0	7	itraconazole plasma concentrations should be monitored when itraconazole and isoniazid are coadministered .
None(e1,e2)	50	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	3	5	the effects of tricyclic_antidepressants on clonidine s analgesic actions are not known .
None(e1,e2)	94	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	5	ketoconazole : concomitant use of ketoconazole is contraindicated .
None(e1,e2)	109	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	23	86	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	25	41	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace inhibitors or angiotensin ii receptor antagonists ( acei/ arb ) .
None(e1,e2)	5	7	lithium-a drug interaction study of eplerenone with lithium has not been conducted .
None(e1,e2)	21	23	of over 3500 patients enrolled in the ibandronate osteoporosis treatment and prevention studies , 15 % used anti-peptic agents ( primarily h2_blockers and ppis ) .
None(e1,e2)	0	24	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type 1c antiarrhythrnics propatenone and flecainide ) .
advise(e1,e2)	3	7	therefore , when heparin_sodium is given with dicumarol or warfarin sodium , a period of at least 5 hours after the last intravenous dose or 24 hours after the last subcutaneous dose should elapse before blood is drawn if a valid prothrombin time is to be obtained .
None(e1,e2)	110	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	37	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	3	7	cholestyramine and colestipol resins : absorption of hydrochlorothiazide is impaired in the presence of anionic exchange resins .
None(e1,e2)	18	20	resistance to the neuromuscular blocking action of nondepolarizing neuromuscular blocking agents has been demonstrated in patients chronically administered phenytoin or carbamazepine .
None(e1,e2)	0	7	cytotoxic_agents : enhanced bone marrow suppression by cyclophosphamide and other cytotoxic agents has been reported among patients with neoplastic disease , except leukemia , in the presence of allopurinol .
None(e1,e2)	0	22	alcohol - although lexapro did not potentiate the cognitive and motor effects of alcohol in a clinical trial , as with other psychotropic_medications , the use of alcohol by patients taking lexapro is not recommended .
mechanism(e1,e2)	14	27	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	129	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	18	dostinex should not be administered concurrently with d2-antagonists , such as phenothiazines , butyrophenones , thioxanthines , or metoclopramide .
None(e1,e2)	7	37	the concomitant administration of uricosuric agents and allopurinol has been associated with a decrease in the excretion of oxypurines ( hypoxanthine and xanthine ) and an increase in urinary uric acid excretion compared with that observed with allopurinol alone .
None(e1,e2)	10	30	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
mechanism(e1,e2)	3	13	plasma concentrations of quinolone_antibiotics are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	3	19	the use of mao_inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone .
None(e1,e2)	34	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	25	35	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	31	35	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	0	11	corticosteroids may also potentiate the replication of some organisms contained in live_attenuated_vaccines .
None(e1,e2)	13	18	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , seriraline , and paroxetine , inhibit p450 2d6 , they may vary in the extent of inhibition .
mechanism(e1,e2)	6	13	cytochrome p-450 inducers , such as phenytoin , carbamazepine and phenobarbital , induce clonazepam metabolism , causing an approximately 30 % decrease in plasma clonazepam levels .
None(e1,e2)	30	41	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl_trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
effect(e1,e2)	34	38	- in isolated cases , a pronounced though reversible , impairment of renal function ( accompanied by a corresponding increase in the serum creatinine level ) has been reported in organ transplant patients receiving immuno-suppressant therapy and concomitant bezafibrate .
None(e1,e2)	0	15	lithium : ibuprofen produced an elevation of plasma lithium levels and a reduction in renal lithium clearance in a study of eleven normal volunteers .
None(e1,e2)	22	24	therefore , esomeprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( eg , ketoconazole , iron salts and digoxin ) .
mechanism(e1,e2)	8	20	ascorbic acid : doses of ascorbic acid ( vitamin_c ) 1 g/day have been reported to increase plasma concentration of synthetic_estrogens by ~47 % , possibly by inhibiting conjugation ;
None(e1,e2)	3	5	effects of other antiepileptic_drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	8	15	although this interaction has not been reported with cinoxacin , caution should be exercised when cinoxacin is given concomitantly with caffeine-containing products .
advise(e1,e2)	6	10	caution is therefore advised when administering peganone to patients receiving coumarin_anticoagulants .
None(e1,e2)	6	21	dose adjustment is not recommended . levetiracetam had no effect on plasma concentrations of carbamazepine , valproate , topiramate , or lamotrigine .
None(e1,e2)	17	25	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central_nervous_system_depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	10	15	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	14	29	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
mechanism(e1,e2)	5	12	in em individuals treated with paroxetine or fluoxetine , the auc of atomoxetine is approximately 6- to 8-fold and css , max is about 3- to 4-fold greater than atomoxetine alone .
None(e1,e2)	37	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	31	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	3	18	insulin or oral hypoglycemics : agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
effect(e1,e2)	0	7	narcotic_analgesics may potentiate the hypotensive effects of clonidine .
None(e1,e2)	4	10	potential drug interactions for doxylamine include , increased sedation if doxylamine is combined with other cns depressant drugs .
None(e1,e2)	11	21	theophylline : as with some other quinolones , concurrent administration of ciprofloxacin with theophylline may lead to elevated serum concentrations of theophylline and prolongation of its elimination half-life .
None(e1,e2)	2	13	although trough citalopram plasma levels were unaffected , given the enzyme-inducing properties of carbamazepine , the possibility that carbamazepine might increase the clearance of escitalopram should be considered if the two drugs are coadministered .
None(e1,e2)	11	19	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns_depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	31	33	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal_anti-inflammatory_drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	65	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	24	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	56	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	8	27	oral hypoglycemic agents : in one study , flurbiprofen was given to adult diabetics who were already receiving glyburide ( n=4 ) , metformin ( n=2 ) chlorpropamide with phenformin ( n= 3 ) or glyburide with phenformin ( n=6 ) .
None(e1,e2)	8	15	inhibitors or substrates of cyp2d6 ( i.e. , quinidine , selective serotonin reuptake inhibitors [ ssris ] ) may increase the plasma concentration of doxepin when administered concomitantly .
None(e1,e2)	57	74	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	41	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	8	29	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	69	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	32	rifampin : following concomitant administration of a single dose of arava to subjects receiving multiple doses of rifampin , m1 peak levels were increased ( ~40 % ) over those seen when arava was given alone .
None(e1,e2)	27	52	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic_antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	18	33	toxicology studies of heroin-related deaths reveal frequent involvement of other central nervous system depressants , including alcohol , benzodiazepines such as diazepam ( valium ) , and , to a rising degree , methadone .
None(e1,e2)	25	62	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	7	13	because of its lack of anti-platelet effect valdecoxib is not a substitute for aspirin for cardiovascular prophylaxis .
effect(e1,e2)	14	16	although there was a slight reduction in blood sugar concentrations during concomitant administration of flurbiprofen and hypoglycemic_agents , there were no signs or symptoms of hypoglycemia .
None(e1,e2)	65	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	1	29	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	59	68	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine * ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	3	6	- alcohol , barbiturates , or narcotics : potentiation of otthostatic hypotension may occur
None(e1,e2)	25	34	since pletal is extensively metabolized by cytochrome p-450 isoenzymes , caution should be exercised when pletal is coadministered with inhibitors of c.p.a . such as ketoconazole and erythromycin or inhibitors of cyp2c19 such as omeprazole .
advise(e1,e2)	0	18	brovana , as with other beta2-agonists , should be administered with extreme caution to patients being treated with monoamine_oxidase_inhibitors , tricyclic antidepressants , or drugs known to prolong the qtc interval because the action of adrenergic agonists on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	3	5	the effect of cyclosporine on diltiazem plasma concentrations has not been evaluated .
None(e1,e2)	7	29	agents affecting cytochrome p450 3a4 isoenzyme system fentanyl is metabolized mainly via the human cytochrome p450 3a4 isoenzyme system ( cyp3a4 ) , therefore potential interactions may occur when duragesic is given concurrently with agents that affect cyp3a4 activity .
None(e1,e2)	14	20	other nonsteroidal anti-inflammatory drugs that inhibit prostaglandin synthesis have been shown to interfere with thiazide_diuretics in some studies and with potassium-sparing_diuretics .
None(e1,e2)	18	31	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	96	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	11	19	close supervision and careful adjustment of the dosage are required when nortriptyline_hydrochloride is used with other anticholinergic drugs or sympathomimetic_drugs .
None(e1,e2)	3	26	drug-drug interactions between keppra and other antiepileptic drugs ( aeds ) phenytoin keppra ( 3000 mg daily ) had no effect on the pharmacokinetic disposition of phenytoin in patients with refractory epilepsy .
None(e1,e2)	4	12	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	0	2	cimetidine : albendazole_sulfoxide concentrations in bile and cystic fluid were increased ( about 2-fold ) in hydatid cyst patients treated with cimetidine ( 10 mg/kg/day ) ( n=7 ) compared with albendazole ( 20 mg/kg/day ) alone ( n=12 ) .
None(e1,e2)	13	20	therophylline : a recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline , and in some instances a slight decrease in the elimination of isoniazid .
None(e1,e2)	10	16	because oral anticoagulants may interfere with the hepatic metabolism of phenytoin , toxic levels of the anticonvulsant may occur when an oral anticoagulant and phenytoin are administered concurrently .
None(e1,e2)	51	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	52	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline_salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	0	21	furosemide : clinical studies , as well as random observations , have shown that ibuprofen can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	21	32	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	17	21	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	0	11	nitroglycerin : dynacirc ( isradipine ) has been safely coadministered with nitroglycerin .
None(e1,e2)	22	29	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid_analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	4	15	coadministration of sular with phenytoin or any known cyp3a4 inducer should be avoided and alternative antihypertensive therapy should be considered .
None(e1,e2)	22	35	results of studies in multiple sclerosis patients taking tysabri and concomitant interferon beta-1a ( avonex 30 mcg im once weekly ) or glatiramer_acetate were inconclusive with regard to the need for dose adjustment of the beta-interferon or glatiramer acetate .
mechanism(e1,e2)	5	14	probenecid : as with other b-lactam_antibiotics , renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80 % increase in the auc for loracarbef .
None(e1,e2)	0	1	loratadine descarboethoxyloratadine
None(e1,e2)	8	11	antidepressants ( tricyclic ) , atropine or other anticholinergic_agents , or digitalis_glycosides : concurrent use with arbutamine may produce additive inotropic and/or chronotropic effects .
None(e1,e2)	135	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	10	14	close supervision and careful adjustment of dosage are required when anafranil is administered with anticholinergic or sympathomimetic drugs .
None(e1,e2)	13	78	the principal drugs given ( number of patients in parentheses ) were : cardiac_glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta_blockers ( 10 ) .
None(e1,e2)	42	52	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	23	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
None(e1,e2)	69	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	4	22	in patients taking an anticonvulsant ( eg , valproic acid , carbamazepine , phenobarbital or phenytoin ) , the concomitant use of mefloquine may reduce seizure control by lowering the plasma levels of the anticonvulsant .
None(e1,e2)	92	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	13	concomitant use of antihistamines with alcohol , tricyclic_antidepressants , barbiturates , or other central_nervous_system_depressants may have an additive effect .
None(e1,e2)	26	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	51	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic_acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	6	11	may interact with cefamandole naftate , cephalothin_sodium , magnesium sulfate , prednisolone_sodium_succinate , and prochlorperazine edisylate .
None(e1,e2)	7	9	persons taking most antibiotics , methotrexate and pyrimethamine invalidate folic_acid and vitamin b12 diagnostic blood assays .
None(e1,e2)	10	42	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	1	15	- skeletal_muscle_relaxants , nondepolarizing ( e.g. , tubocurarine ) : possible increased responsiveness to the muscle_relaxant
None(e1,e2)	1	12	anesthetics/sedatives/ hypnotics /opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	1	6	because cholestyramine binds bile acids , cholestyramine resin may interfere with normal fat digestion and absorption and thus may prevent absorption of fat soluble vitamins such as a , d , e , and k .
None(e1,e2)	33	41	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	71	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	20	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	0	16	phenytoin : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenytoin with or without other enzyme- inducing aeds .
None(e1,e2)	7	17	the following drugs have been coadministered with kerlone and have not altered its pharmacokinetics : cimetidine , nifedipine , chlorthalidone , and hydrochlorothiazide .
None(e1,e2)	17	20	coadministration of alosetron and strong cyp3a4 inhibitors , such as clarithromycin , telithromycin , protease inhibitors , voriconazole , and itraconazole has not been evaluated but should be undertaken with caution because of similar potential drug interactions .
None(e1,e2)	24	26	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	45	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	41	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	45	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	20	flucytosine : while a synergistic relationship with amphotericin b has been reported , concomitant use may increase the toxicity of flucytosine by possibly increasing its cellular uptake and/or impairing its renal excretion .
advise(e1,e2)	3	9	the use of fludara for injection in combination with pentostatin is not recommended due to the risk of severe pulmonary toxicity .
None(e1,e2)	4	15	concomitant use with other calcium -containing medicines ( including antacids ) may cause too much calcium in the blood or urine , which may increase the chance of side effects .
None(e1,e2)	76	87	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	15	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	41	52	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	6	12	based on the chemical resemblance of itraconazole and ketoconazole , coadministration of astemizole with itraconazole is contraindicated .
None(e1,e2)	26	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	4	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	0	35	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
advise(e1,e2)	19	23	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
int(e1,e2)	7	25	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
mechanism(e1,e2)	2	7	rifampin : rifampin increases the metabolism of ethinyl_estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
None(e1,e2)	46	52	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	85	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	17	5ht3_antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	10	14	hyperpyrexia has been reported when amitriptyline hcl is administered with anticholinergic agents or with neuroleptic drugs , particularly during hot weather .
mechanism(e1,e2)	0	8	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
None(e1,e2)	4	6	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	31	66	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	46	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	1	15	since apraclonidine may reduce pulse and blood pressure , caution in using drugs such as beta-blockers ( ophthalmic and systemic ) , antihypertensives , and cardiac glycosides is advised .
None(e1,e2)	1	29	since zarontin ( ethosuximide ) may interact with concurrently administered antiepileptic drugs , periodic serum level determinations of these drugs may be necessary ( eg , ethosuximide may elevate phenytoin serum levels and valproic acid has been reported to both increase and decrease ethosuximide levels ) .
mechanism(e1,e2)	7	17	other strong selective cyp3a4 inhibitors such as ketoconazole can also be expected to increase the exposure of zaleplon .
None(e1,e2)	66	70	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide_antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	6	12	for this reason the dose of adrenaline should be restricted and an antiarrhythmic_agent administered as appropriate .
mechanism(e1,e2)	6	17	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl_estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	2	30	since cholestyramine resin may bind other drugs given concurrently , it is recommended that patients take other drugs at least 1 hour before or 4 to 6 hours after cholestyramine resin ( or at as great an interval as possible ) to avoid impeding their absorption .
None(e1,e2)	3	33	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	2	12	bismuth : bismuth_subsalicylate , given concomitantly with enoxacin or 60 minutes following enoxacin administration , decreased enoxacin bioavailability by approximately 25 % .
None(e1,e2)	9	33	reported examples of this interaction include the following : immunosuppressive s : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	65	86	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	12	22	human pharmacokinetics data indicate that oral ketoconazole potently inhibits the metabolism of cisapride resulting in a mean eight-fold increase in auc of cisapride .
None(e1,e2)	1	14	- lithium : lithium should generally not be given with diuretics ( such as bumetanide ) because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	55	69	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	10	12	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
None(e1,e2)	35	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
advise(e1,e2)	3	5	simultaneous administration of sprycel with antacids should be avoided .
None(e1,e2)	27	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	1	8	anesthetics/sedatives/ hypnotics /opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	46	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	18	20	no significant drug-drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , and nifedipine .
None(e1,e2)	2	6	effects of aliskiren on other drugs aliskiren does not inhibit the cyp450 isoenzymes ( cyp1a2 , 2c8 , 2c9 , 2c19 , 2d6 , 2e1 , and cyp 3a ) or induce cyp 3a4 .
None(e1,e2)	6	22	- a sulfa-based drug such as sulfamethoxazole -trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	24	73	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	16	20	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety agents , the phenothiazines , thioxanthene and butyrophenone classes of antipsychotic agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	74	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	23	29	in vivo interaction studies in humans have demonstrated that digoxin and warfarin do not affect the pk properties of anagrelide , nor does anagrelide affect the pk properties of digoxin or warfarin .
None(e1,e2)	66	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	16	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	59	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	100	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	24	43	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	18	35	additive adverse effects resulting from cholinergic blockade may occur when levsin is administered concomitantly with other antimuscarinics , amantadine , haloperidol , phenothiazines , monoamine oxidase ( mao ) inhibitors , tricyclic antidepressants or some antihistamines .
None(e1,e2)	28	33	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	2	lithium : nonsteroidal_anti-inflammatory_agents have been reported to increase steadystate plasma lithium levels .
None(e1,e2)	0	6	nitrates : the concomitant use of bepridil with long- and short-acting nitrates has been safely tolerated in patients with stable angina pectoris .
None(e1,e2)	39	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	20	33	discontinuing colestipol hydrochloride could pose a hazard to health if a potentially toxic drug that is significantly bound to the resin has been titrated to a maintenance level while the patient was taking colestipol_hydrochloride .
None(e1,e2)	5	21	antacids : concomitant administration of magnesium_hydroxide and aluminum hydroxide does not interfere with the rate or extent of the absorption of ketoprofen administered as orudis .
None(e1,e2)	8	12	in vitro mixing of an aminoglycoside with beta-lactamtype antibiotics ( penicillins or cephalosporins ) may result in a significant mutual inactivation .
None(e1,e2)	25	30	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	1	5	certain tetracyclic_antidepressants ( such as maprotiline ) ;
None(e1,e2)	46	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	20	22	as with other drugs that block angiotensin ii or its effects , concomitant use of potassium-sparing diuretics ( e.g. , spironolactone , triamterene , amiloride ) , potassium supplements , or salt substitutes containing potassium may lead to increases in serum potassium .
None(e1,e2)	12	25	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	2	15	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	5	37	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	3	21	infusion requirements of nimbex in patients administered succinylcholine prior to infusions of nimbex were comparable to or slightly greater than when succinylcholine was not administered .
None(e1,e2)	10	25	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
advise(e1,e2)	0	23	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic_analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	3	5	persons taking most antibiotics , methotrexate and pyrimethamine invalidate folic acid and vitamin b12 diagnostic blood assays .
None(e1,e2)	10	12	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid preparations .
None(e1,e2)	13	15	other drugs : in healthy volunteers , amlodipine , phenytoin , glyburide , ranitidine , omeprazole , hormone replacement therapy ( a combination of conjugated estrogens and medroxyprogesterone ) , antacid ( aluminum and magnesium hydroxides ) and theophylline did not affect the pharmacokinetics of tikosyn .
None(e1,e2)	18	22	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	18	38	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	17	20	dosage adjustment of strattera may be necessary when coadministered with cyp2d6 inhibitors , e.g. , paroxetine , fluoxetine , and quinidine .
None(e1,e2)	14	22	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	6	25	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	61	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	21	36	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace_inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	41	96	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing_compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	5	11	probenecid : as with other b-lactam_antibiotics , co-administration of probenecid with cefditoren_pivoxil resulted in an increase in the plasma exposure of cefditoren , with a 49 % increase in mean cmax , a 122 % increase in mean auc , and a 53 % increase in half-life .
advise(e1,e2)	6	8	it is suggested to monitor both ketoconazole and phenytoin .
None(e1,e2)	21	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	63	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	5	10	use in conjunction with other antiepileptic_drugs : the addition of felbatol to antiepileptic drugs ( aeds ) affects the steady-state plasma concentrations of aeds .
None(e1,e2)	11	18	however , since there is an increased risk of bleeding with xigris , caution should be employed when xigris is used with other drugs that affect hemostasis .
None(e1,e2)	0	2	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	32	40	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	14	55	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	36	41	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	66	68	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	17	with the exception of albuterol , there are no formal studies fully evaluating the interaction effects of atrovent inhalation aerosol and these drugs with respect to effectiveness .
None(e1,e2)	20	22	studies in healthy volunteers have shown that acarbose has no effect on either the pharmacokinetics or pharmacodynamics of digoxin , nifedipine , propranolol , or ranitidine .
None(e1,e2)	36	50	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	30	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	35	44	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	2	carbamazepine ( cbz )
None(e1,e2)	44	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	2	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
advise(e1,e2)	41	45	this interaction , which has not been investigated using higher doses of fluvoxamine , may be more pronounced if a 300 mg daily dose is co-administered , particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg . if alprazolam is co-administered with fluvoxamine tablets , the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended .
None(e1,e2)	54	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	6	16	vasoconstrictors : d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp should not be used with peripheral_vasoconstrictors because the combination may cause synergistic elevation of blood pressure .
None(e1,e2)	23	115	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	25	31	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	16	32	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
None(e1,e2)	36	49	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	34	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
mechanism(e1,e2)	8	41	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	1	9	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	7	17	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	12	16	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central nervous system depressant effects .
None(e1,e2)	13	33	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	4	21	another study showed that alosetron had no clinically significant effect on plasma concentrations of the oral contraceptive agents ethinyl estradiol and levonorgestrel ( cyp3a4 substrates ) .
None(e1,e2)	15	34	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	57	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	46	68	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	30	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	25	37	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	21	23	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	19	29	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic_steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	11	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	8	28	although it has not been definitively demonstrated that fluvoxamine is a potent iiia4 inhibitor , it is likely to be , given the substantial interaction of fluvoxamine with alprazolam .
None(e1,e2)	6	19	steroids enhance the renal toxicity of edetate_calcium_disodium in animals . 7 edetate calcium disodium interferes with the action of zinc_insulin preparations by chelating the zinc . 7
None(e1,e2)	22	24	in vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome cyp 2c9 substrates/inhibitors sulphenazole , tolbutamide and nifedipine .
None(e1,e2)	50	59	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	2	phenytoin , nicotine , and rifampin may decrease clozapine plasma levels , resulting in a decrease in effectiveness of a previously effective clozapine dose .
None(e1,e2)	23	27	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	1	18	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum -containing antacid preparations .
None(e1,e2)	2	13	pimozide and celexa - in a controlled study , a single dose of pimozide 2 mg co-administered with racemic citalopram 40 mg given once daily for 11 days was associated with a mean increase in qtc values of approximately 10 msec compared to pimozide given alone .
None(e1,e2)	19	54	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	11	13	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	17	28	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
mechanism(e1,e2)	5	21	in two clinical studies , cyclosporine ( one 4 mg/kg dose or two 3 mg/kg doses ) increased the auc of caspofungin by approximately 35 % .
None(e1,e2)	28	34	at 24 hours postdose , a similar proportion of patients treated with methotrexate alone ( 94 % ) and subsequently treated with methotrexate co-administered with 75 mg of rofecoxib ( 88 % ) had methotrexate plasma concentrations below the measurable limit ( 5 ng/ml ) .
None(e1,e2)	18	24	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	10	17	- a steroid medicine such as prednisone ( deltasone , orasone , others ) , methylprednisolone ( medrol , others ) , prednisolone ( prelone , pediapred , others ) , and others ;
None(e1,e2)	71	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	47	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	79	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	9	initial doses of adrenergic_agents , such as dopamine or epinephrine , should be reduced and titrated to achieve the desired response .
None(e1,e2)	3	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
effect(e1,e2)	6	17	tablets : the benzodiazepines , including lorazepam , produce cns-depressant effects when administered with such medications as barbiturates or alcohol .
None(e1,e2)	19	24	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic_agents such as quinidine and procainamide , cardiac glycosides and tricyclic anti-depressants .
None(e1,e2)	1	33	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	10	20	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	38	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	0	29	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic analgesics , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns_depressants , causing increased cns depression .
None(e1,e2)	0	8	amiodarone taken concomitantly with digoxin increases the serum digoxin concentration by 70 % after one day .
None(e1,e2)	13	26	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	0	2	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	8	43	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	1	3	include terfenadine , astemizole , cisapride , midazolam , and triazolam .
None(e1,e2)	28	39	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	19	34	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	2	4	interactions for vitamin_d_analogues ( vitamin_d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	38	40	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	16	18	a similar association , though less marked , has been suggested with barbiturates , phenyl-butazone , phenytoin_sodium , carbamazepine and possibly with griseofulvin , ampicillin , and tetracyclines ( 72 )
None(e1,e2)	29	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	11	ketoconazole ) , macrolide_antibiotics ( e.g . erythromycin ) , and hiv_protease_inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	5	12	therefore , concurrent use of trileptal with hormonal contraceptives may render these contraceptives less effective .
None(e1,e2)	49	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	28	36	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	3	26	therefore , when chlorothiazide and non-steroidal anti-inflammatory agents are used concomitantly , the patient should be observed closely to determine if the desired effect of the diuretic is obtained
None(e1,e2)	26	30	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	15	43	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	20	22	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	26	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	17	26	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	7	16	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
effect(e1,e2)	12	18	danazol : the risk of myopathy/rhabdomyolysis is increased by concomitant administration of danazol particularly with higher doses of lovastatin ( see warnings , myopathy/rhabdomyolysis ) .
None(e1,e2)	20	22	the plasma concentration of imipramine may increase when the drug is given concomitantly with hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decrease by concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and adjustment of the dosage of imipramine may therefore be necessary .
None(e1,e2)	44	50	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	0	20	beta-adrenergic_blocking_agents : experience in over 1400 patients in a non-comparative clinical trial has shown that concomitant administration of nifedipine and beta-blocking_agents is usually well tolerated , but there have been occasional literature reports suggesting that the combination may increase the likelihood of congestive heart failure , severe hypotension or exacerbation of angina .
None(e1,e2)	0	2	antacids , sucralfate , metal cations , multivitamins quinolones form chelates with alkaline earth and transition metal cations .
None(e1,e2)	0	13	dopamine_antagonists : since apomorphine is a dopamine agonist , it is possible that dopamine_antagonists , such as the neuroleptics ( phenothiazines , butyrophenones , thioxanthenes ) or metoclopramide , may diminish the effectiveness of apokyn .
None(e1,e2)	0	5	isoflurane or enflurane administered with nitrous_oxide /oxygen to achieve 1.25 mac [ minimum alveolar concentration ] may prolong the clinically effective duration of action of initial and maintenance doses of nimbex and decrease the required infusion rate of nimbex .
None(e1,e2)	8	24	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	23	during concomitant therapy with ibuprofen , the patient should be observed closely for signs of renal failure , as well as to assure diuretic efficacy .
None(e1,e2)	21	40	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	31	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	4	24	anticholinergic agents : although ipratropium_bromide is minimally absorbed into the systemic circulation , there is some potential for an additive interaction with concomitantly used anticholinergic_medications .
None(e1,e2)	8	21	in addition to bleeding associated with heparin and vitamin_k_antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
mechanism(e1,e2)	12	29	because anafranil is highly bound to serum protein , the administration of anafranil to patients taking other drugs that are highly bound to protein ( e.g. , warfarin , digoxin ) may cause an increase in plasma concentrations of these drugs , potentially resulting in adverse effects .
None(e1,e2)	34	59	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	48	65	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	21	63	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	48	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	13	28	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine_sodium from the gastrointestinal tract : aluminum hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous_sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	54	59	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa_reductase_inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	36	42	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
None(e1,e2)	37	44	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium_sparing_diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	2	21	lithium : lithium toxicity has been reported in patients receiving lithium concomitantly with drugs which cause elimination of sodium , including ace_inhibitors .
None(e1,e2)	24	26	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin_hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	5	20	the blood pressure effect of sular tended to be greater in patients on atenolol than in patients on no other antihypertensive therapy .
None(e1,e2)	0	2	tricyclic_antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination hormonal contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	18	48	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic_products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	19	29	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	12	28	heparin sodium injection should not be mixed with doxorubicin , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with heparin and a precipitate may form .
advise(e1,e2)	10	21	if you are also using a steroid inhaler , take bitolterol first and then wait about 15 minutes before using the steroid inhaler .
None(e1,e2)	17	26	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	13	33	therophylline : a recent study has shown that concomitan administration of isoniazid and theophylline may cause elevated plasma levels of theophylline , and in some instances a slight decrease in the elimination of isoniazid .
None(e1,e2)	18	35	concurrent administration of drugs possessing nephrotoxic ( e.g. , aminoglycosides , indomethacin ) , myelotoxic ( e.g. , cytotoxic chemotherapy ) , cardiotoxic ( e.g. , doxorubicin ) or hepatotoxic ( e.g. , methotrexate , asparaginase ) effects with proleukin may increase toxicity in these organ systems .
None(e1,e2)	11	18	- a diuretic ( water pill ) such as hydrochlorothiazide ( hctz , hydrodiuril ) , chlorothiazide ( diuril ) , and others ;
None(e1,e2)	15	63	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
effect(e1,e2)	14	17	nonsteroidal anti-inflammatory agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal_antiinflammatory_agents ) and corticosteroids increases the risk of gastrointestinal side effects .
None(e1,e2)	0	9	sildenafil_citrate - theoretically , l-arginine supplements taken concomitantly with sildenafil_citrate , may potentiate the effects of the drug .
None(e1,e2)	62	111	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	3	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic agents ;
effect(e1,e2)	0	12	folic_acid in large amounts may counteract the antiepileptic effect of phenobarbital , phenytoin and primidone , and increase the frequency of seizures in susceptible pediatric patients .
None(e1,e2)	19	22	cimetidine ) and many that are substrates for p450 2d6 ( many other antidepressants , phenothiazines , and the type_1c_antiarrhythmics propafenone and flecainide ) .
None(e1,e2)	46	54	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	5	32	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	9	17	use of prinivil with potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
None(e1,e2)	50	66	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	17	ampicillin /amoxicillin : an increase in the frequency of skin rash has been reported among patients receiving ampicillin or amoxicillin concurrently with allopurinol compared to patients who are not receiving both drugs .
None(e1,e2)	25	41	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	1	4	aspirin/ nonsteroidal_antiinflammatory_drug s ( nsaids )
None(e1,e2)	10	38	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	0	49	warfarin : in a study in healthy volunteers , no clinically relevant pharmacokinetic or pharmacodynamic interaction between isradipine and racemic warfarin was seen when two single oral doses of warfarin ( 0.7 mg/kg body weight ) were administered during 11 days of multipledose treatment with 5 mg b.i.d . isradipine .
int(e1,e2)	7	18	however , in patients treated with oral carbonic_anhydrase_inhibitors , rare instances of drug interactions have occurred with high-dose salicylate therapy .
None(e1,e2)	26	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	46	83	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	2	6	fluconazole and ketoconazole : ketoconazole and fluconazole are predominantly cyp 3a4 and 2c9 inhibitors , respectively .
None(e1,e2)	105	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	15	21	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
None(e1,e2)	8	15	probenecid : probenecid increases both free and bound ketoprofen by reducing the plasma clearance of ketoprofen to about one-third , as well as decreasing its protein binding .
None(e1,e2)	0	20	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	47	54	phenytoin : in a single ( 400 mg ) and multiple dose ( 400 mg tid ) study of neurontin in epileptic patients ( n=8 ) maintained on phenytoin monotherapy for at least 2 months , gabapentin had no effect on the steady-state trough plasma concentrations of phenytoin and phenytoin had no effect on gabapentin pharmacokinetics .
None(e1,e2)	0	2	azopt ( brinzolamide ophthalmic suspension ) 1 % contains a carbonic anhydrase inhibitor .
None(e1,e2)	30	32	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	8	31	in addition , steady state levels of racemic citalopram were not significantly different in poor metabolizers and extensive cyp2d6 metabolizers after multiple-dose administration of citalopram , suggesting that coadministration , with escitalopram , of a drug that inhibits cyp2d6 , is unlikely to have clinically significant effects on escitalopram metabolism .
None(e1,e2)	0	20	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic_acid , and warfarin .
None(e1,e2)	31	56	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	21	36	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
mechanism(e1,e2)	3	8	concomitant administration of probenecid doubled the auc for cefprozil .
None(e1,e2)	22	41	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	14	33	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
effect(e1,e2)	9	32	immediate and extended release tablets the hypoglycemic action of sulfonylureas may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents , some azoles and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	3	28	cimetidine co-administration of felodipine with cimetidine ( a non-specific cyp-450 inhibitor ) resulted in an increase of approximately 50 % in the auc and the cmax , of felodipine .
None(e1,e2)	55	64	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	24	41	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin_analog ( e.g. , octreotide ) , sulfonamide antibiotics .
effect(e1,e2)	6	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	32	in a drug interaction study , co-administration of orally inhaled ciclesonide and oral erythromycin , an inhibitor of cytochrome p450 3a4 , had no effect on the pharmacokinetics of either des-ciclesonide or erythromycin .
None(e1,e2)	30	51	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	2	13	digoxin : digoxin concentrations are increased by about 15 % when digoxin and carvedilol are administered concomitantly .
None(e1,e2)	8	22	drug-drug interactions given the primary cns effects of aripiprazole , caution should be used when abilify is taken in combination with other centrally_acting_drugs and alcohol .
effect(e1,e2)	2	5	coadministration of ethoxzolamide with other diuretics , amphotericin b , and corticosteroids may cause hypokalemia .
None(e1,e2)	2	9	probenecid or cimetidine : concomitant administration of probenecid or cimetidine decreases the elimination of zalcitabine , most likely by inhibition of renal tubular secretion of zalcitabine .
None(e1,e2)	0	16	warfarin keppra ( 1000 mg twice daily ) did not influence the pharmacokinetics of r and s_warfarin .
None(e1,e2)	2	5	alcohol , barbiturates and other cns_depressants ;
None(e1,e2)	55	59	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	8	37	in a study in which the 2 mg clonazepam orally disintegrating tablet was administered with and without propantheline ( an anticholinergic agent with multiple effects on the gi tract ) to healthy volunteers , the auc of clonazepam was 10 % lower and the cmax of clonazepam was 20 % lower when the orally disintegrating tablet was given with propantheline compared to when it was given alone .
None(e1,e2)	29	43	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	0	2	lithium : valdecoxib 40 mg bid for 7 days produced significant decreases in lithium serum clearance ( 25 % ) and renal clearance ( 30 % ) with a 34 % higher serum exposure compared to lithium alone .
None(e1,e2)	65	112	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	6	32	effects of other antiepileptic drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	3	10	include terfenadine , astemizole , cisapride , midazolam , and triazolam .
advise(e1,e2)	8	13	caution should be exercised during the administration of adrenaline to patients anaesthetised with fluothane as arrhythmias may be precipitated .
None(e1,e2)	58	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	73	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	22	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	112	125	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
advise(e1,e2)	0	11	beta-adrenergic_blocking_agents should be withdrawn at least 48 hours before conducting an arbutamine -mediated stress test .
mechanism(e1,e2)	34	68	although there was no effect of aprepitant on the plasma auc of r ( + ) or s ( - ) warfarin determined on day 3 , there was a 34 % decrease in s_(_-_)_warfarin ( a cyp2c9 substrate ) trough concentration accompanied by a 14 % decrease in the prothrombin time ( reported as international normalized ratio or inr ) 5 days after completion of dosing with aprepitant .
None(e1,e2)	16	18	no significant drug-drug pharmacokinetic ( or pharmacodynamic ) interactions have been found in interaction studies with hydrochlorothiazide , digoxin , warfarin , and nifedipine .
None(e1,e2)	25	27	anticonvulsants : in a pharmacokinetic study , maximum plasma concentrations of felodipine were considerably lower in epileptic patients on long-term anticonvulsant therapy ( eg , phenytoin , carbamazepine , or phenobarbital ) than in healthy volunteers .
None(e1,e2)	4	15	when therapeutic concentrations of furosemide , propranolol , dipyridamole , warfarin , quinidine , or naproxen were added to human plasma ( in vitro ) , the plasma protein binding of nicardipine hcl was not altered .
None(e1,e2)	5	27	clinical trials have indicated that pulmozyme can be effectively and safely used in conjunction with standard cystic fibrosis therapies including oral , inhaled and/or parenteral antibiotics , bronchodilators , enzyme supplements , vitamins , oral or inhaled corticosteroids , and analgesics .
None(e1,e2)	0	10	antacid ( maalox ) : maalox reduced the bioavailability of gabapentin ( n=16 ) by about 20 % .
None(e1,e2)	55	93	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex_sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	5	27	- phenytoin ( e.g. , dilantin ) use of phenytoin with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of phenytoin
None(e1,e2)	6	12	diphenhydramine hydrochloride has additive effects with alcohol and other cns depressants ( hypnotics , sedatives , tranquilizers , etc ) .
None(e1,e2)	9	34	interactions may also occur with the following : anti-depressants/ anti-anxiety_drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	5	11	interactions for vitamin b3 ( niacin ) : antihypertensive therapy : nicotinic_acid may potentiate the effects of ganglionic blocking agents and vasoactive drugs resulting in postural hypotension .
None(e1,e2)	100	120	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	7	13	beta-adrenergic blocking agents : the effect of flurbiprofen on blood pressure response to propranolol and atenolol was evaluated in men with mild uncomplicated hypertension ( n = 10 ) .
None(e1,e2)	11	26	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin_b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	24	32	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	107	115	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	27	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	25	33	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	8	60	agents with increased levels in the presence of carbamazepine : equetrotm increases the plasma levels of the following agents : clomipramine hcl , phenytoin ( 6 ) , and primidone thus , if a patient has been titrated to a stable dosage on one of the agents in this category , and then begins a course of the treatment with equetrotm , it is reasonable to expect that a dose decrease for the concomitant agent may be necessary .
None(e1,e2)	28	40	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	19	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	21	61	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
effect(e1,e2)	0	20	antihistamines may have additive effects with alcohol and other cns depressants , e.g. , hypnotics , sedatives , tranquilizers , antianxiety_agents .
None(e1,e2)	0	2	magnesium / aluminum -containing antacid products : absorption of zalcitabine is moderately reduced ( approximately 25 % ) when coadministered with magnesium/aluminum-containing antacid products .
None(e1,e2)	10	16	pharmacokinetic interaction studies with cetirizine in adults were conducted with pseudoephedrine , antipyrine , ketoconazole , erythromycin and azithromycin .
None(e1,e2)	8	13	the patient was also chronically receiving phenytoin , phenobarbital , digoxin , and levothyroxine_sodium .
None(e1,e2)	10	12	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	31	37	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	44	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	18	insulin or oral hypoglycemics : agents with b-blocking properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
None(e1,e2)	9	11	use of prinivil with potassium-sparing diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
None(e1,e2)	20	30	in in vivo studies , 10- to 30-mg/day doses of aripiprazole had no significant effect on metabolism by cyp2d6 ( dextromethorphan ) , cyp2c9 ( warfarin ) , cyp2c19 ( omeprazole , warfarin ) , and cyp3a4 ( dextromethorphan ) substrates .
None(e1,e2)	8	16	other strong inhibitors of cyp3a4 ( e.g. , itraconazole , clarithromycin , nefazodone , troleandomycin , ritonavir , nelfinavir ) would be expected to behave similarly .
None(e1,e2)	17	19	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	12	25	in general , most patients treated with dirithromycin who are receiving concomitant theophylline therapy may not require empiric adjustment of theophylline dosage or monitoring of theophylline plasma concentrations .
effect(e1,e2)	6	9	profound hypotensive episodes may occur when diazoxide infection and hydralazine are used concomitantly .
None(e1,e2)	26	37	propranolol to healthy volunteers under steady-state conditions had no relevant effect on either drug s bioavailability , auc and cmax , differences were 20 % between isradipine given singly and in combination with propranolol , and between propranolol given singly and in combination with isradipine .
advise(e1,e2)	3	5	concurrent therapy with orencia and tnf_antagonists is not recommended .
effect(e1,e2)	0	11	butyrophenones ( such as haloperidol ) and phenothiazines can suppress the dopamine rgic renal and mesenteric vasodilation induced with low dose dopamine infusion .
None(e1,e2)	23	28	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	7	9	increased toxicity ( cns depression ) : cns_depressants , mao_inhibitors , tricyclic antidepressants , phenothiazines .
None(e1,e2)	42	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	10	17	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	16	23	the clinical basis of this drug interaction has not been established but should be noted when allopurinol is given to patients already on dicumarol therapy .
None(e1,e2)	31	42	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	2	4	interactions with mixed_agonist/antagonist_opioid_analgesics : agonist/antagonist_analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	3	28	oral contraceptives : valdecoxib ( 40 mg bid ) did not induce the metabolism of the combination oral contraceptive norethindrone/ethinyl estradiol ( 1 mg /35 mcg combination , ortho-novum 1/35 ) .
None(e1,e2)	2	10	therefore , cyclosporine serum levels should be monitored and appropriate cyclosporine dosage adjustments made when these drugs are used concomitantly .
None(e1,e2)	0	15	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
effect(e1,e2)	0	8	mao_inhibitors prolong and intensify the anticholinergic effects of antihistamines .
None(e1,e2)	36	44	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	9	11	other agents : prinivil has been used concomitantly with nitrates and/or digoxin without evidence of clinically significant adverse interactions .
None(e1,e2)	12	47	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic_acid , and acetaminophen .
None(e1,e2)	22	31	ketoconazole ) , macrolide antibiotics ( e.g . erythromycin ) , and hiv protease inhibitors ( e.g . ritonavir , indinavir and saquinavir ) should have their dose of subutex or suboxone adjusted .
None(e1,e2)	13	17	in patients in whom cyp3a4 inducers ( eg , dexamethasone , phenytoin , carbamazepine , rifampicin , phenobarbital ) are indicated , alternative agents with less enzyme induction potential should be used .
None(e1,e2)	32	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	2	10	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	146	150	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	38	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	9	29	in view of the long and variable half-life of amiodarone , potential for drug interactions exists not only with concomitant medication but also with drugs administered after discontinuation of amiodarone .
mechanism(e1,e2)	0	9	cimetidine is reported to reduce hepatic metabolism of certain tricyclic_antidepressants , thereby delaying elimination and increasing steady-state concentrations of these drugs .
None(e1,e2)	23	143	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	21	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	1	17	prednisone/ prednisolone : rofecoxib did not have any clinically important effect on the pharmacokinetics of prednisolone or prednisone .
None(e1,e2)	92	118	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	98	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	0	13	gleevec will increase plasmaconcentration of other cyp3a4 metabolized drugs ( e.g. , triazolo- benzodiazepines , dihydropyridine calcium channel blockers , certain hmg-coa reductase inhibitors , etc . ) .
None(e1,e2)	76	85	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	2	9	interactions with mixed_agonist/antagonist_opioid_analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
mechanism(e1,e2)	6	31	the steady state plasma concentrations of imipramine and desipramine have been reported to be increased an average of 31 % and 20 % , respectively , by the concomitant administration of alprazolam tablets in doses up to 4 mg/day .
None(e1,e2)	27	31	caution should be taken when enablex is used concomitantly with medications that are predominantly metabolized by cyp2d6 and which have a narrow therapeutic window , such as flecainide , thioridazine and tricyclic_antidepressants ( see clinical pharmacology ) .
mechanism(e1,e2)	18	77	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	2	11	rifampin : rifampin increases the metabolism of ethinyl estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
advise(e1,e2)	15	33	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	13	18	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .
None(e1,e2)	131	155	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/ sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	3	7	infusion requirements of nimbex in patients administered succinylcholine prior to infusions of nimbex were comparable to or slightly greater than when succinylcholine was not administered .
None(e1,e2)	20	24	in vitro studies show significant inhibition of the formation of oxidized irbesartan metabolites with the known cytochrome cyp 2c9 substrates/inhibitors sulphenazole , tolbutamide and nifedipine .
None(e1,e2)	37	45	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal_anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	3	5	gemfibrozil other fibrates niacin ( nicotinic_acid ) ( =1 g/day )
None(e1,e2)	30	34	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine_oxidase_(_mao_)_inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	49	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	22	propranolol : in normal volunteers , there was no clinically significant pharmacokinetic or pharmacodynamic interaction with concomitant administration of single doses of lovastatin and propranolol .
None(e1,e2)	34	36	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	43	45	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	10	15	clinical studies in healthy volunteers show that the pharmacokinetics of cancidas are not altered by itraconazole , amphotericin b , mycophenolate , nelfinavir , or tacrolimus .
None(e1,e2)	21	30	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	43	45	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	31	59	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	53	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	5	8	aminoglycosides : the mixing of piperacillin with an aminoglycoside in vitro can result in substantial inactivation of the aminoglycoside .
None(e1,e2)	11	33	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	20	30	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	11	15	other cyp3a4 inducers include , but are not limited to , rifabutin , rifapentine , phenytoin , carbamazepine , phenobarbital and st. johns wort .
mechanism(e1,e2)	2	15	naproxen , naproxen_sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
None(e1,e2)	10	18	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
effect(e1,e2)	12	28	non-steroidal anti-inflammatory drugs : in some patients , the administration of a non-steroidal_anti-inflammatory_agent can reduce the diuretic , natriuretic , and antihypertensive effects of loop , potassium-sparing and thiazide_diuretics .
None(e1,e2)	29	36	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	26	50	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary_vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	94	112	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	10	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	21	23	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	2	20	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	58	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	31	however , because some quinolones have been reported to enhance the effects of warfarin or its derivatives , prothrombin time or other suitable anticoagulation test should be monitored closely if a quinolone_antimicrobial is administered with warfarin or its derivatives .
None(e1,e2)	32	38	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
effect(e1,e2)	19	26	patients receiving other narcotic analgesics , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic antidepressants or other cns_depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
None(e1,e2)	23	33	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	0	14	digoxin : when multiple doses of atorvastatin and digoxin were coadministered , steady-state plasma digoxin concentrations increased by approximately 20 % .
None(e1,e2)	4	15	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	59	110	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	20	24	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	35	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	13	medications can interfere with folate utilization , including : anticonvulsant_medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	20	33	therefore , co-administration of clozapine with other drugs that are metabolized by this isozyme , including antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( e.g. , propafenone , flecainide and encainide ) , or that inhibit this enzyme ( e.g. , quinidine ) , should be approached with caution .
None(e1,e2)	53	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	9	15	platelet inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
advise(e1,e2)	4	13	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	12	18	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	26	32	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton_pump_inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	31	55	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
effect(e1,e2)	34	36	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	78	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	51	56	the principal drugs given ( number of patients in parentheses ) were : cardiac glycosides ( 115 ) , sedatives and hypnotics ( 103 ) , coronary vasodilators ( 52 ) , oral hypoglycemics ( 45 ) , cough and cold preparations ( 45 ) , nsaids ( 38 ) , antihyperlipidemics ( 29 ) , antigout_drugs ( 24 ) , oral contraceptives ( 18 ) , bronchodilators ( 13 ) , insulin ( 10 ) , and beta blockers ( 10 ) .
None(e1,e2)	9	22	because prostaglandina play an important role in hemostasis and ketoprofen has an effect on platelet function as well , concurent therapy with ketoprofen and warfarin requires close monitoring of patients on both drugs .
None(e1,e2)	24	30	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl_trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	3	16	the effect of toradol on plasma lithium has not been studied , but cases of increased lithium plasma levels during toradol therapy have been reported .
None(e1,e2)	8	14	therefore , the concomitant administration of tracleer and glyburide is contraindicated , and alternative hypoglycemic_agents should be considered .
None(e1,e2)	10	15	- a sulfa-based drug such as sulfamethoxazole-trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	2	4	amiodarone , disopyramide , lidocaine
None(e1,e2)	7	43	in another study with intravenous administration of midazolam , aprepitant was given as 125 mg on day 1 and 80 mg/day on days 2 and 3 , and midazolam 2 mg iv was given prior to the administration of the 3-day regimen of aprepitant and on days 4 , 8 , and 15 .
None(e1,e2)	35	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	25	theophylline : in three pharmacokinetic studies including 46 normal , healthy subjects , theophylline clearance and concentration were not significantly altered by the addition of lomefloxacin .
None(e1,e2)	19	25	interaction of gabitril with other drugs : cimetidine : co-administration of cimetidine ( 800 mg/day ) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .
None(e1,e2)	39	100	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	65	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	37	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	11	28	cytotoxic agents : enhanced bone marrow suppression by cyclophosphamide and other cytotoxic_agents has been reported among patients with neoplastic disease , except leukemia , in the presence of allopurinol .
mechanism(e1,e2)	13	15	however , in a study of 12 normal subjects , concurrent administration of aspirin decreased ketoprofen protein binding and increased ketoprofen plasma clearance from 0.07 l/kg/h without aspirin to 0.11 l/kg/h with aspirin .
None(e1,e2)	13	39	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	3	23	drug interactions with antacids administration of 120 mg of fexofenadine hydrochloride ( 2 x 60 mg capsule ) within 15 minutes of an aluminum and magnesium containing antacid ( maalox ) decreased fexofenadine auc by 41 % and cmax by 43 % .
int(e1,e2)	61	76	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	108	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	12	16	these include probenecid , cholestyramine , and some antibiotics ( e.g . erythromycin , rifamipicin , ampicillin and chloramphenicol ) .
None(e1,e2)	47	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	2	cephalosporins - cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	54	71	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
int(e1,e2)	0	6	flexeril may have life-threatening interactions with mao_inhibitors .
None(e1,e2)	4	20	other drug interaction information digoxin : studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics of digoxin .
None(e1,e2)	7	19	although deferasirox has a lower affinity for aluminum than for iron , exjade should not be taken with aluminum-containing antacid_preparations .
None(e1,e2)	31	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	1	mao_inhibitors maoi_antidepressants , as well as a metabolite of furazolidone , slow amphetamine metabolism .
None(e1,e2)	3	20	prior administration of succinylcholine had no effect on the duration of neuromuscular block following initial or maintenance bolus doses of nimbex .
None(e1,e2)	30	51	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	20	rifampin may decrease serum digoxin concentration , especially in patients with renal dysfunction , by increasing the non-renal clearance of digoxin .
None(e1,e2)	33	85	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	25	antacids and sucralfate : sucralfate and antacids containing magnesium or aluminum , as well as formulations containing divalent and trivalent cations such as videx ( didanosine ) , chewable/buffered tablets or the pediatric powder for oral solution can form chelation complexes with lomefloxacin and interfere with its bioavailability .
None(e1,e2)	29	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	8	fluoxetine , ocs , sertraline , diltiazem , macrolide_antibiotics ( exercise caution ) .
advise(e1,e2)	2	14	digitalis : vitamin_d dosage must be determined with care in patients undergoing treatment with digitalis , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
None(e1,e2)	65	100	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	13	rifampin : rifampin increases the metabolism of ethinyl estradiol and some progestins ( norethindrone ) resulting in decreased contraceptive effectiveness and increased menstrual irregularities .
None(e1,e2)	4	11	the concomitant administration of quinolones including norfloxacin with glyburide ( a sulfonylurea_agent ) has , on rare occasions , resulted in severe hypoglycemia .
None(e1,e2)	32	62	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	4	12	the concomitant use of vasopressor s , vasoconstricting agents ( such as ergonovine ) and some oxytocic drugs may result in severe hypertension .
None(e1,e2)	61	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	26	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease_inhibitors , quinidine , and verapamil .
None(e1,e2)	5	7	patients taking these drugs with lodosyn and levodopa or carbidopa-levodopa combination products should be carefully observed for loss of therapeutic response .
int(e1,e2)	0	26	benzthiazide may interact with alcohol , blood thinners , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	12	22	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	59	84	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	7	11	interaction of gabitril with other drugs : cimetidine : co-administration of cimetidine ( 800 mg/day ) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .
None(e1,e2)	0	2	ephedrine : ephedrine may enhance the metabolic clearance of corticosteroids , resulting in decreased blood levels and lessened physiologic activity , thus requiring an increase in corticosteroid dosage .
None(e1,e2)	0	13	valproate 500 mg twice daily did not modify the rate or extent of levetiracetam absorption or its plasma clearance or urinary excretion .
None(e1,e2)	29	31	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	5	7	concomitant use of antihistamines with alcohol , tricyclic_antidepressants , barbiturates , or other central nervous system depressants may have an additive effect .
mechanism(e1,e2)	18	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	12	38	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	9	14	reported examples of this interaction include the following : immunosuppressive s : cyclosporine ( cyp3a4 substrate ) administered in combination with oral amiodarone has been reported to produce persistently elevated plasma concentrations of cyclosporine resulting in elevated creatinine , despite reduction in dose of cyclosporine .
None(e1,e2)	29	42	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3_antagonist_class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	36	57	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	24	43	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	12	18	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	27	29	cisapride should not be used concomitantly with other drugs known to prolong the qt interval : certain antiarrhythmics , including those of class ia ( such as quinidine and procainamide ) and class iii ( such as sotalol ) ;
None(e1,e2)	107	150	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
int(e1,e2)	0	7	dexbrompheniramine can interact with alcohol or other cns_depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine oxidase ( mao ) inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	3	10	concomitant treatment with methylxanthines ( aminophylline , theophylline ) , steroids , or diuretics may potentiate any hypokalemic effect of adrenergic agonists .
None(e1,e2)	26	47	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin_k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	24	38	no depressant effect on blood levels in humans was noted when colestipol hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	28	66	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
advise(e1,e2)	7	23	drugs that induce hepatic enzymes such as phenobarbital , phenytoin and rifampin may increase the clearance of corticosteroids and may require increases in corticosteroid dose to achieve the desired response .
None(e1,e2)	0	2	iodine or iodine excess may decrease the effect of carbimazole , and an iodine deficiency can increase the effect of carbimazole .
None(e1,e2)	54	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	10	27	if signs and symptoms suggestive of digoxin toxicity occur when enoxacin and digoxin are given concomitantly , physicians are advised to obtain serum digoxin levels and adjust digoxin doses appropriately .
None(e1,e2)	35	53	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
advise(e1,e2)	4	24	therefore , co-administration of tricyclic_antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	29	30	since cholestyramine resin may bind other drugs given concurrently , it is recommended that patients take other drugs at least 1 hour before or 4 to 6 hours after cholestyramine resin ( or at as great an interval as possible ) to avoid impeding their absorption .
None(e1,e2)	2	14	stavudine and zidovudine ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against hiv .
None(e1,e2)	17	26	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	1	16	when ertapenem is co-administered with probenecid ( 500 mg p.o . every 6 hours ) , probenecid competes for active tubular secretion and reduces the renal clearance of ertapenem .
None(e1,e2)	28	31	a drug-drug interaction study evaluated the effect of the use of aczone gel , 5 % , in combination with double strength ( 160 mg/800 mg ) trimethoprim/ sulfamethoxazole ( tmp/ smx ) .
None(e1,e2)	11	25	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	8	15	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	8	19	other no clinically important pharmacokinetic interactions occurred when lotensin was administered concomitantly with hydrochlorothiazide , chlorthalidone , furosemide , digoxin , propranolol , atenolol , naproxen , or cimetidine .
None(e1,e2)	31	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	20	and calcium channel antagonists e.g. , verapamil ) , cyp1a2 inducers ( omeprazole ) and cyp1a2 inhibitors ( furafylline and clarithromycin ) .
None(e1,e2)	21	45	interactions may occur with the following : adrenocorticoids ( cortisone-like medicine ) , anticoagulants ( blood thinners ) , carbamazepine , corticotropin ( barbiturates may decrease the effects of these medicines ) , central nervous system ( cns ) depressants ( using these medicines with barbiturates may result in increased cns depressant effects ) , divalproex sodium , valproic acid ( using these medicines with barbiturates may change the amount of either medicine that you need to take ) , and oral contraceptives containing estrogens ( barbiturates may decrease the effectiveness of these oral contraceptives , and you may need to change to a different type of birth control ) .
None(e1,e2)	4	10	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	9	18	however , co administration of fexofenadine hydrochloride with either ketoconazole or erythromycin led to increased plasma concentrations of fexofenadine .
None(e1,e2)	1	34	- antidiabetics , oral ( diabetes medicine you take by mouth ) use of oral antidiabetics with sulfapyridine may increase the chance of side effects affecting the blood and/or the side effects or oral antidiabetics
None(e1,e2)	27	42	the iv methylprednisolone dose should be reduced by approximately 25 % , and the oral methylprednisolone dose should be reduced by approximately 50 % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
None(e1,e2)	109	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	15	21	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
effect(e1,e2)	4	12	butalbital , acetaminophen and caffeine may enhance the effects of : other narcotic_analgesic s , alcohol , general anesthetics , tranquilizers such as chlordiazepoxide , sedative-hypnotics , or other cns depressants , causing increased cns depression .
None(e1,e2)	0	3	digoxin : when starlix 120 mg before meals was administered in combination with a single 1-mg dose of digoxin to healthy volunteers , there were no clinically relevant changes in the pharmacokinetics of either agent .
effect(e1,e2)	14	21	antiepileptic drugs : sporadic cases of seizures have been reported during concomitant use of toradol and antiepileptic drugs ( phenytoin , carbamazepine ) .
effect(e1,e2)	5	11	other tnfa-blocking agents ( including remicade ) used in combination with anakinra may also result in similar toxicities .
advise(e1,e2)	10	21	it is recommended not to exceed a single 2.5 mg vardenafil dose in a 24-hour period when used in combination with indinavir .
effect(e1,e2)	5	15	1- adrenergic receptor antagonism , aripiprazole has the potential to enhance the effect of certain antihypertensive_agents .
None(e1,e2)	13	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	7	32	therefore , it is theoretically possible that lansoprazole may interfere with the absorption of drugs where gastric ph is an important determinant of bioavailability ( e.g . ketoconazole , ampicillin esters , iron salts , digoxin ) .
None(e1,e2)	10	20	discontinuation of cimetidine in well-controlled patients receiving tricyclic antidepressants and cimetidine may decrease the plasma levels and efficacy of the antidepressants .
None(e1,e2)	12	17	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	2	9	corticosteroids , methylxanthines and diuretics : concomitant treatment with xanthine_derivatives , steroids , or diuretics may potentiate a possible hypokalemic effect of beta2-agonists .
None(e1,e2)	116	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	2	4	co-administration of tacrolimus and bosentan resulted in markedly increased plasma concentrations of bosentan in animals .
None(e1,e2)	59	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	5	12	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	6	12	- a monoamine oxidase inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	0	15	digitalis : vitamin d dosage must be determined with care in patients undergoing treatment with digitalis , as hypercalcemia in such patients may precipitate cardiac arrhythmias .
None(e1,e2)	5	10	selective serotonin reuptake inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	15	43	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta_blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium_sparing_diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	26	28	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	11	triazolam : erythromycin has been reported to decrease the clearance of triazolam and , thus , may increase the pharmacologic effect of triazolam .
None(e1,e2)	87	126	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	39	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	12	33	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	5	38	in clinical studies performed with fondaparinux , the concomitant use of oral anticoagulants ( warfarin ) , platelet inhibitors ( acetylsalicylic acid ) , nsaids ( piroxicam ) , and digoxin did not significantly affect the pharmacokinetics/pharmacodynamics of fondaparinux_sodium .
None(e1,e2)	2	6	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	36	44	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
None(e1,e2)	21	25	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	15	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	12	16	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	23	33	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	20	36	nephrotoxic agents : concomitant administration of vistide and agents with nephrotoxic potential [ e.g. , intravenous aminoglycosides ( e.g. , tobramycin , gentamicin , and amikacin ) , amphotericin b , foscarnet , intravenous pentamidine , vancomycin , and non-steroidal anti-inflammatory agents ] is contraindicated .
None(e1,e2)	30	58	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	18	27	based on known metabolic profiles , clinically significant drug interactions are not expected between viracept and dapsone , trimethoprim /sulfamethoxazole , clarithromycin , erythromycin , itraconazole or fluconazole .
None(e1,e2)	53	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	21	vecuronium : when used in the perioperative period , piperacillin has been implicated in the prolongation of the neuromuscular blockade of vecuronium .
advise(e1,e2)	14	19	nevertheless , the prothrombin time or other suitable coagulation test should be monitored when warfarin or its derivatives and enoxacin are given concomitantly .
None(e1,e2)	0	10	digoxin : in patients with hypercholesterolemia , concomitant administration of lovastatin and digoxin resulted in no effect on digoxin plasma concentrations .
None(e1,e2)	14	15	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic_agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	78	121	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine_agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
mechanism(e1,e2)	18	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	70	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	66	104	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	93	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	22	38	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	32	40	ace inhibitors and angiotensin ii receptor antagonists ( congestive heart failure post-myocardial infarction ) - in ephesus , 3020 ( 91 % ) patients receiving inspra 25 to 50 mg also received ace_inhibitors or angiotensin ii receptor antagonists ( acei/ arb ) .
None(e1,e2)	10	39	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	0	8	platelet_inhibitors : drugs such as acetylsalicylic acid , dextran , phenylbutazone , ibuprofen , indomethacin , dipyridamole , hydroxychloroquine and others that interfere with platelet-aggregation reactions ( the main hemostatic defense of heparinized patients ) may induce bleeding and should be used with caution in patients receiving heparin sodium .
None(e1,e2)	21	63	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
None(e1,e2)	10	19	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen .in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
advise(e1,e2)	18	22	since bacteriostatic drugs may interfere with the bactericidal action of penicillin , it is advisable to avoid giving tetracyclines in conjunction with penicillin .
None(e1,e2)	3	18	as with other agents_with_b-blocking_properties , if coreg is to be administered orally with calcium channel blockers of the verapamil or diltiazem type , it is recommended that ecg and blood pressure be monitored .
None(e1,e2)	19	31	estazolam : interaction with drugs that inhibit metabolism via cytochrome p450 3a ( cyp3a ) : the metabolism of estazolam to the major circulating metabolite 4-hydroxy-estazolam and the metabolism of other triazolobenzodiazepines is catalyzed by cyp3a .
None(e1,e2)	2	24	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium_channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	5	13	it is not known if hormonal_contraceptives differ in their effectiveness when used with accutane .
None(e1,e2)	0	5	monoamine_oxidase_inhibitors and tricyclic antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	15	30	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	5	metoclopramide : when coadministered with monurol , metoclopramide , a drug which increases gastrointestinal motility , lowers the serum concentration and urinary excretion of fosfomycin .
None(e1,e2)	2	19	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	3	14	drugs that inhibit alprazolam metabolism via cytochrome p450 3a : the initial step in alprazolam metabolism is hydroxylation catalyzed by cytochrome p450 3a ( cyp 3a ) .
None(e1,e2)	23	150	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	15	benzodiazepines : combination hormonal contraceptives may decrease the clearance of some benzodiazepines ( alprazolam , chlordiazepoxide , diazepam ) and increase the clearance of others ( lorazepam , oxazepam , temazepam ) .
None(e1,e2)	29	31	the possibility of hypotensive effects with captopril can be minimized by either discontinuing the diuretic or increasing the salt intake approximately one week prior to initiation of treatment with captopril ( captopril tablets , usp ) or initiating therapy with small doses ( 6.25 or 12.5 mg ) .
mechanism(e1,e2)	29	57	plasma levels of several closely related tricyclic antidepressants have been reported to be increased by the concomitant administration of methylphenidate or hepatic enzyme inhibitors ( e.g. , cimetidine , fluoxetine ) and decreased by the concomitant administration of hepatic enzyme inducers ( e.g. , barbiturates , phenytoin ) , and such an effect may be anticipated with cmi as well .
None(e1,e2)	24	28	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	4	19	an alternative non-cyp3a4 substrate hypnotic_agent may be considered in patients taking cyp3a4 inducers such as rifampin , phenytoin , carbamazepine , and phenobarbital .
None(e1,e2)	2	39	- when bezalip or bezalip retard is used concurrently with anion-exchange resins ( e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of bezalip or bezalip_retard is impaired
None(e1,e2)	0	5	gabapentin had no effect on naproxen pharmacokinetic parameters .
None(e1,e2)	10	25	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	12	16	these agents include medications such as : anticoagulants , platelet inhibitors including acetylsalicylic_acid , sali-cylates , nsaids ( including ketorolac tromethamine ) , dipyridamole , or sulfinpyrazone .
None(e1,e2)	0	26	felbamate treatment resulted in a 42 % decrease in the gestodene auc 0-24 , but no clinically relevant effect was observed on the pharmacokinetic parameters of ethinyl_estradiol .
None(e1,e2)	11	13	drug interactions : flupenthixol may interact with some drugs , like monoamine_oxidase_inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	0	5	antacids : concomitant administration of antacids may reduce plasma levels of diflunisal .
mechanism(e1,e2)	19	22	valproate : the addition of tiagabine to patients taking valproate chronically had no effect on tiagabine pharmacokinetics , but valproate significantly decreased tiagabine binding in vitro from 96.3 to 94.8 % , which resulted in an increase of approximately 40 % in the free tiagabine concentration .
None(e1,e2)	18	35	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide_diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	4	21	the daily dose of dexamethasone administered in clinical studies with aprepitant reflects an approximate 50 % reduction of the dose of dexamethasone .
None(e1,e2)	4	22	an alternative non-cyp3a4 substrate hypnotic_agent may be considered in patients taking cyp3a4 inducers such as rifampin , phenytoin , carbamazepine , and phenobarbital .
mechanism(e1,e2)	0	43	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	4	8	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	0	2	antidepressants , tricyclic amphetamines may enhance the activity of tricyclic antidepressants or sympathomimetic agents ;
advise(e1,e2)	13	18	patients should be warned of the potential danger of the intravenous self-administration of benzodiazepines while under treatment with suboxone or subutex .
None(e1,e2)	0	11	neuroleptic_drugs - l-phenylalanine may potentiate the tardive dyskinesia side reactions of neuroleptic_drugs if used concomitantly with them .
None(e1,e2)	2	22	h2 blockers/ proton_pump_inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	6	32	carbamazepine - combined administration of racemic citalopram ( 40 mg/day for 14 days ) and carbamazepine ( titrated to 400 mg/day for 35 days ) did not significantly affect the pharmacokinetics of carbamazepine , a cyp3a4 substrate .
None(e1,e2)	16	18	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide_diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
effect(e1,e2)	14	16	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic_agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	0	8	central_nervous_system_depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
mechanism(e1,e2)	10	21	the absorption of tetracycline , furosemide , penicillin g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol_hydrochloride ;
None(e1,e2)	37	39	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	14	16	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	0	13	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	12	20	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	52	56	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	56	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	3	9	rifabutin , another rifamycin , is structurally similar to rifampin and may possibly have some of the same drug interactions as rifampin .
None(e1,e2)	4	14	elevated serum levels of cyclosporine have been reported with the concomitant use of some quinolones and cyclosporine .
None(e1,e2)	9	14	there has been little experience with the coadministration of tambocor and either disopyramide or verapamil .
mechanism(e1,e2)	3	15	tricyclic antidepressants ( amitriptyline , imipramine , nortriptyline ) : metabolism may be inhibited by combination_hormonal_contraceptives , increasing plasma levels of antidepressant ;
None(e1,e2)	16	40	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	7	12	tetracyclines : concomitant treatment with accutane and tetracyclines should be avoided because accutane use has been associated with a number of cases of pseudotumor cerebri ( benign intracranial hypertension ) , some of which involved concomitant use of tetracyclines
None(e1,e2)	114	129	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide_diuretics .
None(e1,e2)	3	31	dose reduction of rifabutin to half the standard dose and a dose increase of crixivan to 1000 mg ( three 333-mg capsules ) every 8 hours are recommended when rifabutin and crixivan are coadministered .
None(e1,e2)	15	27	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	12	41	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure_agonist_opioid_analgesic such as levo-dromoran .
None(e1,e2)	0	19	anticoagulants : flurbiprofen like other nonsteroidal anti-inflammatory drugs , has been shown to affect bleeding parameters in patients receiving anti-coagulants , and serious clinical bleeding has been reported .
None(e1,e2)	19	26	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	10	38	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	1	27	- methotrexate ( e.g. , mexate ) use of methotrexate with sulfapyridine may increase the chance of side effects affecting the liver and/or the side effects of methotrexate
None(e1,e2)	15	18	because there is a theoretical basis that these effects may be additive , use of ergotamine -containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and naratriptan within 24 hours is contraindicated .
None(e1,e2)	12	41	this interaction , which has not been investigated using higher doses of fluvoxamine , may be more pronounced if a 300 mg daily dose is co-administered , particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg . if alprazolam is co-administered with fluvoxamine tablets , the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended .
None(e1,e2)	0	11	acarbose did not interfere with the absorption or disposition of the sulfonylurea glyburide in diabetic patients .
None(e1,e2)	8	34	however , because bleeding has been reported when ibuprofen and other nonsteroidal anti-inflammatory agents have been administered to patients on coumarin-type anticoagulants , the physician should be cautious when administering ibuprofen to patients on anticoagulants .
None(e1,e2)	22	36	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	8	16	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
advise(e1,e2)	3	6	patients taking both flurbiprofen and a beta-blocker should be monitored to ensure that a satisfactory hypotensive effect is achieved .
effect(e1,e2)	6	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	23	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	20	43	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	5	7	in em individuals treated with paroxetine or fluoxetine , the auc of atomoxetine is approximately 6- to 8-fold and css , max is about 3- to 4-fold greater than atomoxetine alone .
None(e1,e2)	1	24	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl_estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	6	19	intestinal adsorbents ( e. g. , charcoal ) and digestive enzyme preparations containing carbohydrate-splitting enzymes ( e. g. , amylase , pancreatin ) may reduce the effect of acarbose and should not be taken concomitantly .
int(e1,e2)	0	19	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	13	19	- drugs that may either increase or decrease plasma phenytoin concentrations include : phenobarbital , vaiproic acid , and sodium_valproate .
effect(e1,e2)	9	19	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	1	3	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
None(e1,e2)	16	20	additive depressant effect when used with general anesthetics , sedatives , antianxiety drugs , hypnotics , alcohol , and other opiate_analgesics .
None(e1,e2)	17	35	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine_derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	2	13	cimetidine : cimetidine does not affect the pharmacokinetics of fosfomycin when coadministered with monurol .
advise(e1,e2)	19	49	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	0	17	erythromycin : in healthy individuals , plasma concentrations of atorvastatin increased approximately 40 % with coadministration of atorvastatin and erythromycin , a known inhibitor of cytochrome p450 3a4 .
advise(e1,e2)	0	12	epinephrine also should be used cautiously with other drugs ( e.g. , digitalis , glycosides ) that sensitize the myocardium to the actions of sympathomimetic drugs .
effect(e1,e2)	6	9	aspirin : animal studies wshow that aspirin given with nonsteroidal_anti-inflammatory_agents , including ibuprofen , yields a net decrease in anti-inflammatory activity with lowered blood levels of the non-aspirin drug .
None(e1,e2)	18	56	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	32	50	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth_subsalicylate ( pepto-bismol ) ;
advise(e1,e2)	11	20	the clinical significance of this reduction is not known , hence zalcitabine is not recommended to be ingested simultaneously with magnesium /aluminum-containing antacids .
None(e1,e2)	25	31	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	25	46	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	74	83	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	21	36	high-dose cyclosporin a resulting in concentrations above 2000 ng/ml administered with oral etoposide has led to an 80 % increase in etoposide exposure with a 38 % decrease in total body clearance of etoposide compared to etoposide alone .
None(e1,e2)	45	53	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	24	26	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	11	15	potential interactions between taxol , a substrate of cyp3a4 , and protease_inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
effect(e1,e2)	14	25	hypersensitivity reactions have been reported in patients receiving combination regimens containing sequential high dose proleukin and antineoplastic agents , specifically , dacarbazine , cis-platinum , tamoxifen and interferon-alfa .
None(e1,e2)	24	36	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium_channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	26	38	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
int(e1,e2)	0	30	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	19	because warfarin is metabolized by cyp2c9 and cyp3a4 , patients who require anticoagulation should receive low-molecular weight or standard heparin .
None(e1,e2)	15	18	other concomitant therapies : in clinical trials , the safety profile in subjects treated with acamprosate concomitantly with anxiolytics , hypnotics and sedatives ( including benzodiazepines ) , or non-opioid analgesics was similar to that of subjects taking placebo with these concomitant medications .
None(e1,e2)	40	45	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	44	107	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	4	- cholestyramine and colestipol resins : cholestytamine and colestipol resins have the potential of binding thiazide diuretics and reducing diuretic absorption from the gastrointestinal tract
None(e1,e2)	23	123	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic_acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	28	38	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
mechanism(e1,e2)	9	34	in vitro studies have shown that the metabolism of docetaxel may be modified by the concomitant administration of compounds that induce , inhibit , or are metabolized by cytochrome p450 3a4 , such as cyclosporine , terfenadine , ketoconazole , erythromycin , and troleandomycin .
None(e1,e2)	78	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	26	29	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	1	9	anesthetics/sedatives/hypnotics/ opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	6	16	these increased exposures of norethindrone and ethinyl_estradiol should be taken into consideration when selecting an oral contraceptive for women taking valdecoxib .
None(e1,e2)	40	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	32	34	caution is advised when trisenox is coadministered with other medications that can prolong the qt interval ( e.g . certain antiarrhythmics or thioridazine ) or lead to electrolyte abnormalities ( such as diuretics or amphotericin_b ) .
None(e1,e2)	47	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	10	antidiabetic agents ( insulin , sulfonylureas ) : requirements for insulin or oral antidiabetic agents may be reduced in hypothyroid patients with diabetes mellitus and may subsequently increase with the initiation of thyroid hormone replacement therapy .
None(e1,e2)	1	13	oral contraceptive : based on auc and half-life , multiple-dose pharmacokinetic profiles of norethindrone and ethinyl estradiol following administration of tablets containing 2.5 mg of norethindrone acetate and 50 mcg of ethinyl estradiol were similar with and without coadministration of gabapentin ( 400 mg tid ;
None(e1,e2)	96	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	6	11	the pharmacokinetics and protein binding of fosphenytoin , phenytoin , and diazepam were not altered when diazepam and cerebyx were concurrently administered in single submaximal doses .
None(e1,e2)	25	37	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	14	19	a similar association , though less marked , has been suggested with barbiturates , phenylbutazone , phenytoin sodium , carbamazepine , griseofulvin , topiramate , and possibly with ampicillin and tetracyclines 72 .
None(e1,e2)	1	14	other 5-ht1b/1d_agonists concomitant use of other 5-ht1b/1d agonists within 24 hours of treatment with axert is contraindicated .
None(e1,e2)	0	14	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	3	8	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	21	36	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
advise(e1,e2)	18	27	it is advisable to check coagulation time within the first few days after the start and discontinuation of cisapride therapy , with an appropriate adjustment of the anticoagulant dose , if necessary .
None(e1,e2)	87	153	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim /sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	83	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	14	30	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	65	123	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic_blocking_agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	8	11	alcohol : there was no significant difference between aripiprazole coadministered with ethanol and placebo coadministered with ethanol on performance of gross motor skills or stimulus response in healthy subjects .
None(e1,e2)	14	16	selective serotonin reuptake inhibitors ( ssris ) : ssris ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been rarely reported to cause weakness , hyperreflexia , and incoordination when coadministered with 5-ht1 agonists .
None(e1,e2)	27	29	because anafranil is highly bound to serum protein , the administration of anafranil to patients taking other drugs that are highly bound to protein ( e.g. , warfarin , digoxin ) may cause an increase in plasma concentrations of these drugs , potentially resulting in adverse effects .
None(e1,e2)	17	26	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	0	8	hmg-coa_reductase_inhibitors : the combined use of tricor and hmg-coa_reductase_inhibitors should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk of this drug combination .
None(e1,e2)	105	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	57	98	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	6	151	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos_sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	8	12	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	15	37	venlafaxine : coadministration of a single dose of zaleplon 10 mg and multiple doses of venlafaxine er ( extended release ) 150 mg did not result in any significant changes in the pharmacokinetics of either zaleplon or venlafaxine .
None(e1,e2)	11	24	strong inducers of cytochrome p450 enzymes ( i.e . carbamazepine , phenytoin and phenobarbital ) have been shown to decrease the plasma levels of mhd ( 29-40 % ) .
None(e1,e2)	9	11	anticholinesterases ( neostgmine , physostigmine ) , lignocaine , quinine , procainamide can enhance toxicity and cause cardio respiratory depression .
None(e1,e2)	3	8	drug interactions with beta-blockers : concomitant use of fenoldopam with beta-blockers should be avoided .
effect(e1,e2)	6	24	anticholinergics : concurrent administration of certain anticholinergic_compounds , such as belladonna alkaloids and dicyclomine , would be expected to compromise the beneficial effects of cisapride .
None(e1,e2)	23	50	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic_acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	104	116	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	6	21	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	9	11	however , 10 patients who switched from therapy with interferon_beta to copaxone did not report any serious and unexpected adverse reactions thought to be related to treatment .
None(e1,e2)	42	44	although no specific drug interactions with topical glaucoma drugs or systemic medications were identified in clinical studies of iopidine 0.5 % ophthalmic solution , the possibility of an additive or potentiating effect with cns depressants ( alcohol , barbiturates , opiates , sedatives , anesthetics ) should be considered .
advise(e1,e2)	6	21	therefore , when using doses of trileptal greater than 1200 mg/day during adjunctive therapy , a decrease in the dose of phenytoin may be required .
None(e1,e2)	75	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
mechanism(e1,e2)	4	6	verapamil : coadministration of almotriptan and verapamil resulted in a 24 % increase in plasma concentrations of almotriptan .
None(e1,e2)	0	4	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace inhibitors during therapy with lithium .
None(e1,e2)	14	32	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	0	12	ketoconazole - combined administration of racemic citalopram ( 40 mg ) and ketoconazole ( 200 mg ) decreased the cmax and auc of ketoconazole by 21 % and 10 % , respectively , and did not significantly affect the pharmacokinetics of citalopram .
None(e1,e2)	0	7	zinecard does not influence the pharmacokinetics of doxorubicin .
mechanism(e1,e2)	11	22	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	5	11	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	6	15	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	4	6	increased plasma concentrations of terfenadine , astemizole , and cisapride cause qt prolongation and have been associated with torsades de pointes-type ventricular tachycardia , sometimes fatal .
advise(e1,e2)	0	14	netilmicin should not be administered concomitantly with potent loop diuretics such as furosemide and ethacrynic_acid as the potential for ototoxicity is enhanced by the combination .
None(e1,e2)	9	18	concurrent use of rifampin increases the metabolic clearance of zebeta , resulting in a shortened elimination half-life of zebeta .
None(e1,e2)	9	11	several drug interaction studies have been completed with both invirase and fortovase .
None(e1,e2)	31	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	9	16	talk to your doctor if you are taking certain antibiotics such as erythromycin , clarithromycin or azithromycin .
None(e1,e2)	31	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	76	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	0	9	auranofin should not be used together with penicillamine ( depen , cuprimine ) , another arthritis medication .
None(e1,e2)	32	39	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
None(e1,e2)	9	11	consequently , estazolam should be avoided in patients receiving ketoconazole and itraconazole , which are very potent inhibitors of cyp3a .
None(e1,e2)	30	34	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	7	30	limited clinical experience indicates that requirements for volatile_inhalation_anesthetics are reduced by 30 to 50 % for the first sixty ( 60 ) minutes following alfenta induction the concomitant use of erythromycin with alfenta can significantly inhibit alfenta clearance and may increase the risk of prolonged or delayed respiratory depression .
None(e1,e2)	6	16	caution should be exercised when administering nabumetone with warfarin since interactions have been seen with other nsaids .
None(e1,e2)	8	13	netilmicin should not be administered concomitantly with potent loop_diuretics such as furosemide and ethacrynic_acid as the potential for ototoxicity is enhanced by the combination .
mechanism(e1,e2)	8	21	anticonvulsants ( carbamazepine , felbamate , phenobarbital , phenytoin , topiramate ) : increase the metabolism of ethinyl estradiol and/or some progestins , leading to possible decrease in contraceptive effectiveness .
None(e1,e2)	9	13	allegra should not be taken closely in time with aluminum and magnesium containing antacids .
None(e1,e2)	43	71	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	10	14	although these results do not indicate a significant interaction between toradol and warfarin or heparin , the administration of toradol to patients taking anticoagulants should be done extremely cautiously , and patients should be closely monitored .
mechanism(e1,e2)	19	29	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	10	16	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	0	24	hormonal_contraceptives , including oral , injectable , transdermal , and implantable contraceptives : an interaction study demonstrated that co-administration of bosentan and the oral hormonal_contraceptive ortho-novum produced average decreases of norethindrone and ethinyl estradiol levels of 14 % and 31 % , respectively .
None(e1,e2)	27	53	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	4	40	the potential effects of fulvestrant on the fertility of male animals were not studied but in a 6-month toxicology study , male rats treated with intramuscular doses of 15 mg/kg/30 days , 10 mg/rat/30 days , or 10 mg/rat/15 days fulvestrant showed a loss of spermatozoa from the seminiferous tubules , seminiferous tubular atrophy , and degenerative changes in the epididymides .
None(e1,e2)	4	31	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	0	31	metoprolol - administration of 20 mg/day lexapro for 21 days in healthy volunteers resulted in a 50 % increase in cmax and 82 % increase in auc of the beta-adrenergic blocker metoprolol ( given in a single dose of 100 mg ) .
None(e1,e2)	8	10	administration of doxapram to patients who are receiving sympathomimetic or monoamine_oxidase_inhibiting_drugs may result in an additive pressor effect .
None(e1,e2)	12	40	concomitant administration of fenofibrate ( equivalent to 145 mg tricor ) with atorvastatin ( 20 mg ) once daily for 10 days resulted in approximately 17 % decrease ( range from 67 % decrease to 44 % increase ) in atorvastatin auc values in 22 healthy males .
None(e1,e2)	18	36	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin /flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	49	52	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	28	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	71	102	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	46	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	23	sumatriptan : sumatriptan has been reported to cause coronary artery vasospasm , and its effect could be additive with d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp .
None(e1,e2)	5	47	concomitant medications were grouped as ace_inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide_diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	76	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	4	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	62	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
mechanism(e1,e2)	3	6	concomitant administration of robinul injection and potassium_chloride in a wax matrix may increase the severity of potassium chloride-induced gastrointestinal lesions as a result of a slower gastrointestinal transit time .
None(e1,e2)	9	37	concomitant medications were grouped as ace inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium sparing diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	13	20	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	2	10	broad-spectrum antibiotics- broad-spectrum_antibiotics may sterilize the bowel and decrease the vitamin_k contribution to the body by the intestinal microflora .
None(e1,e2)	0	14	cholestyramine and colestipol resins : absorption of hydrochlorothiazide is impaired in the presence of anionic_exchange_resins .
None(e1,e2)	9	14	for patients receiving both therapies , standard monitoring of tacrolimus blood concentrations and appropriate tacrolimus dosage adjustments are recommended .
None(e1,e2)	80	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	14	35	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease_inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	0	5	antineoplastic_agents ( e. g. , nitrogen_mustard , etc . ) should be given concomitantly only with great caution .
None(e1,e2)	35	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	90	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
effect(e1,e2)	14	28	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	43	53	therefore , co-administration of duloxetine with other drugs that are extensively metabolized by this isozyme and which have a narrow therapeutic index , including certain antidepressants ( tricyclic antidepressants [ tcas ] , such as nortriptyline , amitriptyline , and imipramine ) , phenothiazines and type 1c antiarrhythmics ( e.g. , propafenone , flecainide ) , should be approached with caution .
None(e1,e2)	26	44	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	6	41	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	3	20	the effect of toradol on plasma lithium has not been studied , but cases of increased lithium plasma levels during toradol therapy have been reported .
mechanism(e1,e2)	34	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	10	31	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	9	15	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
None(e1,e2)	44	47	although glucocorticoids have been shown to reduce proleukin-induced side effects including fever , renal insufficiency , hyperbilirubinemia , confusion , and dyspnea , concomitant administration of these agents with proleukin may reduce the antitumor effectiveness of proleukin and thus should be avoided . 12 beta-blockers and other antihypertensives may potentiate the hypotension seen with proleukin .
mechanism(e1,e2)	5	13	also , concomitant administration of quinolones with products containing iron , multivitamins containing zinc , or videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution may result in low urine levels .
None(e1,e2)	46	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	13	43	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
mechanism(e1,e2)	14	28	the following are examples of drugs known to inhibit the metabolism of other related benzodiazepines , presumably through inhibition of cyp3a : nefazodone , fluvoxamine , cimetidine , diltiazem , isoniazide , and some macrolide antibiotics .
None(e1,e2)	9	11	other cns depressant drugs ( e.g . barbiturates , tranquilizers , opioids and general anesthetics ) have additive or potentiating effects with inapsine .
None(e1,e2)	24	52	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	15	19	and disulfiram when amitriptyline hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
effect(e1,e2)	16	23	both the magnitude and duration of central nervous system and cardiovascular effects may be enhanced when alfenta is administered in combination with other cns_depressants such as barbiturates , tranquilizers , opioids , or inhalation general anesthetics .
None(e1,e2)	6	11	- a sulfa-based drug such as sulfamethoxazole -trimethoprim ( bactrim , septra ) , sulfisoxazole ( gantrisin ) , or sulfasalazine ( azulfidine ) ;
None(e1,e2)	98	105	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	7	32	theophylline : following co-administration of two 250-mg dirithromycin tablets administered once daily with 200-mg theophylline tablets administered twice daily for 10 days to 14 healthy subjects , the steady-state plasma concentration of theophylline was not significantly altered .
None(e1,e2)	8	10	quinidine , verapamil , amiodarone , propafenone , indomethacin , itraconazole , alprazolam , and spironolactone raise the serum digoxin concentration due to a reduction in clearance and/or in volume of distribution of the drug , with the implication that digitalis intoxication may result .
None(e1,e2)	7	12	certain antibiotic , cisplatin , cyclosporine , diuretic , foscarnet , and vaccines .
effect(e1,e2)	0	10	diuretic_agents may decrease vascular response to pressor drugs such as epinephrine .
None(e1,e2)	14	19	in addition to the interactions noted above , chronic ( 2 weeks ) oral cordarone administration impairs metabolism of phenytoin , dextromethorphan , and methotrexate .
effect(e1,e2)	11	44	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	2	5	interactions for vitamin_d analogues ( vitamin_d2 , vitamin d3 , calcitriol , and calcidiol ) : cholestyramine : cholestyramine has been reported to reduce intestinal absorption of fat soluble vitamins ;
None(e1,e2)	9	17	cyclosporine : administration of nonsteroial anti-inflammatory drugs concomitantly with cyclosporine has been associated with an increase in cyclosporine -induced toxicity , possibly due to decreased synthesis of renal prostacyclin .
None(e1,e2)	6	13	coadministration of phenytoin with 40 mg sular tablets in epileptic patients lowered the nisoldipine plasma concentrations to undetectable levels .
None(e1,e2)	19	33	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic_antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	10	37	valdecoxib caused a statistically significant increase in plasma exposures of r-warfarin and s-warfarin ( 12 % and 15 % , respectively ) , and in the pharmacodynamic effects ( prothrombin time , measured as inr ) of warfarin .
None(e1,e2)	0	69	cancidas reduced the blood auc0-12 of tacrolimus by approximately 20 % , peak blood concentration ( cmax ) by 16 % , and 12-hour blood concentration ( c12hr ) by 26 % in healthy subjects when tacrolimus ( 2 doses of 0.1 mg/kg 12 hours apart ) was administered on the 10th day of cancidas 70 mg daily , as compared to results from a control period in which tacrolimus was administered alone .
None(e1,e2)	3	48	poor metabolizers of debrisoquin : interactions of carvedilol with strong inhibitors of cyp2d6 ( such as quinidine , fluoxetine , paroxetine , and propafenone ) have not been studied , but these drugs would be expected to increase blood levels of the r ( + ) enantiomer of carvedilol .
mechanism(e1,e2)	18	49	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	2	20	similarly , nateglinide had no influence on the serum protein binding of propranolol , glyburide , nicardipine , warfarin , phenytoin , acetylsalicylic acid , and tolbutamide in vitro .
None(e1,e2)	81	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	14	26	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	12	18	also , there were no clinically significant differences in adverse events when loratadine was administered with or without ketoconazole .
advise(e1,e2)	2	24	if additional adrenergic_drugs are to be administered by any route , they should be used with caution because the pharmacologically predictable sympathetic effects of brovana may be potentiated .
None(e1,e2)	0	4	benzylpenicillin , ampicillin , oxacillin , chlortetracycline , doxycycline , cephalothin , erythromycin , and sulfamethoxazole have no influence in vitro on the protein binding of diclofenac in human serum .
None(e1,e2)	23	54	antacids : in a single dose study ( n=6 ) , ingestion of an antacid containing 1.7-gram of magnesium hydroxide with 500-mg of mefenamic_acid increased the cmax and auc of mefenamic acid by 125 % and 36 % , respectively . a number of compounds are inhibitors of cyp2c9 including fluconazole , lovastatin and trimethoprim .
None(e1,e2)	0	9	dolasetron_mesylate did not inhibit the antitumor activity of four chemotherapeutic_agents ( cisplatin , 5-fluorouracil , doxorubicin , cyclophosphamide ) in four murine models .
None(e1,e2)	33	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	38	triazolam - combined administration of racemic citalopram ( titrated to 40 mg/day for 28 days ) and the cyp3a4 substrate triazolam ( single dose of 0.25 mg ) did not significantly affect the pharmacokinetics of either citalopram or triazolam .
None(e1,e2)	35	85	agents that are cyp inducers that have been found , or are expected , to decrease plasma levels of equetrotm are the following : cisplatin , doxorubicin hcl , felbamate , rifampin , phenobarbital , phenytoin ( 2 ) , primidone , methsuximide , and theophylline thus , if a patient has been titrated to a stable dosage on equetrotm , and then begins a course of treatment with one of these cyp3a4 inducers , it is reasonable to expect that a dose increase for equetrotm may be necessary .
None(e1,e2)	21	40	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	27	41	because prostaglandins play an important role in hemostasis , and nsaids affect platelet function as well , concurrent therapy with all nsaids , including diclofenac , and warfarin requires close monitoring of patients to be certain that no change in their anticoagulant dosage is required .
None(e1,e2)	85	113	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	13	19	in one man , the c max of terfenadine was 8.1 ng/ml with terfenadine alone and 7.2 ng/ml with terfenadine plus dirithromycin .
None(e1,e2)	49	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	18	25	drug-drug interactions : no clinically significant drug interactions have been found with theophylline at a low dose , azithromycin , pseudoephedrine , ketoconazole , or erythromycin .
None(e1,e2)	0	7	cytokines ( interferon , interleukin ) : cytokines have been reported to induce both hyperthyroidism and hypothyroidism .
None(e1,e2)	30	38	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	4	15	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	112	122	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin_analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	31	36	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	49	60	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	97	102	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	1	3	- corticosteroids , acth : intensified electrolyte depletion , particularly hypokalemia
None(e1,e2)	3	22	patients receiving other narcotic_analgesics , antipsychotics , antianxiety agents , or other cns depressants ( including alcohol ) concomitantly with hydrocodone and acetaminophen tablets may exhibit an additive cns depression .
None(e1,e2)	57	61	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	15	ampicillin : in a study of healthy volunteers , chloroquine significantly reduced the bioavailability of ampicillin .
None(e1,e2)	24	38	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	15	27	a clinical study in healthy male volunteers ( n=24 ) demonstrated that mixing novolog with nph_human_insulin immediately before injection produced some attenuation in the peak concentration of novolog , but that the time to peak and the total bioavailability of novolog were not significantly affected .
None(e1,e2)	0	5	urinary_acidifying_agents ( ammonium chloride , sodium_acid_phosphate , etc . ) increase the concentration of the ionized species of the amphetamine molecule , thereby increasing urinary excretion .
None(e1,e2)	11	29	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	7	14	theophylline : following co-administration of two 250-mg dirithromycin tablets administered once daily with 200-mg theophylline tablets administered twice daily for 10 days to 14 healthy subjects , the steady-state plasma concentration of theophylline was not significantly altered .
None(e1,e2)	0	13	lithium : valdecoxib 40 mg bid for 7 days produced significant decreases in lithium serum clearance ( 25 % ) and renal clearance ( 30 % ) with a 34 % higher serum exposure compared to lithium alone .
None(e1,e2)	1	7	plasma valproate concentration should be monitored when isoniazid and valproate are co administered , and appropriate dosage adjustments of valproate should be made .
advise(e1,e2)	16	47	interactions with mixed agonist/antagonist opioid analgesics : agonist/antagonist analgesics ( eg , pentazocine , nalbuphine , butorphanol , dezocine and buprenorphine ) should not be administered to a patient who has received or is receiving a course of therapy with a pure agonist opioid analgesic such as levo-dromoran .
None(e1,e2)	15	17	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	21	23	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	0	5	probenecid : as with other b-lactam_antibiotics , co-administration of probenecid with cefditoren pivoxil resulted in an increase in the plasma exposure of cefditoren , with a 49 % increase in mean cmax , a 122 % increase in mean auc , and a 53 % increase in half-life .
effect(e1,e2)	4	12	therefore , patients receiving probenecid will have erroneously low erpf and tm pah values .
None(e1,e2)	11	15	caution should also be applied for other sympathomimetics , and for aminophylline and theophylline and tricyclic_antidepressants , which may also precipitate arrhythmias .
None(e1,e2)	2	16	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	0	9	esomeprazole may potentially interfere with cyp2c19 , the major esomeprazole metabolizing enzyme .
None(e1,e2)	21	48	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetic products , ace_inhibitors , disopyramide , fibrates , fluoxetine , monoamine oxidase ( mao ) inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	0	8	propoxyphene : in cases of propoxyphene overdosage , amphetamine cns stimulation is potentiated and fatal convulsions can occur .
None(e1,e2)	10	41	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	4	10	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
None(e1,e2)	2	10	coadministration of valdecoxib and ortho-novum 1/35 increased the exposure of norethindrone and ethinyl estradiol by 20 % and 34 % , respectively .
advise(e1,e2)	6	8	therefore , the combined use of lovastatin with fibrates should generally be avoided .
None(e1,e2)	21	34	coadministration of valdecoxib ( 40 mg bid ( day 1 ) and 40 mg qd ( days 2-7 ) ) with glyburide ( 10 mg glyburide bid ) resulted in 21 % increase in glyburide auc0-12 and a 16 % increase in glyburide cmax leading to a 16 % decrease in glucose auc0-24 .
None(e1,e2)	6	26	benzthiazide may interact with alcohol , blood_thinner s , decongestant drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	25	32	pharmacodynamic interactions : the cns-depressant action of the benzodiazepine class of drugs may be potentiated by alcohol , narcotics , barbiturates , nonbarbiturate hypnotics , antianxiety_agents , the phenothiazines , thioxanthene and butyrophenone_classes_of_antipsychotic_agents , monoamine oxidase inhibitors and the tricyclic antidepressants , and by other anticonvulsant drugs .
None(e1,e2)	67	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	46	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	93	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	0	10	quinolones have been shown to interfere with the metabolism of caffeine .
None(e1,e2)	3	26	concomitant administration of sonata ( 10 mg ) and cimetidine ( 800 mg ) produced an 85 % increase in the mean cmax and auc of zaleplon .
effect(e1,e2)	8	32	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
mechanism(e1,e2)	10	25	drugs which inhibit cyp 3a4 ( e.g. , ketoconazole , macrolide_antibiotics such as erythromycin ) have the potential to result in increased plasma concentrations of corticosteroids .
effect(e1,e2)	4	9	the actions of the benzodiazepines may be potentiated by barbiturates , narcotics , phenothiazines , monoamine oxidase inhibitors or other antidepressants .
None(e1,e2)	14	17	drug/ laboratory test interactions certain endocrine and liver function tests may be affected by estrogen -containing oral contraceptives .
None(e1,e2)	97	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	88	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	13	42	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking_agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	14	19	the concurrent use of intravenously or orally administered methylxanthines ( e.g. , aminophylline , theophylline ) by patients receiving brovana has not been completely evaluated .
None(e1,e2)	2	19	effect of clonazepam on the pharmacokinetics of other drugs : clonazepam does not appear to alter the pharmacokinetics of phenytoin , carbamazepine , or phenobarbital .
None(e1,e2)	33	42	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
mechanism(e1,e2)	0	16	naproxen , naproxen sodium and other nsaids have been reported to reduce the tubular secretion of methotrexate in an animal model , possibly increasing the toxicity of methotrexate .
None(e1,e2)	8	15	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	13	27	digoxin , nimodipine and losartan : bosentan has no significant pharmacokinetic interactions with digoxin and nimodipine , and losartan has no significant effect on plasma levels of bosentan .
None(e1,e2)	15	28	heparin sodium injection should not be mixed with doxorubicin , droperidol , ciprofloxacin , or mitoxantrone , since it has been reported that these drugs are incompatible with heparin and a precipitate may form .
None(e1,e2)	24	26	there was no evidence of drug interactions in clinical studies in which dobutamine was administered concurrently with other drugs , including digitalis preparations , furosemide , spironolactone , lidocaine , glyceryl trinitrate , isosorbide dinitrate , morphine , atropine , heparin , protamine , potassium chloride , folic acid , and acetaminophen .
None(e1,e2)	18	37	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	32	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	4	11	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	14	42	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
mechanism(e1,e2)	0	16	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
mechanism(e1,e2)	38	64	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	18	enoxacin interferes with the metabolism of theophylline resulting in a 42 % to 74 % dose-related decrease in theophylline clearance and a subsequent 260 % to 350 % increase in serum theophylline levels .
effect(e1,e2)	20	28	although there are no study data to evaluate the possibility , nitric oxide donor compounds , including sodium nitroprusside and nitroglycerin , may have an additive effect with inomax on the risk of developing methemoglobinemia .
None(e1,e2)	3	10	bacteriostatic antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
None(e1,e2)	21	25	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	14	26	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton_pump_inhibitors ( e.g. , lansoprazole , omeprazole ) .
None(e1,e2)	9	14	john s wort ) may increase the formation of dapsone_hydroxylamine , a metabolite of dapsone associated with hemolysis .
None(e1,e2)	0	12	antibiotics : in vitro and/or in vivo data show that clarithromycin , erythromycin , and troleandomycin markedly inhibit the metabolism of cisapride , which can result in an increase in plasma cisapride levels and prolongation of the qt interval on the ecg .
None(e1,e2)	35	63	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	48	acarbose may affect digoxin bioavailabillty and may require dose adjustment of digoxin by 16 % ( 90 % confidence interval : 8-23 % ) , decrease mean c max digoxin by 26 % ( 90 % confidence interval : 16-34 % ) and decrease mean trough concentrations of digoxin by 9 % ( 90 % confidence limit : 19 % decrease to 2 % increase ) .
None(e1,e2)	14	18	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	18	29	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	3	14	in patients taking furosemide , nifedipine , diltiazem , ace inhibitors , verapamil , glyburide , propranolol , and various chemotherapy agents , no effect was shown on the clearance of hydrodolasetron .
advise(e1,e2)	5	10	careful observation is required when amantadine is administered concurrently with central_nervous_system_stimulants .
None(e1,e2)	14	49	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	5	24	another oral azole antifungal , ketoconazole , inhibits the metabolism of astemizole , resulting in elevated plasma concentrations of astemizole and its active metabolite desmethylastermizole which may prolong qt intervals .
None(e1,e2)	0	34	digitalis : immediate release capsules : since there have been isolated reports of patients with elevated digoxin levels , and there is a possible interaction between digoxin and nifedipine , it is recommended that digoxin levels be monitored when initiating , adjusting , and discontinuing nifedipine to avoid possible over- or under-digitalization .
None(e1,e2)	0	7	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	28	49	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	11	27	h2-receptor antagonists : co-administration of a single dose of intravenously administered famotidine ( 20 mg ) reduced the oral absorption of a single 400 mg dose of cefditoren_pivoxil administered following a meal , as evidenced by a 27 % decrease in mean cmax and a 22 % decrease in mean auc .
None(e1,e2)	11	13	in addition , fondaparinux neither influenced the pharmacodynamics of warfarin , acetylsalicylic_acid , piroxicam , and digoxin , nor the pharmacokinetics of digoxin at steady state .
None(e1,e2)	35	42	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	71	73	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	100	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	131	133	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine * ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	0	24	nelfinavir steady-state cmax , a.c. and cmin were increased by 12 % , 15 % , and 14 % , respectively , by concomitant amprenavir .
None(e1,e2)	25	34	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot_alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	12	22	- drugs whose efficacy is impaired by phenytoin include : anticoagulants , corticosteroids , coumarin , digitoxin , doxycycline , estrogens , furosemide , oral contraceptives , rifampin , quinidine , theophylline , vitamin d .
None(e1,e2)	0	32	cimetidine : albendazole sulfoxide concentrations in bile and cystic fluid were increased ( about 2-fold ) in hydatid cyst patients treated with cimetidine ( 10 mg/kg/day ) ( n=7 ) compared with albendazole ( 20 mg/kg/day ) alone ( n=12 ) .
None(e1,e2)	12	19	furosemide has a tendency to antagonize the skeletal muscle relaxing effect of tubocurarine and may potentiate the action of succinylcholine .
None(e1,e2)	26	37	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral_hydrate * ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	16	33	duloxetine may have a clinically important interaction with the following other drugs : alcohol : when duloxetine and ethanol were administered several hours apart so that peak concentrations of each would coincide , duloxetine did not increase the impairment of mental and motor skills caused by alcohol .
None(e1,e2)	29	35	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	0	19	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
advise(e1,e2)	2	18	if the tarceva dose is adjusted upward , the dose will need to be reduced upon discontinuation of rifampicin or other inducers .
None(e1,e2)	18	42	5ht3 antagonists : based on reports of profound hypotension and loss of consciousness when apomorphine was administered with ondansetron , the concomitant use of apomorphine with drugs of the 5ht3 antagonist class ( including , for example , ondansetron , granisetron , dolasetron , palonosetron , and alosetron ) is contraindicated .
None(e1,e2)	0	3	stavudine and zidovudine ribavirin can antagonize the in vitro antiviral activity of stavudine and zidovudine against hiv .
None(e1,e2)	38	46	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
mechanism(e1,e2)	11	21	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	11	37	no depressant effect on blood levels in humans was noted when colestipol_hydrochloride was administered with any of the following drugs : aspirin , clindamycin , clofibrate , methyldopa , nicotinic acid ( niacin ) , tolbutamide , phenytoin or warfarin .
None(e1,e2)	35	96	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral_hydrate * ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	11	18	upon administration of 10 mg of vardenafil with 800 mg tid indinavir , the cmax and auc of indinavir were reduced by 40 % and 30 % , respectively .
None(e1,e2)	20	36	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type 1c antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
None(e1,e2)	30	33	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	22	30	phenobarbital : coadministration of felbamate with phenobarbital causes an increase in phenobarbital plasma concentrations , in 12 otherwise healthy male volunteers ingesting phenobarbital , the steady-state trough ( cmin ) phenobarbital concentration was 14.2 micrograms/ml .
None(e1,e2)	118	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	24	26	these medications have included heparin , warfarin , beta-adrenergic receptor blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	11	24	fifteen to 30 minutes of exposure to 1.25 mac isoflurane or enflurane had minimal effects on the duration of action of initial doses of nimbex and therefore , no adjustment to the initial dose should be necessary when nimbex is administered shortly after initiation of volatile agents .
None(e1,e2)	0	2	ethosuximide : amphetamines may delay intestinal absorption of ethosuximide .
advise(e1,e2)	13	26	until data on possible interactions between verapamil and disopyramide phosphate are obtained , disopyramide should not be administered within 48 hours before or 24 hours after verapamil administration .
None(e1,e2)	19	28	phenobarbital ( primidone ) : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking phenobarbital ( primidone ) with or without other enzyme-inducing aeds .
effect(e1,e2)	0	7	nitrofurantoin interferes with the therapeutic action of nalidixic_acid .
None(e1,e2)	16	40	drugs that reduce the number of blood platelets by causing bone marrow depression ( such as antineoplastic_agents ) or drugs which inhibit platelet function ( eg , aspirin and other non-steroidal anti-inflammatory drugs , dipyridamole , hydrochloroquine , clofibrate , dextran ) may increase the bleeding tendency produced by anticoagulants without altering prothrombin time determinations .
None(e1,e2)	25	41	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e . 45 ( dihydroergotamine_mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	17	19	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	24	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	28	31	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel_blocking_drugs , and isoniazid .
None(e1,e2)	2	5	therefore , nitroglycerin or other nitrates ( as used for management of angina ) or other drugs having vasodilator activity should , if possible , be discontinued before starting captopril .
effect(e1,e2)	4	15	the benzodiazepines , including alprazolam , produce additive cns depressant effects when co-administered with other psychotropic_medications , anticonvulsants , antihistaminics , ethanol , and other drugs which themselves produce cns depression .
None(e1,e2)	14	19	pharmacokinetic studies document no clinically relevant interactions with other agents given concomitantly , including thiazide_diuretics , digoxin , and cimetidine .
None(e1,e2)	12	26	evidence supporting the conclusion that it is inadvisable to co-administer fluvoxamine and diazepam is derived from a study in which healthy volunteers taking 150 mg/day of fluvoxamine were administered a single oral dose of 10 mg of diazepam .
advise(e1,e2)	9	17	if these agents are to be administered concurrently , cyclosporine concentrations should be monitored , especially when diltiazem therapy is initiated , adjusted , or discontinued .
None(e1,e2)	21	50	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
advise(e1,e2)	8	48	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	59	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	17	28	although additional drug interaction studies have not been conducted , the most common medications used concomitantly with anagrelide in clinical trials were aspirin , acetaminophen , furosemide , iron , ranitidine , hydroxyurea , and allopurinol .
None(e1,e2)	6	17	chlorotrianisene may interact with antidepressants , aspirin , barbiturates , bromocriptine , calcium supplements , corticosteroids , corticotropin , cyclosporine , dantrolene , nicotine , somatropin , tamoxifen , and warfarin .
None(e1,e2)	47	57	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
int(e1,e2)	0	19	flurbiprofen did not affect the pharmacokinetic profile of either drug , and the mechanism under lying the interference with propranolol s hypotensive effect is unknown .
None(e1,e2)	3	5	concomitant treatment with coumarin_derivatives ( vitamin_k_antagonists ) and drugs that affect platelet function may also increase the risk of bleeding .
None(e1,e2)	8	33	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	39	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	81	83	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	63	126	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	8	methotrexate : ibuprofen , as well as other nonsteroidal_anti-inflammatory_drugs , probably reduces the tubular secretion of methotrexate based on in vitro studies in rabbit kidney slices .
None(e1,e2)	6	16	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	23	37	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
None(e1,e2)	43	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	19	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	17	38	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	81	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	15	patients receiving other narcotic_analgesic s , general anesthetics , phenothiazines , tranquilizers , sedative-hypnotics , tricyclic_antidepressants or other cns depressants ( including alcohol ) concomitantly with dilaudid may exhibit an additive cns depression .
advise(e1,e2)	5	8	diazepam : the co-administration of fluvoxamine tablets and diazepam is generally not advisable .
advise(e1,e2)	5	10	caution should be observed when anileridine is coadministered with other opioids , sedatives , phenothiazines , or anesthetics , as these agents may increase respiratory and circulatory depression .
None(e1,e2)	2	14	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	21	23	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	26	35	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic_antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	85	93	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	14	20	anticoagulants including coumarin derivatives , indandione derivatives , and platelet aggregation inhibitors such as nonsteroidal_anti-inflammatory_drugs ( nsaids ) , and aspirin may increase the risk of bleeding when administered concomitantly with ardeparin .
None(e1,e2)	0	33	betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 the effect of alternate-day administration of 0.25 mg of betaseron on drug metabolism in ms patients is unknown .
None(e1,e2)	25	34	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	10	15	antipyrine : because atorvastatin does not affect the pharmacokinetics of antipyrine , interactions with other drugs metabolized via the same cytochrome isozymes are not expected .
None(e1,e2)	25	34	therefore , co-administration of tricyclic antidepressants with other drugs that are metabolized by this isoenzyme , including other antidepressants , phenothiazines , carbamazepine , and type_1c_antiarrhythmics ( eg , propafenone , flecainide , and encainide ) , or that inhibit this enzyme ( eg , quinidine ) , should be approached with caution .
advise(e1,e2)	5	10	although a 3-day regimen of aprepitant given concomitantly with oral contraceptives has not been studied , alternative or back-up methods of contraception should be used .
None(e1,e2)	0	28	probenecid : as with other b-lactam antibiotics , renal excretion of loracarbef is inhibited by probenecid and resulted in an approximate 80 % increase in the auc for loracarbef .
None(e1,e2)	95	97	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	48	this appears to be the only clinically relevant interaction of this kind with mefloquine , although theoretically , coadministration of other drugs known to alter cardiac conduction ( eg , anti-arrhythmic or beta-adrenergic blocking agents , calcium channel blockers , antihistamines or h1-blocking agents , tricyclic antidepressants and phenothiazines ) might also contribute to a prolongation of the qtc interval .
None(e1,e2)	4	15	histamine h2-receptor antagonists : histamine_h2-receptor_antagonists appear to have no significant effect on the bioavailability of ciprofloxacin .
effect(e1,e2)	8	25	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants.when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	9	20	cimetidine is reported to reduce hepatic metabolism of certain tricyclic_antidepressants , thereby delaying elimination and increasing steady-state concentrations of these drugs .
None(e1,e2)	10	28	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	0	32	monoamine_oxidase_(_mao_)_inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
int(e1,e2)	0	5	beta-adrenergic_blocking_agents may also interact with sympathomimetics .
None(e1,e2)	19	21	the concomitant use of transdermal fentanyl with ritonavir or other potent 3a4 inhibitors such as ketoconazole , itraconazole , troleandomycin , clarithromycin , nelfinavir , and nefazadone may result in an increase in fentanyl plasma concentrations .
None(e1,e2)	2	38	coadministration of almotriptan and the potent cyp3a4 inhibitor ketoconazole ( 400 mg q.d . for 3 days ) resulted in an approximately 60 % increase in the area under the plasma concentration-time curve and maximal plasma concentrations of almotriptan .
None(e1,e2)	17	28	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	41	70	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	3	18	digoxin : plasma digoxin levels and digoxin clearance at steady-state were not affected by co-administration of 0.2 mg cerivastatin_sodium .
None(e1,e2)	9	17	therefore , interactions could occur following concomitant administration of psychotropic_drugs ( e.g. , narcotics , analgesics , antiemetics , sedatives , tranquilizers ) .
None(e1,e2)	29	41	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	7	18	in rheumatoid arthritis , concomitant medications besides mtx were nonsteroidal anti-inflammatory agents , folic acid , corticosteroids and/or narcotics .
None(e1,e2)	10	22	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	30	49	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics * ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	85	161	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin_sodium overdosage .
None(e1,e2)	32	36	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
mechanism(e1,e2)	9	16	there was a small decrease in the clearance of cetirizine caused by a 400-mg dose of theophylline ;
None(e1,e2)	11	14	erythromycin has been reported to significantly alter the metabolism of nonsedating antihistamines terfenadine and astemizole when taken concomitantly .
None(e1,e2)	24	26	nsaids : in in vitro studies , m1 was shown to cause increases ranging from 13 - 50 % in the free fraction of diclofenac and ibuprofen at concentrations in the clinical range .
advise(e1,e2)	0	2	nevirapine and ketoconazole should not beadministered concomitantly becausedecreases in ketoconazole plasmaconcentrations may reduce the efficacy of the drug .
None(e1,e2)	75	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	32	57	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	15	42	the iv methylprednisolone dose should be reduced by approximately 25 % , and the oral methylprednisolone dose should be reduced by approximately 50 % when coadministered with aprepitant to achieve exposures of methylprednisolone similar to those obtained when it is given without aprepitant .
None(e1,e2)	31	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	3	anticholinergic_agents : although ipratropium_bromide is minimally absorbed into the systemic circulation , there is some potential for an additive interaction with concomitantly used anticholinergic medications .
None(e1,e2)	33	43	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	38	76	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	12	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
None(e1,e2)	0	10	antipyrine : because atorvastatin does not affect the pharmacokinetics of antipyrine , interactions with other drugs metabolized via the same cytochrome isozymes are not expected .
None(e1,e2)	2	13	the effects celecoxib on the pharmacokinetics and/or pharmacodynamics of glyburide , ketoconazole , methotrexate , phenytoin , tolbutamide , and warfarin have been studied in vivo and clinically important interactions have not been found .
None(e1,e2)	12	32	when cancidas is co-administered with inducers of drug clearance , such as efavirenz , nevirapine , phenytoin , dexamethasone , or carbamazepine , use of a daily dose of 70 mg of cancidas should be considered
None(e1,e2)	45	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	107	130	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic_acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	23	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	11	20	anticoagulants : potentiation of warfarin-type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
None(e1,e2)	35	39	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	10	18	antihypertensive medications , other , especially diazoxide , or pre anesthetic and anesthetic agents used in surgery or skeletal-muscle_relaxants , nondepolarizing , used in surgery
mechanism(e1,e2)	5	8	in vitro studies have shown casodex can displace coumarin_anticoagulant s , such as warfarin , from their protein-binding sites .
None(e1,e2)	18	24	patients who have been treated with mao inhibitors within two to three weeks prior to the administration of dopamine_hcl should receive initial doses of dopamine_hcl no greater than one-tenth ( 1/10 ) of the usual dose .
None(e1,e2)	35	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	111	117	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin_c .
None(e1,e2)	5	15	in patients who have received muscle_relaxants , doxapram may temporarily mask the residual effects of muscle_relaxant_drugs .
None(e1,e2)	87	145	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	64	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	1	14	oral contraceptives multiple doses of cefditoren pivoxil had no effect on the pharmacokinetics of ethinyl_estradiol , the estrogenic component in most oral contraceptives .
None(e1,e2)	26	71	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	22	24	furosemide : clinical studies , as well as post marketing observations , have shown that nsaids can reduce the natriuretic effect of furosemide and thiazides in some patients .
None(e1,e2)	29	48	before using this medication , tell your doctor or pharmacist of all prescription and nonprescription products you may use , especially of : aminoglycosides ( e.g. , gentamicin , amikacin ) , amphotericin b , cyclosporine , non-steroidal anti-inflammatory drugs ( e.g. , ibuprofen ) , tacrolimus , vancomycin .
None(e1,e2)	30	32	the hypoglycemic action of sulfonylurea may be potentiated by certain drugs including nonsteroidal anti-inflammatory agents and other drugs that are highly protein bound , salicylates , sulfonamides , chloramphenicol , probenecid , coumarins , monoamine oxidase inhibitors , and beta adrenergic blocking agents .
None(e1,e2)	8	14	based on the chemical resemblance of itraconazole and ketoconazole , coadministration of astemizole with itraconazole is contraindicated .
None(e1,e2)	3	38	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	12	23	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	139	146	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid_drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	1	24	micro-dosed progesterone preparations : micro-dosed progesterone preparations ( minipills that do not contain an estrogen ) may be an inadequate method of contraception during accutane therapy .
None(e1,e2)	15	22	since apraclonidine may reduce pulse and blood pressure , caution in using drugs such as beta-blockers ( ophthalmic and systemic ) , antihypertensives , and cardiac glycosides is advised .
None(e1,e2)	20	22	concomitant use of sprycel and drugs that inhibit cyp3a4 ( eg , ketoconazole , itraconazole , erythromycin , clarithromycin , ritonavir , atazanavir , indinavir , nefazodone , nelfinavir , saquinavir , telithromycin ) may increase exposure to dasatinib and should be avoided .
None(e1,e2)	14	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	0	15	methadone levels may be decreased ; increased dosages may be required to prevent symptoms of opiate withdrawal . methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly .
None(e1,e2)	43	69	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	6	9	potassium-sparing diuretics such as spironolactone , triamterene , or amiloride , or potassium supplements should be given only for documented hypokalemia , and then with caution , since they may lead to a significant increase of serum potassium .
None(e1,e2)	23	56	interactions may also occur with the following : anti-depressants/anti-anxiety drugs , drugs used to treat an overactive thyroid , beta-blockers ( e.g. , propranolol ) , sparfloxacin , grepafloxacin , guanethidine , guanadrel , metrizamide , cabergoline , lithium , narcotic pain medication ( e.g. , codeine ) , drugs used to aid sleep , drowsiness-causing antihistamines ( e.g. , diphenhydramine ) , any other drugs that may make you drowsy .
None(e1,e2)	0	5	non-selective_mao_inhibitors including tranylcypromine sulfate , phenelzine_sulfate , and pargyline hc1 : concomitant use of l-tyrosine and non-selective mao inhibitors may cause hypertension .
None(e1,e2)	2	6	digoxin , methotrexate , cyclosporine : diclofenac , like other nsaids , may affect renal prostaglandins and increase the toxicity of certain drugs .
None(e1,e2)	22	30	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	38	40	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	29	31	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	45	47	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	3	25	concurrent use of butorphanol with central nervous system depressants ( e.g. , alcohol , barbiturates , tranquilizers , and antihistamines ) may result in increased central_nervous_system_depressant effects .
None(e1,e2)	7	14	loop diuretics : furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients .
None(e1,e2)	1	3	and disulfiram when amitriptyline_hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	29	32	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	30	31	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	14	34	may interact with thyroid medication ( e.g. , levothyroxine ) , iodine-containing products , antacids , h2-antagonists ( e.g. , famotidine , ranitidine ) , and proton pump inhibitors ( e.g. , lansoprazole , omeprazole ) .
mechanism(e1,e2)	6	13	- drugs that may decrease plasma phenytoin concentrations include : carbamazepine , chronic alcohol abuse , reserpine
effect(e1,e2)	4	13	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	0	13	antacid : the effect of an aluminum hydroxide- and magnesium hydroxide-containing antacid ( maalox ) * on the pharmacokinetics of capecitabine was investigated in 12 cancer patients .
None(e1,e2)	10	22	clinical studies in healthy volunteers show that the pharmacokinetics of cancidas are not altered by itraconazole , amphotericin b , mycophenolate , nelfinavir , or tacrolimus .
None(e1,e2)	16	35	if desipramine hydrochloride is to be combined with other psychotropic agents such as tranquilizers or sedative/ hypnotics , careful consideration should be given to the pharmacology of the agents employed since the sedative effects of desipramine and benzodiazepines ( e.g. , chlordiazepoxide or diazepam ) are additive .
None(e1,e2)	7	15	oral neomycin inhibits the gastrointestinal absorption of penicillin_v , oral vitamin b-12 , methotrexate and 5-fluorouracil .
None(e1,e2)	6	9	benzthiazide may interact with alcohol , blood_thinner s , decongestant_drugs ( allergy , cold , and sinus medicines ) , diabetic drugs , lithium , norepinephrine , nsaids like aleve or ibuprofen , and high blood pressure medications .
None(e1,e2)	65	69	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease_inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	10	36	amphotericin , foscarnet , and aminoglycosides : drugs such as amphotericin , foscarnet , and aminoglycosides may increase the risk of developing peripheral neuropathy or other hivid-associated adverse events by interfering with the renal clearance of zalcitabine ( thereby raising systemic exposure ) .
None(e1,e2)	26	124	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged_narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	18	in addition , drugs that are actively secreted via this route ( e.g. , triamterene , metformin and amiloride ) should be co-administered with care as they might increase dofetilide levels .
None(e1,e2)	5	7	serotonergic agents : co-administration of linezolid and serotonergic_agents was not associated with serotonin syndrome in phase 1 , 2 or 3 studies .
None(e1,e2)	4	27	although concomitant use of clozapine and carbamazepine is not recommended , it should be noted that discontinuation of concomitant carbamazepine administration may result in an increase in clozapine plasma levels .
None(e1,e2)	52	63	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2 antagonists , hmg-coa reductase inhibitors , prostaglandin_synthetase_inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	0	25	rifampin : co-administration of vioxx with rifampin 600 mg daily , a potent inducer of hepatic metabolism , produced an approximate 50 % decrease in rofecoxib plasma concentrations .
None(e1,e2)	6	34	effects of other antiepilepsy drugs ( aeds ) on gabitril : carbamazepine : population pharmacokinetic analyses indicate that tiagabine clearance is 60 % greater in patients taking carbamazepine with or without other enzyme- inducing aeds .
None(e1,e2)	36	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	4	33	studies have shown that lansoprazole does not have clinically significant interactions with other drugs metabolized by the cytochrome p450 system , such as warfarin , antipyrine , indomethacin , ibuprofen , phenytoin , propranolol , prednisone , diazepam , clarithromycin , or terfenadine in healthy subjects .
None(e1,e2)	12	17	compounds that have been tested in man include antipyrine , digoxin , propranolol , theophylline , and warfarin and no clinically meaningful interactions were found .
None(e1,e2)	1	47	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
mechanism(e1,e2)	18	27	coadministration with compounds that are potent inducers of cyp3a4 ( eg , phenobarbital , phenytoin , dexamethasone , carbamazepine ) may result in decreased plasma levels of saquinavir .
None(e1,e2)	88	113	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	26	glibenclamide : in a study of 7 healthy male volunteers , acitretin treatment potentiated the blood glucose lowering effect of glibenclamide ( a sulfonylurea similar to chlorpropamide ) in 3 of the 7 subjects .
None(e1,e2)	14	18	avoid the use of preparations such as decongestants and local anesthetics which contain any sympathomimetic_amine ( e.g. , epinephrine , norepinephrine ) , since it has been reported that tricyclic antidepressants can potentiate the effects of catecholamines .
None(e1,e2)	69	79	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
advise(e1,e2)	0	16	azlocillin should not be administered concomitantly with amikacin , ciprofloxacin , gentamicin , netilmicin , or tobramycin .
None(e1,e2)	0	18	aminoglycosides : the mixing of piperacillin with an aminoglycoside in vitro can result in substantial inactivation of the aminoglycoside .
None(e1,e2)	76	129	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	31	36	quinolone antibiotics : videx should be administered at least 2 hours after or 6 hours before dosing with ciprofloxacin because plasma concentrations of ciprofloxacin are decreased when administered with antacids containing magnesium , calcium , or aluminum .
None(e1,e2)	96	116	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
advise(e1,e2)	18	22	however , due to possible pharmacodynamic interactions , when co-administered with precedex , a reduction in dosage of precedex on the concomitant anesthetic , sedative , hypnotic or opioid may be required .
None(e1,e2)	19	38	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	0	7	fluoxetine does not affect the pharmacokinetics of clonazepam .
advise(e1,e2)	8	10	hmg-coa reductase inhibitors : the combined use of tricor and hmg-coa_reductase_inhibitors should be avoided unless the benefit of further alterations in lipid levels is likely to outweigh the increased risk of this drug combination .
None(e1,e2)	26	68	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	28	30	in patients receiving nonselective monoamine oxidase inhibitors ( maois ) ( e.g. , selegiline hydrochloride ) in combination with serotoninergic agents ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , venlafaxine ) , there have been reports of serious , sometimes fatal , reactions .
None(e1,e2)	13	45	the following are examples of substances that may reduce the blood-glucose-lowering effect of insulin : corticosteroids , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , albuterol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	20	22	catecholamine-depleting agents : patients taking both agents with b-blocking properties and a drug that can deplete catecholamines ( e.g. , reserpine and monoamine_oxidase_inhibitors ) should be observed closely for signs of hypotension and/or severe bradycardia .
None(e1,e2)	13	41	in another drug interaction study , co-administration of orally inhaled ciclesonide and oral ketoconazole , a potent inhibitor of cytochrome p450 3a4 , increased the exposure ( auc ) of des-ciclesonide by approximately 3.6-fold at steady state , while levels of ciclesonide remained unchanged .
None(e1,e2)	58	64	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	50	54	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	2	33	- a nonsteroidal_anti-inflammatory_drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	91	118	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	35	37	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	22	29	in 2 separate studies , fexofenadine hydrochloride 120 mg twice daily ( 240 mg total daily dose ) was co-administered with either erythromycin 500 mg every 8 hours or ketoconazole 400 mg once daily under steady-state conditions to healthy volunteers ( n=24 , each study ) .
mechanism(e1,e2)	3	18	conversely , the coumarin_anticoagulants have been reported to increase the serum levels and prolong the serum half-life of phenytoin by inhibiting its metabolism .
None(e1,e2)	59	81	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	18	mao inhibitors , narcotic analgesics ( e.g. , meperidine ) , nitrates and nitrites , sympathomimetic agents , tricyclic_antidepressants , and other drugs having anticholinergic activity .
None(e1,e2)	85	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	11	33	because severe hypoglycemia has been reported in patients concomitantly receiving oral miconazole ( an imidazole ) and oral hypoglycemic agents , such a potential interaction involving the latter agents when used concomitantly with ketoconazole tablets ( an imidazole ) can not be ruled out .
None(e1,e2)	85	102	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease_inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	66	97	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic_acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	5	12	aspirin : concomitant administration of diclofenac and aspirin is not recommended because diclofenac is displaced from its binding sites during the concomitant administration of aspirin , resulting in lower plasma concentrations , peak plasma levels , and auc values .
None(e1,e2)	40	42	tagamet , apparently through an effect on certain microsomal enzyme systems , has been reported to reduce the hepatic metabolism of warfarin-type anticoagulants , phenytoin , propranolol , nifedipine , chlordiazepoxide , diazepam , certain tricyclic antidepressants , lidocaine , theophylline and metronidazole , thereby delaying elimination and increasing blood levels of these drugs .
None(e1,e2)	33	67	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	90	92	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	36	77	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	25	29	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
None(e1,e2)	21	48	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	13	31	however , in a follow-up study in normal subjects , single-dose administration of colestipol_hydrochloride and propranolol and twice-a-day administration for 5 days of both agents did not affect the extent of propranolol absorption , but had a small yet statistically significant effect on its rate of absorption ;
None(e1,e2)	32	46	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	16	35	in vitro studies evaluating the minimum inhibitory concentration ( mic ) of vancomycin , cefazolin , ampicillin , ampicillin/flucoxacillin , ceftazidime , gentamicin , and amphotericin demonstrated no evidence of incompatibility of these antibiotics with extraneal .
None(e1,e2)	12	16	if treatment with inhibitors of cyp3a4 activity ( such as ketoconazole , intraconazole , ritonavir , indinavir , saquinavir , erythromycin , etc . ) is indicated , reduction of the budesonide dose should be considered .
None(e1,e2)	5	43	concomitant medications were grouped as ace_inhibitors , oral anticoagulants , calcium channel blockers , beta blockers , cardiac glycosides , inducers of cyp3a4 , substrates and inhibitors of cyp3a4 , substrates and inhibitors of p-glycoprotein , nitrates , sulphonylureas , loop diuretics , potassium_sparing_diuretics , thiazide diuretics , substrates and inhibitors of tubular organic cation transport , and qtc-prolonging drugs .
None(e1,e2)	0	4	serotonergic_agents : co-administration of linezolid and serotonergic agents was not associated with serotonin syndrome in phase 1 , 2 or 3 studies .
None(e1,e2)	70	73	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide_antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	2	11	h2 blockers/ proton_pump_inhibitors : long-term suppression of gastric acid secretion by h2_blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
None(e1,e2)	10	12	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	15	33	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
effect(e1,e2)	5	53	drug interactions : the central anticholinergic syndrome can occur when anticholinergic agents such as akineton are administered concomitantly with drugs that have secondary anticholinergic actions , e.g. , certain narcotic analgesics such as meperidine , the phenothiazines and other antipsychotics , tricyclic antidepressants , certain antiarrhythmics such as the quinidine salts , and antihistamines .
None(e1,e2)	15	17	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	25	29	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	21	23	these pharmacokinetic effects seen during diltiazem coadministration can result in increased clinical effects ( e.g. , prolonged sodation ) of both midazolam and triazolam .
None(e1,e2)	31	105	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	6	8	cyclosporine : increased activity of both cyclosporine and corticosteroids may occur when the two are used concurrently .
None(e1,e2)	6	33	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	44	72	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	107	109	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	5	13	oral contraceptives multiple doses of cefditoren_pivoxil had no effect on the pharmacokinetics of ethinyl_estradiol , the estrogenic component in most oral contraceptives .
None(e1,e2)	34	51	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium channel blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	30	46	diltiazem : in patients with mild to moderate hypertension , administration of aprepitant once daily , as a tablet formulation comparable to 230 mg of the capsule formulation , with diltiazem 120 mg 3 times daily for 5 days , resulted in a 2-fold increase of aprepitant auc and a simultaneous 1.7-fold increase of diltiazem auc .
None(e1,e2)	3	12	blood levels of hydrodolasetron increased 24 % when dolasetron was coadministered with cimetidine ( nonselective inhibitor of cytochrome p-450 ) for 7 days , and decreased 28 % with coadministration of rifampin ( potent inducer of cytochrome p-450 ) for 7 days .
None(e1,e2)	0	6	bacteriostatic_antibiotics : chloramphenicol , erythromycins , sulfonamides , or tetracyclines may interfere with the bactericidal effect of penicillins .
None(e1,e2)	26	45	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	1	11	- vitamin_k ( e.g. , aquamephyton , synkayvite ) use of sulfapyridine with these medicines may increase the chance of side effects affecting the blood
None(e1,e2)	26	29	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic_hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	24	33	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	53	59	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	10	14	co-administration of lovastatin , atenolol , warfarin , furosemide , digoxin , celecoxib , hydrochlorothiazide , ramipril , valsartan , metformin and amlodipine did not result in clinically significant increases in aliskiren exposure .
None(e1,e2)	20	37	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
None(e1,e2)	13	54	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	4	13	ganciclovir : administration of videx 2 hours prior to or concurrent with oral ganciclovir was associated with a 111 ( 114 ) % increase in the steady-state auc of didanosine ( n = 12 ) .
None(e1,e2)	13	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	7	9	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	49	88	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	25	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	0	6	loop_diuretics : furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients .
None(e1,e2)	6	15	curariform muscle relaxants ( eg , tubocurarine ) and other drugs , including ether , succinylcholine , gallamine , decamethonium and sodium citrate , potentiate the neuromuscular blocking effect and should be used with extreme caution in patients being treated with coly-mycin m parenteral .
effect(e1,e2)	0	11	cardiac_glycosides could exaggerate the depression of av nodal conduction observed with bepridil_hydrochloride .
None(e1,e2)	0	27	omeprazole : the rate and extent of absorption of ciprofloxacin was bioequivalent when proquin xr was given alone or when proquin xr was given 2 hours after omeprazole at the dose that maximally suppresses gastric acid secretion .
None(e1,e2)	102	115	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic_acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	monoamine_oxidase_inhibitors and tricyclic_antidepressants : foradil should be administered with extreme caution in patients being treated with monoamine oxidase inhibitors or tricyclic antidepressants because the action of formoterol on the cardiovascular system may be potentiated by these agents .
None(e1,e2)	1	9	when estrogen therapy is initiated , a reduction in corticosteroid dosage may be required , and increased amounts may be required when estrogen is terminated .
None(e1,e2)	25	27	in general , these are drugs that have one or more pharmacologic activities similar to bepridil hydrochloride , including anti-arrhythmic agents such as quinidine and procainamide , cardiac_glycosides and tricyclic anti-depressants .
None(e1,e2)	5	7	itraconazole ketoconazole erythromycin clarithromycin telithromycin hiv_protease_inhibitors nefazodone cyclosporine large quantities of grapefruit juice ( 1 quart daily )
None(e1,e2)	21	44	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace_inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide_antibiotics .
None(e1,e2)	9	37	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	45	55	other concomitant therapy although specific interaction studies were not performed , finasteride doses of 1 mg or more were concomitantly used in clinical studies with acetaminophen , acetylsalicylic acid , a-blockers , analgesics , angiotensin-converting enzyme ( ace ) inhibitors , anticonvulsants , benzodiazepines , beta_blockers , calcium-channel blockers , cardiac nitrates , diuretics , h2_antagonists , hmg-coa reductase inhibitors , prostaglandin synthetase inhibitors ( also referred to as nsaids ) , and quinolone anti-infectives without evidence of clinically significant adverse interactions .
None(e1,e2)	7	26	however , the peak plasma level of metformin was reduced by approximately 20 % when taking acarbose due to a slight delay in the absorption of metformin .
None(e1,e2)	2	21	- a monoamine_oxidase_inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	9	11	it is important that patients understand how to use foradil ( formoterol_fumarate ) capsules with the supplied aerolizertm inhalation device and how it should be used in relation to other asthma or copd medications they are taking .
None(e1,e2)	16	25	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
None(e1,e2)	3	10	specific effects of felbatol on other antiepileptic drugs phenytoin : felbatol causes an increase in steady-state phenytoin plasma concentrations .
None(e1,e2)	21	44	the following are examples of substances that may reduce the blood-glucose-lowering effect : corticosteroids , niacin , danazol , diuretics , sympathomimetic_agents ( e.g. , epinephrine , salbutamol , terbutaline ) , isoniazid , phenothiazine derivatives , somatropin , thyroid hormones , estrogens , progestogens ( e.g. , in oral contraceptives ) .
None(e1,e2)	31	59	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	16	cyclosporin : after introduction of chloroquine ( oral form ) , a sudden increase in serum cyclosporin level has been reported .
None(e1,e2)	7	10	erythromycin and clarithromycin ( and possibly other macrolide_antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	0	2	nonsteroidal_anti-inflammatory_agents ( nsaids ) : concomitant use of aspirin ( or other nonsteroidal antiinflammatory agents ) and corticosteroids increases the risk of gastrointestinal side effects .
None(e1,e2)	52	70	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	7	13	in a study in diabetics with microalbuminuria inspra 200 mg combined with the ace_inhibitor enalapril 10 mg increased the frequency of hyperkalemia ( serum potassium 5.5 meq/l ) from 17 % on enalapril alone to 38 % .
None(e1,e2)	27	32	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
mechanism(e1,e2)	1	12	the carbamazepine steady-state cmin decreased 31 % to 5 1 micrograms/ml when felbamate ( 3000 mg/day , divided into three doses ) was coadministered .
None(e1,e2)	34	52	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	1	22	serum infliximab concentrations appeared to be unaffected by baseline use of medications for the treatment of crohn s disease including corticosteroids , antibiotics ( metronidazole or ciprofloxacin ) and aminosalicylates .
None(e1,e2)	9	20	in vitro studies have shown no binding displacement between entacapone and other highly bound drugs , such as warfarin , salicylic_acid , phenylbutazone , and diazepam .
None(e1,e2)	81	95	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	8	use of prinivil with potassium-sparing_diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
None(e1,e2)	3	24	the concentrations of sn38 , the active metabolite of irinotecan , were on average 33 % higher in patients receiving bolus-ifl in combination with avastin when compared with bolus-ifl alone .
None(e1,e2)	2	9	antiarrhythmics : bepridil , lidocaine ( systemic ) and quinidine
advise(e1,e2)	25	29	however , since aspirin , nsaids , and bisphosphonates are all associated with gastrointestinal irritation , caution should be exercised in the concomitant use of aspirin or nsaids with ibandronate .
None(e1,e2)	85	135	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	36	70	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease_inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	8	24	these medications have included heparin , warfarin , beta-adrenergic_receptor_blockers , calcium channel antagonists , angiotensin converting enzyme inhibitors , intravenous and oral nitrates , ticlopidine , and aspirin .
None(e1,e2)	26	40	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal_muscle_relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	12	46	in clinical trials , flolan was used with digoxin , diuretics , anticoagulants , oral vasodilators , and supplemental oxygen.in a pharmacokinetic substudy in patients with congestive heart failure receiving furosemide or digoxin in whom therapy with flolan was initiated , apparent oral clearance values for furosemide ( n = 23 ) and digoxin ( n = 30 ) were decreased by 13 % and 15 % , respectively , on the second day of therapy and had returned to baseline values by day 87 .
int(e1,e2)	11	13	based on anecdotal reports , there may be an interaction between buprenorphine and benzodiazepines .
None(e1,e2)	6	8	no clinically relevant pharmacokinetic interactions between anagrelide and acetylsalicylic_acid were observed .
None(e1,e2)	11	19	potential drug interactions between keppra and other aeds ( carbamazepine , gabapentin , lamotrigine , phenobarbital , phenytoin , primidone and valproate ) were also assessed by evaluating the serum concentrations of levetiracetam and these aeds during placebo-controlled clinical studies .
None(e1,e2)	4	20	during clinical trials , iloprost was used concurrently with anticoagulants , diuretics , cardiac glycosides , calcium channel blockers , analgesics , antipyretics , nonsteroidal antiinflammatories , corticosteroids , and other medications .
int(e1,e2)	11	33	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	6	8	antibiotics ( e.g. , erythromycin , trimethoprim and sulfamethoxazole , amoxicillin ) .
None(e1,e2)	12	14	in clinical trials in patients undergoing ptca/pci , co-administration of angiomax with heparin , warfarin , thrombolytics or glycoprotein iib/iiia inhibitors was associated with increased risks of major bleeding events compared to patients not receiving these concomitant medications .
mechanism(e1,e2)	1	12	some quinolones have also been shown to interfere with the metabolism of caffeine .
effect(e1,e2)	3	10	cholinesterase inhibitors : dipyridamole may counteract the anticholinesterase effect of cholinesterase_inhibitors , thereby potentially aggravating myasthenia gravis .
None(e1,e2)	0	8	anakinra : concurrent administration of anakinra ( an interleukin-1_antagonist ) and another tnf-blocking agent has been associated with an increased risk of serious infections , an increased risk of neutropenia and no additional benefit compared to these medicinal products alone .
None(e1,e2)	14	16	potential interactions between taxol , a substrate of cyp3a4 , and protease inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	2	8	beta-blockers , clonidine , lithium salts , and alcohol may either potentiate or weaken the blood-glucose-lowering effect of insulin .
None(e1,e2)	0	42	cimetidine , ranitidine : in normal volunteers ( n=9 ) , pretreatment with cimetidine or ranitidine did not affect flurbiprofen pharmacokinetics except that a small ( 13 % ) but statistically significant increase in the area under the serum concentration curve of flurbiprofen resulted with cimetidine .
None(e1,e2)	20	34	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	63	111	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	31	erythromycin and clarithromycin ( and possibly other macrolide antibiotics ) and tetracycline may increase digoxin absorption in patients who inactivate digoxin by bacterial metabolism in the lower intestine , so that digitalis intoxication may result .
None(e1,e2)	0	21	phenobarbital or primidone : no formal pharmacokinetic studies have been performed examining the addition of tiagabine to regimens containing phenobarbital or primidone .
None(e1,e2)	12	15	antiarrhythmics : other antiarrhythmic drugs , such as quinidine , procainamide , disopyramide , and phenytoin , have been used concurrently with amiodarone .
None(e1,e2)	8	12	calcium channel blockers , dihydropyridine : e.g. , felodipine , nifedipine , nicardipine
None(e1,e2)	31	41	phenytoin : no significant differences were observed in mean phenytoin auc , c max , c min or t max ( although c max increased by 11 % ) when extended phenytoin_sodium capsules ( 100 mg tid ) were coadministered with lomefloxacin ( 400 mg qd ) for five days in 15 healthy males .
None(e1,e2)	13	28	propranolol : in a single dose study in normal volunteers , coadministration of propranolol had a small effect on the rate but no effect on the extent of isradipine bioavailability .
advise(e1,e2)	14	24	because of the danger of a potentially fatal prolongation of the qtc interval , halofantrine must not be given simultaneously with or subsequent to mefloquine .
None(e1,e2)	5	16	when itraconazole was coadministered with phenytoin , rifampin , or h2antagonists , reduced plasma concentrations of itraconazole were reported .
None(e1,e2)	15	31	however , there are limited in vivo data suggesting a modest cyp2d6 inhibitory effect for escitalopram , i.e. , coadministration of escitalopram ( 20 mg/day for 21 days ) with the tricyclic_antidepressant desipramine ( single dose of 50 mg ) , a substrate for cyp2d6 , resulted in a 40 % increase in cmax and a 100 % increase in auc of desipramine .
effect(e1,e2)	4	6	anesthetics/sedatives/hypnotics/opioids : co-administration of precedex with anesthetics , sedatives , hypnotics , and opioids is likely to lead to an enhancement of effects .
None(e1,e2)	22	41	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	21	71	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	55	121	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
effect(e1,e2)	7	52	however , the systemic administration of some quinolones has been shown to elevate plasma concentrations of theophylline , interfere with the metabolism of caffeine , and enhance the effects of the oral anticoagulant warfarin and its derivatives , and has been associated with transient elevations in serum creatinine in patients receiving systemic cyclosporine concomitantly .
None(e1,e2)	5	7	coadministration of nizoral tablets with midazolam or triazolam has resulted in elevated plasma concentrations of the latter two drugs .
None(e1,e2)	7	20	coadministration of oral contraceptives , diazepam , phenytoin , or quinidine did not seem to change the pharmacokinetic profile of esomeprazole .
None(e1,e2)	11	13	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	13	25	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
mechanism(e1,e2)	4	19	therefore , coadministration of aprepitant with drugs that strongly induce cyp3a4 activity ( e.g. , rifampin , carbamazepine , phenytoin ) may result in reduced plasma concentrations of aprepitant that may result in decreased efficacy of aprepitant .
None(e1,e2)	25	32	injection : lorazepam injection , like other injectable benzodiazepines , produces depression of the central nervous system when administered with ethyl alcohol , phenothiazines , barbiturates , mao inhibitors , and other antidepressants .when scopolamine is used concomitantly with injectable lorazepam , an increased incidence of sedation , hallucinations , and irrational behavior has been observed .
None(e1,e2)	12	17	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic_antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	68	88	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
effect(e1,e2)	14	47	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	31	40	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	3	5	certain drugs including thiazides , corticosteroids , thyroid products , and sympathomimetics may reduce the hypoglycemic action of starlix and other oral antidiabetic drugs .
None(e1,e2)	14	16	dose adjustment is not recommended.levetiracetam had no effect on plasma concentrations of carbamazepine , valproate , topiramate , or lamotrigine .
None(e1,e2)	10	45	multivitamins , or other products containing iron or zinc , antacids or sucralfate should not be administered concomitantly with , or within 2 hours of , the administration of norfloxacin , because they may interfere with absorption resulting in lower serum and urine levels of norfloxacin .
None(e1,e2)	20	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	9	31	in two combined 12-week placebo controlled trials that included brovana doses of 15 mcg twice daily , 25 mcg twice daily , and 50 mcg once daily , 54 of 873 brovana -treated subjects received concomitant theophylline at study entry .
None(e1,e2)	11	14	- lofexidine may enhance the cns depressive effects of alcohol , barbiturates and other sedatives
None(e1,e2)	5	15	use of antithrombotics aspirin and heparin have been administered concomitantly with and following infusions of activase in the management of acute myocardial infarction or pulmonary embolism .
None(e1,e2)	11	20	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	35	89	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms_contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	19	39	in addition , studies in healthy volunteers have shown that tikosyn does not affect the pharmacokinetics or pharmacodynamics of warfarin , or the pharmacokinetics of propranolol ( 40 mg twice daily ) , phenytoin , theophylline , or oral contraceptives .
None(e1,e2)	21	40	beta blockers : although the results of a clinical study did not indicate a safe problem associated with the administration of d.h.e_._45 ( dihydroergotamine mesylate ) injection , usp to subjects already receiving propranolol , there have been reports that propranolol may potentiate the vasoconstrictive action of ergotamine by blocking the vasodilating property of epinephrine .
None(e1,e2)	21	25	the daily dose of enablex should not exceed 7.5 mg when coadministered with potent cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , ritonavir , nelfinavir , clarithromycin and nefazadone ) .
None(e1,e2)	15	37	central nervous system depressant ( cns ) drugs including alcohol , antidepressants , antihistamines , antipsychotics , blood pressure medications ( reserpine , methyldopa , beta-blockers ) , motion sickness medications , muscle relaxants , narcotics , sedatives , sleeping pills and tranquilizers
None(e1,e2)	21	23	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	0	2	antidepressants , tricyclic : amphetamines may enhance the activity of tricyclic or sympathomimetic agents ;
None(e1,e2)	18	32	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	29	60	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	4	6	the concomitant administration of quinolones including norfloxacin with glyburide ( a sulfonylurea agent ) has , on rare occasions , resulted in severe hypoglycemia .
None(e1,e2)	38	49	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic_acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	3	10	and disulfiram when amitriptyline_hcl is given with anticholinergic agents or sympathomimetic drugs , including epinephrine combined with local anesthetics , close supervision and careful adjustment of dosages are required .
None(e1,e2)	21	23	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic_acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
mechanism(e1,e2)	18	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	4	7	the gradual withdrawal of guafacine or a cardioselective_beta-blocker could be substituted .
mechanism(e1,e2)	2	15	administration of eplerenone with other cyp3a4 inhibitors ( e.g. , erythromycin 500 mg bid , verapamil 240 mg qd , saquinavir 1200 mg tid , fluconazole 200 mg qd ) resulted in increases in cmax of eplerenone ranging from 1.4- to 1.6- fold and auc from 2.0- to 2.9- fold .
None(e1,e2)	29	58	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	26	70	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	21	39	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	15	27	drugs that should not be coadministered with viracept antiarrhythmics : amiodarone , quinidine antihistamines : astemizole , terfenadine antimigraine : ergot derivatives antimycobacterial agents : rifampin benzodiazepines midazolam , triazolam gi motility agents : cisapride
None(e1,e2)	10	17	in vitro studies demonstrated that the plasma protein binding of des-ciclesonide was not affected by warfarin or salicylic_acid , indicating no potential for protein binding-based drug interactions .
None(e1,e2)	12	16	no interactions have been observed between nizatidine and theophylline , chlordiazepoxide , lorazepam , lidocaine , phenytoin , and warfarin .
None(e1,e2)	1	6	ketoconazole/ itraconazole , macrolides , including erythromycin
None(e1,e2)	11	19	in study 1 , patients with colorectal cancer were given irinotecan/ 5-fu /leucovorin ( bolus-ifl ) with or without avastin .
None(e1,e2)	14	25	drugs which may enhance the neuromuscular blocking action of tracrium include : enflurane ; isoflurane ; halothane ; certain antibiotics , especially the aminoglycosides and polymyxins ; lithium ; magnesium salts ; procainamide ; and quinidine .
effect(e1,e2)	5	13	while the effects of chronic phenytoin or carbamazepine therapy on the action of nimbex are unknown , slightly shorter durations of neuromuscular block may be anticipated and infusion rate requirements may be higher .
None(e1,e2)	24	32	antihypertensives : amiodarone should be used with caution in patients receiving -receptor blocking agents ( e.g. , propranolol , a cyp3a4 inhibitor ) or calcium_channel antagonists ( e.g. , verapamil , a cyp3a4 substrate , and diltiazem , a cyp3a4 inhibitor ) because of the possible potentiation of bradycardia , sinus arrest , and av block ;
mechanism(e1,e2)	18	65	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	16	21	barbiturates may decrease the effectiveness of oral contraceptives , certain antibiotics , quinidine , theophylline , corticosteroids , anticoagulants , and beta_blockers .
None(e1,e2)	0	14	hydrochlorothiazide ( hctz ) alone or in combination with triamterene : concomitant use of hctz alone or in combination with triamterene is contraindicated .
None(e1,e2)	38	42	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing_compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	45	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	24	39	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting_enzyme_inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	48	65	dexbrompheniramine can interact with alcohol or other cns depressants ( may potentiate the cns depressant effects of either these medications or antihistamines ) , anticholinergics or other medications with anticholinergic activity ( anticholinergic effects may be potentiated when these medications are used concurrently with antihistamines ) , and monoamine_oxidase_(_mao_)_inhibitors ( concurrent use with antihistamines may prolong and intensify the anticholinergic and cns depressant effects of antihistamines ) .
None(e1,e2)	4	6	however , co-administration of duloxetine with aluminum - and magnesium-containing antacids ( 51 meq ) or duloxetine with famotidine , had no significant effect on the rate or extent of duloxetine absorption after administration of a 40-mg oral dose .
None(e1,e2)	19	88	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol * ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic_acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	19	23	erythromycin use in patients who are receiving high doses of theophylline may be associated with an increase in serum theophylline levels and potential theophylline toxicity .
None(e1,e2)	3	26	concomitant treatment with thrombolytics ( eg , rt-pa or streptokinase ) may : - increase the risk of bleeding complications - considerably enhance the effect of refludan on aptt prolongation
None(e1,e2)	9	16	lithium : nsaids have produced an elevation of plasma lithium levels and a reduction in renal lithium clearance .
None(e1,e2)	13	39	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	4	9	in clinical trials , antacids were administered concomitantly with lansoprazole delayed-release capsules ;
None(e1,e2)	36	46	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
mechanism(e1,e2)	16	56	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	13	20	cephalosporins-cephalosporins containing side chains of n-methylthiotetrazole ( cefmenoxime , cefoperazone , cefotetan , cefamandole , latamoxef ) or methylthiadiazole ( cefazolin ) can cause vitamin k deficiency and hypoprothrombinemia .
None(e1,e2)	15	22	methadone levels may be decreased ; increased dosages may be required to prevent symptoms of opiate withdrawal . methadone maintained patients beginning nevirapine therapy should be monitored forevidence of withdrawal and methadone dose should be adjusted accordingly .
None(e1,e2)	28	74	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
advise(e1,e2)	2	11	consequently , estazolam should be avoided in patients receiving ketoconazole and itraconazole , which are very potent inhibitors of cyp3a .
None(e1,e2)	30	36	inhibitors of this isoenzyme ( e.g. , macrolide antibiotics , azole antifungal agents , protease inhibitors , serotonin reuptake inhibitors , amiodarone , cannabinoids , diltiazem , grapefruit juice , nefazadone , norfloxacin , quinine , zafirlukast ) should be cautiously coadministered with tikosyn as they can potentially increase dofetilide levels .
None(e1,e2)	36	40	caution should be used when administering or taking tarceva with ketoconazole and other strong cyp3a4 inhibitors such as , but not limited to , atazanavir , clarithromycin , indinavir , itraconazole , nefazodone , nelfinavir , ritonavir , saquinavir , telithromycin , troleandomycin ( tao ) , and voriconazole .
None(e1,e2)	2	12	acetaminophen and methotrexate - l-methionine may decrease hepatic toxicity in those with acetaminophen overdosage or in those taking methotrexate .
None(e1,e2)	15	42	when used in therapeutic doses , azithromycin had a modest effect on the pharmacokinetics of atorvastatin , carbamazepine , cetirizine , didanosine , efavirenz , fluconazole , indinavir , midazolam , rifabutin , sildenafil , theophylline ( intravenous and oral ) , triazolam , trimethoprim/sulfamethoxazole or zidovudine .
None(e1,e2)	110	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	107	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	12	antacids containing aluminum hydroxide and magnesium hydroxide reduce the oral absorption of enoxacin by 75 % .
None(e1,e2)	6	29	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	6	9	furosemide : toradol iv/im reduced the diuretic response to furosemide in normovolemic healthy subjects by approximately 20 % ( mean sodium and urinary output decreased 17 % ) .
None(e1,e2)	7	9	imidazoles ( e. g. , ketoconazole , miconazole , clotrimazole , fluconazole , etc . ) : in vitro and animal studies with the combination of amphotericin b and imidazoles suggest that imidazoles may induce fungal resistance to amphotericin b .
None(e1,e2)	15	17	while all the selective serotonin reuptake inhibitors ( ssris ) , e.g. , fluoxetine , sertraline , paroxetine , and fluvoxamine , inhibit p450 2d6 , they may vary in the extent of inhibition .
None(e1,e2)	4	13	use of prinivil with potassium-sparing_diuretics ( e.g. , spironolactone , triamterene , or amiloride ) , potassium supplements , or potassium-containing salt substitutes may lead to significant increases in serum potassium .
None(e1,e2)	22	42	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic antidepressants
None(e1,e2)	8	54	paroxetine : coadministration of once daily doses of aprepitant , as a tablet formulation comparable to 85 mg or 170 mg of the capsule formulation , with paroxetine 20 mg once daily , resulted in a decrease in auc by approximately 25 % and cmax , by approximately 20 % of both aprepitant and paroxetine .
advise(e1,e2)	2	4	coadministration of sular with phenytoin or any known cyp3a4 inducer should be avoided and alternative antihypertensive therapy should be considered .
None(e1,e2)	46	59	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	24	42	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	31	37	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	3	19	effects of other antiepileptic_drugs on felbatol phenytoin : phenytoin causes an approximate doubling of the clearance of felbatol ( felbamate ) at steady state and , therefore , the addition of phenytoin causes an approximate 45 % decrease in the steady-state trough concentrations of felbatol as compared to the same dose of felbatol given as monotherapy .
None(e1,e2)	22	33	betaseron administration to three cancer patients over a dose range of 0.025 mg to 2.2 mg led to a dose-dependent inhibition of antipyrine elimination.14 the effect of alternate-day administration of 0.25 mg of betaseron on drug metabolism in ms patients is unknown .
None(e1,e2)	26	28	the following are examples of substances that may increase the blood-glucose-lowering effect and susceptibility to hypoglycemia : oral antidiabetes products , ace inhibitors , disopyramide , fibrates , fluoxetine , mao inhibitors , propoxyphene , salicylates , somatostatin analog ( e.g. , octreotide ) , sulfonamide antibiotics .
None(e1,e2)	8	18	no significant interactions with digoxin , hydrochlorothiazide , hydralazine , sulfinpyrazone , oral contraceptives , tolbutamide , or warfarin have been observed .
advise(e1,e2)	0	19	nabilone should be administered with caution to patients who are taking other psychoactive drugs or cns depressants , including alcohol , barbiturates and narcotic analgesics , or to those with a history of psychiatric disorder ( including manic-depressive illness and schizophrenia ) .
None(e1,e2)	2	4	coadministration of lexapro and metoprolol had no clinically significant effects on blood pressure or heart rate .
None(e1,e2)	30	32	other binding proteins may be elevated in serum , i.e. , corticosteroid binding globulin ( cbg ) , sex hormone-binding globulin ( shbg ) , leading to increased total circulating corticosteroids and sex_steroids , respectively .
None(e1,e2)	6	11	trimethoprim alone or in combination with sulfamethoxazole : concomitant use of trimethoprim alone or in combination with sulfamethoxazole is contraindicated .
None(e1,e2)	19	24	effect of clonazepam on the pharmacokinetics of other drugs : clonazepam does not appear to alter the pharmacokinetics of phenytoin , carbamazepine , or phenobarbital .
None(e1,e2)	5	7	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
None(e1,e2)	70	95	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
effect(e1,e2)	18	25	the risk of using bromocriptine mesylate in combination with other drugs has not been systematically evaluated , but alcohol may potentiate the side effects of bromocriptine_mesylate .
None(e1,e2)	38	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	23	31	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
None(e1,e2)	7	15	if concomitant treatment with sumatriptan and an ssri ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline , citalopram , escitalopram ) is clinically warranted , appropriate observation of the patient is advised .
None(e1,e2)	7	15	co-medications that induce cyp3a4 ( e.g. , dexamethasone , phenytoin , carbamazepine , rifampin , phenobarbital or st .
None(e1,e2)	18	20	amphotericin b injection and potassium-depleting agents : when corticosteroids are administered concomitantly with potassium-depleting agents ( e.g. , amphotericin_b , diuretics ) , patients should be observed closely for development of hypokalemia .
None(e1,e2)	3	14	potential interactions between taxol , a substrate of cyp3a4 , and protease inhibitors ( ritonavir , saquinavir , indinavir , and nelfinavir ) , which are substrates and/or inhibitors of cyp3a4 , have not been evaluated in clinical trials .
None(e1,e2)	19	21	no formal clinical studies have been conducted to assess if there is an interactive effect on bone loss between phenytoin and accutane .
None(e1,e2)	0	20	fluconazole , and the 5-ht3 antiemetics ondansetron ( zofran ) and granisetron ( kytril ) have all been used with busulfex .
None(e1,e2)	74	83	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
mechanism(e1,e2)	19	68	agents that are cyp3a4 inhibitors that have been found , or are expected , to increase plasma levels of equetrotm are the following : acetazolamide , azole antifungals , cimetidine , clarithromycin ( 1 ) , dalfopristin , danazol , delavirdine , diltiazem , erythromycin ( 1 ) , fluoxetine , fluvoxamine , grapefruit juice , isoniazid , itraconazole , ketoconazole , loratadine , nefazodone , niacinamide , nicotinamide , protease inhibitors , propoxyphene , quinine , quinupristin , troleandomycin , valproate ( 1 ) , verapamil , zileuton .
None(e1,e2)	3	20	in patients receiving mercaptopurine ( purinethol ) or azathioprine ( imuran ) , the concomitant administration of 300-600 mg of allopurinol per day will require a reduction in dose to approximately one-third to one-fourth of the usual dose of mercaptopurine or azathioprine .
None(e1,e2)	41	61	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid_drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	32	111	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	0	15	digoxin : in a study in 12 patients with congestive heart failure where ketoprofen and digoxin were concomitantly administered , ketoprofen did not alter the serum levels of digoxin .
effect(e1,e2)	0	17	nabilone has been shown to have an additive cns depressant effect when given with either diazepam , secobarbitone_sodium , alcohol or codeine .
None(e1,e2)	14	16	the use of codeine may result in additive cns depressant effects when coadministered with alcohol , antihistamines , psychotropics or other drugs that produce cns depression .
None(e1,e2)	0	18	psychoactive_drugs : hallucinations have been reported when toradol was used in patients taking psychoactive drugs ( fluoxetine , thiothixene , alprazolam ) .
None(e1,e2)	5	9	drugs decreasing heparin effect : digitalis , tetracyclines , nicotine , or antihistamines may partially counteract the anticoagulant action of heparin sodium .
None(e1,e2)	38	56	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	20	37	probenecid : probenecid is known to interact with the metabolism or renal tubular excretion of many drugs ( e.g. , acetaminophen , acyclovir , angiotensin-converting enzyme inhibitors , aminosalicylic acid , barbiturates , benzodiazepines , bumetanide , clofibrate , methotrexate , famotidine , furosemide , nonsteroidal anti-inflammatory agents , theophylline , and zidovudine ) .
None(e1,e2)	11	39	morphine : a literature article reported that when a 60-mg controlled-release morphine capsule was administered 2 hours prior to a 600-mg neurontin capsule ( n=12 ) , mean gabapentin auc increased by 44 % compared to gabapentin administered without morphine .
None(e1,e2)	9	12	this information should be considered when changing from intravenous amiodarone to oral amiodarone .
None(e1,e2)	17	22	after 14 days of co-administration , mean trough concentrations of clozapine and its metabolites , n-desmethylclozapine and clozapine_n-oxide , were elevated with fluvoxamine by about three-fold compared to baseline concentrations .
None(e1,e2)	53	83	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	8	griseofulvin : griseofulvin may induce the metabolism of combination_hormonal_contraceptives causing menstrual changes ;
None(e1,e2)	22	31	although there was no clinical evidence in the vehicle-controlled studies of drug interactions with systemic antiretroviral agents , including protease inhibitors , macrolide_antibiotics , and azole antifungals , the effect of panretin gel on the steady-state concentrations of these drugs is not known .
None(e1,e2)	7	21	these drugs include the thiazides and other diuretics , corticosteroids , phe-nothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimet-ics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	0	2	cyclosporine , hexobarbital and phenytoin concentrations .
None(e1,e2)	8	48	based on adult data , lower doses of caffeine may be needed following coadministration of drugs which are reported to decrease caffeine elimination ( e.g. , cimetidine and ketoconazole ) and higher caffeine doses may be needed following coadministration of drugs that increase caffeine elimination ( e.g. , phenobarbital and phenytoin ) .
None(e1,e2)	0	11	zidovudine : there is no significant pharmacokinetic interaction between zdv and zalcitabine which has been confirmed clinically .
None(e1,e2)	22	34	the following agents may increase certain actions or side effects of anticholinergic drugs . amantadine antiarrhythmic agents of class ( e.g . quinidine ) , antihistamines antipsychotic agents ( e.g . phenothiazines ) , benzodiazepines .
None(e1,e2)	98	127	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine_oxidase_inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	9	11	central nervous system depressants : the concomitant use of duragesic ( fentanyl transdermal system ) with other central nervous system depressants , including but not limited to other opioids , sedatives , hypnotics , tranquilizers ( e.g. , benzodiazepines ) , general anesthetics , phenothiazines , skeletal muscle relaxants , and alcohol , may cause respiratory depression , hypotension , and profound sedation , or potentially result in coma or death .
None(e1,e2)	20	28	although specific studies have not been performed , coadministration with drugs that are mainly metabolized by cyp3a4 ( eg , calcium_channel_blockers , dapsone , disopyramide , quinine , amiodarone , quinidine , warfarin , tacrolimus , cyclosporine , ergot derivatives , pimozide , carbamazepine , fentanyl , alfentanyl , alprazolam , and triazolam ) may have elevated plasma concentrations when coadministered with saquinavir ;
None(e1,e2)	0	32	uricosuric_agents : since the excretion of oxipurinol is similar to that of urate , uricosuric agents , which increase the excretion of urate , are also likely to increase the excretion of oxipurinol and thus lower the degree of inhibition of xanthine oxidase .
None(e1,e2)	0	22	adrenergic_agents : some individuals receiving zyvox may experience a reversible enhancement of the pressor response to indirect-acting sympathomimetic agents , vasopressor or dopaminergic_agents .
None(e1,e2)	12	24	welchol was found to have no significant effect on the bioavailability of digoxin , lovastatin , metoprolol , quinidine , valproic acid , and warfarin .
None(e1,e2)	1	5	oral anticoagulants interaction studies with warfarin and acenocoumarol failed to identify any clinically important effects on the serum concentrations or clinical effects of these anticoagulants .
None(e1,e2)	11	15	additive depressant effect when used with general anesthetics , sedatives , antianxiety_drugs , hypnotics , alcohol , and other opiate analgesics .
None(e1,e2)	5	16	no important interactions to date levosimendan does not have clinically important pharmacokinetic interactions with captopril , beta-blockers , felodipine , digoxin , warfarin , isosorbide mononitrate , carvedilol , ethanol or itraconazole .
None(e1,e2)	37	39	- when bezalip or bezalip retard is used concurrently with anion-exchange resins ( e.g . cholestryramine ) , an interval of at least 2 hours should be maintained between the two medicines , since the absorption of bezalip or bezalip_retard is impaired
None(e1,e2)	5	13	the absorption of tetracycline , furosemide , penicillin g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
None(e1,e2)	69	106	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	18	28	although the interaction between almotriptan and other potent cyp3a4 inhibitors ( e.g. , itraconazole , ritonavir , and erythromycin ) has not been studied , increased exposures to almotriptan may be expected when almotriptan is used concomitantly with these medications .
None(e1,e2)	33	69	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	0	2	antiarrhythmics : amiodarone , bepridil , flecainide , propafenone , quinidine contraindicated due to potential for serious and/or life-threatening reactions .
None(e1,e2)	1	5	if novolog is mixed with nph_human_insulin , novolog should be drawn into the syringe first .
None(e1,e2)	2	15	- a monoamine_oxidase_inhibitor ( maoi ) such as isocarboxazid ( marplan ) , tranylcypromine ( parnate ) , or phenelzine ( nardil ) ;
None(e1,e2)	9	13	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid_products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel blocking drugs , and isoniazid .
None(e1,e2)	0	13	anticonvulsants ( phenytoin ) : steady state plasma exposure ( auc ) of valdecoxib ( 40 mg bid for 12 days ) was decreased by 27 % when co-administered with multiple doses ( 300 mg qd for 12 days ) of phenytoin ( a cyp 3a4 inducer ) .
None(e1,e2)	90	139	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	14	36	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	29	44	hepatic enzyme inducers , inhibitors and substrates : drugs which induce cytochrome p450 3a4 ( cyp 3a4 ) enzyme activity ( e.g. , barbiturates , phenytoin , carbamazepine , rifampin ) may enhance the metabolism of corticosteroids and require that the dosage of the corticosteroid be increased .
effect(e1,e2)	0	7	clonidine_hydrochloride may enhance the cns-depressive effects of alcohol , barbiturates or other sedatives .
effect(e1,e2)	14	49	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nuromax include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistimethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	1	5	- quinine ( e.g. , quinamm ) or
mechanism(e1,e2)	10	25	while no in vivo drug-drug interaction studies were conducted between estazolam and inducers of cyp3a , compounds that are potent cyp3a inducers ( such as carbamazepine , phenytoin , rifampin , and barbiturates ) would be expected to decrease estazolam concentrations .
advise(e1,e2)	10	18	if replacing clonidine by beta-blocker therapy , the introduction of beta_blockers should be delayed for several days after clonidine administration has stopped .
None(e1,e2)	41	63	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	19	28	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium_channel-blocking_drugs , and isoniazid .
None(e1,e2)	26	36	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf_blocking_agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
None(e1,e2)	35	42	other concomitant therapy : although specific interaction studies were not performed , in clinical studies , cerivastatin sodium was used concomitantly with angiotensin- converting enzyme ( ace ) inhibitors , betablockers , calcium-channel blockers , diuretics , and nonsteroidal anti-inflammatory drugs ( nsaids ) without evidence of clinically significant adverse interactions .
None(e1,e2)	32	36	binding to serum proteins : the following agents may either inhibit levothyroxine sodium binding to serum proteins or alter the concentrations of serum binding proteins : androgens and related anabolic hormones , asparaginase , clofibrate , estrogens and estrogen-containing compounds , 5-fluorouracil , furosemide , glucocorticoids , meclofenamic acid , mefenamic acid , methadone , perphenazine , phenylbutazone , phenytoin , salicylates , tamoxifen .
None(e1,e2)	14	32	medications can interfere with folate utilization , including : anticonvulsant medications ( such as phenytoin , and primidone ) metformin ( sometimes prescribed to control blood sugar in type 2 diabetes ) sulfasalazine ( used to control inflammation associated with crohns disease and ulcerative colitis ) triamterene ( a diuretic ) methotrexate there has been concern about the interaction between vitamin b12 and folic acid .
None(e1,e2)	0	17	theophylline serum levels should be monitored and appropriate dose adjustments considered for patients given both theophylline and pegasys .
effect(e1,e2)	10	43	other drugs which may enhance the neuromuscular blocking action of nondepolarizing_agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	32	40	the most commonly occurring drug interactions are listed below : - drugs that may increase plasma phenytoin concentrations include : acute alcohol intake , amiodarone , chboramphenicol , chlordiazepoxide , cimetidine , diazepam , dicumarol , disulfiram , estrogens , ethosuximide , fluoxetine , h2-antagonists , halothane , isoniazid , methylphenidate , phenothiazines , phenylbutazone , salicylates , succinimides , sulfonamides , tolbutamide , trazodone
None(e1,e2)	19	22	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
mechanism(e1,e2)	2	11	warfarin : quinolones , including enoxacin , decrease the clearance of r-warfarin , the less active isomer of racemic warfarin .
None(e1,e2)	8	14	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	27	29	administration of quinolones with antacids containing aluminum , magnesium , or calcium , with sucralfate , with metal cations such as iron , or with multivitamins containing iron or zinc , or with formulations containing divalent and trivalent cations such as videx ( didanosine ) chewable/buffered tablets or the pediatric powder for oral solution , may substantially interfere with the absorption of quinolones , resulting in systemic concentrations considerably lower than desired .
None(e1,e2)	24	46	oral contraceptives : aprepitant , when given once daily for 14 days as a 100-mg capsule with an oral contraceptive containing 35 mcg of ethinyl_estradiol and 1 mg of norethindrone , decreased the auc of ethinyl estradiol by 43 % , and decreased the auc of norethindrone by 8 % ;
None(e1,e2)	53	119	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	0	9	carbamazepine : felbatol causes a decrease in the steady-state carbamazepine plasma concentrations and an increase in the steady-state carbamazepine epoxide plasma concentration .
None(e1,e2)	85	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	21	33	these drugs include the thiazides and other diuretics , corticosteroids , phenothiazines , thyroid products , estrogens , oral contraceptives , phenytoin , nicotinic acid , sympathomimetics , calcium channel-blocking drugs , and isoniazid .
None(e1,e2)	6	23	in addition to bleeding associated with heparin and vitamin k antagonists , drugs that alter platelet function ( such as acetylsalicylic acid , dipyridamole and abciximab ) may increase the risk of bleeding if administered prior to , during , or after activase therapy .
None(e1,e2)	4	7	ethopropazine may interact with alcohol or other cns_depressants , causing increased sedative effects .
None(e1,e2)	3	7	the absorption of tetracycline , furosemide , penicillin_g , hydrochlorothiazide , and gemfibrozil was significantly decreased when given simultaneously with colestipol hydrochloride ;
None(e1,e2)	1	10	- lithium : lithium should generally not be given with diuretics ( such as bumetanide ) because they reduce its renal clearance and add a high risk of lithium toxicity .
None(e1,e2)	18	52	the results of a study of coadministration of ethambutol ( 50 mg/kg ) with an aluminum hydroxide containing antacid to 13 patients with tuberculosis showed a reduction of mean serum concentrations and urinary excretion of ethambutol of approximately 20 % and 13 % , respectively , suggesting that the oral absorption of ethambutol may be reduced by these antacid products .
None(e1,e2)	0	11	selective_serotonin_reuptake_inhibitors ( ssris ) ( e.g. , fluoxetine , fluvoxamine , paroxetine , sertraline ) have been reported , rarely , to cause weakness , hyperreflexia , and incoordination when coadministered with 5-htv agonists .
mechanism(e1,e2)	2	17	cimetidine : cimetidine has been reported to produce clinically significant fluctuations in steady-state serum concentrations of various tricyclic_antidepressants .
None(e1,e2)	31	43	- a nonsteroidal anti-inflammatory drug ( nsaid ) such as ibuprofen ( motrin , advil , nuprin , others ) , ketoprofen ( orudis , orudis kt , oruvail ) , diclofenac ( voltaren , cataflam ) , etodolac ( lodine ) , indomethacin ( indocin ) , nabumetone ( relafen ) , oxaprozin ( daypro ) , and naproxen ( anaprox , naprosyn , aleve ) ;
None(e1,e2)	7	10	mineral oil interferes with the absorption of fat-soluble_vitamins , including vitamin_d_preparations .
None(e1,e2)	0	5	insulin or oral hypoglycemics : agents_with_b-blocking_properties may enhance the blood-sugar-reducing effect of insulin and oral hypoglycemics .
effect(e1,e2)	2	16	haloperidol : haloperidol blocks dopamine and norepinephrine reuptake , thus inhibiting the central stimulant effects of amphetamines .
None(e1,e2)	7	9	drugs that should not be coadministered with invirase / ritonavir
effect(e1,e2)	4	20	the adverse effects of camptosar , such as myelosuppression and diarrhea , would be expected to be exacerbated by other antineoplastic_agents having similar adverse effects .
None(e1,e2)	13	15	the action of the benzodiazepines may be potentiated by anticonvulsants , antihistamines , alcohol , barbiturates , monoamine oxidase inhibitors , narcotics , phenothiazines , psychotropic medications , or other drugs that produce cns depression .
None(e1,e2)	41	84	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic_acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	0	23	h2_blockers /proton pump inhibitors : long-term suppression of gastric acid secretion by h2 blockers or proton pump inhibitors ( eg , famotidine and omeprazole ) is likely to reduce dasatinib exposure .
advise(e1,e2)	12	30	because of foscarnets tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
None(e1,e2)	10	15	- a beta-blocker such as propranolol ( inderal ) , atenolol ( tenormin ) , acebutolol ( sectral ) , metoprolol ( lopressor ) , and others ;
None(e1,e2)	88	100	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	13	15	compounds tested in man include warfarin , theophylline , phenytoin , diazepam , aminopyrine and antipyrine .
None(e1,e2)	59	129	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	55	59	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	29	31	interactions with other cns agents : concurrent use of levo-dromoran with all central nervous system depressants ( eg , alcohol , sedatives , hypnotics , other opioids , general anesthetics , barbiturates , tricyclic antidepressants , phenothiazines , tranquilizers , skeletal muscle relaxants and antihistamines ) may result in additive central nervous system depressant effects .
None(e1,e2)	33	36	high-dose cyclosporin a resulting in concentrations above 2000 ng/ml administered with oral etoposide has led to an 80 % increase in etoposide exposure with a 38 % decrease in total body clearance of etoposide compared to etoposide alone .
None(e1,e2)	0	7	praziquantel : in the fed state , praziquantel ( 40 mg/kg ) increased mean maximum plasma concentration and area under the curve of albendazole sulfoxide by about 50 % in healthy subjects ( n=10 ) compared with a separate group of subjects ( n=6 ) given albendazole alone .
None(e1,e2)	20	22	example inhibitors include azole antifungals , ciprofloxacin , clarithromycin , diclofenac , doxycycline , erythromycin , imatinib , isoniazid , nefazodone , nicardipine , propofol , protease inhibitors , quinidine , and verapamil .
None(e1,e2)	38	41	multivalent cation-containing products : concurrent administration of a quinolone , including ciprofloxacin , with multivalent cation-containing products such as magnesium or aluminum antacids , sucralfate , videx chewable/buffered tablets or pediatric powder , or products containing calcium , iron , or zinc may substantially decrease the absorption of ciprofloxacin , resulting in serum and urine levels considerably lower than desired .
None(e1,e2)	15	47	drug interactions : flupenthixol may interact with some drugs , like monoamine oxidase inhibitors ( maoi ) : maoi could theoretically affect flupenthixol pharmacodynamics - arecoline - eproxindine - ethanol : flupenthixol and ethanol cause additive cns depression - tricyclic antidepressants : flupenthixol increases the effect of tricyclic_antidepressants
None(e1,e2)	26	60	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol * ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin sodium under-dosage .
None(e1,e2)	8	26	monoamine oxidase ( mao ) inhibitors such as isocarboxazid ( e.g. , marplan ) , phenelzine ( e.g. , nardil ) , procarbazine ( e.g. , matulane ) , selegiline ( e.g. , eldepryl ) , and tranylcypromine ( e.g. , parnate ) : using these medicines with l-tryptophan may increase the chance of side effects .
None(e1,e2)	27	34	there have been reports of interactions of erythromycin with carbamazepine , cyclosporine , tacrolimus , hexobarbital , phenytoin , alfentanil , cisapride , disopyramide , lovastatin , bromocriptine , valproate , terfenadine , and astemizole .
mechanism(e1,e2)	11	13	metformin : in healthy subjects given single 500 mg doses of cephalexin and metformin , plasma metformin mean cmax and auc increased by an average of 34 % and 24 % , respectively , and metformin mean renal clearance decreased by 14 % .
None(e1,e2)	20	22	antiacid , clarithromycin , didanosine , fluconazole , fluoxetine , indanavir , ketoconazole , phenytoin , phenobarbitol , carbamazepine , rifabutin , rifampin , ritanovir , saquinavir .
None(e1,e2)	17	21	consequently , concomitant administration of aprepitant with strong cyp3a4 inhibitors ( e.g. , ketoconazole , itraconazole , nefazodone , troleandomycin , clarithromycin , ritonavir , nelfinavir ) should be approached with caution .
None(e1,e2)	12	29	this interaction , which has not been investigated using higher doses of fluvoxamine , may be more pronounced if a 300 mg daily dose is co-administered , particularly since fluvoxamine exhibits non-linear pharmacokinetics over the dosage range 100-300 mg . if alprazolam is co-administered with fluvoxamine tablets , the initial alprazolam dosage should be at least halved and titration to the lowest effective dose is recommended .
None(e1,e2)	28	80	drugs that have been reported to diminish oral anticoagulant response , ie , decreased prothrom-bin time response , in man significantly include : adrenocortical steroids ; alcohol* ; antacids ; antihistamines ; barbiturates ; carbamazepine ; chloral hydrate* ; chlordiazepoxide ; cholestyramine ; diet high in vitamin k ; diuretics* ; ethchlorvynol ; glutethimide ; griseofulvin ; haloperidol ; meprobamate ; oral contraceptives ; paraldehyde ; primidone ; ranitidine* ; rifampin ; unreliable prothrombin time determinations ; vitamin c ; warfarin_sodium under-dosage .
None(e1,e2)	39	42	drugs that have been associated with peripheral neuropathy include antiretroviral nucleoside analogues , chloramphenicol , cisplatin , dapsone , disulfiram , ethionamide , glutethimide , gold , hydralazine , iodoquinol , isoniazid , metronidazole , nitrofurantoin , phenytoin , ribavirin , and vincristine .
None(e1,e2)	11	29	however , if argatroban is to be initiated after cessation of heparin therapy , allow sufficient time for heparins effect on the aptt to decrease prior to initiation of argatroban therapy .
None(e1,e2)	70	109	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	40	43	before taking glimepiride , tell your doctor if you are taking any of the following medicines : - aspirin or another salicylate such as magnesium/choline salicylate ( trilisate ) , salsalate ( disalcid , others ) , choline salicylate ( arthropan ) , magnesium_salicylate ( magan ) , or bismuth subsalicylate ( pepto-bismol ) ;
None(e1,e2)	20	28	levothyroxine sodium absorption : the following agents may bind and decrease absorption of levothyroxine sodium from the gastrointestinal tract : aluminum_hydoxide , cholestyramine resin , colestipol hydrochloride , ferrous_sulfate , sodium polystyrene sulfonate , soybean flour ( e.g. , infant formula ) , sucralfate .
None(e1,e2)	92	137	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	12	14	other drugs : drugs such as quinidine , disopyramide , procainamide , phenothiazines , antihistamines , and tricyclic antidepressants may be associated with qt-interval prolongation and an increased risk of ventricular arrhythmia .
None(e1,e2)	24	77	- phenothiazines ( acetophenazine [ e.g. , tindal ] , chlorpromazine [ e.g. , thorazine ] , fluphenazine [ e.g. , prolixin ] , mesoridazine [ e.g. , serentil ] , perphenazine [ e.g. , trilafon ] , prochlorperazine [ e.g. , compazine ] , promazine [ e.g. , sparine ] , promethazine [ e.g. , phenergan ] , thioridazine [ e.g. , mellaril ] , trifluoperazine [ e.g. , stelazine ] , triflupromazine [ e.g. , vesprin ] , trimeprazine [ e.g. , temaril ] ) or
None(e1,e2)	7	9	pharmacokinetic interactions between nisoldipine and beta-blockers ( atenolol , propranolol ) were variable and not significant .
None(e1,e2)	1	32	discontinuing colestipol_hydrochloride could pose a hazard to health if a potentially toxic drug that is significantly bound to the resin has been titrated to a maintenance level while the patient was taking colestipol_hydrochloride .
None(e1,e2)	25	29	therefore , cyp3a4 substrates known to have a narrow therapeutic index such as alfentanil , astemizole , terfenadine , cisapride , cyclosporine , fentanyl , pimozide , quinidine , sirolimus , tacrolimus , or ergot alkaloids ( ergotamine , dihydroergotamine ) should be administered with caution in patients receiving sprycel .
mechanism(e1,e2)	9	19	- drugs that may either increase or decrease plasma phenytoin concentrations include : phenobarbital , vaiproic acid , and sodium_valproate .
None(e1,e2)	11	19	interaction of gabitril with other drugs : cimetidine : co-administration of cimetidine ( 800 mg/day ) to patients taking tiagabine chronically had no effect on tiagabine pharmacokinetics .
None(e1,e2)	4	10	digoxin , methotrexate , cyclosporine : diclofenac , like other nsaids , may affect renal prostaglandins and increase the toxicity of certain drugs .
None(e1,e2)	44	144	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	33	39	cholestyramine resin may delay or reduce the absorption of concomitant oral medication such as phenylbutazone , warfarin , thiazide diuretics ( acidic ) or propranolol ( basic ) , as well as tetracycline penicillin_g , phenobarbital , thyroid and thyroxine preparations , estrogens and progestins , and digitalis .
None(e1,e2)	8	15	however , no deleterious interactions were seen when romazicon was administered after narcotics , inhalational anesthetics , muscle relaxants and muscle relaxant antagonists administered in conjunction with sedation or anesthesia .
None(e1,e2)	13	21	in one man , the c max of terfenadine was 8.1 ng/ml with terfenadine alone and 7.2 ng/ml with terfenadine plus dirithromycin .
None(e1,e2)	20	38	the majority of patients in ra clinical studies received one or more of the following concomitant medications with orencia : mtx , nsaids , corticosteroids , tnf blocking agents , azathioprine , chloroquine , gold , hydroxychloroquine , leflunomide , sulfasalazine , and anakinra .
mechanism(e1,e2)	1	7	although metoclopramide may increase the bioavailability of levodopa by increasing gastric emptying , metoclopramide may also adversely affect disease control by its dopamine receptor antagonistic properties .
None(e1,e2)	10	78	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	26	30	no significant drug interactions have been reported in studies of candesartan cilexetil given with other drugs such as glyburide , nifedipine , digoxin , warfarin , hydrochlorothiazide , and oral contraceptives in healthy volunteers , or given with enalapril to patients with heart failure ( nyha class ii and iii ) .
None(e1,e2)	26	44	other drugs which may enhance the neuromuscular blocking action of nondepolarizing agents such as nimbex include certain antibiotics ( e. g. , aminoglycosides , tetracyclines , bacitracin , polymyxins , lincomycin , clindamycin , colistin , and sodium colistemethate ) , magnesium salts , lithium , local anesthetics , procainamide , and quinidine .
None(e1,e2)	0	8	meperidine : amphetamines potentiate the analgesic effect of meperidine .
None(e1,e2)	3	7	loop diuretics : furosemide administered concurrently with captopril does not alter the pharmacokinetics of captopril in renally impaired hypertensive patients .
None(e1,e2)	23	40	in three separate controlled , parallel group clinical pharmacology studies , desloratadine at the clinical dose of 5 mg has been coadministered with azithromycin 500 mg followed by 250 mg once daily for 4 days ( n=18 ) or with fluoxetine 20 mg once daily for 7 days after a 23 day pretreatment period with fluoxetine ( n=18 ) or with cimetidine 600 mg every 12 hours for 14 days ( n=18 ) under steady state conditions to normal healthy male and female volunteers .
None(e1,e2)	24	31	zebeta should be used with care when myocardial depressants or inhibitors of av conduction , such as certain calcium antagonists ( particularly of the phenylalkylamine [ verapamil ] and benzothiazepine [ diltiazem ] classes ) , or antiarrhythmic agents , such as disopyramide , are used concurrently .
None(e1,e2)	21	26	tell your doctor if you are taking any of the following drugs : blood thinners ( coumadin ) other antidepressants metoprolol antihistamines carbamazepine ( tegretol ) cimetidine ( tagamet ) estrogens fluoxetine ( prozac ) intraconazole ( sporanox ) ketoconazole ( nizoral ) levodopa lithium muscle relaxants birth control pills sleeping pills thyroid medications
None(e1,e2)	68	85	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	22	40	in vitro displacement studies with highly protein-bound drugs such as furosemide , propranolol , captopril , nicardipine , pravastatin , glyburide , warfarin , phenytoin , acetylsalicylic acid , tolbutamide , and metformin showed no influence on the extent of nateglinide protein binding .
None(e1,e2)	20	35	antacids : in a clinical pharmacology study , coadministration of an antacid ( aluminum hydroxide , magnesium hydroxide , and simethicone ) with fosinopril reduced serum levels and urinary excretion of fosinoprilat as compared with fosinopril administered alone , suggesting that antacids may impair absorption of fosinopril .
None(e1,e2)	6	21	if you are also using a steroid inhaler , take bitolterol first and then wait about 15 minutes before using the steroid inhaler .
None(e1,e2)	32	38	limited clinical experience indicates that requirements for volatile inhalation anesthetics are reduced by 30 to 50 % for the first sixty ( 60 ) minutes following alfenta induction the concomitant use of erythromycin with alfenta can significantly inhibit alfenta clearance and may increase the risk of prolonged or delayed respiratory depression .
int(e1,e2)	11	29	other drugs drug interactions have been reported with concomitant administration of erythromycin and other medications , including cyclosporine , hexobarbital , carbamazepine , alfentanil , disopyramide , phenytoin , bromocriptine , valproate , astemizole , and lovastatin .
None(e1,e2)	68	76	drugs and other substances demonstrated to be cyp 3a inhibitors on the basis of clinical studies involving benzodiazepines metabolized similarly to alprazolam or on the basis of in vitro studies with alprazolam or other benzodiazepines ( caution is recommended during coadministration with alprazolam ) : available data from clinical studies of benzodiazepines other than alprazolam suggest a possible drug interaction with alprazolam for the following : diltiazem , isoniazid , macrolide antibiotics such as erythromycin and clarithromycin , and grapefruit juice .
None(e1,e2)	69	76	thyroid physiology : the following agents may alter thyroid hormone or tsh levels , generally by effects on thyroid hormone synthesis , secretion , distribution , metabolism , hormone action , or elimination , or altered tsh secretion : aminoglutethimide , p-aminosalicylic acid , amiodarone , androgens and related anabolic hormones , complex anions ( thiocyanate , perchlorate , pertechnetate ) , antithyroid drugs , b-adrenergic blocking agents , carbamazepine , chloral hydrate , diazepam , dopamine and dopamine agonists , ethionamide , glucocorticoids , heparin , hepatic enzyme inducers , insulin , iodinated cholestographic agents , iodine-containing compounds , levodopa , lovastatin , lithium , 6-mercaptopurine , metoclopramide , mitotane , nitroprusside , phenobarbital , phenytoin , resorcinol , rifampin , somatostatin analogs , sulfonamides , sulfonylureas , thiazide diuretics .
None(e1,e2)	35	117	agents that have been found , or are expected to have decreased plasma levels in the presence of equetrotm due to induction of cyp enzymes are the following : acetaminophen , alprazolam , amitriptyline , bupropion , buspirone , citalopram , clobazam , clonazepam , clozapine , cyclosporin , delavirdine , desipramine , diazepam , dicumarol , doxycycline , ethosuximide , felbamate , felodipine , glucocorticoids , haloperidol , itraconazole , lamotrigine , levothyroxine , lorazepam , methadone , midazolam , mirtazapine , nortriptyline , olanzapine , oral contraceptives ( 3 ) , oxcarbazepine , phenytoin ( 4 ) , praziquantel , protease inhibitors , quetiapine , risperidone , theophylline , topiramate , tiagabine , tramadol , triazolam , valproate , warfarin ( 5 ) , ziprasidone , and zonisamide .
None(e1,e2)	14	18	in separate single or multiple dose pharmacokinetic interaction studies with chlorthalidone , nifedipine , propanolol , hydrochlorothiazide , cimetidine , metoclopramide , propantheline , digoxin , and warfarin , the bioavailability of fosinoprilat was not altered by coadministration of fosinopril with any one of these drugs .
None(e1,e2)	3	28	therefore , if theophylline is co-administered with fluvoxamine maleate , its dose should be reduced to one third of the usual daily maintenance dose and plasma concentrations of theophylline should to monitored .
None(e1,e2)	31	57	drugs that reportedly may increase oral anticoagulant response , ie , increased prothrombin response , in man include : alcohol* ; allopurinol ; aminosalicylic acid ; amiodarone ; anabolic steroids ; antibiotics ; bromelains ; chloral hydrate* ; chlorpropamide ; chymotrypsin ; cimetidine ; cinchophen ; clofibrate ; dextran ; dextrothyroxine ; diazoxide ; dietary deficiencies ; diflunisal ; disulfiram ; drugs affecting blood elements ; ethacrynic acid ; fenoprofen ; glucagon ; hepatotoxic drugs ; ibuprofen ; indomethacin ; influenza virus vaccine ; inhalation anesthetics ; mefenamic acid ; methyldopa ; methylphenidate ; metronidazole ; miconazole ; monoamine oxidase inhibitors ; nalidixic acid ; naproxen ; oxolinic acid ; oxyphenbutazone ; pentoxifylline ; phenylbutazone ; phenyramidol ; phenytoin ; prolonged hot weather ; prolonged narcotics ; pyrazolones ; quinidine ; quinine ; ranitidine* ; salicylates ; sulfinpyrazone ; sulfonamides , long acting ; sulindac ; thyroid drugs ; tolbutamide ; triclofos sodium ; trimethoprim/sulfamethoxazole ; unreliable prothrombin time determinations ; warfarin sodium overdosage .
None(e1,e2)	4	7	anticoagulants : potentiation of warfarin -type ( cyp2c9 and cyp3a4 substrate ) anticoagulant response is almost always seen in patients receiving amiodarone and can result in serious or fatal bleeding .
int(e1,e2)	0	80	etonogestrel may interact with the following medications : acetaminophen ( tylenol ) , antibiotics such as ampicillin and tetracycline , anticonvulsants ( dilantin , phenobarbital , tegretol , trileptal , topamax , felbatol ) , antifungals ( gris-peg , nizoral , sporanox ) , atorvastatin ( lipitor ) , clofibrate ( atromid-s ) , cyclosporine ( neoral , sandimmune ) , hiv drugs classified as protease inhibitors ( agenerase , crixivan , fortovase , invirase , kaletra , norvir , viracept ) , morphine ( astramorph , kadian , ms contin ) , phenylbutazone , prednisolone ( prelone ) , rifadin ( rifampin ) , st. johns wort , temazepam , theophylline ( theo-dur ) , and vitamin c .
None(e1,e2)	4	17	lithium : increased serum lithium levels and symptoms of lithium toxicity have been reported in patients receiving ace_inhibitors during therapy with lithium .
None(e1,e2)	0	2	haloperidol : haloperidol blocks dopamine receptors , thus inhibiting the central stimulant effects of amphetamines .
advise(e1,e2)	17	25	because there is a theoretical basis that these effects may be additive , use of ergotamine-containing or ergot-type_medications ( like dihydroergotamine or methysergide ) and naratriptan within 24 hours is contraindicated .
None(e1,e2)	1	32	high-dose cyclosporin_a resulting in concentrations above 2000 ng/ml administered with oral etoposide has led to an 80 % increase in etoposide exposure with a 38 % decrease in total body clearance of etoposide compared to etoposide alone .
None(e1,e2)	0	11	trimethoprim alone or in combination with sulfamethoxazole : concomitant use of trimethoprim alone or in combination with sulfamethoxazole is contraindicated .
None(e1,e2)	2	10	nifedipine : vardenafil 20 mg , when co-administered with slow-release nifedipine 30 mg or 60 mg once daily , did not affect the relative bioavailability ( auc ) or maximum concentration ( cmax ) of nifedipine , a drug that is metabolized via cyp3a4 .
None(e1,e2)	24	26	because of foscarnets tendency to cause renal impairment , the use of foscavir should be avoided in combination with potentially nephrotoxic drugs such as aminoglycosides , amphotericin_b and intravenous pentamidine unless the potential benefits outweigh the risks to the patient .
effect(e1,e2)	0	13	digitalis toxicity may be aggravated by the initial release of norepinephrine caused by bretylium_tosylate injection .
